data_1j6t_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1j6t _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.445 HD12 ' HA ' ' A' ' 4' ' ' LEU . 14.4 tp . . . . . 0 N--CA 1.483 1.208 0 N-CA-C 110.502 -0.184 . . . . 0.070000000000000007 110.502 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 1.244 ' CZ ' ' HD2' ' A' ' 147' ' ' ARG . 40.6 p90 -136.09 141.73 44.24 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 117.476 -1.69 . . . . 0.050000000000000003 111.884 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.5 mttp -82.27 142.73 31.86 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 107.944 -1.132 . . . . 0.050000000000000003 107.944 177.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.967 ' HA ' HD22 ' A' ' 11' ' ' ASN . 13.6 tp -136.81 125.64 24.08 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 107.285 -1.376 . . . . 0.050000000000000003 107.285 179.131 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.419 ' HA2' HD22 ' A' ' 141' ' ' LEU . . . -154.02 -166.92 15.44 Favored Glycine 0 C--N 1.289 -2.081 0 N-CA-C 108.557 -1.817 . . . . 0.059999999999999998 108.557 178.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.79 -34.24 77.46 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.599 -0.942 . . . . 0.080000000000000002 111.313 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -65.44 -14.93 62.02 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.759 -1.213 . . . . 0.070000000000000007 112.332 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.967 HD22 ' HA ' ' A' ' 7' ' ' LEU . 2.7 p-10 -123.7 22.85 8.94 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 119.5 -2.0 . . . . 0.050000000000000003 111.869 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 48.8 mt -118.49 123.35 71.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 107.539 -1.282 . . . . 0.059999999999999998 107.539 176.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -126.44 106.98 9.85 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.433 -0.792 . . . . 0.070000000000000007 109.252 -177.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.534 ' HA ' ' HB3' ' A' ' 83' ' ' GLN . 42.4 mt -100.33 160.52 14.27 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-O 122.702 1.239 . . . . 0.080000000000000002 112.883 -177.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 62.34 34.66 89.97 Favored Glycine 0 N--CA 1.497 2.749 0 CA-C-N 114.457 -1.247 . . . . 0.080000000000000002 113.833 175.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.423 ' HA ' ' HE ' ' A' ' 16' ' ' ARG . 1.0 OUTLIER -83.21 169.14 16.09 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 120.238 -1.742 . . . . 0.089999999999999997 109.733 178.348 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -140.89 140.75 34.59 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 107.409 -1.33 . . . . 0.089999999999999997 107.409 178.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -154.17 131.7 11.35 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 108.442 -0.948 . . . . 0.059999999999999998 108.442 179.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -77.48 -25.62 50.58 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.141 -0.975 . . . . 0.070000000000000007 109.69 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 64.2 p -134.75 159.65 40.66 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 119.075 -1.05 . . . . 0.070000000000000007 111.466 -178.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.667 ' HE3' ' OE1' ' A' ' 50' ' ' GLU . 28.2 pttt -65.98 -32.68 74.31 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.892 -0.781 . . . . 0.089999999999999997 108.892 175.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 51.4 mp0 -60.28 -42.8 96.21 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.514 -1.366 . . . . 0.089999999999999997 110.103 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -64.1 -41.73 97.17 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.628 -1.295 . . . . 0.070000000000000007 110.012 177.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.91 -42.51 94.66 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.636 -1.29 . . . . 0.050000000000000003 109.609 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.414 HG23 HD23 ' A' ' 47' ' ' LEU . 86.9 mt -64.37 -42.29 94.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.262 -0.899 . . . . 0.070000000000000007 109.802 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.46 ' HE ' ' HB2' ' A' ' 26' ' ' ARG . 4.4 ttm180 -62.61 -37.52 86.61 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.316 -0.865 . . . . 0.10000000000000001 109.98 178.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -67.25 -49.19 65.34 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.724 -1.235 . . . . 0.070000000000000007 108.403 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.19 -47.05 79.1 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.387 -0.821 . . . . 0.059999999999999998 109.605 178.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.31 -41.34 99.74 Favored Glycine 0 N--CA 1.497 2.722 0 N-CA-C 110.525 -1.03 . . . . 0.080000000000000002 110.525 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -61.18 -37.76 84.08 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.661 -1.494 . . . . 0.089999999999999997 110.331 177.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 92.4 mm-40 -73.17 -36.05 66.53 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.069 -1.019 . . . . 0.080000000000000002 110.181 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 73.5 mt -63.95 -38.2 90.19 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.857 -1.152 . . . . 0.070000000000000007 108.282 174.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.517 HG21 HG22 ' A' ' 38' ' ' VAL . 23.7 t -69.34 -45.48 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 O-C-N 120.879 -1.138 . . . . 0.11 108.178 177.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -57.49 -39.3 76.14 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.665 -0.647 . . . . 0.10000000000000001 112.625 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -86.19 8.42 73.99 Favored Glycine 0 N--CA 1.508 3.486 0 O-C-N 120.236 -1.54 . . . . 0.080000000000000002 112.796 -178.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.63 17.83 78.37 Favored Glycine 0 N--CA 1.488 2.139 0 O-C-N 120.678 -1.483 . . . . 0.089999999999999997 111.443 178.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.532 ' C ' HG13 ' A' ' 38' ' ' VAL . 80.3 m-85 -80.93 -36.24 31.3 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.274 -1.721 . . . . 0.080000000000000002 110.111 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.532 HG13 ' C ' ' A' ' 37' ' ' TYR . 17.4 m -141.96 163.02 19.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-O 122.287 1.042 . . . . 0.10000000000000001 111.437 -177.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.443 ' OE1' ' NH1' ' A' ' 73' ' ' ARG . 83.3 mt-10 -86.63 165.1 34.54 Favored Pre-proline 0 C--N 1.3 -1.546 0 N-CA-C 107.29 -1.374 . . . . 0.14000000000000001 107.29 176.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.426 ' HD2' ' HB3' ' A' ' 39' ' ' GLU . 50.3 Cg_exo -50.53 -36.86 50.88 Favored 'Trans proline' 0 N--CA 1.51 2.443 0 C-N-CA 123.646 2.897 . . . . 0.14000000000000001 115.791 -177.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.421 ' CD ' HH21 ' A' ' 73' ' ' ARG . 41.2 mp0 -62.76 -20.59 65.11 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.508 -1.37 . . . . 0.14999999999999999 112.196 -178.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.94 ' HH ' ' H ' ' A' ' 66' ' ' GLY . 39.9 t80 -67.08 -27.79 67.65 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.616 -1.303 . . . . 0.11 112.313 -179.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 22.8 t -61.19 -49.01 86.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 120.265 -1.522 . . . . 0.10000000000000001 110.396 -179.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 51.8 tp60 -67.11 -35.04 78.91 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.093 -1.004 . . . . 0.13 109.108 179.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.2 -33.35 73.32 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.232 -0.917 . . . . 0.12 109.765 177.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.467 ' HG3' ' O ' ' A' ' 42' ' ' TYR . 94.5 mtp -70.28 -37.93 74.94 Favored 'General case' 0 N--CA 1.482 1.128 0 O-C-N 120.545 -1.347 . . . . 0.10000000000000001 107.719 177.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.505 HD21 ' OE2' ' A' ' 50' ' ' GLU . 93.9 mt -70.14 -40.2 74.93 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.237 -1.023 . . . . 0.10000000000000001 108.237 178.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -60.14 -44.31 95.04 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.36 -0.837 . . . . 0.13 109.203 177.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.557 ' NE ' ' NE2' ' A' ' 65' ' ' HIS . 27.0 tpt180 -62.45 -39.19 92.57 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.843 -1.161 . . . . 2.1200000000000001 110.653 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.667 ' OE1' ' HE3' ' A' ' 21' ' ' LYS . 0.5 OUTLIER -62.54 -39.64 94.24 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.166 -0.959 . . . . 0.10000000000000001 110.895 -178.545 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.559 ' N ' ' HG2' ' A' ' 50' ' ' GLU . 25.8 tttt -62.8 -38.38 90.47 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 116.364 -0.38 . . . . 3.2999999999999998 110.86 -178.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 25.3 tp -64.54 -43.56 93.62 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 120.193 -1.567 . . . . 1.04 108.634 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.7 m -166.11 139.11 3.34 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.044 -1.035 . . . . 1.05 109.71 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -50.34 144.91 22.52 Favored 'Trans proline' 0 C--N 1.314 -1.286 0 C-N-CA 121.175 1.25 . . . . 0.78000000000000003 113.655 178.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 47.2 p -96.54 7.94 45.32 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 114.505 -1.225 . . . . 1.03 107.92 177.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.488 ' HH ' ' H ' ' A' ' 60' ' ' SER . 34.2 t80 -62.36 137.5 58.27 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 105.955 -1.869 . . . . 0.91000000000000003 105.955 174.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 17.8 mt -117.77 11.97 13.76 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 120.856 -1.152 . . . . 1.03 110.224 -178.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 85.56 170.94 47.67 Favored Glycine 0 C--N 1.302 -1.31 0 N-CA-C 108.667 -1.773 . . . . 0.10000000000000001 108.667 -178.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.81 ' CA ' ' N ' ' A' ' 60' ' ' SER . 74.3 mm-40 57.59 35.4 25.7 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.458 -1.025 . . . . 1.8600000000000001 113.527 177.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.81 ' N ' ' CA ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER 65.28 21.48 12.02 Favored 'General case' 0 N--CA 1.514 2.771 0 O-C-N 121.039 -1.038 . . . . 0.080000000000000002 113.555 176.731 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 94.2 mt -121.38 137.48 54.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 120.645 -1.285 . . . . 1.02 111.014 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -129.31 138.85 51.82 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 106.247 -1.76 . . . . 0.059999999999999998 106.247 174.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.416 ' H ' HG23 ' A' ' 63' ' ' VAL . 16.3 m -130.32 74.93 79.87 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.163 -0.96 . . . . 0.070000000000000007 110.103 -179.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -58.08 148.94 74.72 Favored 'Trans proline' 0 N--CA 1.49 1.273 0 C-N-CA 121.809 1.672 . . . . 0.76000000000000001 112.552 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.557 ' NE2' ' NE ' ' A' ' 49' ' ' ARG . 37.2 p-80 -157.19 162.91 39.32 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.637 -0.664 . . . . 0.76000000000000001 109.611 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.94 ' H ' ' HH ' ' A' ' 42' ' ' TYR . . . -79.1 176.17 54.81 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 110.769 -0.932 . . . . 0.12 110.769 -179.064 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 82.0 p -81.07 167.93 19.19 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.612 -0.934 . . . . 1.27 109.376 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.409 ' C ' ' H ' ' A' ' 70' ' ' ALA . 4.7 m -70.52 -23.65 24.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 121.382 -0.824 . . . . 0.14000000000000001 109.751 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.501 ' N ' ' OE1' ' A' ' 69' ' ' GLU . 58.7 mp0 -75.27 9.06 2.26 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.985 -1.072 . . . . 0.14999999999999999 109.725 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.409 ' H ' ' C ' ' A' ' 68' ' ' VAL . . . -121.73 15.27 11.0 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.709 -0.619 . . . . 0.13 109.813 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 49.5 pttt -60.87 -37.95 83.9 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.016 -1.053 . . . . 0.14999999999999999 109.136 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -69.27 -4.13 16.68 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.658 -0.651 . . . . 0.14000000000000001 111.543 -177.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.443 ' NH1' ' OE1' ' A' ' 39' ' ' GLU . 15.6 mmm180 -104.96 7.95 34.32 Favored 'General case' 0 N--CA 1.506 2.33 0 O-C-N 120.444 -1.41 . . . . 0.14000000000000001 109.374 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 91.1 t -95.48 128.49 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 107.082 -1.451 . . . . 0.11 107.082 177.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 28.1 mt -96.75 -17.15 20.47 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 115.721 -0.672 . . . . 0.11 109.455 -178.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 39.6 pttt -176.6 159.67 1.9 Allowed 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.523 -0.918 . . . . 0.089999999999999997 108.523 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 18.2 m -76.29 138.14 40.34 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.355 -0.841 . . . . 1.02 111.079 -179.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -160.69 161.05 32.45 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 118.735 -1.698 . . . . 0.059999999999999998 110.863 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.477 ' O ' HG22 ' A' ' 79' ' ' VAL . 33.3 m -137.65 150.96 25.62 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 O-C-N 121.603 -0.939 . . . . 0.029999999999999999 108.842 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.9 m -127.02 113.14 31.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 106.271 -1.752 . . . . 0.040000000000000001 106.271 175.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -86.02 115.38 23.58 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.789 0.804 . . . . 0.050000000000000003 109.238 -178.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 39.5 m -119.0 122.11 41.44 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 121.86 0.838 . . . . 0.040000000000000001 110.506 -177.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.534 ' HB3' ' HA ' ' A' ' 14' ' ' LEU . 30.7 tt0 -100.71 126.47 47.25 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-O 122.108 0.956 . . . . 0.080000000000000002 111.805 -178.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -123.35 87.24 51.79 Favored Pre-proline 0 C--N 1.302 -1.471 0 N-CA-C 107.025 -1.472 . . . . 0.059999999999999998 107.025 177.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -54.06 -36.05 83.43 Favored 'Trans proline' 0 N--CA 1.501 1.925 0 C-N-CA 122.847 2.365 . . . . 0.080000000000000002 113.081 -177.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -81.73 -13.27 58.02 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.481 -0.762 . . . . 0.080000000000000002 110.323 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 90.08 152.59 27.23 Favored Glycine 0 N--CA 1.485 1.912 0 O-C-N 120.791 -1.193 . . . . 0.059999999999999998 113.024 175.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 61.5 t -136.47 120.43 24.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 106.549 -1.649 . . . . 0.050000000000000003 106.549 177.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.711 ' HA ' HD11 ' A' ' 97' ' ' ILE . 4.3 ttt180 -60.31 121.27 11.58 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.829 -1.169 . . . . 0.089999999999999997 109.131 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -119.77 -11.51 9.36 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 118.656 -1.218 . . . . 1.29 111.573 -178.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -118.54 -158.21 10.74 Favored Glycine 1 N--CA 1.516 4.009 0 O-C-N 119.588 -1.945 . . . . 0.20999999999999999 112.255 -178.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -92.54 -22.8 19.33 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 113.842 1.052 . . . . 0.26000000000000001 113.842 -176.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -96.4 154.45 17.26 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.683 -1.261 . . . . 1.6200000000000001 109.461 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -60.29 -23.89 64.51 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.747 -1.22 . . . . 2.5499999999999998 109.964 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -86.52 1.87 50.02 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.692 -1.255 . . . . 1.74 109.461 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -83.2 60.17 5.39 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 118.764 -1.175 . . . . 0.16 107.98 178.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.711 HD11 ' HA ' ' A' ' 89' ' ' ARG . 41.8 mm -101.6 135.32 38.75 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 CA-C-O 121.723 0.773 . . . . 0.080000000000000002 110.169 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -108.56 130.95 55.28 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 121.545 0.688 . . . . 0.059999999999999998 109.682 178.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.621 HH11 ' HE2' ' A' ' 133' ' ' HIS . 87.2 mtm180 -102.5 -17.07 15.93 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 106.557 -1.646 . . . . 0.089999999999999997 106.557 175.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 71.1 mt -116.87 112.16 20.68 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.12 -1.067 . . . . 0.059999999999999998 108.12 176.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 93.8 t -113.4 104.07 16.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 106.257 -1.757 . . . . 0.040000000000000001 106.257 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 72.3 mt -107.11 102.91 14.65 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.087 0 CA-C-O 122.292 1.044 . . . . 0.040000000000000001 111.035 -176.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -77.6 131.97 11.57 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.023 -1.631 . . . . 0.040000000000000001 109.023 -178.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 19.4 pt -133.45 153.5 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 O-C-N 120.264 -1.727 . . . . 1.03 112.916 -176.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -137.38 133.71 35.13 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 106.189 -1.782 . . . . 1.03 106.189 177.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -147.59 140.97 25.3 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 120.113 -1.617 . . . . 1.02 110.955 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 60.6 mtp180 -70.74 156.29 39.7 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.588 0.709 . . . . 4.3099999999999996 110.331 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 57.81 25.4 11.92 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.069 -0.715 . . . . 2.46 109.069 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.531 ' OD1' ' ND1' ' A' ' 111' ' ' HIS . 61.4 t30 53.27 37.58 25.6 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.172 -0.955 . . . . 1.6100000000000001 109.766 178.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -84.05 28.89 0.58 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.131 -0.981 . . . . 0.17999999999999999 111.093 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . 0.75 ' CA ' ' N ' ' A' ' 112' ' ' ILE . 41.6 p-80 -50.54 -38.3 44.08 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.881 -1.137 . . . . 0.20999999999999999 112.095 179.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.75 ' N ' ' CA ' ' A' ' 111' ' ' HIS . 20.9 tt -63.18 -28.96 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 119.986 -1.696 . . . . 1.03 111.005 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -69.81 -40.94 75.63 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 120.516 -1.365 . . . . 1.46 108.334 178.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 85.1 t -69.38 -43.61 80.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.428 -0.795 . . . . 0.070000000000000007 109.414 178.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 97.0 mt -62.11 -42.46 95.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.132 -0.98 . . . . 1.02 109.471 178.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 97.6 m -62.35 -42.45 99.41 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.295 -0.878 . . . . 1.03 109.899 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 11.2 t -63.66 -45.91 88.0 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.161 -0.962 . . . . 0.070000000000000007 109.572 178.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 57.3 mt -64.09 -48.26 76.87 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.07 -1.019 . . . . 0.070000000000000007 111.173 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 40.4 p -66.38 -28.01 68.31 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 120.986 -1.071 . . . . 1.02 111.589 -178.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -67.81 -35.88 79.41 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 121.007 -1.058 . . . . 1.97 108.145 177.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -80.12 -15.55 56.87 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.967 -1.083 . . . . 0.089999999999999997 109.844 177.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 80.5 mt -106.01 27.86 8.18 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.984 -1.072 . . . . 1.03 110.675 178.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -72.46 -12.73 61.22 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 120.937 -1.102 . . . . 0.48999999999999999 111.879 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -110.66 131.38 55.1 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.588 -1.32 . . . . 0.13 110.619 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -57.72 -34.55 69.6 Favored 'General case' 0 N--CA 1.503 2.181 0 C-N-CA 123.306 0.642 . . . . 0.14999999999999999 112.262 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.446 ' O ' ' HG2' ' A' ' 130' ' ' ARG . 59.7 p -65.75 -34.01 77.18 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 120.694 -1.254 . . . . 0.13 109.88 179.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 85.6 t -65.65 -43.9 93.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.638 -1.289 . . . . 0.11 109.974 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 96.1 mt -64.33 -46.06 94.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.941 -1.1 . . . . 1.02 110.228 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.616 ' HA ' ' OE1' ' A' ' 129' ' ' GLU . 8.7 mm-40 -57.08 -46.85 82.19 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.223 -0.923 . . . . 0.11 109.864 178.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.532 ' NH1' ' HG3' ' A' ' 130' ' ' ARG . 16.5 mmm-85 -63.52 -43.7 96.4 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.215 -0.928 . . . . 0.13 110.214 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 83.3 mt -66.89 -35.04 79.12 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.066 -1.022 . . . . 0.080000000000000002 111.148 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -67.33 -27.18 66.93 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.308 -0.87 . . . . 0.080000000000000002 113.285 -176.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . 0.621 ' HE2' HH11 ' A' ' 99' ' ' ARG . 97.0 m-70 -126.49 1.7 6.92 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 120.082 -1.637 . . . . 0.10000000000000001 113.322 -176.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.696 ' HG1' ' H ' ' A' ' 136' ' ' SER . 9.4 t -68.31 145.89 53.8 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.502 -1.374 . . . . 0.10000000000000001 111.271 -178.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 72.8 p -106.06 9.92 32.29 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.27 -1.381 . . . . 0.12 107.27 176.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 0.696 ' H ' ' HG1' ' A' ' 134' ' ' THR . 47.0 t -107.02 116.4 31.86 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 121.588 0.709 . . . . 0.11 112.696 -178.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 15.9 t -65.59 -41.67 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 108.501 -0.925 . . . . 0.10000000000000001 108.501 176.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -56.87 -39.99 75.35 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.233 -0.917 . . . . 0.11 110.408 178.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -63.66 -42.75 98.03 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.936 -1.103 . . . . 0.11 108.45 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 92.0 t -57.29 -51.27 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 108.508 -0.923 . . . . 0.080000000000000002 108.508 177.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.419 HD22 ' HA2' ' A' ' 8' ' ' GLY . 78.4 mt -57.7 -45.98 84.96 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.238 -0.914 . . . . 0.080000000000000002 110.294 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -58.81 -47.91 83.13 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.814 -1.179 . . . . 0.11 111.02 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 83.7 mt -67.99 -23.49 65.03 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.983 -1.073 . . . . 0.10000000000000001 112.606 -177.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.661 ' O ' ' NH1' ' A' ' 147' ' ' ARG . 91.7 mt -110.05 9.27 24.21 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.367 -1.458 . . . . 0.070000000000000007 111.391 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.694 ' HA ' HH12 ' A' ' 147' ' ' ARG . . . -76.97 -25.25 52.57 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 120.689 -1.257 . . . . 0.080000000000000002 112.305 -178.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -81.77 -8.81 86.32 Favored Glycine 0 N--CA 1.504 3.211 0 O-C-N 120.57 -1.331 . . . . 0.080000000000000002 111.156 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . 1.244 ' HD2' ' CZ ' ' A' ' 5' ' ' PHE . 2.0 ptt-85 . . . . . 0 N--CA 1.486 1.371 0 O-C-N 121.053 -1.263 . . . . 0.070000000000000007 109.64 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 301' ' ' MET . . . . . 0.501 ' HB2' ' HG2' ' B' ' 366' ' ' GLU . 3.4 ttm . . . . . 0 C--O 1.214 -0.786 0 CA-C-O 121.931 0.872 . . . . 0.17000000000000001 108.948 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 302' ' ' PHE . . . . . 0.454 ' N ' ' CG ' ' B' ' 301' ' ' MET . 46.9 t80 -139.74 142.97 36.77 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 107.27 -1.381 . . . . 0.17000000000000001 107.27 178.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 303' ' ' GLN . . . . . 0.497 ' O ' ' HG2' ' B' ' 304' ' ' GLN . 5.4 pt20 -153.0 156.31 38.58 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 120.904 -1.123 . . . . 0.14000000000000001 109.495 179.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 304' ' ' GLN . . . . . 0.497 ' HG2' ' O ' ' B' ' 303' ' ' GLN . 42.2 mm-40 -152.18 149.21 28.51 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 108.033 -1.099 . . . . 0.16 108.033 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -97.19 152.35 18.91 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.046 -1.034 . . . . 0.13 108.428 178.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 7.2 p -147.83 144.34 19.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 N-CA-C 107.478 -1.304 . . . . 0.12 107.478 177.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 85.4 m -96.67 136.54 37.06 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 122.169 0.985 . . . . 0.14000000000000001 110.079 177.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 51.7 mt -84.88 114.25 24.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 105.478 -2.045 . . . . 0.13 105.478 177.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 47.4 p -106.7 -4.39 19.51 Favored 'General case' 0 C--N 1.264 -3.117 0 N-CA-C 114.704 1.372 . . . . 0.17000000000000001 114.704 -178.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 310' ' ' ALA . . . . . 0.544 ' HB1' ' C ' ' B' ' 385' ' ' GLU . . . -71.44 141.87 86.02 Favored Pre-proline 0 N--CA 1.499 2.012 0 O-C-N 119.683 -1.886 . . . . 0.16 110.658 178.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -45.54 -47.63 13.03 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 124.749 3.633 . . . . 0.20000000000000001 114.202 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -102.21 27.61 6.54 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 116.035 -2.266 . . . . 1.6299999999999999 108.725 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 58.83 -149.92 36.59 Favored Glycine 0 N--CA 1.496 2.699 0 C-N-CA 117.708 -2.187 . . . . 0.14000000000000001 109.52 -179.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 314' ' ' LEU . . . . . . . . . . . . . 19.9 tp -83.93 72.58 10.42 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.838 -1.39 . . . . 0.11 109.581 -176.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 12.1 p80 -69.41 -179.71 1.75 Allowed 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 117.846 -1.542 . . . . 1.49 112.131 -177.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 316' ' ' THR . . . . . 0.537 ' OG1' ' NH2' ' A' ' 49' ' ' ARG . 66.4 p -42.1 -66.7 0.32 Allowed 'General case' 0 N--CA 1.505 2.291 0 N-CA-C 117.209 2.299 . . . . 1.04 117.209 -175.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 317' ' ' ARG . . . . . 0.528 ' N ' ' HD2' ' B' ' 318' ' ' PRO . 5.4 ttt-85 -53.2 -53.33 57.0 Favored Pre-proline 0 N--CA 1.493 1.705 0 C-N-CA 120.21 -0.596 . . . . 2.6000000000000001 112.446 -176.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 318' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' B' ' 317' ' ' ARG . 21.0 Cg_endo -66.41 -32.17 41.12 Favored 'Trans proline' 0 N--CA 1.484 0.963 0 C-N-CA 124.707 3.604 . . . . 0.14000000000000001 111.563 -177.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -67.07 -38.8 86.43 Favored 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 119.503 -0.879 . . . . 0.11 109.491 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -70.95 -39.68 72.46 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.865 -0.791 . . . . 1.03 108.865 178.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 67.8 tp60 -64.01 -39.31 93.83 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 117.863 -1.535 . . . . 0.12 109.535 177.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 322' ' ' PHE . . . . . 0.551 ' CE1' HD22 ' B' ' 377' ' ' LEU . 87.3 t80 -62.76 -45.3 93.32 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 122.583 1.182 . . . . 0.089999999999999997 108.703 -177.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 53.4 t -62.58 -42.26 95.24 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.278 0 CA-C-N 114.809 -1.087 . . . . 0.070000000000000007 110.713 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 73.7 tttt -63.87 -40.18 95.93 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.325 -0.859 . . . . 2.1699999999999999 109.851 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 325' ' ' GLU . . . . . 0.496 ' CD ' HD21 ' B' ' 380' ' ' LEU . 31.7 tt0 -68.9 -39.65 79.59 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.37 -0.831 . . . . 0.10000000000000001 109.56 177.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -59.07 -43.99 91.82 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.708 -1.245 . . . . 0.059999999999999998 109.417 178.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -61.37 -16.13 43.21 Favored 'General case' 0 N--CA 1.509 2.512 0 O-C-N 121.226 -0.922 . . . . 1.9399999999999999 113.338 178.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -76.92 -10.65 86.07 Favored Glycine 0 N--CA 1.479 1.529 0 O-C-N 119.999 -1.688 . . . . 0.080000000000000002 109.338 179.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -103.36 143.32 32.83 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.429 -1.63 . . . . 0.10000000000000001 110.101 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 47.8 p -75.66 -30.08 59.31 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.297 -0.877 . . . . 0.12 112.272 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 331' ' ' SER . . . . . . . . . . . . . 15.9 m -59.68 158.57 9.93 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 119.844 -1.785 . . . . 0.11 112.821 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 332' ' ' GLU . . . . . 0.769 ' OE1' ' N ' ' B' ' 333' ' ' ILE . 0.0 OUTLIER -79.0 130.4 35.49 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 102.81 -3.033 . . . . 0.12 102.81 171.266 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 333' ' ' ILE . . . . . 0.769 ' N ' ' OE1' ' B' ' 332' ' ' GLU . 39.2 mt -126.81 136.5 60.61 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.486 0 CA-C-O 122.192 0.996 . . . . 0.080000000000000002 109.305 -178.246 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 334' ' ' THR . . . . . 0.417 HG23 ' N ' ' B' ' 335' ' ' VAL . 93.3 m -124.94 143.21 50.99 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-O 123.216 1.484 . . . . 0.089999999999999997 109.978 178.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 335' ' ' VAL . . . . . 0.417 ' N ' HG23 ' B' ' 334' ' ' THR . 85.3 t -108.14 129.95 61.51 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.633 0 N-CA-C 105.469 -2.049 . . . . 0.059999999999999998 105.469 173.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 336' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' B' ' 340' ' ' LYS . 71.5 m -127.39 119.51 26.35 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 120.862 -1.149 . . . . 0.089999999999999997 109.046 -178.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 29.1 t -122.52 122.61 39.32 Favored 'General case' 0 N--CA 1.501 2.106 0 C-N-CA 119.992 -0.683 . . . . 0.080000000000000002 109.843 177.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 51.73 38.84 24.0 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.886 -1.134 . . . . 0.10000000000000001 112.87 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 81.81 10.86 83.59 Favored Glycine 0 N--CA 1.501 3.009 0 O-C-N 119.944 -1.722 . . . . 0.11 112.522 177.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 340' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' B' ' 336' ' ' THR . 26.5 mttp -119.85 136.3 54.54 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 105.221 -2.14 . . . . 0.11 105.221 177.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 68.3 m -124.8 158.55 33.09 Favored 'General case' 0 C--N 1.276 -2.594 0 CA-C-O 123.738 1.732 . . . . 0.10000000000000001 112.408 -176.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -151.62 151.45 31.53 Favored 'General case' 0 C--N 1.278 -2.51 0 CA-C-N 112.449 -2.159 . . . . 0.080000000000000002 108.634 177.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 343' ' ' SER . . . . . 0.648 ' HG ' ' H ' ' B' ' 345' ' ' LYS . 8.0 t -70.63 135.95 48.78 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 105.556 -2.016 . . . . 0.089999999999999997 105.556 173.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 344' ' ' ALA . . . . . . . . . . . . . . . -72.95 -6.83 47.95 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.691 -1.256 . . . . 0.059999999999999998 110.703 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 345' ' ' LYS . . . . . 0.648 ' H ' ' HG ' ' B' ' 343' ' ' SER . 83.8 mttt -97.5 13.07 31.18 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.631 -1.293 . . . . 0.080000000000000002 109.395 -177.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 9.7 t -133.18 104.25 6.4 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 122.153 0.977 . . . . 0.89000000000000001 110.062 -178.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 347' ' ' LEU . . . . . . . . . . . . . 46.4 tp -57.34 -37.77 73.05 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 115.658 -0.701 . . . . 1.02 109.998 178.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 348' ' ' PHE . . . . . 0.469 ' HB3' ' OE2' ' A' ' 59' ' ' GLU . 77.3 t80 -59.0 -51.35 70.43 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.566 -1.334 . . . . 0.16 113.021 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 37.6 tptt -70.05 -32.46 70.58 Favored 'General case' 0 C--O 1.214 -0.769 0 O-C-N 119.664 -1.898 . . . . 2.1000000000000001 109.109 -178.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 350' ' ' LEU . . . . . . . . . . . . . 32.3 mt -62.84 -33.7 75.79 Favored 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 118.958 -1.097 . . . . 1.03 109.92 -177.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 351' ' ' GLN . . . . . . . . . . . . . 69.5 tp60 -67.69 -10.49 52.89 Favored 'General case' 0 C--N 1.293 -1.852 0 O-C-N 121.599 -0.688 . . . . 0.34000000000000002 109.915 -177.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 352' ' ' THR . . . . . . . . . . . . . 41.7 p -89.72 -7.74 53.87 Favored 'General case' 0 N--CA 1.502 2.132 0 C-N-CA 118.097 -1.441 . . . . 1.03 111.026 -178.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 72.9 mt -93.34 159.34 15.3 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.244 -0.91 . . . . 1.03 110.224 -178.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -86.76 104.8 2.97 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 106.94 -2.464 . . . . 0.089999999999999997 106.94 177.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 15.5 mt -119.46 47.29 1.73 Allowed 'General case' 0 C--N 1.309 -1.186 0 O-C-N 120.625 -1.515 . . . . 1.02 107.471 -178.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 47.6 p -81.36 172.53 13.46 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 118.849 -1.141 . . . . 1.0600000000000001 109.16 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -60.74 140.97 57.36 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 119.349 -0.94 . . . . 2.0899999999999999 109.76 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 91.4 -3.17 79.04 Favored Glycine 0 N--CA 1.5 2.941 0 C-N-CA 120.052 -1.071 . . . . 0.13 111.381 177.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 54.5 m -84.4 135.81 34.13 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 120.918 -1.342 . . . . 0.11 110.66 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 89.2 t -96.47 123.8 48.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 N-CA-C 106.304 -1.739 . . . . 0.12 106.304 176.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 22.3 m -112.27 160.13 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.335 0 C-N-CA 117.354 -1.739 . . . . 0.089999999999999997 110.636 178.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 90.4 m -108.89 128.34 54.83 Favored 'General case' 0 C--O 1.214 -0.789 0 O-C-N 120.596 -1.315 . . . . 0.11 107.565 175.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 363' ' ' ILE . . . . . 0.451 ' O ' ' HA ' ' B' ' 303' ' ' GLN . 33.2 mt -107.92 121.45 60.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 105.344 -2.095 . . . . 0.10000000000000001 105.344 176.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 364' ' ' SER . . . . . 0.407 ' HB3' ' HB3' ' B' ' 303' ' ' GLN . 0.7 OUTLIER -128.57 147.3 50.7 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 107.809 -1.182 . . . . 0.11 107.809 -179.646 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -139.76 153.32 47.13 Favored 'General case' 0 C--N 1.292 -1.925 0 C-N-CA 118.454 -1.298 . . . . 0.13 109.781 -179.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 366' ' ' GLU . . . . . 0.501 ' HG2' ' HB2' ' B' ' 301' ' ' MET . 0.2 OUTLIER -141.14 110.88 6.48 Favored 'General case' 0 C--N 1.288 -2.081 0 C-N-CA 118.592 -1.243 . . . . 0.16 108.078 178.127 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . 165.22 -170.36 40.16 Favored Glycine 0 C--N 1.297 -1.59 0 C-N-CA 117.981 -2.056 . . . . 0.14000000000000001 110.327 178.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -58.27 -40.55 82.18 Favored 'General case' 0 C--N 1.277 -2.57 0 CA-C-N 114.33 -0.935 . . . . 0.16 112.306 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 369' ' ' ASP . . . . . . . . . . . . . 12.0 p30 -114.21 36.85 3.54 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 115.834 -2.346 . . . . 0.14000000000000001 108.519 -178.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 370' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -56.41 -33.56 65.91 Favored 'General case' 0 N--CA 1.521 3.107 0 N-CA-C 116.8 2.148 . . . . 0.16 116.8 -174.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 371' ' ' GLN . . . . . 0.5 ' H ' ' HG2' ' B' ' 371' ' ' GLN . 0.0 OUTLIER -76.95 -45.59 27.1 Favored 'General case' 0 N--CA 1.509 2.514 0 O-C-N 119.526 -1.984 . . . . 0.17999999999999999 110.914 -176.519 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 372' ' ' LYS . . . . . 0.779 ' HZ2' ' CE1' ' B' ' 376' ' ' HIS . 11.9 ttpp -63.56 -40.71 97.69 Favored 'General case' 0 C--N 1.283 -2.315 0 N-CA-C 106.965 -1.495 . . . . 0.14000000000000001 106.965 178.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -59.09 -49.51 77.61 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 117.541 -1.664 . . . . 0.11 110.025 -178.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 374' ' ' VAL . . . . . . . . . . . . . 66.9 t -66.86 -42.25 88.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 CA-C-O 122.187 0.994 . . . . 0.12 109.267 -178.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -55.89 -47.78 76.8 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-O 122.059 0.933 . . . . 0.16 108.737 -178.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 376' ' ' HIS . . . . . 0.779 ' CE1' ' HZ2' ' B' ' 372' ' ' LYS . 13.9 m-70 -69.96 -38.23 76.04 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 116.005 -0.543 . . . . 0.14000000000000001 111.72 -178.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 377' ' ' LEU . . . . . 0.551 HD22 ' CE1' ' B' ' 322' ' ' PHE . 80.5 mt -75.64 -28.56 58.84 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.348 -1.47 . . . . 0.089999999999999997 110.875 -174.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 378' ' ' VAL . . . . . . . . . . . . . 2.1 t -71.44 -39.52 71.3 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.459 0 N-CA-C 106.35 -1.722 . . . . 0.13 106.35 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -67.89 -49.31 62.69 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 108.03 -1.1 . . . . 0.17000000000000001 108.03 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 380' ' ' LEU . . . . . 0.9 ' HG ' HD21 ' B' ' 384' ' ' LEU . 34.1 tp -57.18 -45.24 83.87 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 118.974 -1.09 . . . . 0.12 110.62 177.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 3.6 ttm -62.29 -37.44 85.53 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.871 -1.143 . . . . 0.12 111.508 -177.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -74.89 -31.78 61.67 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.111 -0.993 . . . . 0.14999999999999999 110.29 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -78.87 -32.41 45.92 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.622 -0.673 . . . . 0.17000000000000001 111.247 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 384' ' ' LEU . . . . . 0.9 HD21 ' HG ' ' B' ' 380' ' ' LEU . 0.0 OUTLIER -50.12 125.54 12.48 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-O 124.432 2.063 . . . . 0.14999999999999999 112.762 178.802 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 385' ' ' GLU . . . . . 0.792 ' CD ' ' H ' ' B' ' 385' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.279 -2.48 0 CA-C-N 111.085 -2.779 . . . . 0.17999999999999999 110.093 -177.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.445 HD12 ' HA ' ' A' ' 4' ' ' LEU . 14.4 tp . . . . . 0 N--CA 1.483 1.208 0 N-CA-C 110.502 -0.184 . . . . 0.070000000000000007 110.502 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 1.244 ' CZ ' ' HD2' ' A' ' 147' ' ' ARG . 40.6 p90 -136.09 141.73 44.24 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 117.476 -1.69 . . . . 0.050000000000000003 111.884 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.5 mttp -82.27 142.73 31.86 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 107.944 -1.132 . . . . 0.050000000000000003 107.944 177.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.967 ' HA ' HD22 ' A' ' 11' ' ' ASN . 13.6 tp -136.81 125.64 24.08 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 107.285 -1.376 . . . . 0.050000000000000003 107.285 179.131 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.419 ' HA2' HD22 ' A' ' 141' ' ' LEU . . . -154.02 -166.92 15.44 Favored Glycine 0 C--N 1.289 -2.081 0 N-CA-C 108.557 -1.817 . . . . 0.059999999999999998 108.557 178.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.79 -34.24 77.46 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.599 -0.942 . . . . 0.080000000000000002 111.313 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -65.44 -14.93 62.02 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.759 -1.213 . . . . 0.070000000000000007 112.332 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.967 HD22 ' HA ' ' A' ' 7' ' ' LEU . 2.7 p-10 -123.7 22.85 8.94 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 119.5 -2.0 . . . . 0.050000000000000003 111.869 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 48.8 mt -118.49 123.35 71.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 107.539 -1.282 . . . . 0.059999999999999998 107.539 176.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -126.44 106.98 9.85 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.433 -0.792 . . . . 0.070000000000000007 109.252 -177.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.534 ' HA ' ' HB3' ' A' ' 83' ' ' GLN . 42.4 mt -100.33 160.52 14.27 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-O 122.702 1.239 . . . . 0.080000000000000002 112.883 -177.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 62.34 34.66 89.97 Favored Glycine 0 N--CA 1.497 2.749 0 CA-C-N 114.457 -1.247 . . . . 0.080000000000000002 113.833 175.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.423 ' HA ' ' HE ' ' A' ' 16' ' ' ARG . 1.0 OUTLIER -83.21 169.14 16.09 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 120.238 -1.742 . . . . 0.089999999999999997 109.733 178.348 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -140.89 140.75 34.59 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 107.409 -1.33 . . . . 0.089999999999999997 107.409 178.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -154.17 131.7 11.35 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 108.442 -0.948 . . . . 0.059999999999999998 108.442 179.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -77.48 -25.62 50.58 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.141 -0.975 . . . . 0.070000000000000007 109.69 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 64.2 p -134.75 159.65 40.66 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 119.075 -1.05 . . . . 0.070000000000000007 111.466 -178.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.667 ' HE3' ' OE1' ' A' ' 50' ' ' GLU . 28.2 pttt -65.98 -32.68 74.31 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.892 -0.781 . . . . 0.089999999999999997 108.892 175.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 51.4 mp0 -60.28 -42.8 96.21 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.514 -1.366 . . . . 0.089999999999999997 110.103 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -64.1 -41.73 97.17 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.628 -1.295 . . . . 0.070000000000000007 110.012 177.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.91 -42.51 94.66 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.636 -1.29 . . . . 0.050000000000000003 109.609 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.414 HG23 HD23 ' A' ' 47' ' ' LEU . 86.9 mt -64.37 -42.29 94.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.262 -0.899 . . . . 0.070000000000000007 109.802 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.46 ' HE ' ' HB2' ' A' ' 26' ' ' ARG . 4.4 ttm180 -62.61 -37.52 86.61 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.316 -0.865 . . . . 0.10000000000000001 109.98 178.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -67.25 -49.19 65.34 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.724 -1.235 . . . . 0.070000000000000007 108.403 179.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.19 -47.05 79.1 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.387 -0.821 . . . . 0.059999999999999998 109.605 178.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.31 -41.34 99.74 Favored Glycine 0 N--CA 1.497 2.722 0 N-CA-C 110.525 -1.03 . . . . 0.080000000000000002 110.525 179.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -61.18 -37.76 84.08 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.661 -1.494 . . . . 0.089999999999999997 110.331 177.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 92.4 mm-40 -73.17 -36.05 66.53 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.069 -1.019 . . . . 0.080000000000000002 110.181 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 73.5 mt -63.95 -38.2 90.19 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.857 -1.152 . . . . 0.070000000000000007 108.282 174.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.517 HG21 HG22 ' A' ' 38' ' ' VAL . 23.7 t -69.34 -45.48 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 O-C-N 120.879 -1.138 . . . . 0.11 108.178 177.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -57.49 -39.3 76.14 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.665 -0.647 . . . . 0.10000000000000001 112.625 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -86.19 8.42 73.99 Favored Glycine 0 N--CA 1.508 3.486 0 O-C-N 120.236 -1.54 . . . . 0.080000000000000002 112.796 -178.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.63 17.83 78.37 Favored Glycine 0 N--CA 1.488 2.139 0 O-C-N 120.678 -1.483 . . . . 0.089999999999999997 111.443 178.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.532 ' C ' HG13 ' A' ' 38' ' ' VAL . 80.3 m-85 -80.93 -36.24 31.3 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.274 -1.721 . . . . 0.080000000000000002 110.111 -179.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.532 HG13 ' C ' ' A' ' 37' ' ' TYR . 17.4 m -141.96 163.02 19.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-O 122.287 1.042 . . . . 0.10000000000000001 111.437 -177.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.443 ' OE1' ' NH1' ' A' ' 73' ' ' ARG . 83.3 mt-10 -86.63 165.1 34.54 Favored Pre-proline 0 C--N 1.3 -1.546 0 N-CA-C 107.29 -1.374 . . . . 0.14000000000000001 107.29 176.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.426 ' HD2' ' HB3' ' A' ' 39' ' ' GLU . 50.3 Cg_exo -50.53 -36.86 50.88 Favored 'Trans proline' 0 N--CA 1.51 2.443 0 C-N-CA 123.646 2.897 . . . . 0.14000000000000001 115.791 -177.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.421 ' CD ' HH21 ' A' ' 73' ' ' ARG . 41.2 mp0 -62.76 -20.59 65.11 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.508 -1.37 . . . . 0.14999999999999999 112.196 -178.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.887 ' HH ' ' H ' ' A' ' 66' ' ' GLY . 39.9 t80 -67.08 -27.79 67.65 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.616 -1.303 . . . . 0.11 112.313 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 22.8 t -61.19 -49.01 86.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 120.265 -1.522 . . . . 0.10000000000000001 110.396 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 51.8 tp60 -67.11 -35.04 78.91 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.093 -1.004 . . . . 0.13 109.108 179.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.2 -33.35 73.32 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.232 -0.917 . . . . 0.12 109.765 177.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.467 ' HG3' ' O ' ' A' ' 42' ' ' TYR . 94.5 mtp -70.28 -37.93 74.94 Favored 'General case' 0 N--CA 1.482 1.128 0 O-C-N 120.545 -1.347 . . . . 0.10000000000000001 107.719 177.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.505 HD21 ' OE2' ' A' ' 50' ' ' GLU . 93.9 mt -70.14 -40.2 74.93 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.237 -1.023 . . . . 0.10000000000000001 108.237 178.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -60.14 -44.31 95.04 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.36 -0.837 . . . . 0.13 109.203 177.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 24.5 tpt180 -62.45 -39.19 92.57 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.843 -1.161 . . . . 2.1200000000000001 110.653 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.667 ' OE1' ' HE3' ' A' ' 21' ' ' LYS . 0.5 OUTLIER -62.54 -39.61 94.14 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.166 -0.959 . . . . 0.10000000000000001 110.895 -178.545 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.559 ' N ' ' HG2' ' A' ' 50' ' ' GLU . 28.1 tttt -62.87 -38.22 89.98 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 116.333 -0.394 . . . . 3.2999999999999998 110.853 -178.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 28.7 tp -64.71 -43.56 93.06 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 120.181 -1.574 . . . . 1.04 108.634 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.6 m -166.11 139.11 3.34 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.044 -1.035 . . . . 1.05 109.71 179.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -50.34 144.91 22.52 Favored 'Trans proline' 0 C--N 1.314 -1.286 0 C-N-CA 121.175 1.25 . . . . 0.78000000000000003 113.655 178.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 55.3 p -96.54 7.94 45.32 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 114.505 -1.225 . . . . 1.03 107.92 177.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.5 ' HH ' ' H ' ' A' ' 60' ' ' SER . 33.0 t80 -62.36 137.5 58.27 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 105.955 -1.869 . . . . 0.91000000000000003 105.955 174.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 18.1 mt -117.77 11.97 13.76 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 120.856 -1.152 . . . . 1.03 110.224 -178.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 85.56 170.94 47.67 Favored Glycine 0 C--N 1.302 -1.31 0 N-CA-C 108.667 -1.773 . . . . 0.10000000000000001 108.667 -178.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.81 ' CA ' ' N ' ' A' ' 60' ' ' SER . 76.0 mm-40 57.59 35.4 25.7 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.458 -1.025 . . . . 1.8600000000000001 113.527 177.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.81 ' N ' ' CA ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER 65.28 21.48 12.02 Favored 'General case' 0 N--CA 1.514 2.771 0 O-C-N 121.039 -1.038 . . . . 0.080000000000000002 113.555 176.731 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 94.2 mt -121.38 137.48 54.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 120.645 -1.285 . . . . 1.02 111.014 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -129.31 138.85 51.82 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 106.247 -1.76 . . . . 0.059999999999999998 106.247 174.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.416 ' H ' HG23 ' A' ' 63' ' ' VAL . 16.3 m -130.32 73.41 81.3 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.163 -0.96 . . . . 0.070000000000000007 110.103 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -54.57 146.91 50.96 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 120.854 1.036 . . . . 0.76000000000000001 112.221 -178.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 2.4 p-80 -150.37 159.01 44.77 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.315 -0.866 . . . . 0.76000000000000001 109.447 177.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.887 ' H ' ' HH ' ' A' ' 42' ' ' TYR . . . -76.65 174.81 53.8 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 110.036 -1.226 . . . . 0.12 110.036 -177.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 82.0 p -80.46 167.93 19.57 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.104 -1.233 . . . . 1.27 109.376 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.409 ' C ' ' H ' ' A' ' 70' ' ' ALA . 5.3 m -70.52 -23.65 24.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 121.382 -0.824 . . . . 0.14000000000000001 109.751 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.501 ' N ' ' OE1' ' A' ' 69' ' ' GLU . 58.7 mp0 -75.27 9.06 2.26 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.985 -1.072 . . . . 0.14999999999999999 109.725 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.409 ' H ' ' C ' ' A' ' 68' ' ' VAL . . . -121.73 15.27 11.0 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.709 -0.619 . . . . 0.13 109.813 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 49.5 pttt -60.87 -37.95 83.9 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.016 -1.053 . . . . 0.14999999999999999 109.136 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -69.27 -4.13 16.68 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.658 -0.651 . . . . 0.14000000000000001 111.543 -177.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.443 ' NH1' ' OE1' ' A' ' 39' ' ' GLU . 15.6 mmm180 -104.96 7.95 34.32 Favored 'General case' 0 N--CA 1.506 2.33 0 O-C-N 120.444 -1.41 . . . . 0.14000000000000001 109.374 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 91.1 t -95.48 128.49 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 107.082 -1.451 . . . . 0.11 107.082 177.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 28.1 mt -96.75 -17.15 20.47 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 115.721 -0.672 . . . . 0.11 109.455 -178.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 39.6 pttt -176.6 159.67 1.9 Allowed 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.523 -0.918 . . . . 0.089999999999999997 108.523 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 18.2 m -76.29 138.14 40.34 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.355 -0.841 . . . . 1.02 111.079 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -160.69 161.05 32.45 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 118.735 -1.698 . . . . 0.059999999999999998 110.863 -179.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.477 ' O ' HG22 ' A' ' 79' ' ' VAL . 33.3 m -137.65 150.96 25.62 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 O-C-N 121.603 -0.939 . . . . 0.029999999999999999 108.842 179.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.9 m -127.02 113.14 31.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 106.271 -1.752 . . . . 0.040000000000000001 106.271 175.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -86.02 115.38 23.58 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.789 0.804 . . . . 0.050000000000000003 109.238 -178.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 39.5 m -119.0 122.11 41.44 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 121.86 0.838 . . . . 0.040000000000000001 110.506 -177.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.534 ' HB3' ' HA ' ' A' ' 14' ' ' LEU . 30.7 tt0 -100.71 126.47 47.25 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-O 122.108 0.956 . . . . 0.080000000000000002 111.805 -178.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -123.35 87.24 51.79 Favored Pre-proline 0 C--N 1.302 -1.471 0 N-CA-C 107.025 -1.472 . . . . 0.059999999999999998 107.025 177.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -54.06 -36.05 83.43 Favored 'Trans proline' 0 N--CA 1.501 1.925 0 C-N-CA 122.847 2.365 . . . . 0.080000000000000002 113.081 -177.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -81.73 -13.27 58.02 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.481 -0.762 . . . . 0.080000000000000002 110.323 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 90.08 152.59 27.23 Favored Glycine 0 N--CA 1.485 1.912 0 O-C-N 120.791 -1.193 . . . . 0.059999999999999998 113.024 175.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 61.5 t -136.47 120.43 24.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 106.549 -1.649 . . . . 0.050000000000000003 106.549 177.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.711 ' HA ' HD11 ' A' ' 97' ' ' ILE . 4.3 ttt180 -60.31 121.27 11.58 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.829 -1.169 . . . . 0.089999999999999997 109.131 -179.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -119.77 -11.51 9.36 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 118.656 -1.218 . . . . 1.29 111.573 -178.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -118.54 -158.21 10.74 Favored Glycine 1 N--CA 1.516 4.009 0 O-C-N 119.588 -1.945 . . . . 0.20999999999999999 112.255 -178.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -92.54 -22.8 19.33 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 113.842 1.052 . . . . 0.26000000000000001 113.842 -176.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -96.4 154.45 17.26 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.683 -1.261 . . . . 1.6200000000000001 109.461 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -60.29 -23.89 64.51 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.747 -1.22 . . . . 2.5499999999999998 109.964 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -86.52 1.87 50.02 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.692 -1.255 . . . . 1.74 109.461 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -83.2 60.17 5.39 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 118.764 -1.175 . . . . 0.16 107.98 178.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.711 HD11 ' HA ' ' A' ' 89' ' ' ARG . 41.8 mm -101.6 135.32 38.75 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 CA-C-O 121.723 0.773 . . . . 0.080000000000000002 110.169 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -108.56 130.95 55.28 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 121.545 0.688 . . . . 0.059999999999999998 109.682 178.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.62 HH11 ' HE2' ' A' ' 133' ' ' HIS . 87.3 mtm180 -102.5 -17.07 15.93 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 106.557 -1.646 . . . . 0.089999999999999997 106.557 175.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 71.1 mt -116.87 112.16 20.68 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.12 -1.067 . . . . 0.059999999999999998 108.12 176.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 93.8 t -113.4 104.07 16.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 106.257 -1.757 . . . . 0.040000000000000001 106.257 179.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 72.3 mt -107.11 102.91 14.65 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.087 0 CA-C-O 122.292 1.044 . . . . 0.040000000000000001 111.035 -176.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -77.6 131.97 11.57 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.023 -1.631 . . . . 0.040000000000000001 109.023 -178.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 19.4 pt -133.45 153.5 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 O-C-N 120.264 -1.727 . . . . 1.03 112.916 -176.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -137.38 133.71 35.13 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 106.189 -1.782 . . . . 1.03 106.189 177.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -147.59 140.97 25.3 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 120.113 -1.617 . . . . 1.02 110.955 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 60.6 mtp180 -70.74 156.29 39.7 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.588 0.709 . . . . 4.3099999999999996 110.331 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 57.81 25.4 11.92 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.069 -0.715 . . . . 2.46 109.069 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.525 ' OD1' ' ND1' ' A' ' 111' ' ' HIS . 62.9 t30 53.27 37.58 25.6 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.172 -0.955 . . . . 1.6100000000000001 109.766 178.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -84.05 28.89 0.58 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.131 -0.981 . . . . 0.17999999999999999 111.093 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . 0.75 ' CA ' ' N ' ' A' ' 112' ' ' ILE . 43.1 p-80 -50.54 -38.3 44.08 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.881 -1.137 . . . . 0.20999999999999999 112.095 179.067 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.75 ' N ' ' CA ' ' A' ' 111' ' ' HIS . 20.9 tt -63.18 -28.96 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 119.986 -1.696 . . . . 1.03 111.005 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -69.81 -40.94 75.63 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 120.516 -1.365 . . . . 1.46 108.334 178.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 85.1 t -69.38 -43.61 80.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.428 -0.795 . . . . 0.070000000000000007 109.414 178.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.11 -42.46 95.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.132 -0.98 . . . . 1.02 109.471 178.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 95.7 m -62.35 -42.45 99.41 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.295 -0.878 . . . . 1.03 109.899 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 11.2 t -63.66 -45.91 88.0 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.161 -0.962 . . . . 0.070000000000000007 109.572 178.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 57.3 mt -64.09 -48.26 76.87 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.07 -1.019 . . . . 0.070000000000000007 111.173 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 40.0 p -66.38 -28.01 68.31 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 120.986 -1.071 . . . . 1.02 111.589 -178.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -67.81 -35.88 79.41 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 121.007 -1.058 . . . . 1.97 108.145 177.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -80.12 -15.55 56.87 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.967 -1.083 . . . . 0.089999999999999997 109.844 177.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 80.5 mt -106.01 27.86 8.18 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.984 -1.072 . . . . 1.03 110.675 178.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -72.46 -12.73 61.22 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 120.937 -1.102 . . . . 0.48999999999999999 111.879 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -110.66 131.38 55.1 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.588 -1.32 . . . . 0.13 110.619 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -57.72 -34.55 69.6 Favored 'General case' 0 N--CA 1.503 2.181 0 C-N-CA 123.306 0.642 . . . . 0.14999999999999999 112.262 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.451 ' O ' ' HG2' ' A' ' 130' ' ' ARG . 59.7 p -65.75 -34.01 77.18 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 120.694 -1.254 . . . . 0.13 109.88 179.052 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 85.6 t -65.65 -43.9 93.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.638 -1.289 . . . . 0.11 109.974 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 95.8 mt -64.33 -46.06 94.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.941 -1.1 . . . . 1.02 110.228 -179.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.616 ' HA ' ' OE1' ' A' ' 129' ' ' GLU . 8.7 mm-40 -57.08 -46.85 82.19 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.223 -0.923 . . . . 0.11 109.864 178.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.451 ' HG2' ' O ' ' A' ' 126' ' ' SER . 42.7 mmm-85 -63.52 -43.7 96.4 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.215 -0.928 . . . . 0.13 110.214 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 83.3 mt -66.89 -35.04 79.12 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.066 -1.022 . . . . 0.080000000000000002 111.148 -179.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -67.33 -27.18 66.93 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.308 -0.87 . . . . 0.080000000000000002 113.285 -176.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . 0.62 ' HE2' HH11 ' A' ' 99' ' ' ARG . 97.0 m-70 -126.49 1.7 6.92 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 120.082 -1.637 . . . . 0.10000000000000001 113.322 -176.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.696 ' HG1' ' H ' ' A' ' 136' ' ' SER . 9.4 t -68.31 145.89 53.8 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.502 -1.374 . . . . 0.10000000000000001 111.271 -178.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 72.8 p -106.06 9.92 32.29 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.27 -1.381 . . . . 0.12 107.27 176.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 0.696 ' H ' ' HG1' ' A' ' 134' ' ' THR . 47.0 t -107.02 116.4 31.86 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 121.588 0.709 . . . . 0.11 112.696 -178.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 15.9 t -65.59 -41.67 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 108.501 -0.925 . . . . 0.10000000000000001 108.501 176.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -56.87 -39.99 75.35 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.233 -0.917 . . . . 0.11 110.408 178.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -63.66 -42.75 98.03 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.936 -1.103 . . . . 0.11 108.45 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 92.0 t -57.29 -51.27 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 108.508 -0.923 . . . . 0.080000000000000002 108.508 177.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.419 HD22 ' HA2' ' A' ' 8' ' ' GLY . 78.4 mt -57.7 -45.98 84.96 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.238 -0.914 . . . . 0.080000000000000002 110.294 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -58.81 -47.91 83.13 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.814 -1.179 . . . . 0.11 111.02 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 83.7 mt -67.99 -23.49 65.03 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.983 -1.073 . . . . 0.10000000000000001 112.606 -177.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.661 ' O ' ' NH1' ' A' ' 147' ' ' ARG . 91.7 mt -110.05 9.27 24.21 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.367 -1.458 . . . . 0.070000000000000007 111.391 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.694 ' HA ' HH12 ' A' ' 147' ' ' ARG . . . -76.97 -25.25 52.57 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 120.689 -1.257 . . . . 0.080000000000000002 112.305 -178.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -81.77 -8.81 86.32 Favored Glycine 0 N--CA 1.504 3.211 0 O-C-N 120.57 -1.331 . . . . 0.080000000000000002 111.156 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . 1.244 ' HD2' ' CZ ' ' A' ' 5' ' ' PHE . 2.0 ptt-85 . . . . . 0 N--CA 1.486 1.371 0 O-C-N 121.053 -1.263 . . . . 0.070000000000000007 109.64 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 301' ' ' MET . . . . . 0.501 ' HB2' ' HG2' ' B' ' 366' ' ' GLU . 3.4 ttm . . . . . 0 C--O 1.214 -0.786 0 CA-C-O 121.931 0.872 . . . . 0.17000000000000001 108.948 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 302' ' ' PHE . . . . . 0.454 ' N ' ' CG ' ' B' ' 301' ' ' MET . 46.9 t80 -139.74 142.97 36.77 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 107.27 -1.381 . . . . 0.17000000000000001 107.27 178.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 303' ' ' GLN . . . . . 0.497 ' O ' ' HG2' ' B' ' 304' ' ' GLN . 5.4 pt20 -153.0 156.31 38.58 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 120.904 -1.123 . . . . 0.14000000000000001 109.495 179.236 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 304' ' ' GLN . . . . . 0.497 ' HG2' ' O ' ' B' ' 303' ' ' GLN . 42.2 mm-40 -152.18 149.21 28.51 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 108.033 -1.099 . . . . 0.16 108.033 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -97.19 152.35 18.91 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.046 -1.034 . . . . 0.13 108.428 178.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 7.2 p -147.83 144.34 19.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 N-CA-C 107.478 -1.304 . . . . 0.12 107.478 177.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 85.4 m -96.67 136.54 37.06 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 122.169 0.985 . . . . 0.14000000000000001 110.079 177.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 51.7 mt -84.88 114.25 24.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 105.478 -2.045 . . . . 0.13 105.478 177.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 47.4 p -106.7 -4.39 19.51 Favored 'General case' 0 C--N 1.264 -3.117 0 N-CA-C 114.704 1.372 . . . . 0.17000000000000001 114.704 -178.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 310' ' ' ALA . . . . . 0.544 ' HB1' ' C ' ' B' ' 385' ' ' GLU . . . -71.44 141.87 86.02 Favored Pre-proline 0 N--CA 1.499 2.012 0 O-C-N 119.683 -1.886 . . . . 0.16 110.658 178.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -45.54 -47.63 13.03 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 124.749 3.633 . . . . 0.20000000000000001 114.202 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 44.5 t-20 -102.21 27.61 6.54 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 116.035 -2.266 . . . . 1.6299999999999999 108.725 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 58.83 -147.48 40.68 Favored Glycine 0 N--CA 1.496 2.699 0 C-N-CA 117.708 -2.187 . . . . 0.14000000000000001 109.52 -179.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 314' ' ' LEU . . . . . . . . . . . . . 12.3 tp -92.23 83.31 5.04 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.859 -1.163 . . . . 0.11 107.859 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 315' ' ' HIS . . . . . 0.515 ' O ' ' HB3' ' B' ' 319' ' ' ALA . 6.3 p80 -81.46 -163.55 0.64 Allowed 'General case' 0 C--O 1.197 -1.673 0 O-C-N 121.246 -0.909 . . . . 1.49 108.868 -179.016 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 316' ' ' THR . . . . . 0.608 ' HG1' ' N ' ' B' ' 317' ' ' ARG . 30.9 p -65.43 -54.85 22.6 Favored 'General case' 0 N--CA 1.524 3.226 0 N-CA-C 119.122 3.008 . . . . 1.04 119.122 -173.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 317' ' ' ARG . . . . . 0.619 ' HG2' HH11 ' B' ' 317' ' ' ARG . 4.2 ttt-85 -53.49 -53.33 57.9 Favored Pre-proline 0 N--CA 1.493 1.705 0 C-N-CA 116.88 -1.928 . . . . 2.6000000000000001 112.446 -175.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 318' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' B' ' 317' ' ' ARG . 21.0 Cg_endo -66.41 -32.17 41.12 Favored 'Trans proline' 0 N--CA 1.484 0.963 0 C-N-CA 124.707 3.604 . . . . 0.14000000000000001 111.563 -177.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 319' ' ' ALA . . . . . 0.515 ' HB3' ' O ' ' B' ' 315' ' ' HIS . . . -67.07 -38.8 86.43 Favored 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 119.503 -0.879 . . . . 0.11 109.491 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -70.95 -39.68 72.46 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.865 -0.791 . . . . 1.03 108.865 178.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 67.8 tp60 -64.01 -39.31 93.83 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 117.863 -1.535 . . . . 0.12 109.535 177.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 322' ' ' PHE . . . . . 0.551 ' CE1' HD22 ' B' ' 377' ' ' LEU . 87.3 t80 -62.76 -45.3 93.32 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 122.583 1.182 . . . . 0.089999999999999997 108.703 -177.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 53.4 t -62.58 -42.26 95.24 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.278 0 CA-C-N 114.809 -1.087 . . . . 0.070000000000000007 110.713 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -63.87 -40.18 95.93 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.325 -0.859 . . . . 2.1699999999999999 109.851 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 325' ' ' GLU . . . . . 0.496 ' CD ' HD21 ' B' ' 380' ' ' LEU . 31.7 tt0 -68.9 -39.65 79.59 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.37 -0.831 . . . . 0.10000000000000001 109.56 177.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -59.07 -43.99 91.82 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.708 -1.245 . . . . 0.059999999999999998 109.417 178.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -61.37 -16.13 43.21 Favored 'General case' 0 N--CA 1.509 2.512 0 O-C-N 121.226 -0.922 . . . . 1.9399999999999999 113.338 178.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -76.92 -10.65 86.07 Favored Glycine 0 N--CA 1.479 1.529 0 O-C-N 119.999 -1.688 . . . . 0.080000000000000002 109.338 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -103.36 143.32 32.83 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.429 -1.63 . . . . 0.10000000000000001 110.101 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 47.8 p -75.66 -30.08 59.31 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.297 -0.877 . . . . 0.12 112.272 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 331' ' ' SER . . . . . . . . . . . . . 15.9 m -59.68 158.57 9.93 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 119.844 -1.785 . . . . 0.11 112.821 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 332' ' ' GLU . . . . . 0.769 ' OE1' ' N ' ' B' ' 333' ' ' ILE . 0.0 OUTLIER -79.0 130.4 35.49 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 102.81 -3.033 . . . . 0.12 102.81 171.266 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 333' ' ' ILE . . . . . 0.769 ' N ' ' OE1' ' B' ' 332' ' ' GLU . 39.2 mt -126.81 136.5 60.61 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.486 0 CA-C-O 122.192 0.996 . . . . 0.080000000000000002 109.305 -178.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 334' ' ' THR . . . . . 0.417 HG23 ' N ' ' B' ' 335' ' ' VAL . 93.3 m -124.94 143.21 50.99 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-O 123.216 1.484 . . . . 0.089999999999999997 109.978 178.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 335' ' ' VAL . . . . . 0.417 ' N ' HG23 ' B' ' 334' ' ' THR . 85.3 t -108.14 129.95 61.51 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.633 0 N-CA-C 105.469 -2.049 . . . . 0.059999999999999998 105.469 173.127 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 336' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' B' ' 340' ' ' LYS . 71.5 m -127.39 119.51 26.35 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 120.862 -1.149 . . . . 0.089999999999999997 109.046 -178.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 29.1 t -122.52 122.61 39.32 Favored 'General case' 0 N--CA 1.501 2.106 0 C-N-CA 119.992 -0.683 . . . . 0.080000000000000002 109.843 177.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 51.73 38.84 24.0 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.886 -1.134 . . . . 0.10000000000000001 112.87 -179.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 81.81 10.86 83.59 Favored Glycine 0 N--CA 1.501 3.009 0 O-C-N 119.944 -1.722 . . . . 0.11 112.522 177.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 340' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' B' ' 336' ' ' THR . 26.5 mttp -119.85 136.3 54.54 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 105.221 -2.14 . . . . 0.11 105.221 177.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 68.3 m -124.8 158.55 33.09 Favored 'General case' 0 C--N 1.276 -2.594 0 CA-C-O 123.738 1.732 . . . . 0.10000000000000001 112.408 -176.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -151.62 151.45 31.53 Favored 'General case' 0 C--N 1.278 -2.51 0 CA-C-N 112.449 -2.159 . . . . 0.080000000000000002 108.634 177.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 343' ' ' SER . . . . . 0.648 ' HG ' ' H ' ' B' ' 345' ' ' LYS . 8.0 t -70.63 135.95 48.78 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 105.556 -2.016 . . . . 0.089999999999999997 105.556 173.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 344' ' ' ALA . . . . . . . . . . . . . . . -72.95 -6.83 47.95 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.691 -1.256 . . . . 0.059999999999999998 110.703 179.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 345' ' ' LYS . . . . . 0.648 ' H ' ' HG ' ' B' ' 343' ' ' SER . 83.8 mttt -97.5 13.07 31.18 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.631 -1.293 . . . . 0.080000000000000002 109.395 -177.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 10.8 t -133.18 104.25 6.4 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 122.153 0.977 . . . . 0.89000000000000001 110.062 -178.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 347' ' ' LEU . . . . . . . . . . . . . 43.3 tp -57.34 -37.77 73.05 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 115.658 -0.701 . . . . 1.02 109.998 178.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 348' ' ' PHE . . . . . 0.456 ' HB3' ' OE2' ' A' ' 59' ' ' GLU . 75.3 t80 -59.0 -51.35 70.43 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.566 -1.334 . . . . 0.16 113.021 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 37.5 tptt -70.05 -32.46 70.58 Favored 'General case' 0 C--O 1.214 -0.769 0 O-C-N 119.664 -1.898 . . . . 2.1000000000000001 109.109 -178.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 350' ' ' LEU . . . . . . . . . . . . . 33.7 mt -62.84 -33.7 75.79 Favored 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 118.958 -1.097 . . . . 1.03 109.92 -177.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 351' ' ' GLN . . . . . . . . . . . . . 69.1 tp60 -67.69 -10.49 52.89 Favored 'General case' 0 C--N 1.293 -1.852 0 O-C-N 121.599 -0.688 . . . . 0.34000000000000002 109.915 -177.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 352' ' ' THR . . . . . . . . . . . . . 44.6 p -89.72 -7.74 53.87 Favored 'General case' 0 N--CA 1.502 2.132 0 C-N-CA 118.097 -1.441 . . . . 1.03 111.026 -178.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 81.6 mt -93.34 159.34 15.3 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.244 -0.91 . . . . 1.03 110.224 -178.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -86.76 104.8 2.97 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 106.94 -2.464 . . . . 0.089999999999999997 106.94 177.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 15.7 mt -119.46 47.29 1.73 Allowed 'General case' 0 C--N 1.309 -1.186 0 O-C-N 120.625 -1.515 . . . . 1.02 107.471 -178.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 52.0 p -81.36 172.53 13.46 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 118.849 -1.141 . . . . 1.0600000000000001 109.16 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -60.74 140.97 57.36 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 119.349 -0.94 . . . . 2.0899999999999999 109.76 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 91.4 -3.17 79.04 Favored Glycine 0 N--CA 1.5 2.941 0 C-N-CA 120.052 -1.071 . . . . 0.13 111.381 177.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 54.5 m -84.4 135.81 34.13 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 120.918 -1.342 . . . . 0.11 110.66 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 89.2 t -96.47 123.8 48.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 N-CA-C 106.304 -1.739 . . . . 0.12 106.304 176.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 22.3 m -112.27 160.13 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.335 0 C-N-CA 117.354 -1.739 . . . . 0.089999999999999997 110.636 178.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 90.4 m -108.89 128.34 54.83 Favored 'General case' 0 C--O 1.214 -0.789 0 O-C-N 120.596 -1.315 . . . . 0.11 107.565 175.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 363' ' ' ILE . . . . . 0.451 ' O ' ' HA ' ' B' ' 303' ' ' GLN . 33.2 mt -107.92 121.45 60.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 105.344 -2.095 . . . . 0.10000000000000001 105.344 176.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 364' ' ' SER . . . . . 0.407 ' HB3' ' HB3' ' B' ' 303' ' ' GLN . 0.7 OUTLIER -128.57 147.3 50.7 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 107.809 -1.182 . . . . 0.11 107.809 -179.646 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -139.76 153.32 47.13 Favored 'General case' 0 C--N 1.292 -1.925 0 C-N-CA 118.454 -1.298 . . . . 0.13 109.781 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 366' ' ' GLU . . . . . 0.501 ' HG2' ' HB2' ' B' ' 301' ' ' MET . 0.2 OUTLIER -141.14 110.88 6.48 Favored 'General case' 0 C--N 1.288 -2.081 0 C-N-CA 118.592 -1.243 . . . . 0.16 108.078 178.127 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . 165.22 -170.36 40.16 Favored Glycine 0 C--N 1.297 -1.59 0 C-N-CA 117.981 -2.056 . . . . 0.14000000000000001 110.327 178.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -58.27 -40.55 82.18 Favored 'General case' 0 C--N 1.277 -2.57 0 CA-C-N 114.33 -0.935 . . . . 0.16 112.306 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 369' ' ' ASP . . . . . . . . . . . . . 12.0 p30 -114.21 36.85 3.54 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 115.834 -2.346 . . . . 0.14000000000000001 108.519 -178.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 370' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -56.41 -33.56 65.91 Favored 'General case' 0 N--CA 1.521 3.107 0 N-CA-C 116.8 2.148 . . . . 0.16 116.8 -174.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 371' ' ' GLN . . . . . 0.5 ' H ' ' HG2' ' B' ' 371' ' ' GLN . 0.0 OUTLIER -76.95 -45.59 27.1 Favored 'General case' 0 N--CA 1.509 2.514 0 O-C-N 119.526 -1.984 . . . . 0.17999999999999999 110.914 -176.519 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 372' ' ' LYS . . . . . 0.779 ' HZ2' ' CE1' ' B' ' 376' ' ' HIS . 11.9 ttpp -63.56 -40.71 97.69 Favored 'General case' 0 C--N 1.283 -2.315 0 N-CA-C 106.965 -1.495 . . . . 0.14000000000000001 106.965 178.265 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -59.09 -49.51 77.61 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 117.541 -1.664 . . . . 0.11 110.025 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 374' ' ' VAL . . . . . . . . . . . . . 66.9 t -66.86 -42.25 88.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 CA-C-O 122.187 0.994 . . . . 0.12 109.267 -178.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -55.89 -47.78 76.8 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-O 122.059 0.933 . . . . 0.16 108.737 -178.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 376' ' ' HIS . . . . . 0.779 ' CE1' ' HZ2' ' B' ' 372' ' ' LYS . 13.9 m-70 -69.96 -38.23 76.04 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 116.005 -0.543 . . . . 0.14000000000000001 111.72 -178.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 377' ' ' LEU . . . . . 0.551 HD22 ' CE1' ' B' ' 322' ' ' PHE . 80.5 mt -75.64 -28.56 58.84 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.348 -1.47 . . . . 0.089999999999999997 110.875 -174.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 378' ' ' VAL . . . . . . . . . . . . . 2.1 t -71.44 -39.52 71.3 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.459 0 N-CA-C 106.35 -1.722 . . . . 0.13 106.35 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -67.89 -49.31 62.69 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 108.03 -1.1 . . . . 0.17000000000000001 108.03 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 380' ' ' LEU . . . . . 0.9 ' HG ' HD21 ' B' ' 384' ' ' LEU . 34.1 tp -57.18 -45.24 83.87 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 118.974 -1.09 . . . . 0.12 110.62 177.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 3.6 ttm -62.29 -37.44 85.53 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.871 -1.143 . . . . 0.12 111.508 -177.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -74.89 -31.78 61.67 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.111 -0.993 . . . . 0.14999999999999999 110.29 -178.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -78.87 -32.41 45.92 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.622 -0.673 . . . . 0.17000000000000001 111.247 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 384' ' ' LEU . . . . . 0.9 HD21 ' HG ' ' B' ' 380' ' ' LEU . 0.0 OUTLIER -50.12 125.54 12.48 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-O 124.432 2.063 . . . . 0.14999999999999999 112.762 178.802 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 385' ' ' GLU . . . . . 0.792 ' CD ' ' H ' ' B' ' 385' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.279 -2.48 0 CA-C-N 111.085 -2.779 . . . . 0.17999999999999999 110.093 -177.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.445 HD12 ' HA ' ' A' ' 4' ' ' LEU . 14.4 tp . . . . . 0 N--CA 1.483 1.208 0 N-CA-C 110.502 -0.184 . . . . 0.070000000000000007 110.502 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 1.244 ' CZ ' ' HD2' ' A' ' 147' ' ' ARG . 40.6 p90 -136.09 141.73 44.24 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 117.476 -1.69 . . . . 0.050000000000000003 111.884 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.5 mttp -82.27 142.73 31.86 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 107.944 -1.132 . . . . 0.050000000000000003 107.944 177.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.967 ' HA ' HD22 ' A' ' 11' ' ' ASN . 13.6 tp -136.81 125.64 24.08 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 107.285 -1.376 . . . . 0.050000000000000003 107.285 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.419 ' HA2' HD22 ' A' ' 141' ' ' LEU . . . -154.02 -166.92 15.44 Favored Glycine 0 C--N 1.289 -2.081 0 N-CA-C 108.557 -1.817 . . . . 0.059999999999999998 108.557 178.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.79 -34.24 77.46 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.599 -0.942 . . . . 0.080000000000000002 111.313 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -65.44 -14.93 62.02 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.759 -1.213 . . . . 0.070000000000000007 112.332 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.967 HD22 ' HA ' ' A' ' 7' ' ' LEU . 2.7 p-10 -123.7 22.85 8.94 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 119.5 -2.0 . . . . 0.050000000000000003 111.869 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 48.8 mt -118.49 123.35 71.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 107.539 -1.282 . . . . 0.059999999999999998 107.539 176.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -126.44 106.98 9.85 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.433 -0.792 . . . . 0.070000000000000007 109.252 -177.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.534 ' HA ' ' HB3' ' A' ' 83' ' ' GLN . 42.4 mt -100.33 160.52 14.27 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-O 122.702 1.239 . . . . 0.080000000000000002 112.883 -177.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 62.34 34.66 89.97 Favored Glycine 0 N--CA 1.497 2.749 0 CA-C-N 114.457 -1.247 . . . . 0.080000000000000002 113.833 175.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.423 ' HA ' ' HE ' ' A' ' 16' ' ' ARG . 1.0 OUTLIER -83.21 169.14 16.09 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 120.238 -1.742 . . . . 0.089999999999999997 109.733 178.348 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -140.89 140.75 34.59 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 107.409 -1.33 . . . . 0.089999999999999997 107.409 178.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -154.17 131.7 11.35 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 108.442 -0.948 . . . . 0.059999999999999998 108.442 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -77.48 -25.62 50.58 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.141 -0.975 . . . . 0.070000000000000007 109.69 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 64.2 p -134.75 159.65 40.66 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 119.075 -1.05 . . . . 0.070000000000000007 111.466 -178.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.667 ' HE3' ' OE1' ' A' ' 50' ' ' GLU . 28.2 pttt -65.98 -32.68 74.31 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.892 -0.781 . . . . 0.089999999999999997 108.892 175.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 51.4 mp0 -60.28 -42.8 96.21 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.514 -1.366 . . . . 0.089999999999999997 110.103 179.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -64.1 -41.73 97.17 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.628 -1.295 . . . . 0.070000000000000007 110.012 177.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.91 -42.51 94.66 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.636 -1.29 . . . . 0.050000000000000003 109.609 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.414 HG23 HD23 ' A' ' 47' ' ' LEU . 86.9 mt -64.37 -42.29 94.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.262 -0.899 . . . . 0.070000000000000007 109.802 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.46 ' HE ' ' HB2' ' A' ' 26' ' ' ARG . 4.4 ttm180 -62.61 -37.52 86.61 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.316 -0.865 . . . . 0.10000000000000001 109.98 178.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -67.25 -49.19 65.34 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.724 -1.235 . . . . 0.070000000000000007 108.403 179.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.19 -47.05 79.1 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.387 -0.821 . . . . 0.059999999999999998 109.605 178.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.31 -41.34 99.74 Favored Glycine 0 N--CA 1.497 2.722 0 N-CA-C 110.525 -1.03 . . . . 0.080000000000000002 110.525 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -61.18 -37.76 84.08 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.661 -1.494 . . . . 0.089999999999999997 110.331 177.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 92.4 mm-40 -73.17 -36.05 66.53 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.069 -1.019 . . . . 0.080000000000000002 110.181 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 73.5 mt -63.95 -38.2 90.19 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.857 -1.152 . . . . 0.070000000000000007 108.282 174.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.517 HG21 HG22 ' A' ' 38' ' ' VAL . 23.7 t -69.34 -45.48 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 O-C-N 120.879 -1.138 . . . . 0.11 108.178 177.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -57.49 -39.3 76.14 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.665 -0.647 . . . . 0.10000000000000001 112.625 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -86.19 8.42 73.99 Favored Glycine 0 N--CA 1.508 3.486 0 O-C-N 120.236 -1.54 . . . . 0.080000000000000002 112.796 -178.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.63 17.83 78.37 Favored Glycine 0 N--CA 1.488 2.139 0 O-C-N 120.678 -1.483 . . . . 0.089999999999999997 111.443 178.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.532 ' C ' HG13 ' A' ' 38' ' ' VAL . 80.3 m-85 -80.93 -36.24 31.3 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.274 -1.721 . . . . 0.080000000000000002 110.111 -179.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.532 HG13 ' C ' ' A' ' 37' ' ' TYR . 17.4 m -141.96 163.02 19.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-O 122.287 1.042 . . . . 0.10000000000000001 111.437 -177.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.443 ' OE1' ' NH1' ' A' ' 73' ' ' ARG . 83.3 mt-10 -86.63 165.1 34.54 Favored Pre-proline 0 C--N 1.3 -1.546 0 N-CA-C 107.29 -1.374 . . . . 0.14000000000000001 107.29 176.334 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.426 ' HD2' ' HB3' ' A' ' 39' ' ' GLU . 50.3 Cg_exo -50.53 -36.86 50.88 Favored 'Trans proline' 0 N--CA 1.51 2.443 0 C-N-CA 123.646 2.897 . . . . 0.14000000000000001 115.791 -177.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.421 ' CD ' HH21 ' A' ' 73' ' ' ARG . 41.2 mp0 -62.76 -20.59 65.11 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.508 -1.37 . . . . 0.14999999999999999 112.196 -178.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.795 ' HH ' ' H ' ' A' ' 66' ' ' GLY . 39.9 t80 -67.08 -27.79 67.65 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.616 -1.303 . . . . 0.11 112.313 -179.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 22.8 t -61.19 -49.01 86.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 120.265 -1.522 . . . . 0.10000000000000001 110.396 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 51.8 tp60 -67.11 -35.04 78.91 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.093 -1.004 . . . . 0.13 109.108 179.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.2 -33.35 73.32 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.232 -0.917 . . . . 0.12 109.765 177.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.467 ' HG3' ' O ' ' A' ' 42' ' ' TYR . 94.5 mtp -70.28 -37.93 74.94 Favored 'General case' 0 N--CA 1.482 1.128 0 O-C-N 120.545 -1.347 . . . . 0.10000000000000001 107.719 177.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.505 HD21 ' OE2' ' A' ' 50' ' ' GLU . 93.9 mt -70.14 -40.2 74.93 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.237 -1.023 . . . . 0.10000000000000001 108.237 178.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -60.14 -44.31 95.04 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.36 -0.837 . . . . 0.13 109.203 177.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 15.4 tpt180 -62.45 -39.19 92.57 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.843 -1.161 . . . . 2.1200000000000001 110.653 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.667 ' OE1' ' HE3' ' A' ' 21' ' ' LYS . 0.5 OUTLIER -62.54 -39.71 94.48 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.166 -0.959 . . . . 0.10000000000000001 110.895 -178.545 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.561 ' N ' ' HG2' ' A' ' 50' ' ' GLU . 28.5 tttt -62.75 -38.16 89.47 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 116.312 -0.403 . . . . 3.2999999999999998 110.896 -178.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 29.2 tp -64.76 -43.56 92.91 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 120.186 -1.571 . . . . 1.04 108.634 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.6 m -166.11 139.11 3.34 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.044 -1.035 . . . . 1.05 109.71 179.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -50.34 144.91 22.52 Favored 'Trans proline' 0 C--N 1.314 -1.286 0 C-N-CA 121.175 1.25 . . . . 0.78000000000000003 113.655 178.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 59.6 p -96.54 7.94 45.32 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 114.505 -1.225 . . . . 1.03 107.92 177.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.5 ' HH ' ' H ' ' A' ' 60' ' ' SER . 33.2 t80 -62.36 137.5 58.27 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 105.955 -1.869 . . . . 0.91000000000000003 105.955 174.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 18.1 mt -117.77 11.97 13.76 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 120.856 -1.152 . . . . 1.03 110.224 -178.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 85.56 170.94 47.67 Favored Glycine 0 C--N 1.302 -1.31 0 N-CA-C 108.667 -1.773 . . . . 0.10000000000000001 108.667 -178.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.81 ' CA ' ' N ' ' A' ' 60' ' ' SER . 76.6 mm-40 57.59 35.4 25.7 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.458 -1.025 . . . . 1.8600000000000001 113.527 177.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.81 ' N ' ' CA ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER 65.28 21.48 12.02 Favored 'General case' 0 N--CA 1.514 2.771 0 O-C-N 121.039 -1.038 . . . . 0.080000000000000002 113.555 176.731 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 94.2 mt -121.38 137.48 54.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 120.645 -1.285 . . . . 1.02 111.014 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -129.31 138.85 51.82 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 106.247 -1.76 . . . . 0.059999999999999998 106.247 174.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.416 ' H ' HG23 ' A' ' 63' ' ' VAL . 16.3 m -130.32 72.28 81.96 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.163 -0.96 . . . . 0.070000000000000007 110.103 -179.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -50.24 144.29 23.65 Favored 'Trans proline' 0 C--N 1.298 -2.12 0 CA-C-N 119.874 0.991 . . . . 0.76000000000000001 111.794 -177.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 2.4 p-80 -141.58 153.9 45.1 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 120.821 -1.174 . . . . 0.76000000000000001 108.735 175.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.795 ' H ' ' HH ' ' A' ' 42' ' ' TYR . . . -75.51 173.96 52.77 Favored Glycine 0 N--CA 1.501 2.999 0 N-CA-C 109.522 -1.431 . . . . 0.12 109.522 -177.251 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 82.0 p -80.18 167.93 19.73 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 116.818 -1.953 . . . . 1.27 109.376 179.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.409 ' C ' ' H ' ' A' ' 70' ' ' ALA . 5.3 m -70.52 -23.65 24.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 121.382 -0.824 . . . . 0.14000000000000001 109.751 -179.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.501 ' N ' ' OE1' ' A' ' 69' ' ' GLU . 58.7 mp0 -75.27 9.06 2.26 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.985 -1.072 . . . . 0.14999999999999999 109.725 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.409 ' H ' ' C ' ' A' ' 68' ' ' VAL . . . -121.73 15.27 11.0 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.709 -0.619 . . . . 0.13 109.813 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 49.5 pttt -60.87 -37.95 83.9 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.016 -1.053 . . . . 0.14999999999999999 109.136 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -69.27 -4.13 16.68 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.658 -0.651 . . . . 0.14000000000000001 111.543 -177.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.443 ' NH1' ' OE1' ' A' ' 39' ' ' GLU . 15.6 mmm180 -104.96 7.95 34.32 Favored 'General case' 0 N--CA 1.506 2.33 0 O-C-N 120.444 -1.41 . . . . 0.14000000000000001 109.374 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 91.1 t -95.48 128.49 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 107.082 -1.451 . . . . 0.11 107.082 177.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 28.1 mt -96.75 -17.15 20.47 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 115.721 -0.672 . . . . 0.11 109.455 -178.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 39.6 pttt -176.6 159.67 1.9 Allowed 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.523 -0.918 . . . . 0.089999999999999997 108.523 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 18.2 m -76.29 138.14 40.34 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.355 -0.841 . . . . 1.02 111.079 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -160.69 161.05 32.45 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 118.735 -1.698 . . . . 0.059999999999999998 110.863 -179.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.477 ' O ' HG22 ' A' ' 79' ' ' VAL . 33.3 m -137.65 150.96 25.62 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 O-C-N 121.603 -0.939 . . . . 0.029999999999999999 108.842 179.314 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.9 m -127.02 113.14 31.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 106.271 -1.752 . . . . 0.040000000000000001 106.271 175.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -86.02 115.38 23.58 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.789 0.804 . . . . 0.050000000000000003 109.238 -178.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 39.5 m -119.0 122.11 41.44 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 121.86 0.838 . . . . 0.040000000000000001 110.506 -177.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.534 ' HB3' ' HA ' ' A' ' 14' ' ' LEU . 30.7 tt0 -100.71 126.47 47.25 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-O 122.108 0.956 . . . . 0.080000000000000002 111.805 -178.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -123.35 87.24 51.79 Favored Pre-proline 0 C--N 1.302 -1.471 0 N-CA-C 107.025 -1.472 . . . . 0.059999999999999998 107.025 177.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -54.06 -36.05 83.43 Favored 'Trans proline' 0 N--CA 1.501 1.925 0 C-N-CA 122.847 2.365 . . . . 0.080000000000000002 113.081 -177.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -81.73 -13.27 58.02 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.481 -0.762 . . . . 0.080000000000000002 110.323 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 90.08 152.59 27.23 Favored Glycine 0 N--CA 1.485 1.912 0 O-C-N 120.791 -1.193 . . . . 0.059999999999999998 113.024 175.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 61.5 t -136.47 120.43 24.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 106.549 -1.649 . . . . 0.050000000000000003 106.549 177.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.711 ' HA ' HD11 ' A' ' 97' ' ' ILE . 4.3 ttt180 -60.31 121.27 11.58 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.829 -1.169 . . . . 0.089999999999999997 109.131 -179.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -119.77 -11.51 9.36 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 118.656 -1.218 . . . . 1.29 111.573 -178.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -118.54 -158.21 10.74 Favored Glycine 1 N--CA 1.516 4.009 0 O-C-N 119.588 -1.945 . . . . 0.20999999999999999 112.255 -178.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -92.54 -22.8 19.33 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 113.842 1.052 . . . . 0.26000000000000001 113.842 -176.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -96.4 154.45 17.26 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.683 -1.261 . . . . 1.6200000000000001 109.461 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -60.29 -23.89 64.51 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.747 -1.22 . . . . 2.5499999999999998 109.964 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -86.52 1.87 50.02 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.692 -1.255 . . . . 1.74 109.461 -178.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -83.2 60.17 5.39 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 118.764 -1.175 . . . . 0.16 107.98 178.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.711 HD11 ' HA ' ' A' ' 89' ' ' ARG . 41.8 mm -101.6 135.32 38.75 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 CA-C-O 121.723 0.773 . . . . 0.080000000000000002 110.169 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -108.56 130.95 55.28 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 121.545 0.688 . . . . 0.059999999999999998 109.682 178.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.62 HH11 ' HE2' ' A' ' 133' ' ' HIS . 87.4 mtm180 -102.5 -17.07 15.93 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 106.557 -1.646 . . . . 0.089999999999999997 106.557 175.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 71.1 mt -116.87 112.16 20.68 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.12 -1.067 . . . . 0.059999999999999998 108.12 176.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 93.8 t -113.4 104.07 16.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 106.257 -1.757 . . . . 0.040000000000000001 106.257 179.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 72.3 mt -107.11 102.91 14.65 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.087 0 CA-C-O 122.292 1.044 . . . . 0.040000000000000001 111.035 -176.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -77.6 131.97 11.57 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.023 -1.631 . . . . 0.040000000000000001 109.023 -178.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 19.4 pt -133.45 153.5 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 O-C-N 120.264 -1.727 . . . . 1.03 112.916 -176.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -137.38 133.71 35.13 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 106.189 -1.782 . . . . 1.03 106.189 177.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -147.59 140.97 25.3 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 120.113 -1.617 . . . . 1.02 110.955 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 60.6 mtp180 -70.74 156.29 39.7 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.588 0.709 . . . . 4.3099999999999996 110.331 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 57.81 25.4 11.92 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.069 -0.715 . . . . 2.46 109.069 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.521 ' OD1' ' ND1' ' A' ' 111' ' ' HIS . 63.1 t30 53.27 37.58 25.6 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.172 -0.955 . . . . 1.6100000000000001 109.766 178.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -84.05 28.89 0.58 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.131 -0.981 . . . . 0.17999999999999999 111.093 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . 0.75 ' CA ' ' N ' ' A' ' 112' ' ' ILE . 40.0 p-80 -50.54 -38.3 44.08 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.881 -1.137 . . . . 0.20999999999999999 112.095 179.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.75 ' N ' ' CA ' ' A' ' 111' ' ' HIS . 21.0 tt -63.18 -28.96 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 119.986 -1.696 . . . . 1.03 111.005 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -69.81 -40.94 75.63 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 120.516 -1.365 . . . . 1.46 108.334 178.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 85.1 t -69.38 -43.61 80.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.428 -0.795 . . . . 0.070000000000000007 109.414 178.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.11 -42.46 95.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.132 -0.98 . . . . 1.02 109.471 178.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 94.7 m -62.35 -42.45 99.41 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.295 -0.878 . . . . 1.03 109.899 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 11.2 t -63.66 -45.91 88.0 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.161 -0.962 . . . . 0.070000000000000007 109.572 178.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 57.3 mt -64.09 -48.26 76.87 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.07 -1.019 . . . . 0.070000000000000007 111.173 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 40.0 p -66.38 -28.01 68.31 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 120.986 -1.071 . . . . 1.02 111.589 -178.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -67.81 -35.88 79.41 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 121.007 -1.058 . . . . 1.97 108.145 177.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -80.12 -15.55 56.87 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.967 -1.083 . . . . 0.089999999999999997 109.844 177.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 80.5 mt -106.01 27.86 8.18 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.984 -1.072 . . . . 1.03 110.675 178.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -72.46 -12.73 61.22 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 120.937 -1.102 . . . . 0.48999999999999999 111.879 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -110.66 131.38 55.1 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.588 -1.32 . . . . 0.13 110.619 179.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -57.72 -34.55 69.6 Favored 'General case' 0 N--CA 1.503 2.181 0 C-N-CA 123.306 0.642 . . . . 0.14999999999999999 112.262 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.461 ' O ' ' HG2' ' A' ' 130' ' ' ARG . 59.7 p -65.75 -34.01 77.18 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 120.694 -1.254 . . . . 0.13 109.88 179.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 85.6 t -65.65 -43.9 93.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.638 -1.289 . . . . 0.11 109.974 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 95.8 mt -64.33 -46.06 94.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.941 -1.1 . . . . 1.02 110.228 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.616 ' HA ' ' OE1' ' A' ' 129' ' ' GLU . 8.7 mm-40 -57.08 -46.85 82.19 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.223 -0.923 . . . . 0.11 109.864 178.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.461 ' HG2' ' O ' ' A' ' 126' ' ' SER . 43.4 mmm-85 -63.52 -43.7 96.4 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.215 -0.928 . . . . 0.13 110.214 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 83.3 mt -66.89 -35.04 79.12 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.066 -1.022 . . . . 0.080000000000000002 111.148 -179.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -67.33 -27.18 66.93 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.308 -0.87 . . . . 0.080000000000000002 113.285 -176.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . 0.62 ' HE2' HH11 ' A' ' 99' ' ' ARG . 97.0 m-70 -126.49 1.7 6.92 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 120.082 -1.637 . . . . 0.10000000000000001 113.322 -176.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.696 ' HG1' ' H ' ' A' ' 136' ' ' SER . 9.4 t -68.31 145.89 53.8 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.502 -1.374 . . . . 0.10000000000000001 111.271 -178.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 72.8 p -106.06 9.92 32.29 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.27 -1.381 . . . . 0.12 107.27 176.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 0.696 ' H ' ' HG1' ' A' ' 134' ' ' THR . 47.0 t -107.02 116.4 31.86 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 121.588 0.709 . . . . 0.11 112.696 -178.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 15.9 t -65.59 -41.67 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 108.501 -0.925 . . . . 0.10000000000000001 108.501 176.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -56.87 -39.99 75.35 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.233 -0.917 . . . . 0.11 110.408 178.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -63.66 -42.75 98.03 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.936 -1.103 . . . . 0.11 108.45 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 92.0 t -57.29 -51.27 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 108.508 -0.923 . . . . 0.080000000000000002 108.508 177.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.419 HD22 ' HA2' ' A' ' 8' ' ' GLY . 78.4 mt -57.7 -45.98 84.96 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.238 -0.914 . . . . 0.080000000000000002 110.294 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -58.81 -47.91 83.13 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.814 -1.179 . . . . 0.11 111.02 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 83.7 mt -67.99 -23.49 65.03 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.983 -1.073 . . . . 0.10000000000000001 112.606 -177.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.661 ' O ' ' NH1' ' A' ' 147' ' ' ARG . 91.7 mt -110.05 9.27 24.21 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.367 -1.458 . . . . 0.070000000000000007 111.391 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.694 ' HA ' HH12 ' A' ' 147' ' ' ARG . . . -76.97 -25.25 52.57 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 120.689 -1.257 . . . . 0.080000000000000002 112.305 -178.151 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -81.77 -8.81 86.32 Favored Glycine 0 N--CA 1.504 3.211 0 O-C-N 120.57 -1.331 . . . . 0.080000000000000002 111.156 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . 1.244 ' HD2' ' CZ ' ' A' ' 5' ' ' PHE . 2.0 ptt-85 . . . . . 0 N--CA 1.486 1.371 0 O-C-N 121.053 -1.263 . . . . 0.070000000000000007 109.64 179.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 301' ' ' MET . . . . . 0.501 ' HB2' ' HG2' ' B' ' 366' ' ' GLU . 3.4 ttm . . . . . 0 C--O 1.214 -0.786 0 CA-C-O 121.931 0.872 . . . . 0.17000000000000001 108.948 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 302' ' ' PHE . . . . . 0.454 ' N ' ' CG ' ' B' ' 301' ' ' MET . 46.9 t80 -139.74 142.97 36.77 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 107.27 -1.381 . . . . 0.17000000000000001 107.27 178.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 303' ' ' GLN . . . . . 0.497 ' O ' ' HG2' ' B' ' 304' ' ' GLN . 5.4 pt20 -153.0 156.31 38.58 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 120.904 -1.123 . . . . 0.14000000000000001 109.495 179.236 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 304' ' ' GLN . . . . . 0.497 ' HG2' ' O ' ' B' ' 303' ' ' GLN . 42.2 mm-40 -152.18 149.21 28.51 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 108.033 -1.099 . . . . 0.16 108.033 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -97.19 152.35 18.91 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.046 -1.034 . . . . 0.13 108.428 178.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 7.2 p -147.83 144.34 19.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 N-CA-C 107.478 -1.304 . . . . 0.12 107.478 177.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 85.4 m -96.67 136.54 37.06 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 122.169 0.985 . . . . 0.14000000000000001 110.079 177.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 51.7 mt -84.88 114.25 24.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 105.478 -2.045 . . . . 0.13 105.478 177.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 47.4 p -106.7 -4.39 19.51 Favored 'General case' 0 C--N 1.264 -3.117 0 N-CA-C 114.704 1.372 . . . . 0.17000000000000001 114.704 -178.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 310' ' ' ALA . . . . . 0.544 ' HB1' ' C ' ' B' ' 385' ' ' GLU . . . -71.44 141.87 86.02 Favored Pre-proline 0 N--CA 1.499 2.012 0 O-C-N 119.683 -1.886 . . . . 0.16 110.658 178.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -45.54 -47.63 13.03 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 124.749 3.633 . . . . 0.20000000000000001 114.202 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 44.5 t-20 -102.21 27.61 6.54 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 116.035 -2.266 . . . . 1.6299999999999999 108.725 179.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 58.83 -144.0 44.73 Favored Glycine 0 N--CA 1.496 2.699 0 C-N-CA 117.708 -2.187 . . . . 0.14000000000000001 109.52 -179.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 314' ' ' LEU . . . . . . . . . . . . . 9.8 tp -96.93 82.92 3.3 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.203 -1.175 . . . . 0.11 109.363 178.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 315' ' ' HIS . . . . . 0.609 ' CG ' ' N ' ' B' ' 316' ' ' THR . 0.4 OUTLIER -80.85 -159.83 0.27 Allowed 'General case' 0 N--CA 1.503 2.209 0 N-CA-C 107.277 -1.379 . . . . 1.49 107.277 179.058 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 316' ' ' THR . . . . . 0.609 ' N ' ' CG ' ' B' ' 315' ' ' HIS . 63.7 p -66.39 -53.14 39.31 Favored 'General case' 0 N--CA 1.513 2.687 0 N-CA-C 120.177 3.399 . . . . 1.04 120.177 -174.314 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 317' ' ' ARG . . . . . 0.606 ' HG2' HH11 ' B' ' 317' ' ' ARG . 4.8 ttt-85 -54.9 -53.33 62.23 Favored Pre-proline 0 N--CA 1.493 1.705 0 CA-C-N 122.593 2.451 . . . . 2.6000000000000001 112.446 -174.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 318' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' B' ' 317' ' ' ARG . 21.0 Cg_endo -66.41 -32.17 41.12 Favored 'Trans proline' 0 N--CA 1.484 0.963 0 C-N-CA 124.707 3.604 . . . . 0.14000000000000001 111.563 -177.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 319' ' ' ALA . . . . . 0.539 ' HB3' ' O ' ' B' ' 315' ' ' HIS . . . -67.07 -38.8 86.43 Favored 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 119.503 -0.879 . . . . 0.11 109.491 -179.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -70.95 -39.68 72.46 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.865 -0.791 . . . . 1.03 108.865 178.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 67.8 tp60 -64.01 -39.31 93.83 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 117.863 -1.535 . . . . 0.12 109.535 177.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 322' ' ' PHE . . . . . 0.551 ' CE1' HD22 ' B' ' 377' ' ' LEU . 87.3 t80 -62.76 -45.3 93.32 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 122.583 1.182 . . . . 0.089999999999999997 108.703 -177.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 53.4 t -62.58 -42.26 95.24 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.278 0 CA-C-N 114.809 -1.087 . . . . 0.070000000000000007 110.713 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -63.87 -40.18 95.93 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.325 -0.859 . . . . 2.1699999999999999 109.851 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 325' ' ' GLU . . . . . 0.496 ' CD ' HD21 ' B' ' 380' ' ' LEU . 31.7 tt0 -68.9 -39.65 79.59 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.37 -0.831 . . . . 0.10000000000000001 109.56 177.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -59.07 -43.99 91.82 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.708 -1.245 . . . . 0.059999999999999998 109.417 178.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -61.37 -16.13 43.21 Favored 'General case' 0 N--CA 1.509 2.512 0 O-C-N 121.226 -0.922 . . . . 1.9399999999999999 113.338 178.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -76.92 -10.65 86.07 Favored Glycine 0 N--CA 1.479 1.529 0 O-C-N 119.999 -1.688 . . . . 0.080000000000000002 109.338 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -103.36 143.32 32.83 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.429 -1.63 . . . . 0.10000000000000001 110.101 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 47.8 p -75.66 -30.08 59.31 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.297 -0.877 . . . . 0.12 112.272 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 331' ' ' SER . . . . . . . . . . . . . 15.9 m -59.68 158.57 9.93 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 119.844 -1.785 . . . . 0.11 112.821 -179.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 332' ' ' GLU . . . . . 0.769 ' OE1' ' N ' ' B' ' 333' ' ' ILE . 0.0 OUTLIER -79.0 130.4 35.49 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 102.81 -3.033 . . . . 0.12 102.81 171.266 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 333' ' ' ILE . . . . . 0.769 ' N ' ' OE1' ' B' ' 332' ' ' GLU . 39.2 mt -126.81 136.5 60.61 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.486 0 CA-C-O 122.192 0.996 . . . . 0.080000000000000002 109.305 -178.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 334' ' ' THR . . . . . 0.417 HG23 ' N ' ' B' ' 335' ' ' VAL . 93.3 m -124.94 143.21 50.99 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-O 123.216 1.484 . . . . 0.089999999999999997 109.978 178.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 335' ' ' VAL . . . . . 0.417 ' N ' HG23 ' B' ' 334' ' ' THR . 85.3 t -108.14 129.95 61.51 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.633 0 N-CA-C 105.469 -2.049 . . . . 0.059999999999999998 105.469 173.127 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 336' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' B' ' 340' ' ' LYS . 71.5 m -127.39 119.51 26.35 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 120.862 -1.149 . . . . 0.089999999999999997 109.046 -178.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 29.1 t -122.52 122.61 39.32 Favored 'General case' 0 N--CA 1.501 2.106 0 C-N-CA 119.992 -0.683 . . . . 0.080000000000000002 109.843 177.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 51.73 38.84 24.0 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.886 -1.134 . . . . 0.10000000000000001 112.87 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 81.81 10.86 83.59 Favored Glycine 0 N--CA 1.501 3.009 0 O-C-N 119.944 -1.722 . . . . 0.11 112.522 177.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 340' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' B' ' 336' ' ' THR . 26.5 mttp -119.85 136.3 54.54 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 105.221 -2.14 . . . . 0.11 105.221 177.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 68.3 m -124.8 158.55 33.09 Favored 'General case' 0 C--N 1.276 -2.594 0 CA-C-O 123.738 1.732 . . . . 0.10000000000000001 112.408 -176.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -151.62 151.45 31.53 Favored 'General case' 0 C--N 1.278 -2.51 0 CA-C-N 112.449 -2.159 . . . . 0.080000000000000002 108.634 177.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 343' ' ' SER . . . . . 0.648 ' HG ' ' H ' ' B' ' 345' ' ' LYS . 8.0 t -70.63 135.95 48.78 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 105.556 -2.016 . . . . 0.089999999999999997 105.556 173.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 344' ' ' ALA . . . . . . . . . . . . . . . -72.95 -6.83 47.95 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.691 -1.256 . . . . 0.059999999999999998 110.703 179.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 345' ' ' LYS . . . . . 0.648 ' H ' ' HG ' ' B' ' 343' ' ' SER . 83.8 mttt -97.5 13.07 31.18 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.631 -1.293 . . . . 0.080000000000000002 109.395 -177.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 11.0 t -133.18 104.25 6.4 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 122.153 0.977 . . . . 0.89000000000000001 110.062 -178.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 347' ' ' LEU . . . . . . . . . . . . . 43.1 tp -57.34 -37.77 73.05 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 115.658 -0.701 . . . . 1.02 109.998 178.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 348' ' ' PHE . . . . . 0.441 ' HB3' ' OE2' ' A' ' 59' ' ' GLU . 75.2 t80 -59.0 -51.35 70.43 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.566 -1.334 . . . . 0.16 113.021 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 37.5 tptt -70.05 -32.46 70.58 Favored 'General case' 0 C--O 1.214 -0.769 0 O-C-N 119.664 -1.898 . . . . 2.1000000000000001 109.109 -178.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 350' ' ' LEU . . . . . . . . . . . . . 33.3 mt -62.84 -33.7 75.79 Favored 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 118.958 -1.097 . . . . 1.03 109.92 -177.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 351' ' ' GLN . . . . . . . . . . . . . 69.1 tp60 -67.69 -10.49 52.89 Favored 'General case' 0 C--N 1.293 -1.852 0 O-C-N 121.599 -0.688 . . . . 0.34000000000000002 109.915 -177.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 352' ' ' THR . . . . . . . . . . . . . 45.7 p -89.72 -7.74 53.87 Favored 'General case' 0 N--CA 1.502 2.132 0 C-N-CA 118.097 -1.441 . . . . 1.03 111.026 -178.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 83.2 mt -93.34 159.34 15.3 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.244 -0.91 . . . . 1.03 110.224 -178.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -86.76 104.8 2.97 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 106.94 -2.464 . . . . 0.089999999999999997 106.94 177.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 16.3 mt -119.46 47.29 1.73 Allowed 'General case' 0 C--N 1.309 -1.186 0 O-C-N 120.625 -1.515 . . . . 1.02 107.471 -178.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 52.8 p -81.36 172.53 13.46 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 118.849 -1.141 . . . . 1.0600000000000001 109.16 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -60.74 140.97 57.36 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 119.349 -0.94 . . . . 2.0899999999999999 109.76 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 91.4 -3.17 79.04 Favored Glycine 0 N--CA 1.5 2.941 0 C-N-CA 120.052 -1.071 . . . . 0.13 111.381 177.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 54.5 m -84.4 135.81 34.13 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 120.918 -1.342 . . . . 0.11 110.66 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 89.2 t -96.47 123.8 48.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 N-CA-C 106.304 -1.739 . . . . 0.12 106.304 176.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 22.3 m -112.27 160.13 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.335 0 C-N-CA 117.354 -1.739 . . . . 0.089999999999999997 110.636 178.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 90.4 m -108.89 128.34 54.83 Favored 'General case' 0 C--O 1.214 -0.789 0 O-C-N 120.596 -1.315 . . . . 0.11 107.565 175.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 363' ' ' ILE . . . . . 0.451 ' O ' ' HA ' ' B' ' 303' ' ' GLN . 33.2 mt -107.92 121.45 60.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 105.344 -2.095 . . . . 0.10000000000000001 105.344 176.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 364' ' ' SER . . . . . 0.407 ' HB3' ' HB3' ' B' ' 303' ' ' GLN . 0.7 OUTLIER -128.57 147.3 50.7 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 107.809 -1.182 . . . . 0.11 107.809 -179.646 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -139.76 153.32 47.13 Favored 'General case' 0 C--N 1.292 -1.925 0 C-N-CA 118.454 -1.298 . . . . 0.13 109.781 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 366' ' ' GLU . . . . . 0.501 ' HG2' ' HB2' ' B' ' 301' ' ' MET . 0.2 OUTLIER -141.14 110.88 6.48 Favored 'General case' 0 C--N 1.288 -2.081 0 C-N-CA 118.592 -1.243 . . . . 0.16 108.078 178.127 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . 165.22 -170.36 40.16 Favored Glycine 0 C--N 1.297 -1.59 0 C-N-CA 117.981 -2.056 . . . . 0.14000000000000001 110.327 178.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -58.27 -40.55 82.18 Favored 'General case' 0 C--N 1.277 -2.57 0 CA-C-N 114.33 -0.935 . . . . 0.16 112.306 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 369' ' ' ASP . . . . . . . . . . . . . 12.0 p30 -114.21 36.85 3.54 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 115.834 -2.346 . . . . 0.14000000000000001 108.519 -178.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 370' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -56.41 -33.56 65.91 Favored 'General case' 0 N--CA 1.521 3.107 0 N-CA-C 116.8 2.148 . . . . 0.16 116.8 -174.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 371' ' ' GLN . . . . . 0.5 ' H ' ' HG2' ' B' ' 371' ' ' GLN . 0.0 OUTLIER -76.95 -45.59 27.1 Favored 'General case' 0 N--CA 1.509 2.514 0 O-C-N 119.526 -1.984 . . . . 0.17999999999999999 110.914 -176.519 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 372' ' ' LYS . . . . . 0.779 ' HZ2' ' CE1' ' B' ' 376' ' ' HIS . 11.9 ttpp -63.56 -40.71 97.69 Favored 'General case' 0 C--N 1.283 -2.315 0 N-CA-C 106.965 -1.495 . . . . 0.14000000000000001 106.965 178.265 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -59.09 -49.51 77.61 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 117.541 -1.664 . . . . 0.11 110.025 -178.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 374' ' ' VAL . . . . . . . . . . . . . 66.9 t -66.86 -42.25 88.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 CA-C-O 122.187 0.994 . . . . 0.12 109.267 -178.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -55.89 -47.78 76.8 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-O 122.059 0.933 . . . . 0.16 108.737 -178.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 376' ' ' HIS . . . . . 0.779 ' CE1' ' HZ2' ' B' ' 372' ' ' LYS . 13.9 m-70 -69.96 -38.23 76.04 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 116.005 -0.543 . . . . 0.14000000000000001 111.72 -178.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 377' ' ' LEU . . . . . 0.551 HD22 ' CE1' ' B' ' 322' ' ' PHE . 80.5 mt -75.64 -28.56 58.84 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.348 -1.47 . . . . 0.089999999999999997 110.875 -174.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 378' ' ' VAL . . . . . . . . . . . . . 2.1 t -71.44 -39.52 71.3 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.459 0 N-CA-C 106.35 -1.722 . . . . 0.13 106.35 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -67.89 -49.31 62.69 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 108.03 -1.1 . . . . 0.17000000000000001 108.03 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 380' ' ' LEU . . . . . 0.9 ' HG ' HD21 ' B' ' 384' ' ' LEU . 34.1 tp -57.18 -45.24 83.87 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 118.974 -1.09 . . . . 0.12 110.62 177.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 3.6 ttm -62.29 -37.44 85.53 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.871 -1.143 . . . . 0.12 111.508 -177.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -74.89 -31.78 61.67 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.111 -0.993 . . . . 0.14999999999999999 110.29 -178.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -78.87 -32.41 45.92 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.622 -0.673 . . . . 0.17000000000000001 111.247 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 384' ' ' LEU . . . . . 0.9 HD21 ' HG ' ' B' ' 380' ' ' LEU . 0.0 OUTLIER -50.12 125.54 12.48 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-O 124.432 2.063 . . . . 0.14999999999999999 112.762 178.802 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 385' ' ' GLU . . . . . 0.792 ' CD ' ' H ' ' B' ' 385' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.279 -2.48 0 CA-C-N 111.085 -2.779 . . . . 0.17999999999999999 110.093 -177.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.445 HD12 ' HA ' ' A' ' 4' ' ' LEU . 14.4 tp . . . . . 0 N--CA 1.483 1.208 0 N-CA-C 110.502 -0.184 . . . . 0.070000000000000007 110.502 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 1.244 ' CZ ' ' HD2' ' A' ' 147' ' ' ARG . 40.6 p90 -136.09 141.73 44.24 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 117.476 -1.69 . . . . 0.050000000000000003 111.884 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.5 mttp -82.27 142.73 31.86 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 107.944 -1.132 . . . . 0.050000000000000003 107.944 177.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.967 ' HA ' HD22 ' A' ' 11' ' ' ASN . 13.6 tp -136.81 125.64 24.08 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 107.285 -1.376 . . . . 0.050000000000000003 107.285 179.131 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.419 ' HA2' HD22 ' A' ' 141' ' ' LEU . . . -154.02 -166.92 15.44 Favored Glycine 0 C--N 1.289 -2.081 0 N-CA-C 108.557 -1.817 . . . . 0.059999999999999998 108.557 178.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.79 -34.24 77.46 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.599 -0.942 . . . . 0.080000000000000002 111.313 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -65.44 -14.93 62.02 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.759 -1.213 . . . . 0.070000000000000007 112.332 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.967 HD22 ' HA ' ' A' ' 7' ' ' LEU . 2.7 p-10 -123.7 22.85 8.94 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 119.5 -2.0 . . . . 0.050000000000000003 111.869 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 48.8 mt -118.49 123.35 71.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 107.539 -1.282 . . . . 0.059999999999999998 107.539 176.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -126.44 106.98 9.85 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.433 -0.792 . . . . 0.070000000000000007 109.252 -177.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.534 ' HA ' ' HB3' ' A' ' 83' ' ' GLN . 42.4 mt -100.33 160.52 14.27 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-O 122.702 1.239 . . . . 0.080000000000000002 112.883 -177.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 62.34 34.66 89.97 Favored Glycine 0 N--CA 1.497 2.749 0 CA-C-N 114.457 -1.247 . . . . 0.080000000000000002 113.833 175.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.423 ' HA ' ' HE ' ' A' ' 16' ' ' ARG . 1.0 OUTLIER -83.21 169.14 16.09 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 120.238 -1.742 . . . . 0.089999999999999997 109.733 178.348 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -140.89 140.75 34.59 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 107.409 -1.33 . . . . 0.089999999999999997 107.409 178.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -154.17 131.7 11.35 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 108.442 -0.948 . . . . 0.059999999999999998 108.442 179.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -77.48 -25.62 50.58 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.141 -0.975 . . . . 0.070000000000000007 109.69 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 64.2 p -134.75 159.65 40.66 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 119.075 -1.05 . . . . 0.070000000000000007 111.466 -178.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.667 ' HE3' ' OE1' ' A' ' 50' ' ' GLU . 28.2 pttt -65.98 -32.68 74.31 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.892 -0.781 . . . . 0.089999999999999997 108.892 175.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 51.4 mp0 -60.28 -42.8 96.21 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.514 -1.366 . . . . 0.089999999999999997 110.103 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -64.1 -41.73 97.17 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.628 -1.295 . . . . 0.070000000000000007 110.012 177.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.91 -42.51 94.66 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.636 -1.29 . . . . 0.050000000000000003 109.609 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.414 HG23 HD23 ' A' ' 47' ' ' LEU . 86.9 mt -64.37 -42.29 94.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.262 -0.899 . . . . 0.070000000000000007 109.802 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.46 ' HE ' ' HB2' ' A' ' 26' ' ' ARG . 4.4 ttm180 -62.61 -37.52 86.61 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.316 -0.865 . . . . 0.10000000000000001 109.98 178.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -67.25 -49.19 65.34 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.724 -1.235 . . . . 0.070000000000000007 108.403 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.19 -47.05 79.1 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.387 -0.821 . . . . 0.059999999999999998 109.605 178.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.31 -41.34 99.74 Favored Glycine 0 N--CA 1.497 2.722 0 N-CA-C 110.525 -1.03 . . . . 0.080000000000000002 110.525 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -61.18 -37.76 84.08 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.661 -1.494 . . . . 0.089999999999999997 110.331 177.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 92.4 mm-40 -73.17 -36.05 66.53 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.069 -1.019 . . . . 0.080000000000000002 110.181 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 73.5 mt -63.95 -38.2 90.19 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.857 -1.152 . . . . 0.070000000000000007 108.282 174.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.517 HG21 HG22 ' A' ' 38' ' ' VAL . 23.7 t -69.34 -45.48 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 O-C-N 120.879 -1.138 . . . . 0.11 108.178 177.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -57.49 -39.3 76.14 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.665 -0.647 . . . . 0.10000000000000001 112.625 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -86.19 8.42 73.99 Favored Glycine 0 N--CA 1.508 3.486 0 O-C-N 120.236 -1.54 . . . . 0.080000000000000002 112.796 -178.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.63 17.83 78.37 Favored Glycine 0 N--CA 1.488 2.139 0 O-C-N 120.678 -1.483 . . . . 0.089999999999999997 111.443 178.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.532 ' C ' HG13 ' A' ' 38' ' ' VAL . 80.3 m-85 -80.93 -36.24 31.3 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.274 -1.721 . . . . 0.080000000000000002 110.111 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.532 HG13 ' C ' ' A' ' 37' ' ' TYR . 17.4 m -141.96 163.02 19.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-O 122.287 1.042 . . . . 0.10000000000000001 111.437 -177.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.443 ' OE1' ' NH1' ' A' ' 73' ' ' ARG . 83.3 mt-10 -86.63 165.1 34.54 Favored Pre-proline 0 C--N 1.3 -1.546 0 N-CA-C 107.29 -1.374 . . . . 0.14000000000000001 107.29 176.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.426 ' HD2' ' HB3' ' A' ' 39' ' ' GLU . 50.3 Cg_exo -50.53 -36.86 50.88 Favored 'Trans proline' 0 N--CA 1.51 2.443 0 C-N-CA 123.646 2.897 . . . . 0.14000000000000001 115.791 -177.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.421 ' CD ' HH21 ' A' ' 73' ' ' ARG . 41.2 mp0 -62.76 -20.59 65.11 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.508 -1.37 . . . . 0.14999999999999999 112.196 -178.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.94 ' HH ' ' H ' ' A' ' 66' ' ' GLY . 39.9 t80 -67.08 -27.79 67.65 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.616 -1.303 . . . . 0.11 112.313 -179.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 22.8 t -61.19 -49.01 86.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 120.265 -1.522 . . . . 0.10000000000000001 110.396 -179.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 51.8 tp60 -67.11 -35.04 78.91 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.093 -1.004 . . . . 0.13 109.108 179.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.2 -33.35 73.32 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.232 -0.917 . . . . 0.12 109.765 177.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.467 ' HG3' ' O ' ' A' ' 42' ' ' TYR . 94.5 mtp -70.28 -37.93 74.94 Favored 'General case' 0 N--CA 1.482 1.128 0 O-C-N 120.545 -1.347 . . . . 0.10000000000000001 107.719 177.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.505 HD21 ' OE2' ' A' ' 50' ' ' GLU . 93.9 mt -70.14 -40.2 74.93 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.237 -1.023 . . . . 0.10000000000000001 108.237 178.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -60.14 -44.31 95.04 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.36 -0.837 . . . . 0.13 109.203 177.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.557 ' NE ' ' NE2' ' A' ' 65' ' ' HIS . 27.0 tpt180 -62.45 -39.19 92.57 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.843 -1.161 . . . . 2.1200000000000001 110.653 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.667 ' OE1' ' HE3' ' A' ' 21' ' ' LYS . 0.5 OUTLIER -62.54 -39.64 94.24 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.166 -0.959 . . . . 0.10000000000000001 110.895 -178.545 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.559 ' N ' ' HG2' ' A' ' 50' ' ' GLU . 25.8 tttt -62.8 -38.38 90.47 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 116.364 -0.38 . . . . 3.2999999999999998 110.86 -178.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 25.3 tp -64.54 -43.56 93.62 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 120.193 -1.567 . . . . 1.04 108.634 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.7 m -166.11 139.11 3.34 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.044 -1.035 . . . . 1.05 109.71 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -50.34 144.91 22.52 Favored 'Trans proline' 0 C--N 1.314 -1.286 0 C-N-CA 121.175 1.25 . . . . 0.78000000000000003 113.655 178.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 47.2 p -96.54 7.94 45.32 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 114.505 -1.225 . . . . 1.03 107.92 177.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.488 ' HH ' ' H ' ' A' ' 60' ' ' SER . 34.2 t80 -62.36 137.5 58.27 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 105.955 -1.869 . . . . 0.91000000000000003 105.955 174.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 17.8 mt -117.77 11.97 13.76 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 120.856 -1.152 . . . . 1.03 110.224 -178.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 85.56 170.94 47.67 Favored Glycine 0 C--N 1.302 -1.31 0 N-CA-C 108.667 -1.773 . . . . 0.10000000000000001 108.667 -178.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.81 ' CA ' ' N ' ' A' ' 60' ' ' SER . 74.3 mm-40 57.59 35.4 25.7 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.458 -1.025 . . . . 1.8600000000000001 113.527 177.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.81 ' N ' ' CA ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER 65.28 21.48 12.02 Favored 'General case' 0 N--CA 1.514 2.771 0 O-C-N 121.039 -1.038 . . . . 0.080000000000000002 113.555 176.731 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 94.2 mt -121.38 137.48 54.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 120.645 -1.285 . . . . 1.02 111.014 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -129.31 138.85 51.82 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 106.247 -1.76 . . . . 0.059999999999999998 106.247 174.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.416 ' H ' HG23 ' A' ' 63' ' ' VAL . 16.3 m -130.32 74.93 79.87 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.163 -0.96 . . . . 0.070000000000000007 110.103 -179.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -58.08 148.94 74.72 Favored 'Trans proline' 0 N--CA 1.49 1.273 0 C-N-CA 121.809 1.672 . . . . 0.76000000000000001 112.552 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.557 ' NE2' ' NE ' ' A' ' 49' ' ' ARG . 37.2 p-80 -157.19 162.91 39.32 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.637 -0.664 . . . . 0.76000000000000001 109.611 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.94 ' H ' ' HH ' ' A' ' 42' ' ' TYR . . . -79.1 176.17 54.81 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 110.769 -0.932 . . . . 0.12 110.769 -179.064 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 82.0 p -81.07 167.93 19.19 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.612 -0.934 . . . . 1.27 109.376 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.409 ' C ' ' H ' ' A' ' 70' ' ' ALA . 4.7 m -70.52 -23.65 24.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 121.382 -0.824 . . . . 0.14000000000000001 109.751 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.501 ' N ' ' OE1' ' A' ' 69' ' ' GLU . 58.7 mp0 -75.27 9.06 2.26 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.985 -1.072 . . . . 0.14999999999999999 109.725 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.409 ' H ' ' C ' ' A' ' 68' ' ' VAL . . . -121.73 15.27 11.0 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.709 -0.619 . . . . 0.13 109.813 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 49.5 pttt -60.87 -37.95 83.9 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.016 -1.053 . . . . 0.14999999999999999 109.136 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -69.27 -4.13 16.68 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.658 -0.651 . . . . 0.14000000000000001 111.543 -177.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.443 ' NH1' ' OE1' ' A' ' 39' ' ' GLU . 15.6 mmm180 -104.96 7.95 34.32 Favored 'General case' 0 N--CA 1.506 2.33 0 O-C-N 120.444 -1.41 . . . . 0.14000000000000001 109.374 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 91.1 t -95.48 128.49 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 107.082 -1.451 . . . . 0.11 107.082 177.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 28.1 mt -96.75 -17.15 20.47 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 115.721 -0.672 . . . . 0.11 109.455 -178.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 39.6 pttt -176.6 159.67 1.9 Allowed 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.523 -0.918 . . . . 0.089999999999999997 108.523 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 18.2 m -76.29 138.14 40.34 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.355 -0.841 . . . . 1.02 111.079 -179.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -160.69 161.05 32.45 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 118.735 -1.698 . . . . 0.059999999999999998 110.863 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.477 ' O ' HG22 ' A' ' 79' ' ' VAL . 33.3 m -137.65 150.96 25.62 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 O-C-N 121.603 -0.939 . . . . 0.029999999999999999 108.842 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.9 m -127.02 113.14 31.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 106.271 -1.752 . . . . 0.040000000000000001 106.271 175.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -86.02 115.38 23.58 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.789 0.804 . . . . 0.050000000000000003 109.238 -178.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 39.5 m -119.0 122.11 41.44 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 121.86 0.838 . . . . 0.040000000000000001 110.506 -177.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.534 ' HB3' ' HA ' ' A' ' 14' ' ' LEU . 30.7 tt0 -100.71 126.47 47.25 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-O 122.108 0.956 . . . . 0.080000000000000002 111.805 -178.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -123.35 87.24 51.79 Favored Pre-proline 0 C--N 1.302 -1.471 0 N-CA-C 107.025 -1.472 . . . . 0.059999999999999998 107.025 177.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -54.06 -36.05 83.43 Favored 'Trans proline' 0 N--CA 1.501 1.925 0 C-N-CA 122.847 2.365 . . . . 0.080000000000000002 113.081 -177.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -81.73 -13.27 58.02 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.481 -0.762 . . . . 0.080000000000000002 110.323 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 90.08 152.59 27.23 Favored Glycine 0 N--CA 1.485 1.912 0 O-C-N 120.791 -1.193 . . . . 0.059999999999999998 113.024 175.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 61.5 t -136.47 120.43 24.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 106.549 -1.649 . . . . 0.050000000000000003 106.549 177.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.711 ' HA ' HD11 ' A' ' 97' ' ' ILE . 4.3 ttt180 -60.31 121.27 11.58 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.829 -1.169 . . . . 0.089999999999999997 109.131 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -119.77 -11.51 9.36 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 118.656 -1.218 . . . . 1.29 111.573 -178.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -118.54 -158.21 10.74 Favored Glycine 1 N--CA 1.516 4.009 0 O-C-N 119.588 -1.945 . . . . 0.20999999999999999 112.255 -178.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -92.54 -22.8 19.33 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 113.842 1.052 . . . . 0.26000000000000001 113.842 -176.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -96.4 154.45 17.26 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.683 -1.261 . . . . 1.6200000000000001 109.461 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -60.29 -23.89 64.51 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.747 -1.22 . . . . 2.5499999999999998 109.964 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -86.52 1.87 50.02 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.692 -1.255 . . . . 1.74 109.461 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -83.2 60.17 5.39 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 118.764 -1.175 . . . . 0.16 107.98 178.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.711 HD11 ' HA ' ' A' ' 89' ' ' ARG . 41.8 mm -101.6 135.32 38.75 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 CA-C-O 121.723 0.773 . . . . 0.080000000000000002 110.169 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -108.56 130.95 55.28 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 121.545 0.688 . . . . 0.059999999999999998 109.682 178.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.621 HH11 ' HE2' ' A' ' 133' ' ' HIS . 87.2 mtm180 -102.5 -17.07 15.93 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 106.557 -1.646 . . . . 0.089999999999999997 106.557 175.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 71.1 mt -116.87 112.16 20.68 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.12 -1.067 . . . . 0.059999999999999998 108.12 176.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 93.8 t -113.4 104.07 16.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 106.257 -1.757 . . . . 0.040000000000000001 106.257 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 72.3 mt -107.11 102.91 14.65 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.087 0 CA-C-O 122.292 1.044 . . . . 0.040000000000000001 111.035 -176.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -77.6 131.97 11.57 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.023 -1.631 . . . . 0.040000000000000001 109.023 -178.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 19.4 pt -133.45 153.5 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 O-C-N 120.264 -1.727 . . . . 1.03 112.916 -176.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -137.38 133.71 35.13 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 106.189 -1.782 . . . . 1.03 106.189 177.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -147.59 140.97 25.3 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 120.113 -1.617 . . . . 1.02 110.955 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 60.6 mtp180 -70.74 156.29 39.7 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.588 0.709 . . . . 4.3099999999999996 110.331 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 57.81 25.4 11.92 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.069 -0.715 . . . . 2.46 109.069 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.531 ' OD1' ' ND1' ' A' ' 111' ' ' HIS . 61.4 t30 53.27 37.58 25.6 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.172 -0.955 . . . . 1.6100000000000001 109.766 178.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -84.05 28.89 0.58 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.131 -0.981 . . . . 0.17999999999999999 111.093 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.75 ' CA ' ' N ' ' A' ' 112' ' ' ILE . 41.6 p-80 -50.54 -38.3 44.08 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.881 -1.137 . . . . 0.20999999999999999 112.095 179.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.75 ' N ' ' CA ' ' A' ' 111' ' ' HIS . 20.9 tt -63.18 -28.96 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 119.986 -1.696 . . . . 1.03 111.005 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -69.81 -40.94 75.63 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 120.516 -1.365 . . . . 1.46 108.334 178.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 85.1 t -69.38 -43.61 80.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.428 -0.795 . . . . 0.070000000000000007 109.414 178.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 97.0 mt -62.11 -42.46 95.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.132 -0.98 . . . . 1.02 109.471 178.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 97.6 m -62.35 -42.45 99.41 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.295 -0.878 . . . . 1.03 109.899 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 11.2 t -63.66 -45.91 88.0 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.161 -0.962 . . . . 0.070000000000000007 109.572 178.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 57.3 mt -64.09 -48.26 76.87 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.07 -1.019 . . . . 0.070000000000000007 111.173 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 40.4 p -66.38 -28.01 68.31 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 120.986 -1.071 . . . . 1.02 111.589 -178.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -67.81 -35.88 79.41 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 121.007 -1.058 . . . . 1.97 108.145 177.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -80.12 -15.55 56.87 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.967 -1.083 . . . . 0.089999999999999997 109.844 177.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 80.5 mt -106.01 27.86 8.18 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.984 -1.072 . . . . 1.03 110.675 178.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -72.46 -12.73 61.22 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 120.937 -1.102 . . . . 0.48999999999999999 111.879 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -110.66 131.38 55.1 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.588 -1.32 . . . . 0.13 110.619 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -57.72 -34.55 69.6 Favored 'General case' 0 N--CA 1.503 2.181 0 C-N-CA 123.306 0.642 . . . . 0.14999999999999999 112.262 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.446 ' O ' ' HG2' ' A' ' 130' ' ' ARG . 59.7 p -65.75 -34.01 77.18 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 120.694 -1.254 . . . . 0.13 109.88 179.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 85.6 t -65.65 -43.9 93.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.638 -1.289 . . . . 0.11 109.974 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 96.1 mt -64.33 -46.06 94.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.941 -1.1 . . . . 1.02 110.228 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.616 ' HA ' ' OE1' ' A' ' 129' ' ' GLU . 8.7 mm-40 -57.08 -46.85 82.19 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.223 -0.923 . . . . 0.11 109.864 178.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.532 ' NH1' ' HG3' ' A' ' 130' ' ' ARG . 16.5 mmm-85 -63.52 -43.7 96.4 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.215 -0.928 . . . . 0.13 110.214 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 83.3 mt -66.89 -35.04 79.12 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.066 -1.022 . . . . 0.080000000000000002 111.148 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -67.33 -27.18 66.93 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.308 -0.87 . . . . 0.080000000000000002 113.285 -176.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.621 ' HE2' HH11 ' A' ' 99' ' ' ARG . 97.0 m-70 -126.49 1.7 6.92 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 120.082 -1.637 . . . . 0.10000000000000001 113.322 -176.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.696 ' HG1' ' H ' ' A' ' 136' ' ' SER . 9.4 t -68.31 145.89 53.8 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.502 -1.374 . . . . 0.10000000000000001 111.271 -178.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 72.8 p -106.06 9.92 32.29 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.27 -1.381 . . . . 0.12 107.27 176.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 0.696 ' H ' ' HG1' ' A' ' 134' ' ' THR . 47.0 t -107.02 116.4 31.86 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 121.588 0.709 . . . . 0.11 112.696 -178.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 15.9 t -65.59 -41.67 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 108.501 -0.925 . . . . 0.10000000000000001 108.501 176.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -56.87 -39.99 75.35 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.233 -0.917 . . . . 0.11 110.408 178.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -63.66 -42.75 98.03 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.936 -1.103 . . . . 0.11 108.45 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 92.0 t -57.29 -51.27 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 108.508 -0.923 . . . . 0.080000000000000002 108.508 177.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.419 HD22 ' HA2' ' A' ' 8' ' ' GLY . 78.4 mt -57.7 -45.98 84.96 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.238 -0.914 . . . . 0.080000000000000002 110.294 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -58.81 -47.91 83.13 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.814 -1.179 . . . . 0.11 111.02 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 83.7 mt -67.99 -23.49 65.03 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.983 -1.073 . . . . 0.10000000000000001 112.606 -177.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.661 ' O ' ' NH1' ' A' ' 147' ' ' ARG . 91.7 mt -110.05 9.27 24.21 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.367 -1.458 . . . . 0.070000000000000007 111.391 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.694 ' HA ' HH12 ' A' ' 147' ' ' ARG . . . -76.97 -25.25 52.57 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 120.689 -1.257 . . . . 0.080000000000000002 112.305 -178.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -81.77 -8.81 86.32 Favored Glycine 0 N--CA 1.504 3.211 0 O-C-N 120.57 -1.331 . . . . 0.080000000000000002 111.156 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 1.244 ' HD2' ' CZ ' ' A' ' 5' ' ' PHE . 2.0 ptt-85 . . . . . 0 N--CA 1.486 1.371 0 O-C-N 121.053 -1.263 . . . . 0.070000000000000007 109.64 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 301' ' ' MET . . . . . 0.501 ' HB2' ' HG2' ' B' ' 366' ' ' GLU . 3.4 ttm . . . . . 0 C--O 1.214 -0.786 0 CA-C-O 121.931 0.872 . . . . 0.17000000000000001 108.948 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 302' ' ' PHE . . . . . 0.454 ' N ' ' CG ' ' B' ' 301' ' ' MET . 46.9 t80 -139.74 142.97 36.77 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 107.27 -1.381 . . . . 0.17000000000000001 107.27 178.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 303' ' ' GLN . . . . . 0.497 ' O ' ' HG2' ' B' ' 304' ' ' GLN . 5.4 pt20 -153.0 156.31 38.58 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 120.904 -1.123 . . . . 0.14000000000000001 109.495 179.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 304' ' ' GLN . . . . . 0.497 ' HG2' ' O ' ' B' ' 303' ' ' GLN . 42.2 mm-40 -152.18 149.21 28.51 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 108.033 -1.099 . . . . 0.16 108.033 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -97.19 152.35 18.91 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.046 -1.034 . . . . 0.13 108.428 178.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 7.2 p -147.83 144.34 19.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 N-CA-C 107.478 -1.304 . . . . 0.12 107.478 177.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 85.4 m -96.67 136.54 37.06 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 122.169 0.985 . . . . 0.14000000000000001 110.079 177.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 51.7 mt -84.88 114.25 24.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 105.478 -2.045 . . . . 0.13 105.478 177.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 47.4 p -106.7 -4.39 19.51 Favored 'General case' 0 C--N 1.264 -3.117 0 N-CA-C 114.704 1.372 . . . . 0.17000000000000001 114.704 -178.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 310' ' ' ALA . . . . . 0.544 ' HB1' ' C ' ' B' ' 385' ' ' GLU . . . -71.44 141.87 86.02 Favored Pre-proline 0 N--CA 1.499 2.012 0 O-C-N 119.683 -1.886 . . . . 0.16 110.658 178.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -45.54 -47.63 13.03 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 124.749 3.633 . . . . 0.20000000000000001 114.202 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -102.21 27.61 6.54 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 116.035 -2.266 . . . . 1.6299999999999999 108.725 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 58.83 -149.92 36.59 Favored Glycine 0 N--CA 1.496 2.699 0 C-N-CA 117.708 -2.187 . . . . 0.14000000000000001 109.52 -179.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 314' ' ' LEU . . . . . . . . . . . . . 19.9 tp -83.93 72.58 10.42 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.838 -1.39 . . . . 0.11 109.581 -176.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 12.1 p80 -69.41 -179.71 1.75 Allowed 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 117.846 -1.542 . . . . 1.49 112.131 -177.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 316' ' ' THR . . . . . 0.537 ' OG1' ' NH2' ' A' ' 49' ' ' ARG . 66.4 p -42.1 -66.7 0.32 Allowed 'General case' 0 N--CA 1.505 2.291 0 N-CA-C 117.209 2.299 . . . . 1.04 117.209 -175.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 317' ' ' ARG . . . . . 0.528 ' N ' ' HD2' ' B' ' 318' ' ' PRO . 5.4 ttt-85 -53.2 -53.33 57.0 Favored Pre-proline 0 N--CA 1.493 1.705 0 C-N-CA 120.21 -0.596 . . . . 2.6000000000000001 112.446 -176.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 318' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' B' ' 317' ' ' ARG . 21.0 Cg_endo -66.41 -32.17 41.12 Favored 'Trans proline' 0 N--CA 1.484 0.963 0 C-N-CA 124.707 3.604 . . . . 0.14000000000000001 111.563 -177.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -67.07 -38.8 86.43 Favored 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 119.503 -0.879 . . . . 0.11 109.491 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -70.95 -39.68 72.46 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.865 -0.791 . . . . 1.03 108.865 178.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 67.8 tp60 -64.01 -39.31 93.83 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 117.863 -1.535 . . . . 0.12 109.535 177.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 322' ' ' PHE . . . . . 0.551 ' CE1' HD22 ' B' ' 377' ' ' LEU . 87.3 t80 -62.76 -45.3 93.32 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 122.583 1.182 . . . . 0.089999999999999997 108.703 -177.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 53.4 t -62.58 -42.26 95.24 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.278 0 CA-C-N 114.809 -1.087 . . . . 0.070000000000000007 110.713 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 73.7 tttt -63.87 -40.18 95.93 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.325 -0.859 . . . . 2.1699999999999999 109.851 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 325' ' ' GLU . . . . . 0.496 ' CD ' HD21 ' B' ' 380' ' ' LEU . 31.7 tt0 -68.9 -39.65 79.59 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.37 -0.831 . . . . 0.10000000000000001 109.56 177.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -59.07 -43.99 91.82 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.708 -1.245 . . . . 0.059999999999999998 109.417 178.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -61.37 -16.13 43.21 Favored 'General case' 0 N--CA 1.509 2.512 0 O-C-N 121.226 -0.922 . . . . 1.9399999999999999 113.338 178.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -76.92 -10.65 86.07 Favored Glycine 0 N--CA 1.479 1.529 0 O-C-N 119.999 -1.688 . . . . 0.080000000000000002 109.338 179.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -103.36 143.32 32.83 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.429 -1.63 . . . . 0.10000000000000001 110.101 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 47.8 p -75.66 -30.08 59.31 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.297 -0.877 . . . . 0.12 112.272 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 331' ' ' SER . . . . . . . . . . . . . 15.9 m -59.68 158.57 9.93 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 119.844 -1.785 . . . . 0.11 112.821 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 332' ' ' GLU . . . . . 0.769 ' OE1' ' N ' ' B' ' 333' ' ' ILE . 0.0 OUTLIER -79.0 130.4 35.49 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 102.81 -3.033 . . . . 0.12 102.81 171.266 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 333' ' ' ILE . . . . . 0.769 ' N ' ' OE1' ' B' ' 332' ' ' GLU . 39.2 mt -126.81 136.5 60.61 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.486 0 CA-C-O 122.192 0.996 . . . . 0.080000000000000002 109.305 -178.246 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 334' ' ' THR . . . . . 0.417 HG23 ' N ' ' B' ' 335' ' ' VAL . 93.3 m -124.94 143.21 50.99 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-O 123.216 1.484 . . . . 0.089999999999999997 109.978 178.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 335' ' ' VAL . . . . . 0.417 ' N ' HG23 ' B' ' 334' ' ' THR . 85.3 t -108.14 129.95 61.51 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.633 0 N-CA-C 105.469 -2.049 . . . . 0.059999999999999998 105.469 173.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 336' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' B' ' 340' ' ' LYS . 71.5 m -127.39 119.51 26.35 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 120.862 -1.149 . . . . 0.089999999999999997 109.046 -178.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 29.1 t -122.52 122.61 39.32 Favored 'General case' 0 N--CA 1.501 2.106 0 C-N-CA 119.992 -0.683 . . . . 0.080000000000000002 109.843 177.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 51.73 38.84 24.0 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.886 -1.134 . . . . 0.10000000000000001 112.87 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 81.81 10.86 83.59 Favored Glycine 0 N--CA 1.501 3.009 0 O-C-N 119.944 -1.722 . . . . 0.11 112.522 177.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 340' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' B' ' 336' ' ' THR . 26.5 mttp -119.85 136.3 54.54 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 105.221 -2.14 . . . . 0.11 105.221 177.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 68.3 m -124.8 158.55 33.09 Favored 'General case' 0 C--N 1.276 -2.594 0 CA-C-O 123.738 1.732 . . . . 0.10000000000000001 112.408 -176.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -151.62 151.45 31.53 Favored 'General case' 0 C--N 1.278 -2.51 0 CA-C-N 112.449 -2.159 . . . . 0.080000000000000002 108.634 177.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 343' ' ' SER . . . . . 0.648 ' HG ' ' H ' ' B' ' 345' ' ' LYS . 8.0 t -70.63 135.95 48.78 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 105.556 -2.016 . . . . 0.089999999999999997 105.556 173.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 344' ' ' ALA . . . . . . . . . . . . . . . -72.95 -6.83 47.95 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.691 -1.256 . . . . 0.059999999999999998 110.703 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 345' ' ' LYS . . . . . 0.648 ' H ' ' HG ' ' B' ' 343' ' ' SER . 83.8 mttt -97.5 13.07 31.18 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.631 -1.293 . . . . 0.080000000000000002 109.395 -177.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 9.7 t -133.18 104.25 6.4 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 122.153 0.977 . . . . 0.89000000000000001 110.062 -178.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 347' ' ' LEU . . . . . . . . . . . . . 46.4 tp -57.34 -37.77 73.05 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 115.658 -0.701 . . . . 1.02 109.998 178.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 348' ' ' PHE . . . . . 0.469 ' HB3' ' OE2' ' A' ' 59' ' ' GLU . 77.3 t80 -59.0 -51.35 70.43 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.566 -1.334 . . . . 0.16 113.021 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 37.6 tptt -70.05 -32.46 70.58 Favored 'General case' 0 C--O 1.214 -0.769 0 O-C-N 119.664 -1.898 . . . . 2.1000000000000001 109.109 -178.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 350' ' ' LEU . . . . . . . . . . . . . 32.3 mt -62.84 -33.7 75.79 Favored 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 118.958 -1.097 . . . . 1.03 109.92 -177.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 351' ' ' GLN . . . . . . . . . . . . . 69.5 tp60 -67.69 -10.49 52.89 Favored 'General case' 0 C--N 1.293 -1.852 0 O-C-N 121.599 -0.688 . . . . 0.34000000000000002 109.915 -177.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 352' ' ' THR . . . . . . . . . . . . . 41.7 p -89.72 -7.74 53.87 Favored 'General case' 0 N--CA 1.502 2.132 0 C-N-CA 118.097 -1.441 . . . . 1.03 111.026 -178.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 72.9 mt -93.34 159.34 15.3 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.244 -0.91 . . . . 1.03 110.224 -178.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -86.76 104.8 2.97 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 106.94 -2.464 . . . . 0.089999999999999997 106.94 177.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 15.5 mt -119.46 47.29 1.73 Allowed 'General case' 0 C--N 1.309 -1.186 0 O-C-N 120.625 -1.515 . . . . 1.02 107.471 -178.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 47.6 p -81.36 172.53 13.46 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 118.849 -1.141 . . . . 1.0600000000000001 109.16 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -60.74 140.97 57.36 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 119.349 -0.94 . . . . 2.0899999999999999 109.76 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 91.4 -3.17 79.04 Favored Glycine 0 N--CA 1.5 2.941 0 C-N-CA 120.052 -1.071 . . . . 0.13 111.381 177.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 54.5 m -84.4 135.81 34.13 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 120.918 -1.342 . . . . 0.11 110.66 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 89.2 t -96.47 123.8 48.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 N-CA-C 106.304 -1.739 . . . . 0.12 106.304 176.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 22.3 m -112.27 160.13 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.335 0 C-N-CA 117.354 -1.739 . . . . 0.089999999999999997 110.636 178.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 90.4 m -108.89 128.34 54.83 Favored 'General case' 0 C--O 1.214 -0.789 0 O-C-N 120.596 -1.315 . . . . 0.11 107.565 175.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 363' ' ' ILE . . . . . 0.451 ' O ' ' HA ' ' B' ' 303' ' ' GLN . 33.2 mt -107.92 121.45 60.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 105.344 -2.095 . . . . 0.10000000000000001 105.344 176.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 364' ' ' SER . . . . . 0.407 ' HB3' ' HB3' ' B' ' 303' ' ' GLN . 0.7 OUTLIER -128.57 147.3 50.7 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 107.809 -1.182 . . . . 0.11 107.809 -179.646 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -139.76 153.32 47.13 Favored 'General case' 0 C--N 1.292 -1.925 0 C-N-CA 118.454 -1.298 . . . . 0.13 109.781 -179.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 366' ' ' GLU . . . . . 0.501 ' HG2' ' HB2' ' B' ' 301' ' ' MET . 0.2 OUTLIER -141.14 110.88 6.48 Favored 'General case' 0 C--N 1.288 -2.081 0 C-N-CA 118.592 -1.243 . . . . 0.16 108.078 178.127 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . 165.22 -170.36 40.16 Favored Glycine 0 C--N 1.297 -1.59 0 C-N-CA 117.981 -2.056 . . . . 0.14000000000000001 110.327 178.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -58.27 -40.55 82.18 Favored 'General case' 0 C--N 1.277 -2.57 0 CA-C-N 114.33 -0.935 . . . . 0.16 112.306 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 369' ' ' ASP . . . . . . . . . . . . . 12.0 p30 -114.21 36.85 3.54 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 115.834 -2.346 . . . . 0.14000000000000001 108.519 -178.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 370' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -56.41 -33.56 65.91 Favored 'General case' 0 N--CA 1.521 3.107 0 N-CA-C 116.8 2.148 . . . . 0.16 116.8 -174.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 371' ' ' GLN . . . . . 0.5 ' H ' ' HG2' ' B' ' 371' ' ' GLN . 0.0 OUTLIER -76.95 -45.59 27.1 Favored 'General case' 0 N--CA 1.509 2.514 0 O-C-N 119.526 -1.984 . . . . 0.17999999999999999 110.914 -176.519 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 372' ' ' LYS . . . . . 0.779 ' HZ2' ' CE1' ' B' ' 376' ' ' HIS . 11.9 ttpp -63.56 -40.71 97.69 Favored 'General case' 0 C--N 1.283 -2.315 0 N-CA-C 106.965 -1.495 . . . . 0.14000000000000001 106.965 178.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -59.09 -49.51 77.61 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 117.541 -1.664 . . . . 0.11 110.025 -178.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 374' ' ' VAL . . . . . . . . . . . . . 66.9 t -66.86 -42.25 88.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 CA-C-O 122.187 0.994 . . . . 0.12 109.267 -178.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -55.89 -47.78 76.8 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-O 122.059 0.933 . . . . 0.16 108.737 -178.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 376' ' ' HIS . . . . . 0.779 ' CE1' ' HZ2' ' B' ' 372' ' ' LYS . 13.9 m-70 -69.96 -38.23 76.04 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 116.005 -0.543 . . . . 0.14000000000000001 111.72 -178.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 377' ' ' LEU . . . . . 0.551 HD22 ' CE1' ' B' ' 322' ' ' PHE . 80.5 mt -75.64 -28.56 58.84 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.348 -1.47 . . . . 0.089999999999999997 110.875 -174.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 378' ' ' VAL . . . . . . . . . . . . . 2.1 t -71.44 -39.52 71.3 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.459 0 N-CA-C 106.35 -1.722 . . . . 0.13 106.35 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -67.89 -49.31 62.69 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 108.03 -1.1 . . . . 0.17000000000000001 108.03 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 380' ' ' LEU . . . . . 0.9 ' HG ' HD21 ' B' ' 384' ' ' LEU . 34.1 tp -57.18 -45.24 83.87 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 118.974 -1.09 . . . . 0.12 110.62 177.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 3.6 ttm -62.29 -37.44 85.53 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.871 -1.143 . . . . 0.12 111.508 -177.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -74.89 -31.78 61.67 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.111 -0.993 . . . . 0.14999999999999999 110.29 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -78.87 -32.41 45.92 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.622 -0.673 . . . . 0.17000000000000001 111.247 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 384' ' ' LEU . . . . . 0.9 HD21 ' HG ' ' B' ' 380' ' ' LEU . 0.0 OUTLIER -50.12 125.54 12.48 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-O 124.432 2.063 . . . . 0.14999999999999999 112.762 178.802 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 385' ' ' GLU . . . . . 0.792 ' CD ' ' H ' ' B' ' 385' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.279 -2.48 0 CA-C-N 111.085 -2.779 . . . . 0.17999999999999999 110.093 -177.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.445 HD12 ' HA ' ' A' ' 4' ' ' LEU . 14.4 tp . . . . . 0 N--CA 1.483 1.208 0 N-CA-C 110.502 -0.184 . . . . 0.070000000000000007 110.502 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 1.244 ' CZ ' ' HD2' ' A' ' 147' ' ' ARG . 40.6 p90 -136.09 141.73 44.24 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 117.476 -1.69 . . . . 0.050000000000000003 111.884 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.5 mttp -82.27 142.73 31.86 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 107.944 -1.132 . . . . 0.050000000000000003 107.944 177.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.967 ' HA ' HD22 ' A' ' 11' ' ' ASN . 13.6 tp -136.81 125.64 24.08 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 107.285 -1.376 . . . . 0.050000000000000003 107.285 179.131 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.419 ' HA2' HD22 ' A' ' 141' ' ' LEU . . . -154.02 -166.92 15.44 Favored Glycine 0 C--N 1.289 -2.081 0 N-CA-C 108.557 -1.817 . . . . 0.059999999999999998 108.557 178.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.79 -34.24 77.46 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.599 -0.942 . . . . 0.080000000000000002 111.313 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -65.44 -14.93 62.02 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.759 -1.213 . . . . 0.070000000000000007 112.332 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.967 HD22 ' HA ' ' A' ' 7' ' ' LEU . 2.7 p-10 -123.7 22.85 8.94 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 119.5 -2.0 . . . . 0.050000000000000003 111.869 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 48.8 mt -118.49 123.35 71.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 107.539 -1.282 . . . . 0.059999999999999998 107.539 176.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -126.44 106.98 9.85 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.433 -0.792 . . . . 0.070000000000000007 109.252 -177.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.534 ' HA ' ' HB3' ' A' ' 83' ' ' GLN . 42.4 mt -100.33 160.52 14.27 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-O 122.702 1.239 . . . . 0.080000000000000002 112.883 -177.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 62.34 34.66 89.97 Favored Glycine 0 N--CA 1.497 2.749 0 CA-C-N 114.457 -1.247 . . . . 0.080000000000000002 113.833 175.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.423 ' HA ' ' HE ' ' A' ' 16' ' ' ARG . 1.0 OUTLIER -83.21 169.14 16.09 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 120.238 -1.742 . . . . 0.089999999999999997 109.733 178.348 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -140.89 140.75 34.59 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 107.409 -1.33 . . . . 0.089999999999999997 107.409 178.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -154.17 131.7 11.35 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 108.442 -0.948 . . . . 0.059999999999999998 108.442 179.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -77.48 -25.62 50.58 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.141 -0.975 . . . . 0.070000000000000007 109.69 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 64.2 p -134.75 159.65 40.66 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 119.075 -1.05 . . . . 0.070000000000000007 111.466 -178.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.667 ' HE3' ' OE1' ' A' ' 50' ' ' GLU . 28.2 pttt -65.98 -32.68 74.31 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.892 -0.781 . . . . 0.089999999999999997 108.892 175.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 51.4 mp0 -60.28 -42.8 96.21 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.514 -1.366 . . . . 0.089999999999999997 110.103 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -64.1 -41.73 97.17 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.628 -1.295 . . . . 0.070000000000000007 110.012 177.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.91 -42.51 94.66 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.636 -1.29 . . . . 0.050000000000000003 109.609 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.414 HG23 HD23 ' A' ' 47' ' ' LEU . 86.9 mt -64.37 -42.29 94.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.262 -0.899 . . . . 0.070000000000000007 109.802 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.46 ' HE ' ' HB2' ' A' ' 26' ' ' ARG . 4.4 ttm180 -62.61 -37.52 86.61 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.316 -0.865 . . . . 0.10000000000000001 109.98 178.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -67.25 -49.19 65.34 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.724 -1.235 . . . . 0.070000000000000007 108.403 179.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.19 -47.05 79.1 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.387 -0.821 . . . . 0.059999999999999998 109.605 178.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.31 -41.34 99.74 Favored Glycine 0 N--CA 1.497 2.722 0 N-CA-C 110.525 -1.03 . . . . 0.080000000000000002 110.525 179.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -61.18 -37.76 84.08 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.661 -1.494 . . . . 0.089999999999999997 110.331 177.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 92.4 mm-40 -73.17 -36.05 66.53 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.069 -1.019 . . . . 0.080000000000000002 110.181 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 73.5 mt -63.95 -38.2 90.19 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.857 -1.152 . . . . 0.070000000000000007 108.282 174.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.517 HG21 HG22 ' A' ' 38' ' ' VAL . 23.7 t -69.34 -45.48 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 O-C-N 120.879 -1.138 . . . . 0.11 108.178 177.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -57.49 -39.3 76.14 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.665 -0.647 . . . . 0.10000000000000001 112.625 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -86.19 8.42 73.99 Favored Glycine 0 N--CA 1.508 3.486 0 O-C-N 120.236 -1.54 . . . . 0.080000000000000002 112.796 -178.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.63 17.83 78.37 Favored Glycine 0 N--CA 1.488 2.139 0 O-C-N 120.678 -1.483 . . . . 0.089999999999999997 111.443 178.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.532 ' C ' HG13 ' A' ' 38' ' ' VAL . 80.3 m-85 -80.93 -36.24 31.3 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.274 -1.721 . . . . 0.080000000000000002 110.111 -179.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.532 HG13 ' C ' ' A' ' 37' ' ' TYR . 17.4 m -141.96 163.02 19.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-O 122.287 1.042 . . . . 0.10000000000000001 111.437 -177.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.443 ' OE1' ' NH1' ' A' ' 73' ' ' ARG . 83.3 mt-10 -86.63 165.1 34.54 Favored Pre-proline 0 C--N 1.3 -1.546 0 N-CA-C 107.29 -1.374 . . . . 0.14000000000000001 107.29 176.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.426 ' HD2' ' HB3' ' A' ' 39' ' ' GLU . 50.3 Cg_exo -50.53 -36.86 50.88 Favored 'Trans proline' 0 N--CA 1.51 2.443 0 C-N-CA 123.646 2.897 . . . . 0.14000000000000001 115.791 -177.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.421 ' CD ' HH21 ' A' ' 73' ' ' ARG . 41.2 mp0 -62.76 -20.59 65.11 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.508 -1.37 . . . . 0.14999999999999999 112.196 -178.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.887 ' HH ' ' H ' ' A' ' 66' ' ' GLY . 39.9 t80 -67.08 -27.79 67.65 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.616 -1.303 . . . . 0.11 112.313 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 22.8 t -61.19 -49.01 86.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 120.265 -1.522 . . . . 0.10000000000000001 110.396 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 51.8 tp60 -67.11 -35.04 78.91 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.093 -1.004 . . . . 0.13 109.108 179.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.2 -33.35 73.32 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.232 -0.917 . . . . 0.12 109.765 177.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.467 ' HG3' ' O ' ' A' ' 42' ' ' TYR . 94.5 mtp -70.28 -37.93 74.94 Favored 'General case' 0 N--CA 1.482 1.128 0 O-C-N 120.545 -1.347 . . . . 0.10000000000000001 107.719 177.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.505 HD21 ' OE2' ' A' ' 50' ' ' GLU . 93.9 mt -70.14 -40.2 74.93 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.237 -1.023 . . . . 0.10000000000000001 108.237 178.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -60.14 -44.31 95.04 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.36 -0.837 . . . . 0.13 109.203 177.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.864 HH21 ' P ' ' B' ' 200' ' ' PO3 . 24.5 tpt180 -62.45 -39.19 92.57 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.843 -1.161 . . . . 2.1200000000000001 110.653 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.667 ' OE1' ' HE3' ' A' ' 21' ' ' LYS . 0.5 OUTLIER -62.54 -39.61 94.14 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.166 -0.959 . . . . 0.10000000000000001 110.895 -178.545 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.559 ' N ' ' HG2' ' A' ' 50' ' ' GLU . 28.1 tttt -62.87 -38.22 89.98 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 116.333 -0.394 . . . . 3.2999999999999998 110.853 -178.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 28.7 tp -64.71 -43.56 93.06 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 120.181 -1.574 . . . . 1.04 108.634 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.6 m -166.11 139.11 3.34 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.044 -1.035 . . . . 1.05 109.71 179.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -50.34 144.91 22.52 Favored 'Trans proline' 0 C--N 1.314 -1.286 0 C-N-CA 121.175 1.25 . . . . 0.78000000000000003 113.655 178.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 55.3 p -96.54 7.94 45.32 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 114.505 -1.225 . . . . 1.03 107.92 177.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.5 ' HH ' ' H ' ' A' ' 60' ' ' SER . 33.0 t80 -62.36 137.5 58.27 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 105.955 -1.869 . . . . 0.91000000000000003 105.955 174.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 18.1 mt -117.77 11.97 13.76 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 120.856 -1.152 . . . . 1.03 110.224 -178.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 85.56 170.94 47.67 Favored Glycine 0 C--N 1.302 -1.31 0 N-CA-C 108.667 -1.773 . . . . 0.10000000000000001 108.667 -178.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.81 ' CA ' ' N ' ' A' ' 60' ' ' SER . 76.0 mm-40 57.59 35.4 25.7 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.458 -1.025 . . . . 1.8600000000000001 113.527 177.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.81 ' N ' ' CA ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER 65.28 21.48 12.02 Favored 'General case' 0 N--CA 1.514 2.771 0 O-C-N 121.039 -1.038 . . . . 0.080000000000000002 113.555 176.731 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 94.2 mt -121.38 137.48 54.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 120.645 -1.285 . . . . 1.02 111.014 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -129.31 138.85 51.82 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 106.247 -1.76 . . . . 0.059999999999999998 106.247 174.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.416 ' H ' HG23 ' A' ' 63' ' ' VAL . 16.3 m -130.32 73.41 81.3 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.163 -0.96 . . . . 0.070000000000000007 110.103 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -54.57 146.91 50.96 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 120.854 1.036 . . . . 0.76000000000000001 112.221 -178.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 2.4 p-80 -150.37 159.01 44.77 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.315 -0.866 . . . . 0.76000000000000001 109.447 177.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.887 ' H ' ' HH ' ' A' ' 42' ' ' TYR . . . -76.65 174.81 53.8 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 110.036 -1.226 . . . . 0.12 110.036 -177.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 82.0 p -80.46 167.93 19.57 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.104 -1.233 . . . . 1.27 109.376 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.409 ' C ' ' H ' ' A' ' 70' ' ' ALA . 5.3 m -70.52 -23.65 24.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 121.382 -0.824 . . . . 0.14000000000000001 109.751 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.501 ' N ' ' OE1' ' A' ' 69' ' ' GLU . 58.7 mp0 -75.27 9.06 2.26 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.985 -1.072 . . . . 0.14999999999999999 109.725 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.409 ' H ' ' C ' ' A' ' 68' ' ' VAL . . . -121.73 15.27 11.0 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.709 -0.619 . . . . 0.13 109.813 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 49.5 pttt -60.87 -37.95 83.9 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.016 -1.053 . . . . 0.14999999999999999 109.136 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -69.27 -4.13 16.68 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.658 -0.651 . . . . 0.14000000000000001 111.543 -177.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.443 ' NH1' ' OE1' ' A' ' 39' ' ' GLU . 15.6 mmm180 -104.96 7.95 34.32 Favored 'General case' 0 N--CA 1.506 2.33 0 O-C-N 120.444 -1.41 . . . . 0.14000000000000001 109.374 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 91.1 t -95.48 128.49 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 107.082 -1.451 . . . . 0.11 107.082 177.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 28.1 mt -96.75 -17.15 20.47 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 115.721 -0.672 . . . . 0.11 109.455 -178.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 39.6 pttt -176.6 159.67 1.9 Allowed 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.523 -0.918 . . . . 0.089999999999999997 108.523 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 18.2 m -76.29 138.14 40.34 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.355 -0.841 . . . . 1.02 111.079 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -160.69 161.05 32.45 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 118.735 -1.698 . . . . 0.059999999999999998 110.863 -179.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.477 ' O ' HG22 ' A' ' 79' ' ' VAL . 33.3 m -137.65 150.96 25.62 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 O-C-N 121.603 -0.939 . . . . 0.029999999999999999 108.842 179.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.9 m -127.02 113.14 31.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 106.271 -1.752 . . . . 0.040000000000000001 106.271 175.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -86.02 115.38 23.58 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.789 0.804 . . . . 0.050000000000000003 109.238 -178.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 39.5 m -119.0 122.11 41.44 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 121.86 0.838 . . . . 0.040000000000000001 110.506 -177.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.534 ' HB3' ' HA ' ' A' ' 14' ' ' LEU . 30.7 tt0 -100.71 126.47 47.25 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-O 122.108 0.956 . . . . 0.080000000000000002 111.805 -178.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -123.35 87.24 51.79 Favored Pre-proline 0 C--N 1.302 -1.471 0 N-CA-C 107.025 -1.472 . . . . 0.059999999999999998 107.025 177.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -54.06 -36.05 83.43 Favored 'Trans proline' 0 N--CA 1.501 1.925 0 C-N-CA 122.847 2.365 . . . . 0.080000000000000002 113.081 -177.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -81.73 -13.27 58.02 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.481 -0.762 . . . . 0.080000000000000002 110.323 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 90.08 152.59 27.23 Favored Glycine 0 N--CA 1.485 1.912 0 O-C-N 120.791 -1.193 . . . . 0.059999999999999998 113.024 175.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 61.5 t -136.47 120.43 24.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 106.549 -1.649 . . . . 0.050000000000000003 106.549 177.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.711 ' HA ' HD11 ' A' ' 97' ' ' ILE . 4.3 ttt180 -60.31 121.27 11.58 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.829 -1.169 . . . . 0.089999999999999997 109.131 -179.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -119.77 -11.51 9.36 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 118.656 -1.218 . . . . 1.29 111.573 -178.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -118.54 -158.21 10.74 Favored Glycine 1 N--CA 1.516 4.009 0 O-C-N 119.588 -1.945 . . . . 0.20999999999999999 112.255 -178.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -92.54 -22.8 19.33 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 113.842 1.052 . . . . 0.26000000000000001 113.842 -176.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -96.4 154.45 17.26 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.683 -1.261 . . . . 1.6200000000000001 109.461 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -60.29 -23.89 64.51 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.747 -1.22 . . . . 2.5499999999999998 109.964 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -86.52 1.87 50.02 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.692 -1.255 . . . . 1.74 109.461 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -83.2 60.17 5.39 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 118.764 -1.175 . . . . 0.16 107.98 178.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.711 HD11 ' HA ' ' A' ' 89' ' ' ARG . 41.8 mm -101.6 135.32 38.75 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 CA-C-O 121.723 0.773 . . . . 0.080000000000000002 110.169 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -108.56 130.95 55.28 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 121.545 0.688 . . . . 0.059999999999999998 109.682 178.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.62 HH11 ' HE2' ' A' ' 133' ' ' HIS . 87.3 mtm180 -102.5 -17.07 15.93 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 106.557 -1.646 . . . . 0.089999999999999997 106.557 175.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 71.1 mt -116.87 112.16 20.68 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.12 -1.067 . . . . 0.059999999999999998 108.12 176.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 93.8 t -113.4 104.07 16.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 106.257 -1.757 . . . . 0.040000000000000001 106.257 179.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 72.3 mt -107.11 102.91 14.65 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.087 0 CA-C-O 122.292 1.044 . . . . 0.040000000000000001 111.035 -176.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -77.6 131.97 11.57 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.023 -1.631 . . . . 0.040000000000000001 109.023 -178.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 19.4 pt -133.45 153.5 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 O-C-N 120.264 -1.727 . . . . 1.03 112.916 -176.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -137.38 133.71 35.13 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 106.189 -1.782 . . . . 1.03 106.189 177.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -147.59 140.97 25.3 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 120.113 -1.617 . . . . 1.02 110.955 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 60.6 mtp180 -70.74 156.29 39.7 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.588 0.709 . . . . 4.3099999999999996 110.331 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 57.81 25.4 11.92 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.069 -0.715 . . . . 2.46 109.069 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.525 ' OD1' ' ND1' ' A' ' 111' ' ' HIS . 62.9 t30 53.27 37.58 25.6 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.172 -0.955 . . . . 1.6100000000000001 109.766 178.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -84.05 28.89 0.58 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.131 -0.981 . . . . 0.17999999999999999 111.093 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.75 ' CA ' ' N ' ' A' ' 112' ' ' ILE . 43.1 p-80 -50.54 -38.3 44.08 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.881 -1.137 . . . . 0.20999999999999999 112.095 179.067 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.75 ' N ' ' CA ' ' A' ' 111' ' ' HIS . 20.9 tt -63.18 -28.96 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 119.986 -1.696 . . . . 1.03 111.005 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -69.81 -40.94 75.63 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 120.516 -1.365 . . . . 1.46 108.334 178.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 85.1 t -69.38 -43.61 80.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.428 -0.795 . . . . 0.070000000000000007 109.414 178.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.11 -42.46 95.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.132 -0.98 . . . . 1.02 109.471 178.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 95.7 m -62.35 -42.45 99.41 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.295 -0.878 . . . . 1.03 109.899 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 11.2 t -63.66 -45.91 88.0 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.161 -0.962 . . . . 0.070000000000000007 109.572 178.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 57.3 mt -64.09 -48.26 76.87 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.07 -1.019 . . . . 0.070000000000000007 111.173 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 40.0 p -66.38 -28.01 68.31 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 120.986 -1.071 . . . . 1.02 111.589 -178.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -67.81 -35.88 79.41 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 121.007 -1.058 . . . . 1.97 108.145 177.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -80.12 -15.55 56.87 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.967 -1.083 . . . . 0.089999999999999997 109.844 177.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 80.5 mt -106.01 27.86 8.18 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.984 -1.072 . . . . 1.03 110.675 178.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -72.46 -12.73 61.22 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 120.937 -1.102 . . . . 0.48999999999999999 111.879 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -110.66 131.38 55.1 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.588 -1.32 . . . . 0.13 110.619 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -57.72 -34.55 69.6 Favored 'General case' 0 N--CA 1.503 2.181 0 C-N-CA 123.306 0.642 . . . . 0.14999999999999999 112.262 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.451 ' O ' ' HG2' ' A' ' 130' ' ' ARG . 59.7 p -65.75 -34.01 77.18 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 120.694 -1.254 . . . . 0.13 109.88 179.052 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 85.6 t -65.65 -43.9 93.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.638 -1.289 . . . . 0.11 109.974 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 95.8 mt -64.33 -46.06 94.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.941 -1.1 . . . . 1.02 110.228 -179.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.616 ' HA ' ' OE1' ' A' ' 129' ' ' GLU . 8.7 mm-40 -57.08 -46.85 82.19 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.223 -0.923 . . . . 0.11 109.864 178.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.451 ' HG2' ' O ' ' A' ' 126' ' ' SER . 42.7 mmm-85 -63.52 -43.7 96.4 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.215 -0.928 . . . . 0.13 110.214 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 83.3 mt -66.89 -35.04 79.12 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.066 -1.022 . . . . 0.080000000000000002 111.148 -179.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -67.33 -27.18 66.93 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.308 -0.87 . . . . 0.080000000000000002 113.285 -176.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.62 ' HE2' HH11 ' A' ' 99' ' ' ARG . 97.0 m-70 -126.49 1.7 6.92 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 120.082 -1.637 . . . . 0.10000000000000001 113.322 -176.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.696 ' HG1' ' H ' ' A' ' 136' ' ' SER . 9.4 t -68.31 145.89 53.8 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.502 -1.374 . . . . 0.10000000000000001 111.271 -178.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 72.8 p -106.06 9.92 32.29 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.27 -1.381 . . . . 0.12 107.27 176.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 0.696 ' H ' ' HG1' ' A' ' 134' ' ' THR . 47.0 t -107.02 116.4 31.86 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 121.588 0.709 . . . . 0.11 112.696 -178.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 15.9 t -65.59 -41.67 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 108.501 -0.925 . . . . 0.10000000000000001 108.501 176.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -56.87 -39.99 75.35 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.233 -0.917 . . . . 0.11 110.408 178.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -63.66 -42.75 98.03 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.936 -1.103 . . . . 0.11 108.45 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 92.0 t -57.29 -51.27 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 108.508 -0.923 . . . . 0.080000000000000002 108.508 177.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.419 HD22 ' HA2' ' A' ' 8' ' ' GLY . 78.4 mt -57.7 -45.98 84.96 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.238 -0.914 . . . . 0.080000000000000002 110.294 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -58.81 -47.91 83.13 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.814 -1.179 . . . . 0.11 111.02 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 83.7 mt -67.99 -23.49 65.03 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.983 -1.073 . . . . 0.10000000000000001 112.606 -177.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.661 ' O ' ' NH1' ' A' ' 147' ' ' ARG . 91.7 mt -110.05 9.27 24.21 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.367 -1.458 . . . . 0.070000000000000007 111.391 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.694 ' HA ' HH12 ' A' ' 147' ' ' ARG . . . -76.97 -25.25 52.57 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 120.689 -1.257 . . . . 0.080000000000000002 112.305 -178.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -81.77 -8.81 86.32 Favored Glycine 0 N--CA 1.504 3.211 0 O-C-N 120.57 -1.331 . . . . 0.080000000000000002 111.156 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 1.244 ' HD2' ' CZ ' ' A' ' 5' ' ' PHE . 2.0 ptt-85 . . . . . 0 N--CA 1.486 1.371 0 O-C-N 121.053 -1.263 . . . . 0.070000000000000007 109.64 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 301' ' ' MET . . . . . 0.501 ' HB2' ' HG2' ' B' ' 366' ' ' GLU . 3.4 ttm . . . . . 0 C--O 1.214 -0.786 0 CA-C-O 121.931 0.872 . . . . 0.17000000000000001 108.948 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 302' ' ' PHE . . . . . 0.454 ' N ' ' CG ' ' B' ' 301' ' ' MET . 46.9 t80 -139.74 142.97 36.77 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 107.27 -1.381 . . . . 0.17000000000000001 107.27 178.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 303' ' ' GLN . . . . . 0.497 ' O ' ' HG2' ' B' ' 304' ' ' GLN . 5.4 pt20 -153.0 156.31 38.58 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 120.904 -1.123 . . . . 0.14000000000000001 109.495 179.236 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 304' ' ' GLN . . . . . 0.497 ' HG2' ' O ' ' B' ' 303' ' ' GLN . 42.2 mm-40 -152.18 149.21 28.51 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 108.033 -1.099 . . . . 0.16 108.033 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -97.19 152.35 18.91 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.046 -1.034 . . . . 0.13 108.428 178.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 7.2 p -147.83 144.34 19.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 N-CA-C 107.478 -1.304 . . . . 0.12 107.478 177.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 85.4 m -96.67 136.54 37.06 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 122.169 0.985 . . . . 0.14000000000000001 110.079 177.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 51.7 mt -84.88 114.25 24.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 105.478 -2.045 . . . . 0.13 105.478 177.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 47.4 p -106.7 -4.39 19.51 Favored 'General case' 0 C--N 1.264 -3.117 0 N-CA-C 114.704 1.372 . . . . 0.17000000000000001 114.704 -178.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 310' ' ' ALA . . . . . 0.544 ' HB1' ' C ' ' B' ' 385' ' ' GLU . . . -71.44 141.87 86.02 Favored Pre-proline 0 N--CA 1.499 2.012 0 O-C-N 119.683 -1.886 . . . . 0.16 110.658 178.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -45.54 -47.63 13.03 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 124.749 3.633 . . . . 0.20000000000000001 114.202 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 44.5 t-20 -102.21 27.61 6.54 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 116.035 -2.266 . . . . 1.6299999999999999 108.725 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 58.83 -147.48 40.68 Favored Glycine 0 N--CA 1.496 2.699 0 C-N-CA 117.708 -2.187 . . . . 0.14000000000000001 109.52 -179.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 314' ' ' LEU . . . . . . . . . . . . . 12.3 tp -92.23 83.31 5.04 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.859 -1.163 . . . . 0.11 107.859 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 315' ' ' HIS . . . . . 0.515 ' O ' ' HB3' ' B' ' 319' ' ' ALA . 6.3 p80 -81.46 -163.55 0.64 Allowed 'General case' 0 C--O 1.197 -1.673 0 O-C-N 121.246 -0.909 . . . . 1.49 108.868 -179.016 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 316' ' ' THR . . . . . 0.756 ' OG1' ' O3 ' ' B' ' 200' ' ' PO3 . 30.9 p -65.43 -54.85 22.6 Favored 'General case' 0 N--CA 1.524 3.226 0 N-CA-C 119.122 3.008 . . . . 1.04 119.122 -173.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 317' ' ' ARG . . . . . 0.619 ' HG2' HH11 ' B' ' 317' ' ' ARG . 4.2 ttt-85 -53.49 -53.33 57.9 Favored Pre-proline 0 N--CA 1.493 1.705 0 C-N-CA 116.88 -1.928 . . . . 2.6000000000000001 112.446 -175.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 318' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' B' ' 317' ' ' ARG . 21.0 Cg_endo -66.41 -32.17 41.12 Favored 'Trans proline' 0 N--CA 1.484 0.963 0 C-N-CA 124.707 3.604 . . . . 0.14000000000000001 111.563 -177.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 319' ' ' ALA . . . . . 0.515 ' HB3' ' O ' ' B' ' 315' ' ' HIS . . . -67.07 -38.8 86.43 Favored 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 119.503 -0.879 . . . . 0.11 109.491 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -70.95 -39.68 72.46 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.865 -0.791 . . . . 1.03 108.865 178.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 67.8 tp60 -64.01 -39.31 93.83 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 117.863 -1.535 . . . . 0.12 109.535 177.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 322' ' ' PHE . . . . . 0.551 ' CE1' HD22 ' B' ' 377' ' ' LEU . 87.3 t80 -62.76 -45.3 93.32 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 122.583 1.182 . . . . 0.089999999999999997 108.703 -177.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 53.4 t -62.58 -42.26 95.24 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.278 0 CA-C-N 114.809 -1.087 . . . . 0.070000000000000007 110.713 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -63.87 -40.18 95.93 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.325 -0.859 . . . . 2.1699999999999999 109.851 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 325' ' ' GLU . . . . . 0.496 ' CD ' HD21 ' B' ' 380' ' ' LEU . 31.7 tt0 -68.9 -39.65 79.59 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.37 -0.831 . . . . 0.10000000000000001 109.56 177.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -59.07 -43.99 91.82 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.708 -1.245 . . . . 0.059999999999999998 109.417 178.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -61.37 -16.13 43.21 Favored 'General case' 0 N--CA 1.509 2.512 0 O-C-N 121.226 -0.922 . . . . 1.9399999999999999 113.338 178.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -76.92 -10.65 86.07 Favored Glycine 0 N--CA 1.479 1.529 0 O-C-N 119.999 -1.688 . . . . 0.080000000000000002 109.338 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -103.36 143.32 32.83 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.429 -1.63 . . . . 0.10000000000000001 110.101 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 47.8 p -75.66 -30.08 59.31 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.297 -0.877 . . . . 0.12 112.272 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 331' ' ' SER . . . . . . . . . . . . . 15.9 m -59.68 158.57 9.93 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 119.844 -1.785 . . . . 0.11 112.821 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 332' ' ' GLU . . . . . 0.769 ' OE1' ' N ' ' B' ' 333' ' ' ILE . 0.0 OUTLIER -79.0 130.4 35.49 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 102.81 -3.033 . . . . 0.12 102.81 171.266 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 333' ' ' ILE . . . . . 0.769 ' N ' ' OE1' ' B' ' 332' ' ' GLU . 39.2 mt -126.81 136.5 60.61 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.486 0 CA-C-O 122.192 0.996 . . . . 0.080000000000000002 109.305 -178.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 334' ' ' THR . . . . . 0.417 HG23 ' N ' ' B' ' 335' ' ' VAL . 93.3 m -124.94 143.21 50.99 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-O 123.216 1.484 . . . . 0.089999999999999997 109.978 178.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 335' ' ' VAL . . . . . 0.417 ' N ' HG23 ' B' ' 334' ' ' THR . 85.3 t -108.14 129.95 61.51 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.633 0 N-CA-C 105.469 -2.049 . . . . 0.059999999999999998 105.469 173.127 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 336' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' B' ' 340' ' ' LYS . 71.5 m -127.39 119.51 26.35 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 120.862 -1.149 . . . . 0.089999999999999997 109.046 -178.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 29.1 t -122.52 122.61 39.32 Favored 'General case' 0 N--CA 1.501 2.106 0 C-N-CA 119.992 -0.683 . . . . 0.080000000000000002 109.843 177.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 51.73 38.84 24.0 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.886 -1.134 . . . . 0.10000000000000001 112.87 -179.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 81.81 10.86 83.59 Favored Glycine 0 N--CA 1.501 3.009 0 O-C-N 119.944 -1.722 . . . . 0.11 112.522 177.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 340' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' B' ' 336' ' ' THR . 26.5 mttp -119.85 136.3 54.54 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 105.221 -2.14 . . . . 0.11 105.221 177.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 68.3 m -124.8 158.55 33.09 Favored 'General case' 0 C--N 1.276 -2.594 0 CA-C-O 123.738 1.732 . . . . 0.10000000000000001 112.408 -176.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -151.62 151.45 31.53 Favored 'General case' 0 C--N 1.278 -2.51 0 CA-C-N 112.449 -2.159 . . . . 0.080000000000000002 108.634 177.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 343' ' ' SER . . . . . 0.648 ' HG ' ' H ' ' B' ' 345' ' ' LYS . 8.0 t -70.63 135.95 48.78 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 105.556 -2.016 . . . . 0.089999999999999997 105.556 173.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 344' ' ' ALA . . . . . . . . . . . . . . . -72.95 -6.83 47.95 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.691 -1.256 . . . . 0.059999999999999998 110.703 179.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 345' ' ' LYS . . . . . 0.648 ' H ' ' HG ' ' B' ' 343' ' ' SER . 83.8 mttt -97.5 13.07 31.18 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.631 -1.293 . . . . 0.080000000000000002 109.395 -177.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 10.8 t -133.18 104.25 6.4 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 122.153 0.977 . . . . 0.89000000000000001 110.062 -178.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 347' ' ' LEU . . . . . . . . . . . . . 43.3 tp -57.34 -37.77 73.05 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 115.658 -0.701 . . . . 1.02 109.998 178.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 348' ' ' PHE . . . . . 0.456 ' HB3' ' OE2' ' A' ' 59' ' ' GLU . 75.3 t80 -59.0 -51.35 70.43 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.566 -1.334 . . . . 0.16 113.021 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 37.5 tptt -70.05 -32.46 70.58 Favored 'General case' 0 C--O 1.214 -0.769 0 O-C-N 119.664 -1.898 . . . . 2.1000000000000001 109.109 -178.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 350' ' ' LEU . . . . . . . . . . . . . 33.7 mt -62.84 -33.7 75.79 Favored 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 118.958 -1.097 . . . . 1.03 109.92 -177.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 351' ' ' GLN . . . . . . . . . . . . . 69.1 tp60 -67.69 -10.49 52.89 Favored 'General case' 0 C--N 1.293 -1.852 0 O-C-N 121.599 -0.688 . . . . 0.34000000000000002 109.915 -177.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 352' ' ' THR . . . . . . . . . . . . . 44.6 p -89.72 -7.74 53.87 Favored 'General case' 0 N--CA 1.502 2.132 0 C-N-CA 118.097 -1.441 . . . . 1.03 111.026 -178.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 81.6 mt -93.34 159.34 15.3 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.244 -0.91 . . . . 1.03 110.224 -178.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -86.76 104.8 2.97 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 106.94 -2.464 . . . . 0.089999999999999997 106.94 177.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 15.7 mt -119.46 47.29 1.73 Allowed 'General case' 0 C--N 1.309 -1.186 0 O-C-N 120.625 -1.515 . . . . 1.02 107.471 -178.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 52.0 p -81.36 172.53 13.46 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 118.849 -1.141 . . . . 1.0600000000000001 109.16 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -60.74 140.97 57.36 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 119.349 -0.94 . . . . 2.0899999999999999 109.76 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 91.4 -3.17 79.04 Favored Glycine 0 N--CA 1.5 2.941 0 C-N-CA 120.052 -1.071 . . . . 0.13 111.381 177.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 54.5 m -84.4 135.81 34.13 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 120.918 -1.342 . . . . 0.11 110.66 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 89.2 t -96.47 123.8 48.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 N-CA-C 106.304 -1.739 . . . . 0.12 106.304 176.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 22.3 m -112.27 160.13 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.335 0 C-N-CA 117.354 -1.739 . . . . 0.089999999999999997 110.636 178.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 90.4 m -108.89 128.34 54.83 Favored 'General case' 0 C--O 1.214 -0.789 0 O-C-N 120.596 -1.315 . . . . 0.11 107.565 175.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 363' ' ' ILE . . . . . 0.451 ' O ' ' HA ' ' B' ' 303' ' ' GLN . 33.2 mt -107.92 121.45 60.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 105.344 -2.095 . . . . 0.10000000000000001 105.344 176.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 364' ' ' SER . . . . . 0.407 ' HB3' ' HB3' ' B' ' 303' ' ' GLN . 0.7 OUTLIER -128.57 147.3 50.7 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 107.809 -1.182 . . . . 0.11 107.809 -179.646 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -139.76 153.32 47.13 Favored 'General case' 0 C--N 1.292 -1.925 0 C-N-CA 118.454 -1.298 . . . . 0.13 109.781 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 366' ' ' GLU . . . . . 0.501 ' HG2' ' HB2' ' B' ' 301' ' ' MET . 0.2 OUTLIER -141.14 110.88 6.48 Favored 'General case' 0 C--N 1.288 -2.081 0 C-N-CA 118.592 -1.243 . . . . 0.16 108.078 178.127 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . 165.22 -170.36 40.16 Favored Glycine 0 C--N 1.297 -1.59 0 C-N-CA 117.981 -2.056 . . . . 0.14000000000000001 110.327 178.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -58.27 -40.55 82.18 Favored 'General case' 0 C--N 1.277 -2.57 0 CA-C-N 114.33 -0.935 . . . . 0.16 112.306 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 369' ' ' ASP . . . . . . . . . . . . . 12.0 p30 -114.21 36.85 3.54 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 115.834 -2.346 . . . . 0.14000000000000001 108.519 -178.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 370' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -56.41 -33.56 65.91 Favored 'General case' 0 N--CA 1.521 3.107 0 N-CA-C 116.8 2.148 . . . . 0.16 116.8 -174.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 371' ' ' GLN . . . . . 0.5 ' H ' ' HG2' ' B' ' 371' ' ' GLN . 0.0 OUTLIER -76.95 -45.59 27.1 Favored 'General case' 0 N--CA 1.509 2.514 0 O-C-N 119.526 -1.984 . . . . 0.17999999999999999 110.914 -176.519 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 372' ' ' LYS . . . . . 0.779 ' HZ2' ' CE1' ' B' ' 376' ' ' HIS . 11.9 ttpp -63.56 -40.71 97.69 Favored 'General case' 0 C--N 1.283 -2.315 0 N-CA-C 106.965 -1.495 . . . . 0.14000000000000001 106.965 178.265 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -59.09 -49.51 77.61 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 117.541 -1.664 . . . . 0.11 110.025 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 374' ' ' VAL . . . . . . . . . . . . . 66.9 t -66.86 -42.25 88.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 CA-C-O 122.187 0.994 . . . . 0.12 109.267 -178.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -55.89 -47.78 76.8 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-O 122.059 0.933 . . . . 0.16 108.737 -178.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 376' ' ' HIS . . . . . 0.779 ' CE1' ' HZ2' ' B' ' 372' ' ' LYS . 13.9 m-70 -69.96 -38.23 76.04 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 116.005 -0.543 . . . . 0.14000000000000001 111.72 -178.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 377' ' ' LEU . . . . . 0.551 HD22 ' CE1' ' B' ' 322' ' ' PHE . 80.5 mt -75.64 -28.56 58.84 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.348 -1.47 . . . . 0.089999999999999997 110.875 -174.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 378' ' ' VAL . . . . . . . . . . . . . 2.1 t -71.44 -39.52 71.3 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.459 0 N-CA-C 106.35 -1.722 . . . . 0.13 106.35 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -67.89 -49.31 62.69 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 108.03 -1.1 . . . . 0.17000000000000001 108.03 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 380' ' ' LEU . . . . . 0.9 ' HG ' HD21 ' B' ' 384' ' ' LEU . 34.1 tp -57.18 -45.24 83.87 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 118.974 -1.09 . . . . 0.12 110.62 177.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 3.6 ttm -62.29 -37.44 85.53 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.871 -1.143 . . . . 0.12 111.508 -177.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -74.89 -31.78 61.67 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.111 -0.993 . . . . 0.14999999999999999 110.29 -178.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -78.87 -32.41 45.92 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.622 -0.673 . . . . 0.17000000000000001 111.247 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 384' ' ' LEU . . . . . 0.9 HD21 ' HG ' ' B' ' 380' ' ' LEU . 0.0 OUTLIER -50.12 125.54 12.48 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-O 124.432 2.063 . . . . 0.14999999999999999 112.762 178.802 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 385' ' ' GLU . . . . . 0.792 ' CD ' ' H ' ' B' ' 385' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.279 -2.48 0 CA-C-N 111.085 -2.779 . . . . 0.17999999999999999 110.093 -177.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 200' ' ' PO3 . . . . . 0.864 ' P ' HH21 ' A' ' 49' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.445 HD12 ' HA ' ' A' ' 4' ' ' LEU . 14.4 tp . . . . . 0 N--CA 1.483 1.208 0 N-CA-C 110.502 -0.184 . . . . 0.070000000000000007 110.502 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 1.244 ' CZ ' ' HD2' ' A' ' 147' ' ' ARG . 40.6 p90 -136.09 141.73 44.24 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 117.476 -1.69 . . . . 0.050000000000000003 111.884 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.5 mttp -82.27 142.73 31.86 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 107.944 -1.132 . . . . 0.050000000000000003 107.944 177.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.967 ' HA ' HD22 ' A' ' 11' ' ' ASN . 13.6 tp -136.81 125.64 24.08 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 107.285 -1.376 . . . . 0.050000000000000003 107.285 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.419 ' HA2' HD22 ' A' ' 141' ' ' LEU . . . -154.02 -166.92 15.44 Favored Glycine 0 C--N 1.289 -2.081 0 N-CA-C 108.557 -1.817 . . . . 0.059999999999999998 108.557 178.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.79 -34.24 77.46 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.599 -0.942 . . . . 0.080000000000000002 111.313 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -65.44 -14.93 62.02 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.759 -1.213 . . . . 0.070000000000000007 112.332 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.967 HD22 ' HA ' ' A' ' 7' ' ' LEU . 2.7 p-10 -123.7 22.85 8.94 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 119.5 -2.0 . . . . 0.050000000000000003 111.869 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 48.8 mt -118.49 123.35 71.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 107.539 -1.282 . . . . 0.059999999999999998 107.539 176.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -126.44 106.98 9.85 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.433 -0.792 . . . . 0.070000000000000007 109.252 -177.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.534 ' HA ' ' HB3' ' A' ' 83' ' ' GLN . 42.4 mt -100.33 160.52 14.27 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-O 122.702 1.239 . . . . 0.080000000000000002 112.883 -177.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 62.34 34.66 89.97 Favored Glycine 0 N--CA 1.497 2.749 0 CA-C-N 114.457 -1.247 . . . . 0.080000000000000002 113.833 175.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.423 ' HA ' ' HE ' ' A' ' 16' ' ' ARG . 1.0 OUTLIER -83.21 169.14 16.09 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 120.238 -1.742 . . . . 0.089999999999999997 109.733 178.348 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -140.89 140.75 34.59 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 107.409 -1.33 . . . . 0.089999999999999997 107.409 178.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -154.17 131.7 11.35 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 108.442 -0.948 . . . . 0.059999999999999998 108.442 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -77.48 -25.62 50.58 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.141 -0.975 . . . . 0.070000000000000007 109.69 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 64.2 p -134.75 159.65 40.66 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 119.075 -1.05 . . . . 0.070000000000000007 111.466 -178.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.667 ' HE3' ' OE1' ' A' ' 50' ' ' GLU . 28.2 pttt -65.98 -32.68 74.31 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.892 -0.781 . . . . 0.089999999999999997 108.892 175.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 51.4 mp0 -60.28 -42.8 96.21 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.514 -1.366 . . . . 0.089999999999999997 110.103 179.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -64.1 -41.73 97.17 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.628 -1.295 . . . . 0.070000000000000007 110.012 177.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.91 -42.51 94.66 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.636 -1.29 . . . . 0.050000000000000003 109.609 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.414 HG23 HD23 ' A' ' 47' ' ' LEU . 86.9 mt -64.37 -42.29 94.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.262 -0.899 . . . . 0.070000000000000007 109.802 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.46 ' HE ' ' HB2' ' A' ' 26' ' ' ARG . 4.4 ttm180 -62.61 -37.52 86.61 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.316 -0.865 . . . . 0.10000000000000001 109.98 178.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -67.25 -49.19 65.34 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.724 -1.235 . . . . 0.070000000000000007 108.403 179.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.19 -47.05 79.1 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.387 -0.821 . . . . 0.059999999999999998 109.605 178.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.31 -41.34 99.74 Favored Glycine 0 N--CA 1.497 2.722 0 N-CA-C 110.525 -1.03 . . . . 0.080000000000000002 110.525 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -61.18 -37.76 84.08 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.661 -1.494 . . . . 0.089999999999999997 110.331 177.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 92.4 mm-40 -73.17 -36.05 66.53 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.069 -1.019 . . . . 0.080000000000000002 110.181 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 73.5 mt -63.95 -38.2 90.19 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.857 -1.152 . . . . 0.070000000000000007 108.282 174.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.517 HG21 HG22 ' A' ' 38' ' ' VAL . 23.7 t -69.34 -45.48 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 O-C-N 120.879 -1.138 . . . . 0.11 108.178 177.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -57.49 -39.3 76.14 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.665 -0.647 . . . . 0.10000000000000001 112.625 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -86.19 8.42 73.99 Favored Glycine 0 N--CA 1.508 3.486 0 O-C-N 120.236 -1.54 . . . . 0.080000000000000002 112.796 -178.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.63 17.83 78.37 Favored Glycine 0 N--CA 1.488 2.139 0 O-C-N 120.678 -1.483 . . . . 0.089999999999999997 111.443 178.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.532 ' C ' HG13 ' A' ' 38' ' ' VAL . 80.3 m-85 -80.93 -36.24 31.3 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.274 -1.721 . . . . 0.080000000000000002 110.111 -179.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.532 HG13 ' C ' ' A' ' 37' ' ' TYR . 17.4 m -141.96 163.02 19.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-O 122.287 1.042 . . . . 0.10000000000000001 111.437 -177.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.443 ' OE1' ' NH1' ' A' ' 73' ' ' ARG . 83.3 mt-10 -86.63 165.1 34.54 Favored Pre-proline 0 C--N 1.3 -1.546 0 N-CA-C 107.29 -1.374 . . . . 0.14000000000000001 107.29 176.334 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.426 ' HD2' ' HB3' ' A' ' 39' ' ' GLU . 50.3 Cg_exo -50.53 -36.86 50.88 Favored 'Trans proline' 0 N--CA 1.51 2.443 0 C-N-CA 123.646 2.897 . . . . 0.14000000000000001 115.791 -177.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.421 ' CD ' HH21 ' A' ' 73' ' ' ARG . 41.2 mp0 -62.76 -20.59 65.11 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.508 -1.37 . . . . 0.14999999999999999 112.196 -178.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.795 ' HH ' ' H ' ' A' ' 66' ' ' GLY . 39.9 t80 -67.08 -27.79 67.65 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.616 -1.303 . . . . 0.11 112.313 -179.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 22.8 t -61.19 -49.01 86.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 120.265 -1.522 . . . . 0.10000000000000001 110.396 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 51.8 tp60 -67.11 -35.04 78.91 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.093 -1.004 . . . . 0.13 109.108 179.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.2 -33.35 73.32 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.232 -0.917 . . . . 0.12 109.765 177.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.467 ' HG3' ' O ' ' A' ' 42' ' ' TYR . 94.5 mtp -70.28 -37.93 74.94 Favored 'General case' 0 N--CA 1.482 1.128 0 O-C-N 120.545 -1.347 . . . . 0.10000000000000001 107.719 177.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.505 HD21 ' OE2' ' A' ' 50' ' ' GLU . 93.9 mt -70.14 -40.2 74.93 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.237 -1.023 . . . . 0.10000000000000001 108.237 178.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -60.14 -44.31 95.04 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.36 -0.837 . . . . 0.13 109.203 177.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.529 HH21 ' P ' ' B' ' 200' ' ' PO3 . 15.4 tpt180 -62.45 -39.19 92.57 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.843 -1.161 . . . . 2.1200000000000001 110.653 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.667 ' OE1' ' HE3' ' A' ' 21' ' ' LYS . 0.5 OUTLIER -62.54 -39.71 94.48 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.166 -0.959 . . . . 0.10000000000000001 110.895 -178.545 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.561 ' N ' ' HG2' ' A' ' 50' ' ' GLU . 28.5 tttt -62.75 -38.16 89.47 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 116.312 -0.403 . . . . 3.2999999999999998 110.896 -178.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 29.2 tp -64.76 -43.56 92.91 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 120.186 -1.571 . . . . 1.04 108.634 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.6 m -166.11 139.11 3.34 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.044 -1.035 . . . . 1.05 109.71 179.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -50.34 144.91 22.52 Favored 'Trans proline' 0 C--N 1.314 -1.286 0 C-N-CA 121.175 1.25 . . . . 0.78000000000000003 113.655 178.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 59.6 p -96.54 7.94 45.32 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 114.505 -1.225 . . . . 1.03 107.92 177.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.5 ' HH ' ' H ' ' A' ' 60' ' ' SER . 33.2 t80 -62.36 137.5 58.27 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 105.955 -1.869 . . . . 0.91000000000000003 105.955 174.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 18.1 mt -117.77 11.97 13.76 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 120.856 -1.152 . . . . 1.03 110.224 -178.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 85.56 170.94 47.67 Favored Glycine 0 C--N 1.302 -1.31 0 N-CA-C 108.667 -1.773 . . . . 0.10000000000000001 108.667 -178.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.81 ' CA ' ' N ' ' A' ' 60' ' ' SER . 76.6 mm-40 57.59 35.4 25.7 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.458 -1.025 . . . . 1.8600000000000001 113.527 177.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.81 ' N ' ' CA ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER 65.28 21.48 12.02 Favored 'General case' 0 N--CA 1.514 2.771 0 O-C-N 121.039 -1.038 . . . . 0.080000000000000002 113.555 176.731 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 94.2 mt -121.38 137.48 54.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 120.645 -1.285 . . . . 1.02 111.014 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -129.31 138.85 51.82 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 106.247 -1.76 . . . . 0.059999999999999998 106.247 174.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.416 ' H ' HG23 ' A' ' 63' ' ' VAL . 16.3 m -130.32 72.28 81.96 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.163 -0.96 . . . . 0.070000000000000007 110.103 -179.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -50.24 144.29 23.65 Favored 'Trans proline' 0 C--N 1.298 -2.12 0 CA-C-N 119.874 0.991 . . . . 0.76000000000000001 111.794 -177.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 1.177 ' NE2' ' P ' ' B' ' 200' ' ' PO3 . 2.4 p-80 -141.58 153.9 45.1 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 120.821 -1.174 . . . . 0.76000000000000001 108.735 175.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.795 ' H ' ' HH ' ' A' ' 42' ' ' TYR . . . -75.51 173.96 52.77 Favored Glycine 0 N--CA 1.501 2.999 0 N-CA-C 109.522 -1.431 . . . . 0.12 109.522 -177.251 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 82.0 p -80.18 167.93 19.73 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 116.818 -1.953 . . . . 1.27 109.376 179.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.409 ' C ' ' H ' ' A' ' 70' ' ' ALA . 5.3 m -70.52 -23.65 24.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 121.382 -0.824 . . . . 0.14000000000000001 109.751 -179.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.501 ' N ' ' OE1' ' A' ' 69' ' ' GLU . 58.7 mp0 -75.27 9.06 2.26 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.985 -1.072 . . . . 0.14999999999999999 109.725 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.409 ' H ' ' C ' ' A' ' 68' ' ' VAL . . . -121.73 15.27 11.0 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.709 -0.619 . . . . 0.13 109.813 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 49.5 pttt -60.87 -37.95 83.9 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.016 -1.053 . . . . 0.14999999999999999 109.136 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -69.27 -4.13 16.68 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.658 -0.651 . . . . 0.14000000000000001 111.543 -177.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.443 ' NH1' ' OE1' ' A' ' 39' ' ' GLU . 15.6 mmm180 -104.96 7.95 34.32 Favored 'General case' 0 N--CA 1.506 2.33 0 O-C-N 120.444 -1.41 . . . . 0.14000000000000001 109.374 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 91.1 t -95.48 128.49 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 107.082 -1.451 . . . . 0.11 107.082 177.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 28.1 mt -96.75 -17.15 20.47 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 115.721 -0.672 . . . . 0.11 109.455 -178.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 39.6 pttt -176.6 159.67 1.9 Allowed 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.523 -0.918 . . . . 0.089999999999999997 108.523 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 18.2 m -76.29 138.14 40.34 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.355 -0.841 . . . . 1.02 111.079 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -160.69 161.05 32.45 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 118.735 -1.698 . . . . 0.059999999999999998 110.863 -179.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.477 ' O ' HG22 ' A' ' 79' ' ' VAL . 33.3 m -137.65 150.96 25.62 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 O-C-N 121.603 -0.939 . . . . 0.029999999999999999 108.842 179.314 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.9 m -127.02 113.14 31.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 106.271 -1.752 . . . . 0.040000000000000001 106.271 175.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -86.02 115.38 23.58 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.789 0.804 . . . . 0.050000000000000003 109.238 -178.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 39.5 m -119.0 122.11 41.44 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 121.86 0.838 . . . . 0.040000000000000001 110.506 -177.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.534 ' HB3' ' HA ' ' A' ' 14' ' ' LEU . 30.7 tt0 -100.71 126.47 47.25 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-O 122.108 0.956 . . . . 0.080000000000000002 111.805 -178.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -123.35 87.24 51.79 Favored Pre-proline 0 C--N 1.302 -1.471 0 N-CA-C 107.025 -1.472 . . . . 0.059999999999999998 107.025 177.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -54.06 -36.05 83.43 Favored 'Trans proline' 0 N--CA 1.501 1.925 0 C-N-CA 122.847 2.365 . . . . 0.080000000000000002 113.081 -177.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -81.73 -13.27 58.02 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.481 -0.762 . . . . 0.080000000000000002 110.323 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 90.08 152.59 27.23 Favored Glycine 0 N--CA 1.485 1.912 0 O-C-N 120.791 -1.193 . . . . 0.059999999999999998 113.024 175.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 61.5 t -136.47 120.43 24.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 106.549 -1.649 . . . . 0.050000000000000003 106.549 177.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.711 ' HA ' HD11 ' A' ' 97' ' ' ILE . 4.3 ttt180 -60.31 121.27 11.58 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.829 -1.169 . . . . 0.089999999999999997 109.131 -179.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -119.77 -11.51 9.36 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 118.656 -1.218 . . . . 1.29 111.573 -178.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -118.54 -158.21 10.74 Favored Glycine 1 N--CA 1.516 4.009 0 O-C-N 119.588 -1.945 . . . . 0.20999999999999999 112.255 -178.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -92.54 -22.8 19.33 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 113.842 1.052 . . . . 0.26000000000000001 113.842 -176.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -96.4 154.45 17.26 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.683 -1.261 . . . . 1.6200000000000001 109.461 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -60.29 -23.89 64.51 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.747 -1.22 . . . . 2.5499999999999998 109.964 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -86.52 1.87 50.02 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.692 -1.255 . . . . 1.74 109.461 -178.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -83.2 60.17 5.39 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 118.764 -1.175 . . . . 0.16 107.98 178.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.711 HD11 ' HA ' ' A' ' 89' ' ' ARG . 41.8 mm -101.6 135.32 38.75 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 CA-C-O 121.723 0.773 . . . . 0.080000000000000002 110.169 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -108.56 130.95 55.28 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 121.545 0.688 . . . . 0.059999999999999998 109.682 178.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.62 HH11 ' HE2' ' A' ' 133' ' ' HIS . 87.4 mtm180 -102.5 -17.07 15.93 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 106.557 -1.646 . . . . 0.089999999999999997 106.557 175.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 71.1 mt -116.87 112.16 20.68 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.12 -1.067 . . . . 0.059999999999999998 108.12 176.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 93.8 t -113.4 104.07 16.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 106.257 -1.757 . . . . 0.040000000000000001 106.257 179.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 72.3 mt -107.11 102.91 14.65 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.087 0 CA-C-O 122.292 1.044 . . . . 0.040000000000000001 111.035 -176.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -77.6 131.97 11.57 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.023 -1.631 . . . . 0.040000000000000001 109.023 -178.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 19.4 pt -133.45 153.5 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 O-C-N 120.264 -1.727 . . . . 1.03 112.916 -176.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -137.38 133.71 35.13 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 106.189 -1.782 . . . . 1.03 106.189 177.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -147.59 140.97 25.3 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 120.113 -1.617 . . . . 1.02 110.955 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 60.6 mtp180 -70.74 156.29 39.7 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.588 0.709 . . . . 4.3099999999999996 110.331 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 57.81 25.4 11.92 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.069 -0.715 . . . . 2.46 109.069 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.521 ' OD1' ' ND1' ' A' ' 111' ' ' HIS . 63.1 t30 53.27 37.58 25.6 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.172 -0.955 . . . . 1.6100000000000001 109.766 178.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -84.05 28.89 0.58 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.131 -0.981 . . . . 0.17999999999999999 111.093 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.75 ' CA ' ' N ' ' A' ' 112' ' ' ILE . 40.0 p-80 -50.54 -38.3 44.08 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.881 -1.137 . . . . 0.20999999999999999 112.095 179.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.75 ' N ' ' CA ' ' A' ' 111' ' ' HIS . 21.0 tt -63.18 -28.96 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 119.986 -1.696 . . . . 1.03 111.005 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -69.81 -40.94 75.63 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 120.516 -1.365 . . . . 1.46 108.334 178.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 85.1 t -69.38 -43.61 80.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.428 -0.795 . . . . 0.070000000000000007 109.414 178.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.11 -42.46 95.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.132 -0.98 . . . . 1.02 109.471 178.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 94.7 m -62.35 -42.45 99.41 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.295 -0.878 . . . . 1.03 109.899 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 11.2 t -63.66 -45.91 88.0 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.161 -0.962 . . . . 0.070000000000000007 109.572 178.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 57.3 mt -64.09 -48.26 76.87 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.07 -1.019 . . . . 0.070000000000000007 111.173 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 40.0 p -66.38 -28.01 68.31 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 120.986 -1.071 . . . . 1.02 111.589 -178.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -67.81 -35.88 79.41 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 121.007 -1.058 . . . . 1.97 108.145 177.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -80.12 -15.55 56.87 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.967 -1.083 . . . . 0.089999999999999997 109.844 177.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 80.5 mt -106.01 27.86 8.18 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.984 -1.072 . . . . 1.03 110.675 178.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -72.46 -12.73 61.22 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 120.937 -1.102 . . . . 0.48999999999999999 111.879 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -110.66 131.38 55.1 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.588 -1.32 . . . . 0.13 110.619 179.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -57.72 -34.55 69.6 Favored 'General case' 0 N--CA 1.503 2.181 0 C-N-CA 123.306 0.642 . . . . 0.14999999999999999 112.262 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.461 ' O ' ' HG2' ' A' ' 130' ' ' ARG . 59.7 p -65.75 -34.01 77.18 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 120.694 -1.254 . . . . 0.13 109.88 179.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 85.6 t -65.65 -43.9 93.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.638 -1.289 . . . . 0.11 109.974 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 95.8 mt -64.33 -46.06 94.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.941 -1.1 . . . . 1.02 110.228 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.616 ' HA ' ' OE1' ' A' ' 129' ' ' GLU . 8.7 mm-40 -57.08 -46.85 82.19 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.223 -0.923 . . . . 0.11 109.864 178.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.461 ' HG2' ' O ' ' A' ' 126' ' ' SER . 43.4 mmm-85 -63.52 -43.7 96.4 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.215 -0.928 . . . . 0.13 110.214 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 83.3 mt -66.89 -35.04 79.12 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.066 -1.022 . . . . 0.080000000000000002 111.148 -179.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -67.33 -27.18 66.93 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.308 -0.87 . . . . 0.080000000000000002 113.285 -176.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.62 ' HE2' HH11 ' A' ' 99' ' ' ARG . 97.0 m-70 -126.49 1.7 6.92 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 120.082 -1.637 . . . . 0.10000000000000001 113.322 -176.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.696 ' HG1' ' H ' ' A' ' 136' ' ' SER . 9.4 t -68.31 145.89 53.8 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.502 -1.374 . . . . 0.10000000000000001 111.271 -178.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 72.8 p -106.06 9.92 32.29 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.27 -1.381 . . . . 0.12 107.27 176.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 0.696 ' H ' ' HG1' ' A' ' 134' ' ' THR . 47.0 t -107.02 116.4 31.86 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 121.588 0.709 . . . . 0.11 112.696 -178.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 15.9 t -65.59 -41.67 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 108.501 -0.925 . . . . 0.10000000000000001 108.501 176.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -56.87 -39.99 75.35 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.233 -0.917 . . . . 0.11 110.408 178.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -63.66 -42.75 98.03 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.936 -1.103 . . . . 0.11 108.45 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 92.0 t -57.29 -51.27 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 108.508 -0.923 . . . . 0.080000000000000002 108.508 177.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.419 HD22 ' HA2' ' A' ' 8' ' ' GLY . 78.4 mt -57.7 -45.98 84.96 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.238 -0.914 . . . . 0.080000000000000002 110.294 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -58.81 -47.91 83.13 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.814 -1.179 . . . . 0.11 111.02 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 83.7 mt -67.99 -23.49 65.03 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.983 -1.073 . . . . 0.10000000000000001 112.606 -177.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.661 ' O ' ' NH1' ' A' ' 147' ' ' ARG . 91.7 mt -110.05 9.27 24.21 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.367 -1.458 . . . . 0.070000000000000007 111.391 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.694 ' HA ' HH12 ' A' ' 147' ' ' ARG . . . -76.97 -25.25 52.57 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 120.689 -1.257 . . . . 0.080000000000000002 112.305 -178.151 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -81.77 -8.81 86.32 Favored Glycine 0 N--CA 1.504 3.211 0 O-C-N 120.57 -1.331 . . . . 0.080000000000000002 111.156 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 1.244 ' HD2' ' CZ ' ' A' ' 5' ' ' PHE . 2.0 ptt-85 . . . . . 0 N--CA 1.486 1.371 0 O-C-N 121.053 -1.263 . . . . 0.070000000000000007 109.64 179.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 301' ' ' MET . . . . . 0.501 ' HB2' ' HG2' ' B' ' 366' ' ' GLU . 3.4 ttm . . . . . 0 C--O 1.214 -0.786 0 CA-C-O 121.931 0.872 . . . . 0.17000000000000001 108.948 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 302' ' ' PHE . . . . . 0.454 ' N ' ' CG ' ' B' ' 301' ' ' MET . 46.9 t80 -139.74 142.97 36.77 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 107.27 -1.381 . . . . 0.17000000000000001 107.27 178.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 303' ' ' GLN . . . . . 0.497 ' O ' ' HG2' ' B' ' 304' ' ' GLN . 5.4 pt20 -153.0 156.31 38.58 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 120.904 -1.123 . . . . 0.14000000000000001 109.495 179.236 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 304' ' ' GLN . . . . . 0.497 ' HG2' ' O ' ' B' ' 303' ' ' GLN . 42.2 mm-40 -152.18 149.21 28.51 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 108.033 -1.099 . . . . 0.16 108.033 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -97.19 152.35 18.91 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.046 -1.034 . . . . 0.13 108.428 178.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 7.2 p -147.83 144.34 19.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 N-CA-C 107.478 -1.304 . . . . 0.12 107.478 177.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 85.4 m -96.67 136.54 37.06 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 122.169 0.985 . . . . 0.14000000000000001 110.079 177.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 51.7 mt -84.88 114.25 24.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 105.478 -2.045 . . . . 0.13 105.478 177.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 47.4 p -106.7 -4.39 19.51 Favored 'General case' 0 C--N 1.264 -3.117 0 N-CA-C 114.704 1.372 . . . . 0.17000000000000001 114.704 -178.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 310' ' ' ALA . . . . . 0.544 ' HB1' ' C ' ' B' ' 385' ' ' GLU . . . -71.44 141.87 86.02 Favored Pre-proline 0 N--CA 1.499 2.012 0 O-C-N 119.683 -1.886 . . . . 0.16 110.658 178.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -45.54 -47.63 13.03 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 124.749 3.633 . . . . 0.20000000000000001 114.202 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 44.5 t-20 -102.21 27.61 6.54 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 116.035 -2.266 . . . . 1.6299999999999999 108.725 179.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 58.83 -144.0 44.73 Favored Glycine 0 N--CA 1.496 2.699 0 C-N-CA 117.708 -2.187 . . . . 0.14000000000000001 109.52 -179.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 314' ' ' LEU . . . . . . . . . . . . . 9.8 tp -96.93 82.92 3.3 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.203 -1.175 . . . . 0.11 109.363 178.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 315' ' ' HIS . . . . . 1.162 ' ND1' ' P ' ' B' ' 200' ' ' PO3 . 0.4 OUTLIER -80.85 -159.83 0.27 Allowed 'General case' 0 N--CA 1.503 2.209 0 N-CA-C 107.277 -1.379 . . . . 1.49 107.277 179.058 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 316' ' ' THR . . . . . 0.609 ' N ' ' CG ' ' B' ' 315' ' ' HIS . 63.7 p -66.39 -53.14 39.31 Favored 'General case' 0 N--CA 1.513 2.687 0 N-CA-C 120.177 3.399 . . . . 1.04 120.177 -174.314 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 317' ' ' ARG . . . . . 0.606 ' HG2' HH11 ' B' ' 317' ' ' ARG . 4.8 ttt-85 -54.9 -53.33 62.23 Favored Pre-proline 0 N--CA 1.493 1.705 0 CA-C-N 122.593 2.451 . . . . 2.6000000000000001 112.446 -174.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 318' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' B' ' 317' ' ' ARG . 21.0 Cg_endo -66.41 -32.17 41.12 Favored 'Trans proline' 0 N--CA 1.484 0.963 0 C-N-CA 124.707 3.604 . . . . 0.14000000000000001 111.563 -177.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 319' ' ' ALA . . . . . 0.539 ' HB3' ' O ' ' B' ' 315' ' ' HIS . . . -67.07 -38.8 86.43 Favored 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 119.503 -0.879 . . . . 0.11 109.491 -179.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -70.95 -39.68 72.46 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.865 -0.791 . . . . 1.03 108.865 178.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 67.8 tp60 -64.01 -39.31 93.83 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 117.863 -1.535 . . . . 0.12 109.535 177.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 322' ' ' PHE . . . . . 0.551 ' CE1' HD22 ' B' ' 377' ' ' LEU . 87.3 t80 -62.76 -45.3 93.32 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 122.583 1.182 . . . . 0.089999999999999997 108.703 -177.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 53.4 t -62.58 -42.26 95.24 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.278 0 CA-C-N 114.809 -1.087 . . . . 0.070000000000000007 110.713 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -63.87 -40.18 95.93 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.325 -0.859 . . . . 2.1699999999999999 109.851 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 325' ' ' GLU . . . . . 0.496 ' CD ' HD21 ' B' ' 380' ' ' LEU . 31.7 tt0 -68.9 -39.65 79.59 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.37 -0.831 . . . . 0.10000000000000001 109.56 177.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -59.07 -43.99 91.82 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.708 -1.245 . . . . 0.059999999999999998 109.417 178.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -61.37 -16.13 43.21 Favored 'General case' 0 N--CA 1.509 2.512 0 O-C-N 121.226 -0.922 . . . . 1.9399999999999999 113.338 178.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -76.92 -10.65 86.07 Favored Glycine 0 N--CA 1.479 1.529 0 O-C-N 119.999 -1.688 . . . . 0.080000000000000002 109.338 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -103.36 143.32 32.83 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.429 -1.63 . . . . 0.10000000000000001 110.101 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 47.8 p -75.66 -30.08 59.31 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.297 -0.877 . . . . 0.12 112.272 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 331' ' ' SER . . . . . . . . . . . . . 15.9 m -59.68 158.57 9.93 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 119.844 -1.785 . . . . 0.11 112.821 -179.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 332' ' ' GLU . . . . . 0.769 ' OE1' ' N ' ' B' ' 333' ' ' ILE . 0.0 OUTLIER -79.0 130.4 35.49 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 102.81 -3.033 . . . . 0.12 102.81 171.266 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 333' ' ' ILE . . . . . 0.769 ' N ' ' OE1' ' B' ' 332' ' ' GLU . 39.2 mt -126.81 136.5 60.61 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.486 0 CA-C-O 122.192 0.996 . . . . 0.080000000000000002 109.305 -178.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 334' ' ' THR . . . . . 0.417 HG23 ' N ' ' B' ' 335' ' ' VAL . 93.3 m -124.94 143.21 50.99 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-O 123.216 1.484 . . . . 0.089999999999999997 109.978 178.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 335' ' ' VAL . . . . . 0.417 ' N ' HG23 ' B' ' 334' ' ' THR . 85.3 t -108.14 129.95 61.51 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.633 0 N-CA-C 105.469 -2.049 . . . . 0.059999999999999998 105.469 173.127 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 336' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' B' ' 340' ' ' LYS . 71.5 m -127.39 119.51 26.35 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 120.862 -1.149 . . . . 0.089999999999999997 109.046 -178.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 29.1 t -122.52 122.61 39.32 Favored 'General case' 0 N--CA 1.501 2.106 0 C-N-CA 119.992 -0.683 . . . . 0.080000000000000002 109.843 177.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 51.73 38.84 24.0 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.886 -1.134 . . . . 0.10000000000000001 112.87 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 81.81 10.86 83.59 Favored Glycine 0 N--CA 1.501 3.009 0 O-C-N 119.944 -1.722 . . . . 0.11 112.522 177.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 340' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' B' ' 336' ' ' THR . 26.5 mttp -119.85 136.3 54.54 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 105.221 -2.14 . . . . 0.11 105.221 177.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 68.3 m -124.8 158.55 33.09 Favored 'General case' 0 C--N 1.276 -2.594 0 CA-C-O 123.738 1.732 . . . . 0.10000000000000001 112.408 -176.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -151.62 151.45 31.53 Favored 'General case' 0 C--N 1.278 -2.51 0 CA-C-N 112.449 -2.159 . . . . 0.080000000000000002 108.634 177.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 343' ' ' SER . . . . . 0.648 ' HG ' ' H ' ' B' ' 345' ' ' LYS . 8.0 t -70.63 135.95 48.78 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 105.556 -2.016 . . . . 0.089999999999999997 105.556 173.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 344' ' ' ALA . . . . . . . . . . . . . . . -72.95 -6.83 47.95 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.691 -1.256 . . . . 0.059999999999999998 110.703 179.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 345' ' ' LYS . . . . . 0.648 ' H ' ' HG ' ' B' ' 343' ' ' SER . 83.8 mttt -97.5 13.07 31.18 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.631 -1.293 . . . . 0.080000000000000002 109.395 -177.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 11.0 t -133.18 104.25 6.4 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 122.153 0.977 . . . . 0.89000000000000001 110.062 -178.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 347' ' ' LEU . . . . . . . . . . . . . 43.1 tp -57.34 -37.77 73.05 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 115.658 -0.701 . . . . 1.02 109.998 178.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 348' ' ' PHE . . . . . 0.441 ' HB3' ' OE2' ' A' ' 59' ' ' GLU . 75.2 t80 -59.0 -51.35 70.43 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.566 -1.334 . . . . 0.16 113.021 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 37.5 tptt -70.05 -32.46 70.58 Favored 'General case' 0 C--O 1.214 -0.769 0 O-C-N 119.664 -1.898 . . . . 2.1000000000000001 109.109 -178.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 350' ' ' LEU . . . . . . . . . . . . . 33.3 mt -62.84 -33.7 75.79 Favored 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 118.958 -1.097 . . . . 1.03 109.92 -177.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 351' ' ' GLN . . . . . . . . . . . . . 69.1 tp60 -67.69 -10.49 52.89 Favored 'General case' 0 C--N 1.293 -1.852 0 O-C-N 121.599 -0.688 . . . . 0.34000000000000002 109.915 -177.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 352' ' ' THR . . . . . . . . . . . . . 45.7 p -89.72 -7.74 53.87 Favored 'General case' 0 N--CA 1.502 2.132 0 C-N-CA 118.097 -1.441 . . . . 1.03 111.026 -178.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 83.2 mt -93.34 159.34 15.3 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.244 -0.91 . . . . 1.03 110.224 -178.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -86.76 104.8 2.97 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 106.94 -2.464 . . . . 0.089999999999999997 106.94 177.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 16.3 mt -119.46 47.29 1.73 Allowed 'General case' 0 C--N 1.309 -1.186 0 O-C-N 120.625 -1.515 . . . . 1.02 107.471 -178.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 52.8 p -81.36 172.53 13.46 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 118.849 -1.141 . . . . 1.0600000000000001 109.16 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -60.74 140.97 57.36 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 119.349 -0.94 . . . . 2.0899999999999999 109.76 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 91.4 -3.17 79.04 Favored Glycine 0 N--CA 1.5 2.941 0 C-N-CA 120.052 -1.071 . . . . 0.13 111.381 177.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 54.5 m -84.4 135.81 34.13 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 120.918 -1.342 . . . . 0.11 110.66 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 89.2 t -96.47 123.8 48.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 N-CA-C 106.304 -1.739 . . . . 0.12 106.304 176.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 22.3 m -112.27 160.13 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.335 0 C-N-CA 117.354 -1.739 . . . . 0.089999999999999997 110.636 178.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 90.4 m -108.89 128.34 54.83 Favored 'General case' 0 C--O 1.214 -0.789 0 O-C-N 120.596 -1.315 . . . . 0.11 107.565 175.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 363' ' ' ILE . . . . . 0.451 ' O ' ' HA ' ' B' ' 303' ' ' GLN . 33.2 mt -107.92 121.45 60.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 105.344 -2.095 . . . . 0.10000000000000001 105.344 176.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 364' ' ' SER . . . . . 0.407 ' HB3' ' HB3' ' B' ' 303' ' ' GLN . 0.7 OUTLIER -128.57 147.3 50.7 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 107.809 -1.182 . . . . 0.11 107.809 -179.646 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -139.76 153.32 47.13 Favored 'General case' 0 C--N 1.292 -1.925 0 C-N-CA 118.454 -1.298 . . . . 0.13 109.781 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 366' ' ' GLU . . . . . 0.501 ' HG2' ' HB2' ' B' ' 301' ' ' MET . 0.2 OUTLIER -141.14 110.88 6.48 Favored 'General case' 0 C--N 1.288 -2.081 0 C-N-CA 118.592 -1.243 . . . . 0.16 108.078 178.127 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . 165.22 -170.36 40.16 Favored Glycine 0 C--N 1.297 -1.59 0 C-N-CA 117.981 -2.056 . . . . 0.14000000000000001 110.327 178.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -58.27 -40.55 82.18 Favored 'General case' 0 C--N 1.277 -2.57 0 CA-C-N 114.33 -0.935 . . . . 0.16 112.306 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 369' ' ' ASP . . . . . . . . . . . . . 12.0 p30 -114.21 36.85 3.54 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 115.834 -2.346 . . . . 0.14000000000000001 108.519 -178.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 370' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -56.41 -33.56 65.91 Favored 'General case' 0 N--CA 1.521 3.107 0 N-CA-C 116.8 2.148 . . . . 0.16 116.8 -174.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 371' ' ' GLN . . . . . 0.5 ' H ' ' HG2' ' B' ' 371' ' ' GLN . 0.0 OUTLIER -76.95 -45.59 27.1 Favored 'General case' 0 N--CA 1.509 2.514 0 O-C-N 119.526 -1.984 . . . . 0.17999999999999999 110.914 -176.519 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 372' ' ' LYS . . . . . 0.779 ' HZ2' ' CE1' ' B' ' 376' ' ' HIS . 11.9 ttpp -63.56 -40.71 97.69 Favored 'General case' 0 C--N 1.283 -2.315 0 N-CA-C 106.965 -1.495 . . . . 0.14000000000000001 106.965 178.265 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -59.09 -49.51 77.61 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 117.541 -1.664 . . . . 0.11 110.025 -178.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 374' ' ' VAL . . . . . . . . . . . . . 66.9 t -66.86 -42.25 88.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 CA-C-O 122.187 0.994 . . . . 0.12 109.267 -178.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -55.89 -47.78 76.8 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-O 122.059 0.933 . . . . 0.16 108.737 -178.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 376' ' ' HIS . . . . . 0.779 ' CE1' ' HZ2' ' B' ' 372' ' ' LYS . 13.9 m-70 -69.96 -38.23 76.04 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 116.005 -0.543 . . . . 0.14000000000000001 111.72 -178.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 377' ' ' LEU . . . . . 0.551 HD22 ' CE1' ' B' ' 322' ' ' PHE . 80.5 mt -75.64 -28.56 58.84 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.348 -1.47 . . . . 0.089999999999999997 110.875 -174.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 378' ' ' VAL . . . . . . . . . . . . . 2.1 t -71.44 -39.52 71.3 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.459 0 N-CA-C 106.35 -1.722 . . . . 0.13 106.35 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -67.89 -49.31 62.69 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 108.03 -1.1 . . . . 0.17000000000000001 108.03 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 380' ' ' LEU . . . . . 0.9 ' HG ' HD21 ' B' ' 384' ' ' LEU . 34.1 tp -57.18 -45.24 83.87 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 118.974 -1.09 . . . . 0.12 110.62 177.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 3.6 ttm -62.29 -37.44 85.53 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.871 -1.143 . . . . 0.12 111.508 -177.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -74.89 -31.78 61.67 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.111 -0.993 . . . . 0.14999999999999999 110.29 -178.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -78.87 -32.41 45.92 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.622 -0.673 . . . . 0.17000000000000001 111.247 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 384' ' ' LEU . . . . . 0.9 HD21 ' HG ' ' B' ' 380' ' ' LEU . 0.0 OUTLIER -50.12 125.54 12.48 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-O 124.432 2.063 . . . . 0.14999999999999999 112.762 178.802 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 385' ' ' GLU . . . . . 0.792 ' CD ' ' H ' ' B' ' 385' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.279 -2.48 0 CA-C-N 111.085 -2.779 . . . . 0.17999999999999999 110.093 -177.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 200' ' ' PO3 . . . . . 1.177 ' P ' ' NE2' ' A' ' 65' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 14.4 tp . . . . . 0 N--CA 1.483 1.208 0 N-CA-C 110.502 -0.184 . . . . 0.06 110.502 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 1.259 ' CZ ' ' HD2' ' A' ' 147' ' ' ARG . 40.6 p90 -136.09 141.73 44.24 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 117.476 -1.69 . . . . 0.04 111.884 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.5 mttp -82.27 142.73 31.86 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 107.944 -1.132 . . . . 0.05 107.944 177.36 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 1.02 ' HA ' HD21 ' A' ' 11' ' ' ASN . 13.6 tp -136.81 125.64 24.08 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 107.285 -1.376 . . . . 0.05 107.285 179.131 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -154.02 -166.92 15.44 Favored Glycine 0 C--N 1.289 -2.081 0 N-CA-C 108.557 -1.817 . . . . 0.06 108.557 178.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.79 -34.24 77.46 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.599 -0.942 . . . . 0.08 111.313 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -65.44 -14.93 62.02 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.759 -1.213 . . . . 0.07 112.332 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 1.02 HD21 ' HA ' ' A' ' 7' ' ' LEU . 2.7 p-10 -123.7 22.85 8.94 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 119.5 -2.0 . . . . 0.05 111.869 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 48.8 mt -118.49 123.35 71.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 107.539 -1.282 . . . . 0.06 107.539 176.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -126.44 106.98 9.85 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.433 -0.792 . . . . 0.06 109.252 -177.548 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.559 ' HA ' ' HB3' ' A' ' 83' ' ' GLN . 42.4 mt -100.33 160.52 14.27 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-O 122.702 1.239 . . . . 0.08 112.883 -177.423 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 62.34 34.66 89.97 Favored Glycine 0 N--CA 1.497 2.749 0 CA-C-N 114.457 -1.247 . . . . 0.08 113.833 175.273 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.46 ' HA ' ' HE ' ' A' ' 16' ' ' ARG . 1.0 OUTLIER -83.21 169.14 16.09 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 120.238 -1.742 . . . . 0.08 109.733 178.348 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -140.89 140.75 34.59 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 107.409 -1.33 . . . . 0.08 107.409 178.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -154.17 131.7 11.35 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 108.442 -0.948 . . . . 0.06 108.442 179.134 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -77.48 -25.62 50.58 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.141 -0.975 . . . . 0.06 109.69 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 64.2 p -134.75 159.65 40.66 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 119.075 -1.05 . . . . 0.07 111.466 -178.387 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.669 ' HE3' ' OE1' ' A' ' 50' ' ' GLU . 28.2 pttt -65.98 -32.68 74.31 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.892 -0.781 . . . . 0.09 108.892 175.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 51.4 mp0 -60.28 -42.8 96.21 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.514 -1.366 . . . . 0.08 110.103 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -64.1 -41.73 97.17 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.628 -1.295 . . . . 0.07 110.012 177.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.91 -42.51 94.66 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.636 -1.29 . . . . 0.05 109.609 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.37 -42.29 94.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.262 -0.899 . . . . 0.07 109.802 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.46 ' HE ' ' HB2' ' A' ' 26' ' ' ARG . 4.4 ttm180 -62.61 -37.52 86.61 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.316 -0.865 . . . . 0.1 109.98 178.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -67.25 -49.19 65.34 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.724 -1.235 . . . . 0.07 108.403 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.19 -47.05 79.1 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.387 -0.821 . . . . 0.06 109.605 178.333 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.31 -41.34 99.74 Favored Glycine 0 N--CA 1.497 2.722 0 N-CA-C 110.525 -1.03 . . . . 0.08 110.525 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -61.18 -37.76 84.08 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.661 -1.494 . . . . 0.09 110.331 177.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 92.4 mm-40 -73.17 -36.05 66.53 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.069 -1.019 . . . . 0.08 110.181 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 73.5 mt -63.95 -38.2 90.19 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.857 -1.152 . . . . 0.07 108.282 174.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 23.7 t -69.34 -45.48 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 O-C-N 120.879 -1.138 . . . . 0.1 108.178 177.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -57.49 -39.3 76.14 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.665 -0.647 . . . . 0.1 112.625 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -86.19 8.42 73.99 Favored Glycine 0 N--CA 1.508 3.486 0 O-C-N 120.236 -1.54 . . . . 0.08 112.796 -178.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.63 17.83 78.37 Favored Glycine 0 N--CA 1.488 2.139 0 O-C-N 120.678 -1.483 . . . . 0.09 111.443 178.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.422 ' CD1' ' HA3' ' A' ' 78' ' ' GLY . 80.3 m-85 -80.93 -36.24 31.3 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.274 -1.721 . . . . 0.08 110.111 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 17.4 m -141.96 163.02 19.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-O 122.287 1.042 . . . . 0.1 111.437 -177.648 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.443 ' OE1' ' NH1' ' A' ' 73' ' ' ARG . 83.3 mt-10 -86.63 165.1 34.54 Favored Pre-proline 0 C--N 1.3 -1.546 0 N-CA-C 107.29 -1.374 . . . . 0.14 107.29 176.334 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.429 ' HD2' ' HB3' ' A' ' 39' ' ' GLU . 50.3 Cg_exo -50.53 -36.86 50.88 Favored 'Trans proline' 0 N--CA 1.51 2.443 0 C-N-CA 123.646 2.897 . . . . 0.13 115.791 -177.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.44 ' CD ' HH21 ' A' ' 73' ' ' ARG . 41.2 mp0 -62.76 -20.59 65.11 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.508 -1.37 . . . . 0.15 112.196 -178.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.466 ' O ' ' HG3' ' A' ' 46' ' ' MET . 39.9 t80 -67.08 -27.79 67.65 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.616 -1.303 . . . . 0.11 112.313 -179.462 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 22.8 t -61.19 -49.01 86.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 120.265 -1.522 . . . . 0.1 110.396 -179.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 51.8 tp60 -67.11 -35.04 78.91 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.093 -1.004 . . . . 0.12 109.108 179.017 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.2 -33.35 73.32 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.232 -0.917 . . . . 0.11 109.765 177.144 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.466 ' HG3' ' O ' ' A' ' 42' ' ' TYR . 94.5 mtp -70.28 -37.93 74.94 Favored 'General case' 0 N--CA 1.482 1.128 0 O-C-N 120.545 -1.347 . . . . 0.1 107.719 177.24 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 93.9 mt -70.14 -40.2 74.93 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.237 -1.023 . . . . 0.1 108.237 178.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -60.14 -44.31 95.04 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.36 -0.837 . . . . 0.13 109.203 177.153 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.557 ' NE ' ' NE2' ' A' ' 65' ' ' HIS . 27.0 tpt180 -62.45 -39.19 92.57 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.843 -1.161 . . . . 1.51 110.653 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.669 ' OE1' ' HE3' ' A' ' 21' ' ' LYS . 0.5 OUTLIER -62.54 -39.64 94.24 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.166 -0.959 . . . . 0.1 110.895 -178.545 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.579 ' N ' ' HG2' ' A' ' 50' ' ' GLU . 25.8 tttt -62.8 -38.38 90.47 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 116.364 -0.38 . . . . 2.88 110.86 -178.763 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 25.3 tp -64.54 -43.56 93.62 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 120.193 -1.567 . . . . 0.16 108.634 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.7 m -166.11 139.11 3.34 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.044 -1.035 . . . . 0.19 109.71 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -50.34 144.91 22.52 Favored 'Trans proline' 0 C--N 1.314 -1.286 0 C-N-CA 121.175 1.25 . . . . 0.37 113.655 178.181 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 47.2 p -96.54 7.94 45.32 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 114.505 -1.225 . . . . 0.16 107.92 177.298 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 34.2 t80 -62.36 137.5 58.27 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 105.955 -1.869 . . . . 0.09 105.955 174.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 17.8 mt -117.77 11.97 13.76 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 120.856 -1.152 . . . . 0.1 110.224 -178.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 85.56 170.94 47.67 Favored Glycine 0 C--N 1.302 -1.31 0 N-CA-C 108.667 -1.773 . . . . 0.1 108.667 -178.234 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.81 ' CA ' ' N ' ' A' ' 60' ' ' SER . 74.3 mm-40 57.59 35.4 25.7 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.458 -1.025 . . . . 1.86 113.527 177.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.81 ' N ' ' CA ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER 65.28 21.48 12.02 Favored 'General case' 0 N--CA 1.514 2.771 0 O-C-N 121.039 -1.038 . . . . 0.08 113.555 176.731 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 94.2 mt -121.38 137.48 54.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 120.645 -1.285 . . . . 0.07 111.014 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -129.31 138.85 51.82 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 106.247 -1.76 . . . . 0.06 106.247 174.41 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.494 ' O ' HG23 ' A' ' 63' ' ' VAL . 16.3 m -130.32 74.93 79.87 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.163 -0.96 . . . . 0.07 110.103 -179.373 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -58.08 148.94 74.72 Favored 'Trans proline' 0 N--CA 1.49 1.273 0 C-N-CA 121.809 1.672 . . . . 0.38 112.552 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.557 ' NE2' ' NE ' ' A' ' 49' ' ' ARG . 37.2 p-80 -157.19 162.91 39.32 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.637 -0.664 . . . . 0.59 109.611 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -79.1 176.17 54.81 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 110.769 -0.932 . . . . 0.12 110.769 -179.064 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 82.0 p -81.07 167.93 19.19 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.612 -0.934 . . . . 0.59 109.376 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.585 HG12 ' ND2' ' A' ' 109' ' ' ASN . 4.7 m -70.52 -23.65 24.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 121.382 -0.824 . . . . 0.14 109.751 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.501 ' OE1' ' N ' ' A' ' 69' ' ' GLU . 58.7 mp0 -75.27 9.06 2.26 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.985 -1.072 . . . . 0.15 109.725 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -121.73 15.27 11.0 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.709 -0.619 . . . . 0.13 109.813 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 49.5 pttt -60.87 -37.95 83.9 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.016 -1.053 . . . . 0.14 109.136 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -69.27 -4.13 16.68 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.658 -0.651 . . . . 0.14 111.543 -177.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.443 ' NH1' ' OE1' ' A' ' 39' ' ' GLU . 15.6 mmm180 -104.96 7.95 34.32 Favored 'General case' 0 N--CA 1.506 2.33 0 O-C-N 120.444 -1.41 . . . . 0.13 109.374 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 91.1 t -95.48 128.49 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 107.082 -1.451 . . . . 0.11 107.082 177.488 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 28.1 mt -96.75 -17.15 20.47 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 115.721 -0.672 . . . . 0.11 109.455 -178.016 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 39.6 pttt -176.6 159.67 1.9 Allowed 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.523 -0.918 . . . . 0.09 108.523 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 18.2 m -76.29 138.14 40.34 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.355 -0.841 . . . . 0.13 111.079 -179.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.422 ' HA3' ' CD1' ' A' ' 37' ' ' TYR . . . -160.69 161.05 32.45 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 118.735 -1.698 . . . . 0.06 110.863 -179.537 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 33.3 m -137.65 150.96 25.62 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 O-C-N 121.603 -0.939 . . . . 0.03 108.842 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 80' ' ' VAL . 15.9 m -127.02 113.14 31.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 106.271 -1.752 . . . . 0.04 106.271 175.439 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.649 ' CZ ' HD22 ' A' ' 100' ' ' LEU . 61.6 t80 -86.02 115.38 23.58 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.789 0.804 . . . . 0.05 109.238 -178.528 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 39.5 m -119.0 122.11 41.44 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 121.86 0.838 . . . . 0.04 110.506 -177.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.559 ' HB3' ' HA ' ' A' ' 14' ' ' LEU . 30.7 tt0 -100.71 126.47 47.25 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-O 122.108 0.956 . . . . 0.07 111.805 -178.463 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -123.35 87.24 51.79 Favored Pre-proline 0 C--N 1.302 -1.471 0 N-CA-C 107.025 -1.472 . . . . 0.06 107.025 177.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -54.06 -36.05 83.43 Favored 'Trans proline' 0 N--CA 1.501 1.925 0 C-N-CA 122.847 2.365 . . . . 0.08 113.081 -177.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -81.73 -13.27 58.02 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.481 -0.762 . . . . 0.08 110.323 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 90.08 152.59 27.23 Favored Glycine 0 N--CA 1.485 1.912 0 O-C-N 120.791 -1.193 . . . . 0.06 113.024 175.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 61.5 t -136.47 120.43 24.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 106.549 -1.649 . . . . 0.05 106.549 177.569 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.873 ' HA ' HD13 ' A' ' 97' ' ' ILE . 4.3 ttt180 -60.31 121.27 11.58 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.829 -1.169 . . . . 0.09 109.131 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -119.77 -11.51 9.36 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 118.656 -1.218 . . . . 1.03 111.573 -178.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -118.54 -158.21 10.74 Favored Glycine 1 N--CA 1.516 4.009 0 O-C-N 119.588 -1.945 . . . . 0.14 112.255 -178.61 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -92.54 -22.8 19.33 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 113.842 1.052 . . . . 0.26 113.842 -176.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -96.4 154.45 17.26 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.683 -1.261 . . . . 1.62 109.461 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -60.29 -23.89 64.51 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.747 -1.22 . . . . 2.55 109.964 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -86.52 1.87 50.02 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.692 -1.255 . . . . 1.74 109.461 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -83.2 60.17 5.39 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 118.764 -1.175 . . . . 0.16 107.98 178.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.873 HD13 ' HA ' ' A' ' 89' ' ' ARG . 41.8 mm -101.6 135.32 38.75 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 CA-C-O 121.723 0.773 . . . . 0.08 110.169 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -108.56 130.95 55.28 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 121.545 0.688 . . . . 0.06 109.682 178.323 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 87.2 mtm180 -102.5 -17.07 15.93 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 106.557 -1.646 . . . . 0.09 106.557 175.365 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.649 HD22 ' CZ ' ' A' ' 81' ' ' PHE . 71.1 mt -116.87 112.16 20.68 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.12 -1.067 . . . . 0.06 108.12 176.675 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 93.8 t -113.4 104.07 16.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 106.257 -1.757 . . . . 0.04 106.257 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 72.3 mt -107.11 102.91 14.65 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.087 0 CA-C-O 122.292 1.044 . . . . 0.04 111.035 -176.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -77.6 131.97 11.57 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.023 -1.631 . . . . 0.04 109.023 -178.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.409 HD13 HG21 ' A' ' 104' ' ' ILE . 19.4 pt -133.45 153.5 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 O-C-N 120.264 -1.727 . . . . 0.1 112.916 -176.143 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -137.38 133.71 35.13 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 106.189 -1.782 . . . . 0.12 106.189 177.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -147.59 140.97 25.3 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 120.113 -1.617 . . . . 0.13 110.955 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 60.6 mtp180 -70.74 156.29 39.7 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.588 0.709 . . . . 3.71 110.331 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 57.81 25.4 11.92 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.069 -0.715 . . . . 1.98 109.069 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.585 ' ND2' HG12 ' A' ' 68' ' ' VAL . 61.4 t30 53.27 37.58 25.6 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.172 -0.955 . . . . 1.22 109.766 178.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -84.05 28.89 0.58 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.131 -0.981 . . . . 0.18 111.093 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' HIS . . . . . 0.75 ' CA ' ' N ' ' A' ' 112' ' ' ILE . 41.6 p-80 -50.54 -38.3 44.08 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.881 -1.137 . . . . 0.18 112.095 179.067 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.75 ' N ' ' CA ' ' A' ' 111' ' ' HIS . 20.9 tt -63.18 -28.96 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 119.986 -1.696 . . . . 0.12 111.005 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -69.81 -40.94 75.63 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 120.516 -1.365 . . . . 0.87 108.334 178.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 85.1 t -69.38 -43.61 80.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.428 -0.795 . . . . 0.07 109.414 178.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 97.0 mt -62.11 -42.46 95.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.132 -0.98 . . . . 0.08 109.471 178.41 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 97.6 m -62.35 -42.45 99.41 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.295 -0.878 . . . . 0.14 109.899 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 11.2 t -63.66 -45.91 88.0 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.161 -0.962 . . . . 0.07 109.572 178.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 57.3 mt -64.09 -48.26 76.87 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.07 -1.019 . . . . 0.07 111.173 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 40.4 p -66.38 -28.01 68.31 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 120.986 -1.071 . . . . 0.09 111.589 -178.011 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -67.81 -35.88 79.41 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 121.007 -1.058 . . . . 1.13 108.145 177.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -80.12 -15.55 56.87 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.967 -1.083 . . . . 0.09 109.844 177.295 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 80.5 mt -106.01 27.86 8.18 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.984 -1.072 . . . . 0.17 110.675 178.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -72.46 -12.73 61.22 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 120.937 -1.102 . . . . 0.49 111.879 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -110.66 131.38 55.1 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.588 -1.32 . . . . 0.13 110.619 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -57.72 -34.55 69.6 Favored 'General case' 0 N--CA 1.503 2.181 0 C-N-CA 123.306 0.642 . . . . 0.15 112.262 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.449 ' O ' ' HG2' ' A' ' 130' ' ' ARG . 59.7 p -65.75 -34.01 77.18 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 120.694 -1.254 . . . . 0.13 109.88 179.052 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 85.6 t -65.65 -43.9 93.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.638 -1.289 . . . . 0.11 109.974 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 96.1 mt -64.33 -46.06 94.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.941 -1.1 . . . . 0.1 110.228 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.614 ' HA ' ' OE1' ' A' ' 129' ' ' GLU . 8.7 mm-40 -57.08 -46.85 82.19 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.223 -0.923 . . . . 0.11 109.864 178.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.524 ' NH1' ' HG3' ' A' ' 130' ' ' ARG . 16.5 mmm-85 -63.52 -43.7 96.4 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.215 -0.928 . . . . 0.13 110.214 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 83.3 mt -66.89 -35.04 79.12 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.066 -1.022 . . . . 0.08 111.148 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -67.33 -27.18 66.93 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.308 -0.87 . . . . 0.08 113.285 -176.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -126.49 1.7 6.92 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 120.082 -1.637 . . . . 0.1 113.322 -176.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 9.4 t -68.31 145.89 53.8 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.502 -1.374 . . . . 0.1 111.271 -178.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 72.8 p -106.06 9.92 32.29 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.27 -1.381 . . . . 0.12 107.27 176.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 47.0 t -107.02 116.4 31.86 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 121.588 0.709 . . . . 0.11 112.696 -178.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 15.9 t -65.59 -41.67 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 108.501 -0.925 . . . . 0.09 108.501 176.392 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -56.87 -39.99 75.35 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.233 -0.917 . . . . 0.11 110.408 178.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -63.66 -42.75 98.03 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.936 -1.103 . . . . 0.11 108.45 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 92.0 t -57.29 -51.27 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 108.508 -0.923 . . . . 0.08 108.508 177.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 141' ' ' LEU . 78.4 mt -57.7 -45.98 84.96 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.238 -0.914 . . . . 0.07 110.294 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -58.81 -47.91 83.13 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.814 -1.179 . . . . 0.11 111.02 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 83.7 mt -67.99 -23.49 65.03 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.983 -1.073 . . . . 0.1 112.606 -177.148 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.661 ' O ' ' NH1' ' A' ' 147' ' ' ARG . 91.7 mt -110.05 9.27 24.21 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.367 -1.458 . . . . 0.07 111.391 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.711 ' HA ' HH12 ' A' ' 147' ' ' ARG . . . -76.97 -25.25 52.57 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 120.689 -1.257 . . . . 0.07 112.305 -178.151 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -81.77 -8.81 86.32 Favored Glycine 0 N--CA 1.504 3.211 0 O-C-N 120.57 -1.331 . . . . 0.08 111.156 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ARG . . . . . 1.259 ' HD2' ' CZ ' ' A' ' 5' ' ' PHE . 2.0 ptt-85 . . . . . 0 N--CA 1.486 1.371 0 O-C-N 121.053 -1.263 . . . . 0.07 109.64 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 301' ' ' MET . . . . . 0.517 ' HB2' ' HG2' ' B' ' 366' ' ' GLU . 3.4 ttm . . . . . 0 C--O 1.214 -0.786 0 CA-C-O 121.931 0.872 . . . . 0.17 108.948 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 302' ' ' PHE . . . . . 0.454 ' N ' ' CG ' ' B' ' 301' ' ' MET . 46.9 t80 -139.74 142.97 36.77 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 107.27 -1.381 . . . . 0.16 107.27 178.511 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 303' ' ' GLN . . . . . 0.49 ' O ' ' HG2' ' B' ' 304' ' ' GLN . 5.4 pt20 -153.0 156.31 38.58 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 120.904 -1.123 . . . . 0.14 109.495 179.236 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 304' ' ' GLN . . . . . 0.49 ' HG2' ' O ' ' B' ' 303' ' ' GLN . 42.2 mm-40 -152.18 149.21 28.51 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 108.033 -1.099 . . . . 0.15 108.033 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -97.19 152.35 18.91 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.046 -1.034 . . . . 0.13 108.428 178.335 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 7.2 p -147.83 144.34 19.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 N-CA-C 107.478 -1.304 . . . . 0.12 107.478 177.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 85.4 m -96.67 136.54 37.06 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 122.169 0.985 . . . . 0.13 110.079 177.197 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 51.7 mt -84.88 114.25 24.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 105.478 -2.045 . . . . 0.13 105.478 177.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 47.4 p -106.7 -4.39 19.51 Favored 'General case' 0 C--N 1.264 -3.117 0 N-CA-C 114.704 1.372 . . . . 0.16 114.704 -178.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -71.44 141.87 86.02 Favored Pre-proline 0 N--CA 1.499 2.012 0 O-C-N 119.683 -1.886 . . . . 0.16 110.658 178.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -45.54 -47.63 13.03 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 124.749 3.633 . . . . 0.19 114.202 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -102.21 27.61 6.54 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 116.035 -2.266 . . . . 0.99 108.725 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 58.83 -149.92 36.59 Favored Glycine 0 N--CA 1.496 2.699 0 C-N-CA 117.708 -2.187 . . . . 0.13 109.52 -179.098 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 314' ' ' LEU . . . . . 0.403 ' HA ' HD12 ' B' ' 314' ' ' LEU . 19.9 tp -83.93 72.58 10.42 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.838 -1.39 . . . . 0.11 109.581 -176.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 315' ' ' HIS . . . . . 0.486 ' CE1' ' HG3' ' B' ' 318' ' ' PRO . 54.1 p-80 -69.41 -179.71 1.75 Allowed 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 117.846 -1.542 . . . . 1.2 112.131 -177.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 316' ' ' THR . . . . . 0.537 ' OG1' ' NH2' ' A' ' 49' ' ' ARG . 66.4 p -42.1 -66.7 0.32 Allowed 'General case' 0 N--CA 1.505 2.291 0 N-CA-C 117.209 2.299 . . . . 0.16 117.209 -175.703 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 317' ' ' ARG . . . . . 0.542 ' N ' ' HD2' ' B' ' 318' ' ' PRO . 5.4 ttt-85 -53.2 -53.33 57.0 Favored Pre-proline 0 N--CA 1.493 1.705 0 C-N-CA 120.21 -0.596 . . . . 1.91 112.446 -176.428 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 318' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' B' ' 317' ' ' ARG . 21.0 Cg_endo -66.41 -32.17 41.12 Favored 'Trans proline' 0 N--CA 1.484 0.963 0 C-N-CA 124.707 3.604 . . . . 0.13 111.563 -177.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 319' ' ' ALA . . . . . 0.419 ' O ' HG23 ' B' ' 323' ' ' VAL . . . -67.07 -38.8 86.43 Favored 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 119.503 -0.879 . . . . 0.1 109.491 -179.399 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -70.95 -39.68 72.46 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.865 -0.791 . . . . 0.11 108.865 178.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 67.8 tp60 -64.01 -39.31 93.83 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 117.863 -1.535 . . . . 0.12 109.535 177.106 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 322' ' ' PHE . . . . . 0.44 ' CE1' HD22 ' B' ' 377' ' ' LEU . 87.3 t80 -62.76 -45.3 93.32 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 122.583 1.182 . . . . 0.08 108.703 -177.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 323' ' ' VAL . . . . . 0.419 HG23 ' O ' ' B' ' 319' ' ' ALA . 53.4 t -62.58 -42.26 95.24 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.278 0 CA-C-N 114.809 -1.087 . . . . 0.07 110.713 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 73.7 tttt -63.87 -40.18 95.93 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.325 -0.859 . . . . 1.68 109.851 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 325' ' ' GLU . . . . . 0.494 ' OE1' HD22 ' B' ' 380' ' ' LEU . 31.7 tt0 -68.9 -39.65 79.59 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.37 -0.831 . . . . 0.1 109.56 177.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -59.07 -43.99 91.82 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.708 -1.245 . . . . 0.06 109.417 178.539 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -61.37 -16.13 43.21 Favored 'General case' 0 N--CA 1.509 2.512 0 O-C-N 121.226 -0.922 . . . . 1.5 113.338 178.537 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -76.92 -10.65 86.07 Favored Glycine 0 N--CA 1.479 1.529 0 O-C-N 119.999 -1.688 . . . . 0.08 109.338 179.058 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 329' ' ' PHE . . . . . 0.402 ' HE1' ' HE3' ' B' ' 372' ' ' LYS . 92.8 m-85 -103.36 143.32 32.83 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.429 -1.63 . . . . 0.09 110.101 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 47.8 p -75.66 -30.08 59.31 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.297 -0.877 . . . . 0.11 112.272 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 331' ' ' SER . . . . . . . . . . . . . 15.9 m -59.68 158.57 9.93 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 119.844 -1.785 . . . . 0.11 112.821 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 332' ' ' GLU . . . . . 0.769 ' OE1' ' N ' ' B' ' 333' ' ' ILE . 0.0 OUTLIER -79.0 130.4 35.49 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 102.81 -3.033 . . . . 0.11 102.81 171.266 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 333' ' ' ILE . . . . . 0.769 ' N ' ' OE1' ' B' ' 332' ' ' GLU . 39.2 mt -126.81 136.5 60.61 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.486 0 CA-C-O 122.192 0.996 . . . . 0.08 109.305 -178.246 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 93.3 m -124.94 143.21 50.99 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-O 123.216 1.484 . . . . 0.09 109.978 178.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 335' ' ' VAL . . . . . 0.442 HG23 ' HB2' ' B' ' 344' ' ' ALA . 85.3 t -108.14 129.95 61.51 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.633 0 N-CA-C 105.469 -2.049 . . . . 0.06 105.469 173.127 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 336' ' ' THR . . . . . 0.419 ' HB ' ' HB ' ' B' ' 362' ' ' THR . 71.5 m -127.39 119.51 26.35 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 120.862 -1.149 . . . . 0.09 109.046 -178.47 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 29.1 t -122.52 122.61 39.32 Favored 'General case' 0 N--CA 1.501 2.106 0 C-N-CA 119.992 -0.683 . . . . 0.08 109.843 177.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 62.5 t30 51.73 38.84 24.0 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.886 -1.134 . . . . 0.1 112.87 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 81.81 10.86 83.59 Favored Glycine 0 N--CA 1.501 3.009 0 O-C-N 119.944 -1.722 . . . . 0.11 112.522 177.336 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 340' ' ' LYS . . . . . 0.408 ' O ' ' HA ' ' B' ' 336' ' ' THR . 26.5 mttp -119.85 136.3 54.54 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 105.221 -2.14 . . . . 0.1 105.221 177.642 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 68.3 m -124.8 158.55 33.09 Favored 'General case' 0 C--N 1.276 -2.594 0 CA-C-O 123.738 1.732 . . . . 0.09 112.408 -176.052 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -151.62 151.45 31.53 Favored 'General case' 0 C--N 1.278 -2.51 0 CA-C-N 112.449 -2.159 . . . . 0.08 108.634 177.454 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 8.0 t -70.63 135.95 48.78 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 105.556 -2.016 . . . . 0.08 105.556 173.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 344' ' ' ALA . . . . . 0.442 ' HB2' HG23 ' B' ' 335' ' ' VAL . . . -72.95 -6.83 47.95 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.691 -1.256 . . . . 0.05 110.703 179.219 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -97.5 13.07 31.18 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.631 -1.293 . . . . 0.08 109.395 -177.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 9.7 t -133.18 104.25 6.4 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 122.153 0.977 . . . . 0.12 110.062 -178.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 347' ' ' LEU . . . . . . . . . . . . . 46.4 tp -57.34 -37.77 73.05 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 115.658 -0.701 . . . . 0.1 109.998 178.232 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 348' ' ' PHE . . . . . 0.534 ' HB3' ' OE2' ' A' ' 59' ' ' GLU . 77.3 t80 -59.0 -51.35 70.43 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.566 -1.334 . . . . 0.13 113.021 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 37.6 tptt -70.05 -32.46 70.58 Favored 'General case' 0 C--O 1.214 -0.769 0 O-C-N 119.664 -1.898 . . . . 1.55 109.109 -178.333 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 350' ' ' LEU . . . . . . . . . . . . . 32.3 mt -62.84 -33.7 75.79 Favored 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 118.958 -1.097 . . . . 0.16 109.92 -177.433 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 351' ' ' GLN . . . . . . . . . . . . . 12.5 tp-100 -67.69 -10.49 52.89 Favored 'General case' 0 C--N 1.293 -1.852 0 O-C-N 121.599 -0.688 . . . . 0.26 109.915 -177.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 352' ' ' THR . . . . . . . . . . . . . 41.7 p -89.72 -7.74 53.87 Favored 'General case' 0 N--CA 1.502 2.132 0 C-N-CA 118.097 -1.441 . . . . 0.12 111.026 -178.496 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 72.9 mt -93.34 159.34 15.3 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.244 -0.91 . . . . 0.1 110.224 -178.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -86.76 104.8 2.97 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 106.94 -2.464 . . . . 0.08 106.94 177.047 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 15.5 mt -119.46 47.29 1.73 Allowed 'General case' 0 C--N 1.309 -1.186 0 O-C-N 120.625 -1.515 . . . . 0.1 107.471 -178.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 47.6 p -81.36 172.53 13.46 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 118.849 -1.141 . . . . 0.2 109.16 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -60.74 140.97 57.36 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 119.349 -0.94 . . . . 1.61 109.76 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 91.4 -3.17 79.04 Favored Glycine 0 N--CA 1.5 2.941 0 C-N-CA 120.052 -1.071 . . . . 0.13 111.381 177.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 54.5 m -84.4 135.81 34.13 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 120.918 -1.342 . . . . 0.11 110.66 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 89.2 t -96.47 123.8 48.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 N-CA-C 106.304 -1.739 . . . . 0.11 106.304 176.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 361' ' ' VAL . . . . . 0.487 HG21 ' SD ' ' B' ' 381' ' ' MET . 22.3 m -112.27 160.13 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.335 0 C-N-CA 117.354 -1.739 . . . . 0.09 110.636 178.585 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 362' ' ' THR . . . . . 0.419 ' HB ' ' HB ' ' B' ' 336' ' ' THR . 90.4 m -108.89 128.34 54.83 Favored 'General case' 0 C--O 1.214 -0.789 0 O-C-N 120.596 -1.315 . . . . 0.1 107.565 175.559 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 363' ' ' ILE . . . . . 0.459 ' O ' ' HA ' ' B' ' 303' ' ' GLN . 33.2 mt -107.92 121.45 60.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 105.344 -2.095 . . . . 0.1 105.344 176.33 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 364' ' ' SER . . . . . 0.411 ' HB3' ' HB3' ' B' ' 303' ' ' GLN . 0.7 OUTLIER -128.57 147.3 50.7 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 107.809 -1.182 . . . . 0.1 107.809 -179.646 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -139.76 153.32 47.13 Favored 'General case' 0 C--N 1.292 -1.925 0 C-N-CA 118.454 -1.298 . . . . 0.13 109.781 -179.251 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 366' ' ' GLU . . . . . 0.517 ' HG2' ' HB2' ' B' ' 301' ' ' MET . 0.2 OUTLIER -141.14 110.88 6.48 Favored 'General case' 0 C--N 1.288 -2.081 0 C-N-CA 118.592 -1.243 . . . . 0.16 108.078 178.127 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . 165.22 -170.36 40.16 Favored Glycine 0 C--N 1.297 -1.59 0 C-N-CA 117.981 -2.056 . . . . 0.14 110.327 178.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -58.27 -40.55 82.18 Favored 'General case' 0 C--N 1.277 -2.57 0 CA-C-N 114.33 -0.935 . . . . 0.16 112.306 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 369' ' ' ASP . . . . . . . . . . . . . 12.0 p30 -114.21 36.85 3.54 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 115.834 -2.346 . . . . 0.13 108.519 -178.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 370' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -56.41 -33.56 65.91 Favored 'General case' 0 N--CA 1.521 3.107 0 N-CA-C 116.8 2.148 . . . . 0.16 116.8 -174.039 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.95 -45.59 27.1 Favored 'General case' 0 N--CA 1.509 2.514 0 O-C-N 119.526 -1.984 . . . . 0.18 110.914 -176.519 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 372' ' ' LYS . . . . . 0.783 ' HG2' ' CE1' ' B' ' 376' ' ' HIS . 11.9 ttpp -63.56 -40.71 97.69 Favored 'General case' 0 C--N 1.283 -2.315 0 N-CA-C 106.965 -1.495 . . . . 0.13 106.965 178.265 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -59.09 -49.51 77.61 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 117.541 -1.664 . . . . 0.11 110.025 -178.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 374' ' ' VAL . . . . . . . . . . . . . 66.9 t -66.86 -42.25 88.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 CA-C-O 122.187 0.994 . . . . 0.11 109.267 -178.094 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -55.89 -47.78 76.8 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-O 122.059 0.933 . . . . 0.16 108.737 -178.285 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 376' ' ' HIS . . . . . 0.783 ' CE1' ' HG2' ' B' ' 372' ' ' LYS . 6.3 m80 -69.96 -38.23 76.04 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 116.005 -0.543 . . . . 0.13 111.72 -178.644 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 377' ' ' LEU . . . . . 0.44 HD22 ' CE1' ' B' ' 322' ' ' PHE . 80.5 mt -75.64 -28.56 58.84 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.348 -1.47 . . . . 0.09 110.875 -174.318 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 378' ' ' VAL . . . . . . . . . . . . . 2.1 t -71.44 -39.52 71.3 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.459 0 N-CA-C 106.35 -1.722 . . . . 0.13 106.35 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -67.89 -49.31 62.69 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 108.03 -1.1 . . . . 0.16 108.03 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 380' ' ' LEU . . . . . 0.641 ' O ' HD22 ' B' ' 384' ' ' LEU . 34.1 tp -57.18 -45.24 83.87 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 118.974 -1.09 . . . . 0.12 110.62 177.611 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 381' ' ' MET . . . . . 0.487 ' SD ' HG21 ' B' ' 361' ' ' VAL . 3.6 ttm -62.29 -37.44 85.53 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.871 -1.143 . . . . 0.12 111.508 -177.495 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -74.89 -31.78 61.67 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.111 -0.993 . . . . 0.15 110.29 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -78.87 -32.41 45.92 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.622 -0.673 . . . . 0.17 111.247 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 384' ' ' LEU . . . . . 0.641 HD22 ' O ' ' B' ' 380' ' ' LEU . 0.0 OUTLIER -50.12 125.54 12.48 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-O 124.432 2.063 . . . . 0.15 112.762 178.802 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 385' ' ' GLU . . . . . 0.966 ' CD ' ' H ' ' B' ' 385' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.279 -2.48 0 CA-C-N 111.085 -2.779 . . . . 0.18 110.093 -177.598 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 14.4 tp . . . . . 0 N--CA 1.483 1.208 0 N-CA-C 110.502 -0.184 . . . . 0.06 110.502 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 1.259 ' CZ ' ' HD2' ' A' ' 147' ' ' ARG . 40.6 p90 -136.09 141.73 44.24 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 117.476 -1.69 . . . . 0.04 111.884 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.5 mttp -82.27 142.73 31.86 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 107.944 -1.132 . . . . 0.05 107.944 177.36 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 1.02 ' HA ' HD21 ' A' ' 11' ' ' ASN . 13.6 tp -136.81 125.64 24.08 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 107.285 -1.376 . . . . 0.05 107.285 179.131 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -154.02 -166.92 15.44 Favored Glycine 0 C--N 1.289 -2.081 0 N-CA-C 108.557 -1.817 . . . . 0.06 108.557 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.79 -34.24 77.46 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.599 -0.942 . . . . 0.08 111.313 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -65.44 -14.93 62.02 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.759 -1.213 . . . . 0.07 112.332 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 1.02 HD21 ' HA ' ' A' ' 7' ' ' LEU . 2.7 p-10 -123.7 22.85 8.94 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 119.5 -2.0 . . . . 0.05 111.869 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 48.8 mt -118.49 123.35 71.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 107.539 -1.282 . . . . 0.06 107.539 176.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -126.44 106.98 9.85 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.433 -0.792 . . . . 0.06 109.252 -177.548 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.559 ' HA ' ' HB3' ' A' ' 83' ' ' GLN . 42.4 mt -100.33 160.52 14.27 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-O 122.702 1.239 . . . . 0.08 112.883 -177.423 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 62.34 34.66 89.97 Favored Glycine 0 N--CA 1.497 2.749 0 CA-C-N 114.457 -1.247 . . . . 0.08 113.833 175.273 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.46 ' HA ' ' HE ' ' A' ' 16' ' ' ARG . 1.0 OUTLIER -83.21 169.14 16.09 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 120.238 -1.742 . . . . 0.08 109.733 178.348 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -140.89 140.75 34.59 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 107.409 -1.33 . . . . 0.08 107.409 178.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -154.17 131.7 11.35 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 108.442 -0.948 . . . . 0.06 108.442 179.134 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -77.48 -25.62 50.58 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.141 -0.975 . . . . 0.06 109.69 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 64.2 p -134.75 159.65 40.66 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 119.075 -1.05 . . . . 0.07 111.466 -178.387 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.669 ' HE3' ' OE1' ' A' ' 50' ' ' GLU . 28.2 pttt -65.98 -32.68 74.31 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.892 -0.781 . . . . 0.09 108.892 175.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 51.4 mp0 -60.28 -42.8 96.21 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.514 -1.366 . . . . 0.08 110.103 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -64.1 -41.73 97.17 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.628 -1.295 . . . . 0.07 110.012 177.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.91 -42.51 94.66 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.636 -1.29 . . . . 0.05 109.609 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.37 -42.29 94.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.262 -0.899 . . . . 0.07 109.802 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.46 ' HE ' ' HB2' ' A' ' 26' ' ' ARG . 4.4 ttm180 -62.61 -37.52 86.61 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.316 -0.865 . . . . 0.1 109.98 178.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -67.25 -49.19 65.34 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.724 -1.235 . . . . 0.07 108.403 179.062 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.19 -47.05 79.1 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.387 -0.821 . . . . 0.06 109.605 178.333 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.31 -41.34 99.74 Favored Glycine 0 N--CA 1.497 2.722 0 N-CA-C 110.525 -1.03 . . . . 0.08 110.525 179.502 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -61.18 -37.76 84.08 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.661 -1.494 . . . . 0.09 110.331 177.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 92.4 mm-40 -73.17 -36.05 66.53 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.069 -1.019 . . . . 0.08 110.181 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 73.5 mt -63.95 -38.2 90.19 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.857 -1.152 . . . . 0.07 108.282 174.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 23.7 t -69.34 -45.48 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 O-C-N 120.879 -1.138 . . . . 0.1 108.178 177.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -57.49 -39.3 76.14 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.665 -0.647 . . . . 0.1 112.625 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -86.19 8.42 73.99 Favored Glycine 0 N--CA 1.508 3.486 0 O-C-N 120.236 -1.54 . . . . 0.08 112.796 -178.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.63 17.83 78.37 Favored Glycine 0 N--CA 1.488 2.139 0 O-C-N 120.678 -1.483 . . . . 0.09 111.443 178.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.422 ' CD1' ' HA3' ' A' ' 78' ' ' GLY . 80.3 m-85 -80.93 -36.24 31.3 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.274 -1.721 . . . . 0.08 110.111 -179.256 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 17.4 m -141.96 163.02 19.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-O 122.287 1.042 . . . . 0.1 111.437 -177.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.443 ' OE1' ' NH1' ' A' ' 73' ' ' ARG . 83.3 mt-10 -86.63 165.1 34.54 Favored Pre-proline 0 C--N 1.3 -1.546 0 N-CA-C 107.29 -1.374 . . . . 0.14 107.29 176.334 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.429 ' HD2' ' HB3' ' A' ' 39' ' ' GLU . 50.3 Cg_exo -50.53 -36.86 50.88 Favored 'Trans proline' 0 N--CA 1.51 2.443 0 C-N-CA 123.646 2.897 . . . . 0.13 115.791 -177.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.44 ' CD ' HH21 ' A' ' 73' ' ' ARG . 41.2 mp0 -62.76 -20.59 65.11 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.508 -1.37 . . . . 0.15 112.196 -178.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.466 ' O ' ' HG3' ' A' ' 46' ' ' MET . 39.9 t80 -67.08 -27.79 67.65 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.616 -1.303 . . . . 0.11 112.313 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 22.8 t -61.19 -49.01 86.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 120.265 -1.522 . . . . 0.1 110.396 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 51.8 tp60 -67.11 -35.04 78.91 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.093 -1.004 . . . . 0.12 109.108 179.017 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.2 -33.35 73.32 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.232 -0.917 . . . . 0.11 109.765 177.144 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.466 ' HG3' ' O ' ' A' ' 42' ' ' TYR . 94.5 mtp -70.28 -37.93 74.94 Favored 'General case' 0 N--CA 1.482 1.128 0 O-C-N 120.545 -1.347 . . . . 0.1 107.719 177.24 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 93.9 mt -70.14 -40.2 74.93 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.237 -1.023 . . . . 0.1 108.237 178.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -60.14 -44.31 95.04 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.36 -0.837 . . . . 0.13 109.203 177.153 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 24.5 tpt180 -62.45 -39.19 92.57 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.843 -1.161 . . . . 1.51 110.653 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.669 ' OE1' ' HE3' ' A' ' 21' ' ' LYS . 0.5 OUTLIER -62.54 -39.61 94.14 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.166 -0.959 . . . . 0.1 110.895 -178.545 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.579 ' N ' ' HG2' ' A' ' 50' ' ' GLU . 28.1 tttt -62.87 -38.22 89.98 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 116.333 -0.394 . . . . 2.88 110.853 -178.721 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 28.7 tp -64.71 -43.56 93.06 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 120.181 -1.574 . . . . 0.16 108.634 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.6 m -166.11 139.11 3.34 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.044 -1.035 . . . . 0.19 109.71 179.181 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -50.34 144.91 22.52 Favored 'Trans proline' 0 C--N 1.314 -1.286 0 C-N-CA 121.175 1.25 . . . . 0.37 113.655 178.181 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.454 HG21 ' HA ' ' A' ' 64' ' ' PRO . 55.3 p -96.54 7.94 45.32 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 114.505 -1.225 . . . . 0.16 107.92 177.298 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -62.36 137.5 58.27 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 105.955 -1.869 . . . . 0.09 105.955 174.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 18.1 mt -117.77 11.97 13.76 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 120.856 -1.152 . . . . 0.1 110.224 -178.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 85.56 170.94 47.67 Favored Glycine 0 C--N 1.302 -1.31 0 N-CA-C 108.667 -1.773 . . . . 0.1 108.667 -178.234 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.81 ' CA ' ' N ' ' A' ' 60' ' ' SER . 76.0 mm-40 57.59 35.4 25.7 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.458 -1.025 . . . . 1.86 113.527 177.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.81 ' N ' ' CA ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER 65.28 21.48 12.02 Favored 'General case' 0 N--CA 1.514 2.771 0 O-C-N 121.039 -1.038 . . . . 0.08 113.555 176.731 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 94.2 mt -121.38 137.48 54.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 120.645 -1.285 . . . . 0.07 111.014 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -129.31 138.85 51.82 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 106.247 -1.76 . . . . 0.06 106.247 174.41 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.494 ' O ' HG23 ' A' ' 63' ' ' VAL . 16.3 m -130.32 73.41 81.3 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.163 -0.96 . . . . 0.07 110.103 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.454 ' HA ' HG21 ' A' ' 55' ' ' THR . 8.1 Cg_endo -54.57 146.91 50.96 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 120.854 1.036 . . . . 0.38 112.221 -178.708 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 2.4 p-80 -150.37 159.01 44.77 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.315 -0.866 . . . . 0.59 109.447 177.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -76.65 174.81 53.8 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 110.036 -1.226 . . . . 0.12 110.036 -177.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 82.0 p -80.46 167.93 19.57 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.104 -1.233 . . . . 0.59 109.376 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.592 HG12 ' ND2' ' A' ' 109' ' ' ASN . 5.3 m -70.52 -23.65 24.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 121.382 -0.824 . . . . 0.14 109.751 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.501 ' OE1' ' N ' ' A' ' 69' ' ' GLU . 58.7 mp0 -75.27 9.06 2.26 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.985 -1.072 . . . . 0.15 109.725 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -121.73 15.27 11.0 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.709 -0.619 . . . . 0.13 109.813 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 49.5 pttt -60.87 -37.95 83.9 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.016 -1.053 . . . . 0.14 109.136 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -69.27 -4.13 16.68 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.658 -0.651 . . . . 0.14 111.543 -177.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.443 ' NH1' ' OE1' ' A' ' 39' ' ' GLU . 15.6 mmm180 -104.96 7.95 34.32 Favored 'General case' 0 N--CA 1.506 2.33 0 O-C-N 120.444 -1.41 . . . . 0.13 109.374 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 91.1 t -95.48 128.49 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 107.082 -1.451 . . . . 0.11 107.082 177.488 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 28.1 mt -96.75 -17.15 20.47 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 115.721 -0.672 . . . . 0.11 109.455 -178.016 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 39.6 pttt -176.6 159.67 1.9 Allowed 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.523 -0.918 . . . . 0.09 108.523 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 18.2 m -76.29 138.14 40.34 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.355 -0.841 . . . . 0.13 111.079 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.422 ' HA3' ' CD1' ' A' ' 37' ' ' TYR . . . -160.69 161.05 32.45 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 118.735 -1.698 . . . . 0.06 110.863 -179.537 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 33.3 m -137.65 150.96 25.62 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 O-C-N 121.603 -0.939 . . . . 0.03 108.842 179.314 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 80' ' ' VAL . 15.9 m -127.02 113.14 31.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 106.271 -1.752 . . . . 0.04 106.271 175.439 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.649 ' CZ ' HD22 ' A' ' 100' ' ' LEU . 61.6 t80 -86.02 115.38 23.58 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.789 0.804 . . . . 0.05 109.238 -178.528 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 39.5 m -119.0 122.11 41.44 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 121.86 0.838 . . . . 0.04 110.506 -177.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.559 ' HB3' ' HA ' ' A' ' 14' ' ' LEU . 30.7 tt0 -100.71 126.47 47.25 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-O 122.108 0.956 . . . . 0.07 111.805 -178.463 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -123.35 87.24 51.79 Favored Pre-proline 0 C--N 1.302 -1.471 0 N-CA-C 107.025 -1.472 . . . . 0.06 107.025 177.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -54.06 -36.05 83.43 Favored 'Trans proline' 0 N--CA 1.501 1.925 0 C-N-CA 122.847 2.365 . . . . 0.08 113.081 -177.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -81.73 -13.27 58.02 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.481 -0.762 . . . . 0.08 110.323 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 90.08 152.59 27.23 Favored Glycine 0 N--CA 1.485 1.912 0 O-C-N 120.791 -1.193 . . . . 0.06 113.024 175.577 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 61.5 t -136.47 120.43 24.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 106.549 -1.649 . . . . 0.05 106.549 177.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.873 ' HA ' HD13 ' A' ' 97' ' ' ILE . 4.3 ttt180 -60.31 121.27 11.58 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.829 -1.169 . . . . 0.09 109.131 -179.398 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -119.77 -11.51 9.36 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 118.656 -1.218 . . . . 1.03 111.573 -178.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -118.54 -158.21 10.74 Favored Glycine 1 N--CA 1.516 4.009 0 O-C-N 119.588 -1.945 . . . . 0.14 112.255 -178.61 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -92.54 -22.8 19.33 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 113.842 1.052 . . . . 0.26 113.842 -176.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -96.4 154.45 17.26 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.683 -1.261 . . . . 1.62 109.461 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -60.29 -23.89 64.51 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.747 -1.22 . . . . 2.55 109.964 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -86.52 1.87 50.02 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.692 -1.255 . . . . 1.74 109.461 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -83.2 60.17 5.39 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 118.764 -1.175 . . . . 0.16 107.98 178.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.873 HD13 ' HA ' ' A' ' 89' ' ' ARG . 41.8 mm -101.6 135.32 38.75 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 CA-C-O 121.723 0.773 . . . . 0.08 110.169 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -108.56 130.95 55.28 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 121.545 0.688 . . . . 0.06 109.682 178.323 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 87.3 mtm180 -102.5 -17.07 15.93 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 106.557 -1.646 . . . . 0.09 106.557 175.365 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.649 HD22 ' CZ ' ' A' ' 81' ' ' PHE . 71.1 mt -116.87 112.16 20.68 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.12 -1.067 . . . . 0.06 108.12 176.675 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 93.8 t -113.4 104.07 16.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 106.257 -1.757 . . . . 0.04 106.257 179.102 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 72.3 mt -107.11 102.91 14.65 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.087 0 CA-C-O 122.292 1.044 . . . . 0.04 111.035 -176.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -77.6 131.97 11.57 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.023 -1.631 . . . . 0.04 109.023 -178.391 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.409 HD13 HG21 ' A' ' 104' ' ' ILE . 19.4 pt -133.45 153.5 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 O-C-N 120.264 -1.727 . . . . 0.1 112.916 -176.143 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -137.38 133.71 35.13 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 106.189 -1.782 . . . . 0.12 106.189 177.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -147.59 140.97 25.3 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 120.113 -1.617 . . . . 0.13 110.955 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 60.6 mtp180 -70.74 156.29 39.7 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.588 0.709 . . . . 3.71 110.331 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 57.81 25.4 11.92 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.069 -0.715 . . . . 1.98 109.069 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.592 ' ND2' HG12 ' A' ' 68' ' ' VAL . 62.9 t30 53.27 37.58 25.6 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.172 -0.955 . . . . 1.22 109.766 178.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -84.05 28.89 0.58 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.131 -0.981 . . . . 0.18 111.093 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' HIS . . . . . 0.75 ' CA ' ' N ' ' A' ' 112' ' ' ILE . 43.1 p-80 -50.54 -38.3 44.08 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.881 -1.137 . . . . 0.18 112.095 179.067 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.75 ' N ' ' CA ' ' A' ' 111' ' ' HIS . 20.9 tt -63.18 -28.96 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 119.986 -1.696 . . . . 0.12 111.005 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -69.81 -40.94 75.63 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 120.516 -1.365 . . . . 0.87 108.334 178.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 85.1 t -69.38 -43.61 80.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.428 -0.795 . . . . 0.07 109.414 178.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.11 -42.46 95.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.132 -0.98 . . . . 0.08 109.471 178.41 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 95.7 m -62.35 -42.45 99.41 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.295 -0.878 . . . . 0.14 109.899 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 11.2 t -63.66 -45.91 88.0 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.161 -0.962 . . . . 0.07 109.572 178.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 57.3 mt -64.09 -48.26 76.87 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.07 -1.019 . . . . 0.07 111.173 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 40.0 p -66.38 -28.01 68.31 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 120.986 -1.071 . . . . 0.09 111.589 -178.011 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -67.81 -35.88 79.41 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 121.007 -1.058 . . . . 1.13 108.145 177.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -80.12 -15.55 56.87 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.967 -1.083 . . . . 0.09 109.844 177.295 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 80.5 mt -106.01 27.86 8.18 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.984 -1.072 . . . . 0.17 110.675 178.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -72.46 -12.73 61.22 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 120.937 -1.102 . . . . 0.49 111.879 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -110.66 131.38 55.1 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.588 -1.32 . . . . 0.13 110.619 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -57.72 -34.55 69.6 Favored 'General case' 0 N--CA 1.503 2.181 0 C-N-CA 123.306 0.642 . . . . 0.15 112.262 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.484 ' O ' ' HG2' ' A' ' 130' ' ' ARG . 59.7 p -65.75 -34.01 77.18 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 120.694 -1.254 . . . . 0.13 109.88 179.052 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 85.6 t -65.65 -43.9 93.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.638 -1.289 . . . . 0.11 109.974 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 95.8 mt -64.33 -46.06 94.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.941 -1.1 . . . . 0.1 110.228 -179.153 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.614 ' HA ' ' OE1' ' A' ' 129' ' ' GLU . 8.7 mm-40 -57.08 -46.85 82.19 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.223 -0.923 . . . . 0.11 109.864 178.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.484 ' HG2' ' O ' ' A' ' 126' ' ' SER . 42.7 mmm-85 -63.52 -43.7 96.4 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.215 -0.928 . . . . 0.13 110.214 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 83.3 mt -66.89 -35.04 79.12 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.066 -1.022 . . . . 0.08 111.148 -179.277 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -67.33 -27.18 66.93 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.308 -0.87 . . . . 0.08 113.285 -176.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -126.49 1.7 6.92 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 120.082 -1.637 . . . . 0.1 113.322 -176.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 9.4 t -68.31 145.89 53.8 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.502 -1.374 . . . . 0.1 111.271 -178.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 72.8 p -106.06 9.92 32.29 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.27 -1.381 . . . . 0.12 107.27 176.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 47.0 t -107.02 116.4 31.86 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 121.588 0.709 . . . . 0.11 112.696 -178.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 15.9 t -65.59 -41.67 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 108.501 -0.925 . . . . 0.09 108.501 176.392 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -56.87 -39.99 75.35 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.233 -0.917 . . . . 0.11 110.408 178.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -63.66 -42.75 98.03 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.936 -1.103 . . . . 0.11 108.45 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 92.0 t -57.29 -51.27 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 108.508 -0.923 . . . . 0.08 108.508 177.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 141' ' ' LEU . 78.4 mt -57.7 -45.98 84.96 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.238 -0.914 . . . . 0.07 110.294 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -58.81 -47.91 83.13 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.814 -1.179 . . . . 0.11 111.02 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 83.7 mt -67.99 -23.49 65.03 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.983 -1.073 . . . . 0.1 112.606 -177.148 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.661 ' O ' ' NH1' ' A' ' 147' ' ' ARG . 91.7 mt -110.05 9.27 24.21 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.367 -1.458 . . . . 0.07 111.391 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.711 ' HA ' HH12 ' A' ' 147' ' ' ARG . . . -76.97 -25.25 52.57 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 120.689 -1.257 . . . . 0.07 112.305 -178.151 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -81.77 -8.81 86.32 Favored Glycine 0 N--CA 1.504 3.211 0 O-C-N 120.57 -1.331 . . . . 0.08 111.156 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ARG . . . . . 1.259 ' HD2' ' CZ ' ' A' ' 5' ' ' PHE . 2.0 ptt-85 . . . . . 0 N--CA 1.486 1.371 0 O-C-N 121.053 -1.263 . . . . 0.07 109.64 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 301' ' ' MET . . . . . 0.517 ' HB2' ' HG2' ' B' ' 366' ' ' GLU . 3.4 ttm . . . . . 0 C--O 1.214 -0.786 0 CA-C-O 121.931 0.872 . . . . 0.17 108.948 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 302' ' ' PHE . . . . . 0.454 ' N ' ' CG ' ' B' ' 301' ' ' MET . 46.9 t80 -139.74 142.97 36.77 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 107.27 -1.381 . . . . 0.16 107.27 178.511 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 303' ' ' GLN . . . . . 0.49 ' O ' ' HG2' ' B' ' 304' ' ' GLN . 5.4 pt20 -153.0 156.31 38.58 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 120.904 -1.123 . . . . 0.14 109.495 179.236 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 304' ' ' GLN . . . . . 0.49 ' HG2' ' O ' ' B' ' 303' ' ' GLN . 42.2 mm-40 -152.18 149.21 28.51 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 108.033 -1.099 . . . . 0.15 108.033 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -97.19 152.35 18.91 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.046 -1.034 . . . . 0.13 108.428 178.335 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 7.2 p -147.83 144.34 19.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 N-CA-C 107.478 -1.304 . . . . 0.12 107.478 177.434 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 85.4 m -96.67 136.54 37.06 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 122.169 0.985 . . . . 0.13 110.079 177.197 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 51.7 mt -84.88 114.25 24.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 105.478 -2.045 . . . . 0.13 105.478 177.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 47.4 p -106.7 -4.39 19.51 Favored 'General case' 0 C--N 1.264 -3.117 0 N-CA-C 114.704 1.372 . . . . 0.16 114.704 -178.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -71.44 141.87 86.02 Favored Pre-proline 0 N--CA 1.499 2.012 0 O-C-N 119.683 -1.886 . . . . 0.16 110.658 178.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -45.54 -47.63 13.03 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 124.749 3.633 . . . . 0.19 114.202 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 44.5 t-20 -102.21 27.61 6.54 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 116.035 -2.266 . . . . 0.99 108.725 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 58.83 -147.48 40.68 Favored Glycine 0 N--CA 1.496 2.699 0 C-N-CA 117.708 -2.187 . . . . 0.13 109.52 -179.098 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 314' ' ' LEU . . . . . . . . . . . . . 12.3 tp -92.23 83.31 5.04 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.859 -1.163 . . . . 0.11 107.859 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -81.46 -163.55 0.64 Allowed 'General case' 0 C--O 1.197 -1.673 0 O-C-N 121.246 -0.909 . . . . 1.2 108.868 -179.016 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 30.9 p -65.43 -54.85 22.6 Favored 'General case' 0 N--CA 1.524 3.226 0 N-CA-C 119.122 3.008 . . . . 0.16 119.122 -173.105 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 317' ' ' ARG . . . . . 0.678 HH11 ' HG2' ' B' ' 317' ' ' ARG . 4.2 ttt-85 -53.49 -53.33 57.9 Favored Pre-proline 0 N--CA 1.493 1.705 0 C-N-CA 116.88 -1.928 . . . . 1.91 112.446 -175.597 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 318' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' B' ' 317' ' ' ARG . 21.0 Cg_endo -66.41 -32.17 41.12 Favored 'Trans proline' 0 N--CA 1.484 0.963 0 C-N-CA 124.707 3.604 . . . . 0.13 111.563 -177.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 319' ' ' ALA . . . . . 0.419 ' O ' HG23 ' B' ' 323' ' ' VAL . . . -67.07 -38.8 86.43 Favored 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 119.503 -0.879 . . . . 0.1 109.491 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -70.95 -39.68 72.46 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.865 -0.791 . . . . 0.11 108.865 178.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 67.8 tp60 -64.01 -39.31 93.83 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 117.863 -1.535 . . . . 0.12 109.535 177.106 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 322' ' ' PHE . . . . . 0.44 ' CE1' HD22 ' B' ' 377' ' ' LEU . 87.3 t80 -62.76 -45.3 93.32 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 122.583 1.182 . . . . 0.08 108.703 -177.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 323' ' ' VAL . . . . . 0.419 HG23 ' O ' ' B' ' 319' ' ' ALA . 53.4 t -62.58 -42.26 95.24 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.278 0 CA-C-N 114.809 -1.087 . . . . 0.07 110.713 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -63.87 -40.18 95.93 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.325 -0.859 . . . . 1.68 109.851 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 325' ' ' GLU . . . . . 0.494 ' OE1' HD22 ' B' ' 380' ' ' LEU . 31.7 tt0 -68.9 -39.65 79.59 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.37 -0.831 . . . . 0.1 109.56 177.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -59.07 -43.99 91.82 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.708 -1.245 . . . . 0.06 109.417 178.539 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -61.37 -16.13 43.21 Favored 'General case' 0 N--CA 1.509 2.512 0 O-C-N 121.226 -0.922 . . . . 1.5 113.338 178.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -76.92 -10.65 86.07 Favored Glycine 0 N--CA 1.479 1.529 0 O-C-N 119.999 -1.688 . . . . 0.08 109.338 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 329' ' ' PHE . . . . . 0.402 ' HE1' ' HE3' ' B' ' 372' ' ' LYS . 92.8 m-85 -103.36 143.32 32.83 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.429 -1.63 . . . . 0.09 110.101 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 47.8 p -75.66 -30.08 59.31 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.297 -0.877 . . . . 0.11 112.272 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 331' ' ' SER . . . . . . . . . . . . . 15.9 m -59.68 158.57 9.93 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 119.844 -1.785 . . . . 0.11 112.821 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 332' ' ' GLU . . . . . 0.769 ' OE1' ' N ' ' B' ' 333' ' ' ILE . 0.0 OUTLIER -79.0 130.4 35.49 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 102.81 -3.033 . . . . 0.11 102.81 171.266 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 333' ' ' ILE . . . . . 0.769 ' N ' ' OE1' ' B' ' 332' ' ' GLU . 39.2 mt -126.81 136.5 60.61 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.486 0 CA-C-O 122.192 0.996 . . . . 0.08 109.305 -178.246 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 93.3 m -124.94 143.21 50.99 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-O 123.216 1.484 . . . . 0.09 109.978 178.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 335' ' ' VAL . . . . . 0.442 HG23 ' HB2' ' B' ' 344' ' ' ALA . 85.3 t -108.14 129.95 61.51 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.633 0 N-CA-C 105.469 -2.049 . . . . 0.06 105.469 173.127 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 336' ' ' THR . . . . . 0.419 ' HB ' ' HB ' ' B' ' 362' ' ' THR . 71.5 m -127.39 119.51 26.35 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 120.862 -1.149 . . . . 0.09 109.046 -178.47 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 29.1 t -122.52 122.61 39.32 Favored 'General case' 0 N--CA 1.501 2.106 0 C-N-CA 119.992 -0.683 . . . . 0.08 109.843 177.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 62.5 t30 51.73 38.84 24.0 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.886 -1.134 . . . . 0.1 112.87 -179.267 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 81.81 10.86 83.59 Favored Glycine 0 N--CA 1.501 3.009 0 O-C-N 119.944 -1.722 . . . . 0.11 112.522 177.336 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 340' ' ' LYS . . . . . 0.408 ' O ' ' HA ' ' B' ' 336' ' ' THR . 26.5 mttp -119.85 136.3 54.54 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 105.221 -2.14 . . . . 0.1 105.221 177.642 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 68.3 m -124.8 158.55 33.09 Favored 'General case' 0 C--N 1.276 -2.594 0 CA-C-O 123.738 1.732 . . . . 0.09 112.408 -176.052 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -151.62 151.45 31.53 Favored 'General case' 0 C--N 1.278 -2.51 0 CA-C-N 112.449 -2.159 . . . . 0.08 108.634 177.454 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 8.0 t -70.63 135.95 48.78 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 105.556 -2.016 . . . . 0.08 105.556 173.566 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 344' ' ' ALA . . . . . 0.442 ' HB2' HG23 ' B' ' 335' ' ' VAL . . . -72.95 -6.83 47.95 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.691 -1.256 . . . . 0.05 110.703 179.219 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -97.5 13.07 31.18 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.631 -1.293 . . . . 0.08 109.395 -177.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 10.8 t -133.18 104.25 6.4 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 122.153 0.977 . . . . 0.12 110.062 -178.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 347' ' ' LEU . . . . . . . . . . . . . 43.3 tp -57.34 -37.77 73.05 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 115.658 -0.701 . . . . 0.1 109.998 178.232 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 348' ' ' PHE . . . . . 0.522 ' HB3' ' OE2' ' A' ' 59' ' ' GLU . 75.3 t80 -59.0 -51.35 70.43 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.566 -1.334 . . . . 0.13 113.021 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 37.5 tptt -70.05 -32.46 70.58 Favored 'General case' 0 C--O 1.214 -0.769 0 O-C-N 119.664 -1.898 . . . . 1.55 109.109 -178.333 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 350' ' ' LEU . . . . . . . . . . . . . 33.7 mt -62.84 -33.7 75.79 Favored 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 118.958 -1.097 . . . . 0.16 109.92 -177.433 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 351' ' ' GLN . . . . . . . . . . . . . 12.5 tp-100 -67.69 -10.49 52.89 Favored 'General case' 0 C--N 1.293 -1.852 0 O-C-N 121.599 -0.688 . . . . 0.26 109.915 -177.612 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 352' ' ' THR . . . . . . . . . . . . . 44.6 p -89.72 -7.74 53.87 Favored 'General case' 0 N--CA 1.502 2.132 0 C-N-CA 118.097 -1.441 . . . . 0.12 111.026 -178.496 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 81.6 mt -93.34 159.34 15.3 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.244 -0.91 . . . . 0.1 110.224 -178.573 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -86.76 104.8 2.97 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 106.94 -2.464 . . . . 0.08 106.94 177.047 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 15.7 mt -119.46 47.29 1.73 Allowed 'General case' 0 C--N 1.309 -1.186 0 O-C-N 120.625 -1.515 . . . . 0.1 107.471 -178.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 52.0 p -81.36 172.53 13.46 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 118.849 -1.141 . . . . 0.2 109.16 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -60.74 140.97 57.36 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 119.349 -0.94 . . . . 1.61 109.76 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 91.4 -3.17 79.04 Favored Glycine 0 N--CA 1.5 2.941 0 C-N-CA 120.052 -1.071 . . . . 0.13 111.381 177.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 54.5 m -84.4 135.81 34.13 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 120.918 -1.342 . . . . 0.11 110.66 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 89.2 t -96.47 123.8 48.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 N-CA-C 106.304 -1.739 . . . . 0.11 106.304 176.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 361' ' ' VAL . . . . . 0.487 HG21 ' SD ' ' B' ' 381' ' ' MET . 22.3 m -112.27 160.13 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.335 0 C-N-CA 117.354 -1.739 . . . . 0.09 110.636 178.585 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 362' ' ' THR . . . . . 0.419 ' HB ' ' HB ' ' B' ' 336' ' ' THR . 90.4 m -108.89 128.34 54.83 Favored 'General case' 0 C--O 1.214 -0.789 0 O-C-N 120.596 -1.315 . . . . 0.1 107.565 175.559 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 363' ' ' ILE . . . . . 0.459 ' O ' ' HA ' ' B' ' 303' ' ' GLN . 33.2 mt -107.92 121.45 60.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 105.344 -2.095 . . . . 0.1 105.344 176.33 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 364' ' ' SER . . . . . 0.411 ' HB3' ' HB3' ' B' ' 303' ' ' GLN . 0.7 OUTLIER -128.57 147.3 50.7 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 107.809 -1.182 . . . . 0.1 107.809 -179.646 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -139.76 153.32 47.13 Favored 'General case' 0 C--N 1.292 -1.925 0 C-N-CA 118.454 -1.298 . . . . 0.13 109.781 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 366' ' ' GLU . . . . . 0.517 ' HG2' ' HB2' ' B' ' 301' ' ' MET . 0.2 OUTLIER -141.14 110.88 6.48 Favored 'General case' 0 C--N 1.288 -2.081 0 C-N-CA 118.592 -1.243 . . . . 0.16 108.078 178.127 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . 165.22 -170.36 40.16 Favored Glycine 0 C--N 1.297 -1.59 0 C-N-CA 117.981 -2.056 . . . . 0.14 110.327 178.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -58.27 -40.55 82.18 Favored 'General case' 0 C--N 1.277 -2.57 0 CA-C-N 114.33 -0.935 . . . . 0.16 112.306 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 369' ' ' ASP . . . . . . . . . . . . . 12.0 p30 -114.21 36.85 3.54 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 115.834 -2.346 . . . . 0.13 108.519 -178.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 370' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -56.41 -33.56 65.91 Favored 'General case' 0 N--CA 1.521 3.107 0 N-CA-C 116.8 2.148 . . . . 0.16 116.8 -174.039 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.95 -45.59 27.1 Favored 'General case' 0 N--CA 1.509 2.514 0 O-C-N 119.526 -1.984 . . . . 0.18 110.914 -176.519 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 372' ' ' LYS . . . . . 0.783 ' HG2' ' CE1' ' B' ' 376' ' ' HIS . 11.9 ttpp -63.56 -40.71 97.69 Favored 'General case' 0 C--N 1.283 -2.315 0 N-CA-C 106.965 -1.495 . . . . 0.13 106.965 178.265 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -59.09 -49.51 77.61 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 117.541 -1.664 . . . . 0.11 110.025 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 374' ' ' VAL . . . . . . . . . . . . . 66.9 t -66.86 -42.25 88.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 CA-C-O 122.187 0.994 . . . . 0.11 109.267 -178.094 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -55.89 -47.78 76.8 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-O 122.059 0.933 . . . . 0.16 108.737 -178.285 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 376' ' ' HIS . . . . . 0.783 ' CE1' ' HG2' ' B' ' 372' ' ' LYS . 6.3 m80 -69.96 -38.23 76.04 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 116.005 -0.543 . . . . 0.13 111.72 -178.644 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 377' ' ' LEU . . . . . 0.44 HD22 ' CE1' ' B' ' 322' ' ' PHE . 80.5 mt -75.64 -28.56 58.84 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.348 -1.47 . . . . 0.09 110.875 -174.318 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 378' ' ' VAL . . . . . . . . . . . . . 2.1 t -71.44 -39.52 71.3 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.459 0 N-CA-C 106.35 -1.722 . . . . 0.13 106.35 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -67.89 -49.31 62.69 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 108.03 -1.1 . . . . 0.16 108.03 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 380' ' ' LEU . . . . . 0.641 ' O ' HD22 ' B' ' 384' ' ' LEU . 34.1 tp -57.18 -45.24 83.87 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 118.974 -1.09 . . . . 0.12 110.62 177.611 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 381' ' ' MET . . . . . 0.487 ' SD ' HG21 ' B' ' 361' ' ' VAL . 3.6 ttm -62.29 -37.44 85.53 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.871 -1.143 . . . . 0.12 111.508 -177.495 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -74.89 -31.78 61.67 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.111 -0.993 . . . . 0.15 110.29 -178.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -78.87 -32.41 45.92 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.622 -0.673 . . . . 0.17 111.247 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 384' ' ' LEU . . . . . 0.641 HD22 ' O ' ' B' ' 380' ' ' LEU . 0.0 OUTLIER -50.12 125.54 12.48 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-O 124.432 2.063 . . . . 0.15 112.762 178.802 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 385' ' ' GLU . . . . . 0.966 ' CD ' ' H ' ' B' ' 385' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.279 -2.48 0 CA-C-N 111.085 -2.779 . . . . 0.18 110.093 -177.598 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 14.4 tp . . . . . 0 N--CA 1.483 1.208 0 N-CA-C 110.502 -0.184 . . . . 0.06 110.502 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 1.259 ' CZ ' ' HD2' ' A' ' 147' ' ' ARG . 40.6 p90 -136.09 141.73 44.24 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 117.476 -1.69 . . . . 0.04 111.884 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.5 mttp -82.27 142.73 31.86 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 107.944 -1.132 . . . . 0.05 107.944 177.36 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 1.02 ' HA ' HD21 ' A' ' 11' ' ' ASN . 13.6 tp -136.81 125.64 24.08 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 107.285 -1.376 . . . . 0.05 107.285 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -154.02 -166.92 15.44 Favored Glycine 0 C--N 1.289 -2.081 0 N-CA-C 108.557 -1.817 . . . . 0.06 108.557 178.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.79 -34.24 77.46 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.599 -0.942 . . . . 0.08 111.313 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -65.44 -14.93 62.02 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.759 -1.213 . . . . 0.07 112.332 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 1.02 HD21 ' HA ' ' A' ' 7' ' ' LEU . 2.7 p-10 -123.7 22.85 8.94 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 119.5 -2.0 . . . . 0.05 111.869 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 48.8 mt -118.49 123.35 71.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 107.539 -1.282 . . . . 0.06 107.539 176.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -126.44 106.98 9.85 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.433 -0.792 . . . . 0.06 109.252 -177.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.559 ' HA ' ' HB3' ' A' ' 83' ' ' GLN . 42.4 mt -100.33 160.52 14.27 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-O 122.702 1.239 . . . . 0.08 112.883 -177.423 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 62.34 34.66 89.97 Favored Glycine 0 N--CA 1.497 2.749 0 CA-C-N 114.457 -1.247 . . . . 0.08 113.833 175.273 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.46 ' HA ' ' HE ' ' A' ' 16' ' ' ARG . 1.0 OUTLIER -83.21 169.14 16.09 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 120.238 -1.742 . . . . 0.08 109.733 178.348 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -140.89 140.75 34.59 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 107.409 -1.33 . . . . 0.08 107.409 178.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -154.17 131.7 11.35 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 108.442 -0.948 . . . . 0.06 108.442 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -77.48 -25.62 50.58 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.141 -0.975 . . . . 0.06 109.69 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 64.2 p -134.75 159.65 40.66 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 119.075 -1.05 . . . . 0.07 111.466 -178.387 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.669 ' HE3' ' OE1' ' A' ' 50' ' ' GLU . 28.2 pttt -65.98 -32.68 74.31 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.892 -0.781 . . . . 0.09 108.892 175.807 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 51.4 mp0 -60.28 -42.8 96.21 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.514 -1.366 . . . . 0.08 110.103 179.126 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -64.1 -41.73 97.17 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.628 -1.295 . . . . 0.07 110.012 177.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.91 -42.51 94.66 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.636 -1.29 . . . . 0.05 109.609 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.37 -42.29 94.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.262 -0.899 . . . . 0.07 109.802 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.46 ' HE ' ' HB2' ' A' ' 26' ' ' ARG . 4.4 ttm180 -62.61 -37.52 86.61 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.316 -0.865 . . . . 0.1 109.98 178.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -67.25 -49.19 65.34 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.724 -1.235 . . . . 0.07 108.403 179.062 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.19 -47.05 79.1 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.387 -0.821 . . . . 0.06 109.605 178.333 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.31 -41.34 99.74 Favored Glycine 0 N--CA 1.497 2.722 0 N-CA-C 110.525 -1.03 . . . . 0.08 110.525 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -61.18 -37.76 84.08 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.661 -1.494 . . . . 0.09 110.331 177.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 92.4 mm-40 -73.17 -36.05 66.53 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.069 -1.019 . . . . 0.08 110.181 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 73.5 mt -63.95 -38.2 90.19 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.857 -1.152 . . . . 0.07 108.282 174.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 23.7 t -69.34 -45.48 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 O-C-N 120.879 -1.138 . . . . 0.1 108.178 177.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -57.49 -39.3 76.14 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.665 -0.647 . . . . 0.1 112.625 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -86.19 8.42 73.99 Favored Glycine 0 N--CA 1.508 3.486 0 O-C-N 120.236 -1.54 . . . . 0.08 112.796 -178.453 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.63 17.83 78.37 Favored Glycine 0 N--CA 1.488 2.139 0 O-C-N 120.678 -1.483 . . . . 0.09 111.443 178.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.422 ' CD1' ' HA3' ' A' ' 78' ' ' GLY . 80.3 m-85 -80.93 -36.24 31.3 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.274 -1.721 . . . . 0.08 110.111 -179.256 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 17.4 m -141.96 163.02 19.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-O 122.287 1.042 . . . . 0.1 111.437 -177.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.443 ' OE1' ' NH1' ' A' ' 73' ' ' ARG . 83.3 mt-10 -86.63 165.1 34.54 Favored Pre-proline 0 C--N 1.3 -1.546 0 N-CA-C 107.29 -1.374 . . . . 0.14 107.29 176.334 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.429 ' HD2' ' HB3' ' A' ' 39' ' ' GLU . 50.3 Cg_exo -50.53 -36.86 50.88 Favored 'Trans proline' 0 N--CA 1.51 2.443 0 C-N-CA 123.646 2.897 . . . . 0.13 115.791 -177.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.44 ' CD ' HH21 ' A' ' 73' ' ' ARG . 41.2 mp0 -62.76 -20.59 65.11 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.508 -1.37 . . . . 0.15 112.196 -178.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.466 ' O ' ' HG3' ' A' ' 46' ' ' MET . 39.9 t80 -67.08 -27.79 67.65 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.616 -1.303 . . . . 0.11 112.313 -179.462 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 22.8 t -61.19 -49.01 86.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 120.265 -1.522 . . . . 0.1 110.396 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 51.8 tp60 -67.11 -35.04 78.91 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.093 -1.004 . . . . 0.12 109.108 179.017 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.2 -33.35 73.32 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.232 -0.917 . . . . 0.11 109.765 177.144 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.466 ' HG3' ' O ' ' A' ' 42' ' ' TYR . 94.5 mtp -70.28 -37.93 74.94 Favored 'General case' 0 N--CA 1.482 1.128 0 O-C-N 120.545 -1.347 . . . . 0.1 107.719 177.24 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 93.9 mt -70.14 -40.2 74.93 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.237 -1.023 . . . . 0.1 108.237 178.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -60.14 -44.31 95.04 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.36 -0.837 . . . . 0.13 109.203 177.153 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 15.4 tpt180 -62.45 -39.19 92.57 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.843 -1.161 . . . . 1.51 110.653 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.669 ' OE1' ' HE3' ' A' ' 21' ' ' LYS . 0.5 OUTLIER -62.54 -39.71 94.48 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.166 -0.959 . . . . 0.1 110.895 -178.545 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.581 ' N ' ' HG2' ' A' ' 50' ' ' GLU . 28.5 tttt -62.75 -38.16 89.47 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 116.312 -0.403 . . . . 2.88 110.896 -178.804 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 29.2 tp -64.76 -43.56 92.91 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 120.186 -1.571 . . . . 0.16 108.634 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.6 m -166.11 139.11 3.34 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.044 -1.035 . . . . 0.19 109.71 179.181 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -50.34 144.91 22.52 Favored 'Trans proline' 0 C--N 1.314 -1.286 0 C-N-CA 121.175 1.25 . . . . 0.37 113.655 178.181 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.51 HG21 ' HA ' ' A' ' 64' ' ' PRO . 59.6 p -96.54 7.94 45.32 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 114.505 -1.225 . . . . 0.16 107.92 177.298 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 33.2 t80 -62.36 137.5 58.27 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 105.955 -1.869 . . . . 0.09 105.955 174.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 18.1 mt -117.77 11.97 13.76 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 120.856 -1.152 . . . . 0.1 110.224 -178.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 85.56 170.94 47.67 Favored Glycine 0 C--N 1.302 -1.31 0 N-CA-C 108.667 -1.773 . . . . 0.1 108.667 -178.234 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.81 ' CA ' ' N ' ' A' ' 60' ' ' SER . 76.6 mm-40 57.59 35.4 25.7 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.458 -1.025 . . . . 1.86 113.527 177.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.81 ' N ' ' CA ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER 65.28 21.48 12.02 Favored 'General case' 0 N--CA 1.514 2.771 0 O-C-N 121.039 -1.038 . . . . 0.08 113.555 176.731 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 94.2 mt -121.38 137.48 54.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 120.645 -1.285 . . . . 0.07 111.014 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -129.31 138.85 51.82 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 106.247 -1.76 . . . . 0.06 106.247 174.41 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.494 ' O ' HG23 ' A' ' 63' ' ' VAL . 16.3 m -130.32 72.28 81.96 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.163 -0.96 . . . . 0.07 110.103 -179.373 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.51 ' HA ' HG21 ' A' ' 55' ' ' THR . 2.4 Cg_endo -50.24 144.29 23.65 Favored 'Trans proline' 0 C--N 1.298 -2.12 0 CA-C-N 119.874 0.991 . . . . 0.38 111.794 -177.609 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 2.4 p-80 -141.58 153.9 45.1 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 120.821 -1.174 . . . . 0.59 108.735 175.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -75.51 173.96 52.77 Favored Glycine 0 N--CA 1.501 2.999 0 N-CA-C 109.522 -1.431 . . . . 0.12 109.522 -177.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 82.0 p -80.18 167.93 19.73 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 116.818 -1.953 . . . . 0.59 109.376 179.324 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.592 HG12 ' ND2' ' A' ' 109' ' ' ASN . 5.3 m -70.52 -23.65 24.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 121.382 -0.824 . . . . 0.14 109.751 -179.441 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.501 ' OE1' ' N ' ' A' ' 69' ' ' GLU . 58.7 mp0 -75.27 9.06 2.26 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.985 -1.072 . . . . 0.15 109.725 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -121.73 15.27 11.0 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.709 -0.619 . . . . 0.13 109.813 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 49.5 pttt -60.87 -37.95 83.9 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.016 -1.053 . . . . 0.14 109.136 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -69.27 -4.13 16.68 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.658 -0.651 . . . . 0.14 111.543 -177.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.443 ' NH1' ' OE1' ' A' ' 39' ' ' GLU . 15.6 mmm180 -104.96 7.95 34.32 Favored 'General case' 0 N--CA 1.506 2.33 0 O-C-N 120.444 -1.41 . . . . 0.13 109.374 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 91.1 t -95.48 128.49 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 107.082 -1.451 . . . . 0.11 107.082 177.488 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 28.1 mt -96.75 -17.15 20.47 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 115.721 -0.672 . . . . 0.11 109.455 -178.016 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 39.6 pttt -176.6 159.67 1.9 Allowed 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.523 -0.918 . . . . 0.09 108.523 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 18.2 m -76.29 138.14 40.34 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.355 -0.841 . . . . 0.13 111.079 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.422 ' HA3' ' CD1' ' A' ' 37' ' ' TYR . . . -160.69 161.05 32.45 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 118.735 -1.698 . . . . 0.06 110.863 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 33.3 m -137.65 150.96 25.62 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 O-C-N 121.603 -0.939 . . . . 0.03 108.842 179.314 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 80' ' ' VAL . 15.9 m -127.02 113.14 31.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 106.271 -1.752 . . . . 0.04 106.271 175.439 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.649 ' CZ ' HD22 ' A' ' 100' ' ' LEU . 61.6 t80 -86.02 115.38 23.58 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.789 0.804 . . . . 0.05 109.238 -178.528 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 39.5 m -119.0 122.11 41.44 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 121.86 0.838 . . . . 0.04 110.506 -177.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.559 ' HB3' ' HA ' ' A' ' 14' ' ' LEU . 30.7 tt0 -100.71 126.47 47.25 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-O 122.108 0.956 . . . . 0.07 111.805 -178.463 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -123.35 87.24 51.79 Favored Pre-proline 0 C--N 1.302 -1.471 0 N-CA-C 107.025 -1.472 . . . . 0.06 107.025 177.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -54.06 -36.05 83.43 Favored 'Trans proline' 0 N--CA 1.501 1.925 0 C-N-CA 122.847 2.365 . . . . 0.08 113.081 -177.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -81.73 -13.27 58.02 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.481 -0.762 . . . . 0.08 110.323 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 90.08 152.59 27.23 Favored Glycine 0 N--CA 1.485 1.912 0 O-C-N 120.791 -1.193 . . . . 0.06 113.024 175.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 61.5 t -136.47 120.43 24.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 106.549 -1.649 . . . . 0.05 106.549 177.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.873 ' HA ' HD13 ' A' ' 97' ' ' ILE . 4.3 ttt180 -60.31 121.27 11.58 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.829 -1.169 . . . . 0.09 109.131 -179.398 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -119.77 -11.51 9.36 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 118.656 -1.218 . . . . 1.03 111.573 -178.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -118.54 -158.21 10.74 Favored Glycine 1 N--CA 1.516 4.009 0 O-C-N 119.588 -1.945 . . . . 0.14 112.255 -178.61 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -92.54 -22.8 19.33 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 113.842 1.052 . . . . 0.26 113.842 -176.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -96.4 154.45 17.26 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.683 -1.261 . . . . 1.62 109.461 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -60.29 -23.89 64.51 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.747 -1.22 . . . . 2.55 109.964 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -86.52 1.87 50.02 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.692 -1.255 . . . . 1.74 109.461 -178.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -83.2 60.17 5.39 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 118.764 -1.175 . . . . 0.16 107.98 178.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.873 HD13 ' HA ' ' A' ' 89' ' ' ARG . 41.8 mm -101.6 135.32 38.75 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 CA-C-O 121.723 0.773 . . . . 0.08 110.169 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -108.56 130.95 55.28 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 121.545 0.688 . . . . 0.06 109.682 178.323 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -102.5 -17.07 15.93 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 106.557 -1.646 . . . . 0.09 106.557 175.365 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.649 HD22 ' CZ ' ' A' ' 81' ' ' PHE . 71.1 mt -116.87 112.16 20.68 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.12 -1.067 . . . . 0.06 108.12 176.675 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 93.8 t -113.4 104.07 16.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 106.257 -1.757 . . . . 0.04 106.257 179.102 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 72.3 mt -107.11 102.91 14.65 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.087 0 CA-C-O 122.292 1.044 . . . . 0.04 111.035 -176.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -77.6 131.97 11.57 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.023 -1.631 . . . . 0.04 109.023 -178.391 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.409 HD13 HG21 ' A' ' 104' ' ' ILE . 19.4 pt -133.45 153.5 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 O-C-N 120.264 -1.727 . . . . 0.1 112.916 -176.143 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -137.38 133.71 35.13 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 106.189 -1.782 . . . . 0.12 106.189 177.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -147.59 140.97 25.3 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 120.113 -1.617 . . . . 0.13 110.955 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 60.6 mtp180 -70.74 156.29 39.7 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.588 0.709 . . . . 3.71 110.331 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 57.81 25.4 11.92 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.069 -0.715 . . . . 1.98 109.069 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.592 ' ND2' HG12 ' A' ' 68' ' ' VAL . 63.1 t30 53.27 37.58 25.6 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.172 -0.955 . . . . 1.22 109.766 178.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -84.05 28.89 0.58 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.131 -0.981 . . . . 0.18 111.093 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' HIS . . . . . 0.75 ' CA ' ' N ' ' A' ' 112' ' ' ILE . 40.0 p-80 -50.54 -38.3 44.08 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.881 -1.137 . . . . 0.18 112.095 179.067 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.75 ' N ' ' CA ' ' A' ' 111' ' ' HIS . 21.0 tt -63.18 -28.96 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 119.986 -1.696 . . . . 0.12 111.005 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -69.81 -40.94 75.63 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 120.516 -1.365 . . . . 0.87 108.334 178.542 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 85.1 t -69.38 -43.61 80.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.428 -0.795 . . . . 0.07 109.414 178.562 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.11 -42.46 95.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.132 -0.98 . . . . 0.08 109.471 178.41 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 94.7 m -62.35 -42.45 99.41 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.295 -0.878 . . . . 0.14 109.899 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 11.2 t -63.66 -45.91 88.0 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.161 -0.962 . . . . 0.07 109.572 178.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 57.3 mt -64.09 -48.26 76.87 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.07 -1.019 . . . . 0.07 111.173 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 40.0 p -66.38 -28.01 68.31 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 120.986 -1.071 . . . . 0.09 111.589 -178.011 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -67.81 -35.88 79.41 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 121.007 -1.058 . . . . 1.13 108.145 177.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -80.12 -15.55 56.87 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.967 -1.083 . . . . 0.09 109.844 177.295 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 80.5 mt -106.01 27.86 8.18 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.984 -1.072 . . . . 0.17 110.675 178.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -72.46 -12.73 61.22 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 120.937 -1.102 . . . . 0.49 111.879 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -110.66 131.38 55.1 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.588 -1.32 . . . . 0.13 110.619 179.22 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -57.72 -34.55 69.6 Favored 'General case' 0 N--CA 1.503 2.181 0 C-N-CA 123.306 0.642 . . . . 0.15 112.262 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.495 ' O ' ' HG2' ' A' ' 130' ' ' ARG . 59.7 p -65.75 -34.01 77.18 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 120.694 -1.254 . . . . 0.13 109.88 179.052 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 85.6 t -65.65 -43.9 93.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.638 -1.289 . . . . 0.11 109.974 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 95.8 mt -64.33 -46.06 94.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.941 -1.1 . . . . 0.1 110.228 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.614 ' HA ' ' OE1' ' A' ' 129' ' ' GLU . 8.7 mm-40 -57.08 -46.85 82.19 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.223 -0.923 . . . . 0.11 109.864 178.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.495 ' HG2' ' O ' ' A' ' 126' ' ' SER . 43.4 mmm-85 -63.52 -43.7 96.4 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.215 -0.928 . . . . 0.13 110.214 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 83.3 mt -66.89 -35.04 79.12 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.066 -1.022 . . . . 0.08 111.148 -179.277 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -67.33 -27.18 66.93 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.308 -0.87 . . . . 0.08 113.285 -176.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -126.49 1.7 6.92 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 120.082 -1.637 . . . . 0.1 113.322 -176.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 9.4 t -68.31 145.89 53.8 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.502 -1.374 . . . . 0.1 111.271 -178.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 72.8 p -106.06 9.92 32.29 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.27 -1.381 . . . . 0.12 107.27 176.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 47.0 t -107.02 116.4 31.86 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 121.588 0.709 . . . . 0.11 112.696 -178.538 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 15.9 t -65.59 -41.67 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 108.501 -0.925 . . . . 0.09 108.501 176.392 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -56.87 -39.99 75.35 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.233 -0.917 . . . . 0.11 110.408 178.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -63.66 -42.75 98.03 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.936 -1.103 . . . . 0.11 108.45 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 92.0 t -57.29 -51.27 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 108.508 -0.923 . . . . 0.08 108.508 177.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 141' ' ' LEU . 78.4 mt -57.7 -45.98 84.96 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.238 -0.914 . . . . 0.07 110.294 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -58.81 -47.91 83.13 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.814 -1.179 . . . . 0.11 111.02 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 83.7 mt -67.99 -23.49 65.03 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.983 -1.073 . . . . 0.1 112.606 -177.148 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.661 ' O ' ' NH1' ' A' ' 147' ' ' ARG . 91.7 mt -110.05 9.27 24.21 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.367 -1.458 . . . . 0.07 111.391 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.711 ' HA ' HH12 ' A' ' 147' ' ' ARG . . . -76.97 -25.25 52.57 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 120.689 -1.257 . . . . 0.07 112.305 -178.151 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -81.77 -8.81 86.32 Favored Glycine 0 N--CA 1.504 3.211 0 O-C-N 120.57 -1.331 . . . . 0.08 111.156 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ARG . . . . . 1.259 ' HD2' ' CZ ' ' A' ' 5' ' ' PHE . 2.0 ptt-85 . . . . . 0 N--CA 1.486 1.371 0 O-C-N 121.053 -1.263 . . . . 0.07 109.64 179.23 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 301' ' ' MET . . . . . 0.517 ' HB2' ' HG2' ' B' ' 366' ' ' GLU . 3.4 ttm . . . . . 0 C--O 1.214 -0.786 0 CA-C-O 121.931 0.872 . . . . 0.17 108.948 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 302' ' ' PHE . . . . . 0.454 ' N ' ' CG ' ' B' ' 301' ' ' MET . 46.9 t80 -139.74 142.97 36.77 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 107.27 -1.381 . . . . 0.16 107.27 178.511 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 303' ' ' GLN . . . . . 0.49 ' O ' ' HG2' ' B' ' 304' ' ' GLN . 5.4 pt20 -153.0 156.31 38.58 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 120.904 -1.123 . . . . 0.14 109.495 179.236 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 304' ' ' GLN . . . . . 0.49 ' HG2' ' O ' ' B' ' 303' ' ' GLN . 42.2 mm-40 -152.18 149.21 28.51 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 108.033 -1.099 . . . . 0.15 108.033 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -97.19 152.35 18.91 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.046 -1.034 . . . . 0.13 108.428 178.335 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 7.2 p -147.83 144.34 19.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 N-CA-C 107.478 -1.304 . . . . 0.12 107.478 177.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 85.4 m -96.67 136.54 37.06 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 122.169 0.985 . . . . 0.13 110.079 177.197 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 51.7 mt -84.88 114.25 24.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 105.478 -2.045 . . . . 0.13 105.478 177.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 47.4 p -106.7 -4.39 19.51 Favored 'General case' 0 C--N 1.264 -3.117 0 N-CA-C 114.704 1.372 . . . . 0.16 114.704 -178.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -71.44 141.87 86.02 Favored Pre-proline 0 N--CA 1.499 2.012 0 O-C-N 119.683 -1.886 . . . . 0.16 110.658 178.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -45.54 -47.63 13.03 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 124.749 3.633 . . . . 0.19 114.202 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 44.5 t-20 -102.21 27.61 6.54 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 116.035 -2.266 . . . . 0.99 108.725 179.398 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 58.83 -144.0 44.73 Favored Glycine 0 N--CA 1.496 2.699 0 C-N-CA 117.708 -2.187 . . . . 0.13 109.52 -179.098 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 314' ' ' LEU . . . . . . . . . . . . . 9.8 tp -96.93 82.92 3.3 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.203 -1.175 . . . . 0.11 109.363 178.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 315' ' ' HIS . . . . . 0.609 ' CG ' ' N ' ' B' ' 316' ' ' THR . 0.4 OUTLIER -80.85 -159.83 0.27 Allowed 'General case' 0 N--CA 1.503 2.209 0 N-CA-C 107.277 -1.379 . . . . 1.2 107.277 179.058 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 316' ' ' THR . . . . . 0.609 ' N ' ' CG ' ' B' ' 315' ' ' HIS . 63.7 p -66.39 -53.14 39.31 Favored 'General case' 0 N--CA 1.513 2.687 0 N-CA-C 120.177 3.399 . . . . 0.16 120.177 -174.314 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 317' ' ' ARG . . . . . 0.659 HH11 ' HG2' ' B' ' 317' ' ' ARG . 4.8 ttt-85 -54.9 -53.33 62.23 Favored Pre-proline 0 N--CA 1.493 1.705 0 CA-C-N 122.593 2.451 . . . . 1.91 112.446 -174.661 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 318' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' B' ' 317' ' ' ARG . 21.0 Cg_endo -66.41 -32.17 41.12 Favored 'Trans proline' 0 N--CA 1.484 0.963 0 C-N-CA 124.707 3.604 . . . . 0.13 111.563 -177.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 319' ' ' ALA . . . . . 0.419 ' O ' HG23 ' B' ' 323' ' ' VAL . . . -67.07 -38.8 86.43 Favored 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 119.503 -0.879 . . . . 0.1 109.491 -179.399 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -70.95 -39.68 72.46 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.865 -0.791 . . . . 0.11 108.865 178.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 67.8 tp60 -64.01 -39.31 93.83 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 117.863 -1.535 . . . . 0.12 109.535 177.106 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 322' ' ' PHE . . . . . 0.44 ' CE1' HD22 ' B' ' 377' ' ' LEU . 87.3 t80 -62.76 -45.3 93.32 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 122.583 1.182 . . . . 0.08 108.703 -177.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 323' ' ' VAL . . . . . 0.419 HG23 ' O ' ' B' ' 319' ' ' ALA . 53.4 t -62.58 -42.26 95.24 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.278 0 CA-C-N 114.809 -1.087 . . . . 0.07 110.713 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -63.87 -40.18 95.93 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.325 -0.859 . . . . 1.68 109.851 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 325' ' ' GLU . . . . . 0.494 ' OE1' HD22 ' B' ' 380' ' ' LEU . 31.7 tt0 -68.9 -39.65 79.59 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.37 -0.831 . . . . 0.1 109.56 177.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -59.07 -43.99 91.82 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.708 -1.245 . . . . 0.06 109.417 178.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -61.37 -16.13 43.21 Favored 'General case' 0 N--CA 1.509 2.512 0 O-C-N 121.226 -0.922 . . . . 1.5 113.338 178.537 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -76.92 -10.65 86.07 Favored Glycine 0 N--CA 1.479 1.529 0 O-C-N 119.999 -1.688 . . . . 0.08 109.338 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 329' ' ' PHE . . . . . 0.402 ' HE1' ' HE3' ' B' ' 372' ' ' LYS . 92.8 m-85 -103.36 143.32 32.83 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.429 -1.63 . . . . 0.09 110.101 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 47.8 p -75.66 -30.08 59.31 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.297 -0.877 . . . . 0.11 112.272 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 331' ' ' SER . . . . . . . . . . . . . 15.9 m -59.68 158.57 9.93 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 119.844 -1.785 . . . . 0.11 112.821 -179.177 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 332' ' ' GLU . . . . . 0.769 ' OE1' ' N ' ' B' ' 333' ' ' ILE . 0.0 OUTLIER -79.0 130.4 35.49 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 102.81 -3.033 . . . . 0.11 102.81 171.266 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 333' ' ' ILE . . . . . 0.769 ' N ' ' OE1' ' B' ' 332' ' ' GLU . 39.2 mt -126.81 136.5 60.61 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.486 0 CA-C-O 122.192 0.996 . . . . 0.08 109.305 -178.246 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 93.3 m -124.94 143.21 50.99 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-O 123.216 1.484 . . . . 0.09 109.978 178.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 335' ' ' VAL . . . . . 0.442 HG23 ' HB2' ' B' ' 344' ' ' ALA . 85.3 t -108.14 129.95 61.51 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.633 0 N-CA-C 105.469 -2.049 . . . . 0.06 105.469 173.127 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 336' ' ' THR . . . . . 0.419 ' HB ' ' HB ' ' B' ' 362' ' ' THR . 71.5 m -127.39 119.51 26.35 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 120.862 -1.149 . . . . 0.09 109.046 -178.47 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 29.1 t -122.52 122.61 39.32 Favored 'General case' 0 N--CA 1.501 2.106 0 C-N-CA 119.992 -0.683 . . . . 0.08 109.843 177.542 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 62.5 t30 51.73 38.84 24.0 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.886 -1.134 . . . . 0.1 112.87 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 81.81 10.86 83.59 Favored Glycine 0 N--CA 1.501 3.009 0 O-C-N 119.944 -1.722 . . . . 0.11 112.522 177.336 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 340' ' ' LYS . . . . . 0.408 ' O ' ' HA ' ' B' ' 336' ' ' THR . 26.5 mttp -119.85 136.3 54.54 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 105.221 -2.14 . . . . 0.1 105.221 177.642 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 68.3 m -124.8 158.55 33.09 Favored 'General case' 0 C--N 1.276 -2.594 0 CA-C-O 123.738 1.732 . . . . 0.09 112.408 -176.052 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -151.62 151.45 31.53 Favored 'General case' 0 C--N 1.278 -2.51 0 CA-C-N 112.449 -2.159 . . . . 0.08 108.634 177.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 8.0 t -70.63 135.95 48.78 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 105.556 -2.016 . . . . 0.08 105.556 173.566 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 344' ' ' ALA . . . . . 0.442 ' HB2' HG23 ' B' ' 335' ' ' VAL . . . -72.95 -6.83 47.95 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.691 -1.256 . . . . 0.05 110.703 179.219 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -97.5 13.07 31.18 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.631 -1.293 . . . . 0.08 109.395 -177.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 11.0 t -133.18 104.25 6.4 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 122.153 0.977 . . . . 0.12 110.062 -178.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 347' ' ' LEU . . . . . . . . . . . . . 43.1 tp -57.34 -37.77 73.05 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 115.658 -0.701 . . . . 0.1 109.998 178.232 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 348' ' ' PHE . . . . . 0.505 ' HB3' ' OE2' ' A' ' 59' ' ' GLU . 75.2 t80 -59.0 -51.35 70.43 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.566 -1.334 . . . . 0.13 113.021 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 37.5 tptt -70.05 -32.46 70.58 Favored 'General case' 0 C--O 1.214 -0.769 0 O-C-N 119.664 -1.898 . . . . 1.55 109.109 -178.333 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 350' ' ' LEU . . . . . . . . . . . . . 33.3 mt -62.84 -33.7 75.79 Favored 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 118.958 -1.097 . . . . 0.16 109.92 -177.433 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 351' ' ' GLN . . . . . . . . . . . . . 12.5 tp-100 -67.69 -10.49 52.89 Favored 'General case' 0 C--N 1.293 -1.852 0 O-C-N 121.599 -0.688 . . . . 0.26 109.915 -177.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 352' ' ' THR . . . . . . . . . . . . . 45.7 p -89.72 -7.74 53.87 Favored 'General case' 0 N--CA 1.502 2.132 0 C-N-CA 118.097 -1.441 . . . . 0.12 111.026 -178.496 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 83.2 mt -93.34 159.34 15.3 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.244 -0.91 . . . . 0.1 110.224 -178.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -86.76 104.8 2.97 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 106.94 -2.464 . . . . 0.08 106.94 177.047 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 16.3 mt -119.46 47.29 1.73 Allowed 'General case' 0 C--N 1.309 -1.186 0 O-C-N 120.625 -1.515 . . . . 0.1 107.471 -178.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 52.8 p -81.36 172.53 13.46 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 118.849 -1.141 . . . . 0.2 109.16 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -60.74 140.97 57.36 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 119.349 -0.94 . . . . 1.61 109.76 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 91.4 -3.17 79.04 Favored Glycine 0 N--CA 1.5 2.941 0 C-N-CA 120.052 -1.071 . . . . 0.13 111.381 177.659 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 54.5 m -84.4 135.81 34.13 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 120.918 -1.342 . . . . 0.11 110.66 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 89.2 t -96.47 123.8 48.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 N-CA-C 106.304 -1.739 . . . . 0.11 106.304 176.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 361' ' ' VAL . . . . . 0.487 HG21 ' SD ' ' B' ' 381' ' ' MET . 22.3 m -112.27 160.13 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.335 0 C-N-CA 117.354 -1.739 . . . . 0.09 110.636 178.585 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 362' ' ' THR . . . . . 0.419 ' HB ' ' HB ' ' B' ' 336' ' ' THR . 90.4 m -108.89 128.34 54.83 Favored 'General case' 0 C--O 1.214 -0.789 0 O-C-N 120.596 -1.315 . . . . 0.1 107.565 175.559 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 363' ' ' ILE . . . . . 0.459 ' O ' ' HA ' ' B' ' 303' ' ' GLN . 33.2 mt -107.92 121.45 60.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 105.344 -2.095 . . . . 0.1 105.344 176.33 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 364' ' ' SER . . . . . 0.411 ' HB3' ' HB3' ' B' ' 303' ' ' GLN . 0.7 OUTLIER -128.57 147.3 50.7 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 107.809 -1.182 . . . . 0.1 107.809 -179.646 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -139.76 153.32 47.13 Favored 'General case' 0 C--N 1.292 -1.925 0 C-N-CA 118.454 -1.298 . . . . 0.13 109.781 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 366' ' ' GLU . . . . . 0.517 ' HG2' ' HB2' ' B' ' 301' ' ' MET . 0.2 OUTLIER -141.14 110.88 6.48 Favored 'General case' 0 C--N 1.288 -2.081 0 C-N-CA 118.592 -1.243 . . . . 0.16 108.078 178.127 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . 165.22 -170.36 40.16 Favored Glycine 0 C--N 1.297 -1.59 0 C-N-CA 117.981 -2.056 . . . . 0.14 110.327 178.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -58.27 -40.55 82.18 Favored 'General case' 0 C--N 1.277 -2.57 0 CA-C-N 114.33 -0.935 . . . . 0.16 112.306 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 369' ' ' ASP . . . . . . . . . . . . . 12.0 p30 -114.21 36.85 3.54 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 115.834 -2.346 . . . . 0.13 108.519 -178.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 370' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -56.41 -33.56 65.91 Favored 'General case' 0 N--CA 1.521 3.107 0 N-CA-C 116.8 2.148 . . . . 0.16 116.8 -174.039 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.95 -45.59 27.1 Favored 'General case' 0 N--CA 1.509 2.514 0 O-C-N 119.526 -1.984 . . . . 0.18 110.914 -176.519 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 372' ' ' LYS . . . . . 0.783 ' HG2' ' CE1' ' B' ' 376' ' ' HIS . 11.9 ttpp -63.56 -40.71 97.69 Favored 'General case' 0 C--N 1.283 -2.315 0 N-CA-C 106.965 -1.495 . . . . 0.13 106.965 178.265 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -59.09 -49.51 77.61 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 117.541 -1.664 . . . . 0.11 110.025 -178.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 374' ' ' VAL . . . . . . . . . . . . . 66.9 t -66.86 -42.25 88.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 CA-C-O 122.187 0.994 . . . . 0.11 109.267 -178.094 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -55.89 -47.78 76.8 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-O 122.059 0.933 . . . . 0.16 108.737 -178.285 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 376' ' ' HIS . . . . . 0.783 ' CE1' ' HG2' ' B' ' 372' ' ' LYS . 6.3 m80 -69.96 -38.23 76.04 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 116.005 -0.543 . . . . 0.13 111.72 -178.644 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 377' ' ' LEU . . . . . 0.44 HD22 ' CE1' ' B' ' 322' ' ' PHE . 80.5 mt -75.64 -28.56 58.84 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.348 -1.47 . . . . 0.09 110.875 -174.318 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 378' ' ' VAL . . . . . . . . . . . . . 2.1 t -71.44 -39.52 71.3 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.459 0 N-CA-C 106.35 -1.722 . . . . 0.13 106.35 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -67.89 -49.31 62.69 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 108.03 -1.1 . . . . 0.16 108.03 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 380' ' ' LEU . . . . . 0.641 ' O ' HD22 ' B' ' 384' ' ' LEU . 34.1 tp -57.18 -45.24 83.87 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 118.974 -1.09 . . . . 0.12 110.62 177.611 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 381' ' ' MET . . . . . 0.487 ' SD ' HG21 ' B' ' 361' ' ' VAL . 3.6 ttm -62.29 -37.44 85.53 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.871 -1.143 . . . . 0.12 111.508 -177.495 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -74.89 -31.78 61.67 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.111 -0.993 . . . . 0.15 110.29 -178.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -78.87 -32.41 45.92 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.622 -0.673 . . . . 0.17 111.247 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 384' ' ' LEU . . . . . 0.641 HD22 ' O ' ' B' ' 380' ' ' LEU . 0.0 OUTLIER -50.12 125.54 12.48 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-O 124.432 2.063 . . . . 0.15 112.762 178.802 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 385' ' ' GLU . . . . . 0.966 ' CD ' ' H ' ' B' ' 385' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.279 -2.48 0 CA-C-N 111.085 -2.779 . . . . 0.18 110.093 -177.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 14.4 tp . . . . . 0 N--CA 1.483 1.208 0 N-CA-C 110.502 -0.184 . . . . 0.06 110.502 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 1.259 ' CZ ' ' HD2' ' A' ' 147' ' ' ARG . 40.6 p90 -136.09 141.73 44.24 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 117.476 -1.69 . . . . 0.04 111.884 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.5 mttp -82.27 142.73 31.86 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 107.944 -1.132 . . . . 0.05 107.944 177.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 1.02 ' HA ' HD21 ' A' ' 11' ' ' ASN . 13.6 tp -136.81 125.64 24.08 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 107.285 -1.376 . . . . 0.05 107.285 179.131 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -154.02 -166.92 15.44 Favored Glycine 0 C--N 1.289 -2.081 0 N-CA-C 108.557 -1.817 . . . . 0.06 108.557 178.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.79 -34.24 77.46 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.599 -0.942 . . . . 0.08 111.313 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -65.44 -14.93 62.02 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.759 -1.213 . . . . 0.07 112.332 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 1.02 HD21 ' HA ' ' A' ' 7' ' ' LEU . 2.7 p-10 -123.7 22.85 8.94 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 119.5 -2.0 . . . . 0.05 111.869 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 48.8 mt -118.49 123.35 71.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 107.539 -1.282 . . . . 0.06 107.539 176.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -126.44 106.98 9.85 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.433 -0.792 . . . . 0.06 109.252 -177.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.559 ' HA ' ' HB3' ' A' ' 83' ' ' GLN . 42.4 mt -100.33 160.52 14.27 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-O 122.702 1.239 . . . . 0.08 112.883 -177.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 62.34 34.66 89.97 Favored Glycine 0 N--CA 1.497 2.749 0 CA-C-N 114.457 -1.247 . . . . 0.08 113.833 175.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.46 ' HA ' ' HE ' ' A' ' 16' ' ' ARG . 1.0 OUTLIER -83.21 169.14 16.09 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 120.238 -1.742 . . . . 0.08 109.733 178.348 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -140.89 140.75 34.59 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 107.409 -1.33 . . . . 0.08 107.409 178.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -154.17 131.7 11.35 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 108.442 -0.948 . . . . 0.06 108.442 179.134 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -77.48 -25.62 50.58 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.141 -0.975 . . . . 0.06 109.69 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 64.2 p -134.75 159.65 40.66 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 119.075 -1.05 . . . . 0.07 111.466 -178.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.669 ' HE3' ' OE1' ' A' ' 50' ' ' GLU . 28.2 pttt -65.98 -32.68 74.31 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.892 -0.781 . . . . 0.09 108.892 175.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 51.4 mp0 -60.28 -42.8 96.21 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.514 -1.366 . . . . 0.08 110.103 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -64.1 -41.73 97.17 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.628 -1.295 . . . . 0.07 110.012 177.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.91 -42.51 94.66 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.636 -1.29 . . . . 0.05 109.609 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.37 -42.29 94.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.262 -0.899 . . . . 0.07 109.802 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.46 ' HE ' ' HB2' ' A' ' 26' ' ' ARG . 4.4 ttm180 -62.61 -37.52 86.61 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.316 -0.865 . . . . 0.1 109.98 178.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -67.25 -49.19 65.34 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.724 -1.235 . . . . 0.07 108.403 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.19 -47.05 79.1 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.387 -0.821 . . . . 0.06 109.605 178.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.31 -41.34 99.74 Favored Glycine 0 N--CA 1.497 2.722 0 N-CA-C 110.525 -1.03 . . . . 0.08 110.525 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -61.18 -37.76 84.08 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.661 -1.494 . . . . 0.09 110.331 177.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 92.4 mm-40 -73.17 -36.05 66.53 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.069 -1.019 . . . . 0.08 110.181 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 73.5 mt -63.95 -38.2 90.19 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.857 -1.152 . . . . 0.07 108.282 174.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 23.7 t -69.34 -45.48 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 O-C-N 120.879 -1.138 . . . . 0.1 108.178 177.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -57.49 -39.3 76.14 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.665 -0.647 . . . . 0.1 112.625 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -86.19 8.42 73.99 Favored Glycine 0 N--CA 1.508 3.486 0 O-C-N 120.236 -1.54 . . . . 0.08 112.796 -178.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.63 17.83 78.37 Favored Glycine 0 N--CA 1.488 2.139 0 O-C-N 120.678 -1.483 . . . . 0.09 111.443 178.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.422 ' CD1' ' HA3' ' A' ' 78' ' ' GLY . 80.3 m-85 -80.93 -36.24 31.3 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.274 -1.721 . . . . 0.08 110.111 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 17.4 m -141.96 163.02 19.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-O 122.287 1.042 . . . . 0.1 111.437 -177.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.443 ' OE1' ' NH1' ' A' ' 73' ' ' ARG . 83.3 mt-10 -86.63 165.1 34.54 Favored Pre-proline 0 C--N 1.3 -1.546 0 N-CA-C 107.29 -1.374 . . . . 0.14 107.29 176.334 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.429 ' HD2' ' HB3' ' A' ' 39' ' ' GLU . 50.3 Cg_exo -50.53 -36.86 50.88 Favored 'Trans proline' 0 N--CA 1.51 2.443 0 C-N-CA 123.646 2.897 . . . . 0.13 115.791 -177.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.44 ' CD ' HH21 ' A' ' 73' ' ' ARG . 41.2 mp0 -62.76 -20.59 65.11 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.508 -1.37 . . . . 0.15 112.196 -178.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.466 ' O ' ' HG3' ' A' ' 46' ' ' MET . 39.9 t80 -67.08 -27.79 67.65 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.616 -1.303 . . . . 0.11 112.313 -179.462 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 22.8 t -61.19 -49.01 86.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 120.265 -1.522 . . . . 0.1 110.396 -179.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 51.8 tp60 -67.11 -35.04 78.91 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.093 -1.004 . . . . 0.12 109.108 179.017 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.2 -33.35 73.32 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.232 -0.917 . . . . 0.11 109.765 177.144 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.466 ' HG3' ' O ' ' A' ' 42' ' ' TYR . 94.5 mtp -70.28 -37.93 74.94 Favored 'General case' 0 N--CA 1.482 1.128 0 O-C-N 120.545 -1.347 . . . . 0.1 107.719 177.24 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 93.9 mt -70.14 -40.2 74.93 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.237 -1.023 . . . . 0.1 108.237 178.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -60.14 -44.31 95.04 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.36 -0.837 . . . . 0.13 109.203 177.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.557 ' NE ' ' NE2' ' A' ' 65' ' ' HIS . 27.0 tpt180 -62.45 -39.19 92.57 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.843 -1.161 . . . . 1.51 110.653 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.669 ' OE1' ' HE3' ' A' ' 21' ' ' LYS . 0.5 OUTLIER -62.54 -39.64 94.24 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.166 -0.959 . . . . 0.1 110.895 -178.545 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.579 ' N ' ' HG2' ' A' ' 50' ' ' GLU . 25.8 tttt -62.8 -38.38 90.47 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 116.364 -0.38 . . . . 2.88 110.86 -178.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 25.3 tp -64.54 -43.56 93.62 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 120.193 -1.567 . . . . 0.16 108.634 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.7 m -166.11 139.11 3.34 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.044 -1.035 . . . . 0.19 109.71 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -50.34 144.91 22.52 Favored 'Trans proline' 0 C--N 1.314 -1.286 0 C-N-CA 121.175 1.25 . . . . 0.37 113.655 178.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 47.2 p -96.54 7.94 45.32 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 114.505 -1.225 . . . . 0.16 107.92 177.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 34.2 t80 -62.36 137.5 58.27 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 105.955 -1.869 . . . . 0.09 105.955 174.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 17.8 mt -117.77 11.97 13.76 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 120.856 -1.152 . . . . 0.1 110.224 -178.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 85.56 170.94 47.67 Favored Glycine 0 C--N 1.302 -1.31 0 N-CA-C 108.667 -1.773 . . . . 0.1 108.667 -178.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.81 ' CA ' ' N ' ' A' ' 60' ' ' SER . 74.3 mm-40 57.59 35.4 25.7 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.458 -1.025 . . . . 1.86 113.527 177.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.81 ' N ' ' CA ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER 65.28 21.48 12.02 Favored 'General case' 0 N--CA 1.514 2.771 0 O-C-N 121.039 -1.038 . . . . 0.08 113.555 176.731 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 94.2 mt -121.38 137.48 54.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 120.645 -1.285 . . . . 0.07 111.014 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -129.31 138.85 51.82 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 106.247 -1.76 . . . . 0.06 106.247 174.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.494 ' O ' HG23 ' A' ' 63' ' ' VAL . 16.3 m -130.32 74.93 79.87 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.163 -0.96 . . . . 0.07 110.103 -179.373 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -58.08 148.94 74.72 Favored 'Trans proline' 0 N--CA 1.49 1.273 0 C-N-CA 121.809 1.672 . . . . 0.38 112.552 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.557 ' NE2' ' NE ' ' A' ' 49' ' ' ARG . 37.2 p-80 -157.19 162.91 39.32 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.637 -0.664 . . . . 0.59 109.611 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -79.1 176.17 54.81 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 110.769 -0.932 . . . . 0.12 110.769 -179.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 82.0 p -81.07 167.93 19.19 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.612 -0.934 . . . . 0.59 109.376 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.585 HG12 ' ND2' ' A' ' 109' ' ' ASN . 4.7 m -70.52 -23.65 24.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 121.382 -0.824 . . . . 0.14 109.751 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.501 ' OE1' ' N ' ' A' ' 69' ' ' GLU . 58.7 mp0 -75.27 9.06 2.26 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.985 -1.072 . . . . 0.15 109.725 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -121.73 15.27 11.0 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.709 -0.619 . . . . 0.13 109.813 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 49.5 pttt -60.87 -37.95 83.9 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.016 -1.053 . . . . 0.14 109.136 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -69.27 -4.13 16.68 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.658 -0.651 . . . . 0.14 111.543 -177.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.443 ' NH1' ' OE1' ' A' ' 39' ' ' GLU . 15.6 mmm180 -104.96 7.95 34.32 Favored 'General case' 0 N--CA 1.506 2.33 0 O-C-N 120.444 -1.41 . . . . 0.13 109.374 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 91.1 t -95.48 128.49 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 107.082 -1.451 . . . . 0.11 107.082 177.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 28.1 mt -96.75 -17.15 20.47 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 115.721 -0.672 . . . . 0.11 109.455 -178.016 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 39.6 pttt -176.6 159.67 1.9 Allowed 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.523 -0.918 . . . . 0.09 108.523 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 18.2 m -76.29 138.14 40.34 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.355 -0.841 . . . . 0.13 111.079 -179.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.422 ' HA3' ' CD1' ' A' ' 37' ' ' TYR . . . -160.69 161.05 32.45 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 118.735 -1.698 . . . . 0.06 110.863 -179.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 33.3 m -137.65 150.96 25.62 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 O-C-N 121.603 -0.939 . . . . 0.03 108.842 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 80' ' ' VAL . 15.9 m -127.02 113.14 31.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 106.271 -1.752 . . . . 0.04 106.271 175.439 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.649 ' CZ ' HD22 ' A' ' 100' ' ' LEU . 61.6 t80 -86.02 115.38 23.58 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.789 0.804 . . . . 0.05 109.238 -178.528 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 39.5 m -119.0 122.11 41.44 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 121.86 0.838 . . . . 0.04 110.506 -177.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.559 ' HB3' ' HA ' ' A' ' 14' ' ' LEU . 30.7 tt0 -100.71 126.47 47.25 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-O 122.108 0.956 . . . . 0.07 111.805 -178.463 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -123.35 87.24 51.79 Favored Pre-proline 0 C--N 1.302 -1.471 0 N-CA-C 107.025 -1.472 . . . . 0.06 107.025 177.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -54.06 -36.05 83.43 Favored 'Trans proline' 0 N--CA 1.501 1.925 0 C-N-CA 122.847 2.365 . . . . 0.08 113.081 -177.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -81.73 -13.27 58.02 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.481 -0.762 . . . . 0.08 110.323 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 90.08 152.59 27.23 Favored Glycine 0 N--CA 1.485 1.912 0 O-C-N 120.791 -1.193 . . . . 0.06 113.024 175.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 61.5 t -136.47 120.43 24.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 106.549 -1.649 . . . . 0.05 106.549 177.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.873 ' HA ' HD13 ' A' ' 97' ' ' ILE . 4.3 ttt180 -60.31 121.27 11.58 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.829 -1.169 . . . . 0.09 109.131 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -119.77 -11.51 9.36 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 118.656 -1.218 . . . . 1.03 111.573 -178.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -118.54 -158.21 10.74 Favored Glycine 1 N--CA 1.516 4.009 0 O-C-N 119.588 -1.945 . . . . 0.14 112.255 -178.61 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -92.54 -22.8 19.33 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 113.842 1.052 . . . . 0.26 113.842 -176.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -96.4 154.45 17.26 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.683 -1.261 . . . . 1.62 109.461 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -60.29 -23.89 64.51 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.747 -1.22 . . . . 2.55 109.964 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -86.52 1.87 50.02 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.692 -1.255 . . . . 1.74 109.461 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -83.2 60.17 5.39 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 118.764 -1.175 . . . . 0.16 107.98 178.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.873 HD13 ' HA ' ' A' ' 89' ' ' ARG . 41.8 mm -101.6 135.32 38.75 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 CA-C-O 121.723 0.773 . . . . 0.08 110.169 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -108.56 130.95 55.28 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 121.545 0.688 . . . . 0.06 109.682 178.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 87.2 mtm180 -102.5 -17.07 15.93 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 106.557 -1.646 . . . . 0.09 106.557 175.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.649 HD22 ' CZ ' ' A' ' 81' ' ' PHE . 71.1 mt -116.87 112.16 20.68 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.12 -1.067 . . . . 0.06 108.12 176.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 93.8 t -113.4 104.07 16.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 106.257 -1.757 . . . . 0.04 106.257 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 72.3 mt -107.11 102.91 14.65 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.087 0 CA-C-O 122.292 1.044 . . . . 0.04 111.035 -176.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -77.6 131.97 11.57 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.023 -1.631 . . . . 0.04 109.023 -178.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.409 HD13 HG21 ' A' ' 104' ' ' ILE . 19.4 pt -133.45 153.5 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 O-C-N 120.264 -1.727 . . . . 0.1 112.916 -176.143 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -137.38 133.71 35.13 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 106.189 -1.782 . . . . 0.12 106.189 177.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -147.59 140.97 25.3 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 120.113 -1.617 . . . . 0.13 110.955 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 60.6 mtp180 -70.74 156.29 39.7 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.588 0.709 . . . . 3.71 110.331 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 57.81 25.4 11.92 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.069 -0.715 . . . . 1.98 109.069 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.585 ' ND2' HG12 ' A' ' 68' ' ' VAL . 61.4 t30 53.27 37.58 25.6 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.172 -0.955 . . . . 1.22 109.766 178.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -84.05 28.89 0.58 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.131 -0.981 . . . . 0.18 111.093 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.75 ' CA ' ' N ' ' A' ' 112' ' ' ILE . 41.6 p-80 -50.54 -38.3 44.08 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.881 -1.137 . . . . 0.18 112.095 179.067 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.75 ' N ' ' CA ' ' A' ' 111' ' ' HIS . 20.9 tt -63.18 -28.96 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 119.986 -1.696 . . . . 0.12 111.005 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -69.81 -40.94 75.63 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 120.516 -1.365 . . . . 0.87 108.334 178.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 85.1 t -69.38 -43.61 80.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.428 -0.795 . . . . 0.07 109.414 178.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 97.0 mt -62.11 -42.46 95.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.132 -0.98 . . . . 0.08 109.471 178.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 97.6 m -62.35 -42.45 99.41 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.295 -0.878 . . . . 0.14 109.899 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 11.2 t -63.66 -45.91 88.0 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.161 -0.962 . . . . 0.07 109.572 178.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 57.3 mt -64.09 -48.26 76.87 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.07 -1.019 . . . . 0.07 111.173 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 40.4 p -66.38 -28.01 68.31 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 120.986 -1.071 . . . . 0.09 111.589 -178.011 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -67.81 -35.88 79.41 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 121.007 -1.058 . . . . 1.13 108.145 177.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -80.12 -15.55 56.87 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.967 -1.083 . . . . 0.09 109.844 177.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 80.5 mt -106.01 27.86 8.18 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.984 -1.072 . . . . 0.17 110.675 178.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -72.46 -12.73 61.22 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 120.937 -1.102 . . . . 0.49 111.879 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -110.66 131.38 55.1 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.588 -1.32 . . . . 0.13 110.619 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -57.72 -34.55 69.6 Favored 'General case' 0 N--CA 1.503 2.181 0 C-N-CA 123.306 0.642 . . . . 0.15 112.262 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.449 ' O ' ' HG2' ' A' ' 130' ' ' ARG . 59.7 p -65.75 -34.01 77.18 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 120.694 -1.254 . . . . 0.13 109.88 179.052 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 85.6 t -65.65 -43.9 93.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.638 -1.289 . . . . 0.11 109.974 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 96.1 mt -64.33 -46.06 94.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.941 -1.1 . . . . 0.1 110.228 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.614 ' HA ' ' OE1' ' A' ' 129' ' ' GLU . 8.7 mm-40 -57.08 -46.85 82.19 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.223 -0.923 . . . . 0.11 109.864 178.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.524 ' NH1' ' HG3' ' A' ' 130' ' ' ARG . 16.5 mmm-85 -63.52 -43.7 96.4 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.215 -0.928 . . . . 0.13 110.214 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 83.3 mt -66.89 -35.04 79.12 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.066 -1.022 . . . . 0.08 111.148 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -67.33 -27.18 66.93 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.308 -0.87 . . . . 0.08 113.285 -176.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -126.49 1.7 6.92 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 120.082 -1.637 . . . . 0.1 113.322 -176.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 9.4 t -68.31 145.89 53.8 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.502 -1.374 . . . . 0.1 111.271 -178.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 72.8 p -106.06 9.92 32.29 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.27 -1.381 . . . . 0.12 107.27 176.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 47.0 t -107.02 116.4 31.86 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 121.588 0.709 . . . . 0.11 112.696 -178.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 15.9 t -65.59 -41.67 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 108.501 -0.925 . . . . 0.09 108.501 176.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -56.87 -39.99 75.35 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.233 -0.917 . . . . 0.11 110.408 178.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -63.66 -42.75 98.03 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.936 -1.103 . . . . 0.11 108.45 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 92.0 t -57.29 -51.27 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 108.508 -0.923 . . . . 0.08 108.508 177.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 141' ' ' LEU . 78.4 mt -57.7 -45.98 84.96 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.238 -0.914 . . . . 0.07 110.294 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -58.81 -47.91 83.13 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.814 -1.179 . . . . 0.11 111.02 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 83.7 mt -67.99 -23.49 65.03 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.983 -1.073 . . . . 0.1 112.606 -177.148 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.661 ' O ' ' NH1' ' A' ' 147' ' ' ARG . 91.7 mt -110.05 9.27 24.21 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.367 -1.458 . . . . 0.07 111.391 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.711 ' HA ' HH12 ' A' ' 147' ' ' ARG . . . -76.97 -25.25 52.57 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 120.689 -1.257 . . . . 0.07 112.305 -178.151 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -81.77 -8.81 86.32 Favored Glycine 0 N--CA 1.504 3.211 0 O-C-N 120.57 -1.331 . . . . 0.08 111.156 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 1.259 ' HD2' ' CZ ' ' A' ' 5' ' ' PHE . 2.0 ptt-85 . . . . . 0 N--CA 1.486 1.371 0 O-C-N 121.053 -1.263 . . . . 0.07 109.64 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 301' ' ' MET . . . . . 0.517 ' HB2' ' HG2' ' B' ' 366' ' ' GLU . 3.4 ttm . . . . . 0 C--O 1.214 -0.786 0 CA-C-O 121.931 0.872 . . . . 0.17 108.948 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 302' ' ' PHE . . . . . 0.454 ' N ' ' CG ' ' B' ' 301' ' ' MET . 46.9 t80 -139.74 142.97 36.77 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 107.27 -1.381 . . . . 0.16 107.27 178.511 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 303' ' ' GLN . . . . . 0.49 ' O ' ' HG2' ' B' ' 304' ' ' GLN . 5.4 pt20 -153.0 156.31 38.58 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 120.904 -1.123 . . . . 0.14 109.495 179.236 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 304' ' ' GLN . . . . . 0.49 ' HG2' ' O ' ' B' ' 303' ' ' GLN . 42.2 mm-40 -152.18 149.21 28.51 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 108.033 -1.099 . . . . 0.15 108.033 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -97.19 152.35 18.91 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.046 -1.034 . . . . 0.13 108.428 178.335 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 7.2 p -147.83 144.34 19.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 N-CA-C 107.478 -1.304 . . . . 0.12 107.478 177.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 85.4 m -96.67 136.54 37.06 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 122.169 0.985 . . . . 0.13 110.079 177.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 51.7 mt -84.88 114.25 24.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 105.478 -2.045 . . . . 0.13 105.478 177.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 47.4 p -106.7 -4.39 19.51 Favored 'General case' 0 C--N 1.264 -3.117 0 N-CA-C 114.704 1.372 . . . . 0.16 114.704 -178.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -71.44 141.87 86.02 Favored Pre-proline 0 N--CA 1.499 2.012 0 O-C-N 119.683 -1.886 . . . . 0.16 110.658 178.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -45.54 -47.63 13.03 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 124.749 3.633 . . . . 0.19 114.202 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -102.21 27.61 6.54 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 116.035 -2.266 . . . . 0.99 108.725 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 58.83 -149.92 36.59 Favored Glycine 0 N--CA 1.496 2.699 0 C-N-CA 117.708 -2.187 . . . . 0.13 109.52 -179.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 314' ' ' LEU . . . . . 0.403 ' HA ' HD12 ' B' ' 314' ' ' LEU . 19.9 tp -83.93 72.58 10.42 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.838 -1.39 . . . . 0.11 109.581 -176.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 315' ' ' HIS . . . . . 0.486 ' CE1' ' HG3' ' B' ' 318' ' ' PRO . 54.1 p-80 -69.41 -179.71 1.75 Allowed 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 117.846 -1.542 . . . . 1.2 112.131 -177.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 316' ' ' THR . . . . . 0.537 ' OG1' ' NH2' ' A' ' 49' ' ' ARG . 66.4 p -42.1 -66.7 0.32 Allowed 'General case' 0 N--CA 1.505 2.291 0 N-CA-C 117.209 2.299 . . . . 0.16 117.209 -175.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 317' ' ' ARG . . . . . 0.542 ' N ' ' HD2' ' B' ' 318' ' ' PRO . 5.4 ttt-85 -53.2 -53.33 57.0 Favored Pre-proline 0 N--CA 1.493 1.705 0 C-N-CA 120.21 -0.596 . . . . 1.91 112.446 -176.428 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 318' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' B' ' 317' ' ' ARG . 21.0 Cg_endo -66.41 -32.17 41.12 Favored 'Trans proline' 0 N--CA 1.484 0.963 0 C-N-CA 124.707 3.604 . . . . 0.13 111.563 -177.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 319' ' ' ALA . . . . . 0.419 ' O ' HG23 ' B' ' 323' ' ' VAL . . . -67.07 -38.8 86.43 Favored 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 119.503 -0.879 . . . . 0.1 109.491 -179.399 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -70.95 -39.68 72.46 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.865 -0.791 . . . . 0.11 108.865 178.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 67.8 tp60 -64.01 -39.31 93.83 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 117.863 -1.535 . . . . 0.12 109.535 177.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 322' ' ' PHE . . . . . 0.44 ' CE1' HD22 ' B' ' 377' ' ' LEU . 87.3 t80 -62.76 -45.3 93.32 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 122.583 1.182 . . . . 0.08 108.703 -177.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 323' ' ' VAL . . . . . 0.419 HG23 ' O ' ' B' ' 319' ' ' ALA . 53.4 t -62.58 -42.26 95.24 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.278 0 CA-C-N 114.809 -1.087 . . . . 0.07 110.713 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 73.7 tttt -63.87 -40.18 95.93 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.325 -0.859 . . . . 1.68 109.851 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 325' ' ' GLU . . . . . 0.494 ' OE1' HD22 ' B' ' 380' ' ' LEU . 31.7 tt0 -68.9 -39.65 79.59 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.37 -0.831 . . . . 0.1 109.56 177.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -59.07 -43.99 91.82 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.708 -1.245 . . . . 0.06 109.417 178.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -61.37 -16.13 43.21 Favored 'General case' 0 N--CA 1.509 2.512 0 O-C-N 121.226 -0.922 . . . . 1.5 113.338 178.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -76.92 -10.65 86.07 Favored Glycine 0 N--CA 1.479 1.529 0 O-C-N 119.999 -1.688 . . . . 0.08 109.338 179.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 329' ' ' PHE . . . . . 0.402 ' HE1' ' HE3' ' B' ' 372' ' ' LYS . 92.8 m-85 -103.36 143.32 32.83 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.429 -1.63 . . . . 0.09 110.101 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 47.8 p -75.66 -30.08 59.31 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.297 -0.877 . . . . 0.11 112.272 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 331' ' ' SER . . . . . . . . . . . . . 15.9 m -59.68 158.57 9.93 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 119.844 -1.785 . . . . 0.11 112.821 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 332' ' ' GLU . . . . . 0.769 ' OE1' ' N ' ' B' ' 333' ' ' ILE . 0.0 OUTLIER -79.0 130.4 35.49 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 102.81 -3.033 . . . . 0.11 102.81 171.266 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 333' ' ' ILE . . . . . 0.769 ' N ' ' OE1' ' B' ' 332' ' ' GLU . 39.2 mt -126.81 136.5 60.61 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.486 0 CA-C-O 122.192 0.996 . . . . 0.08 109.305 -178.246 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 93.3 m -124.94 143.21 50.99 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-O 123.216 1.484 . . . . 0.09 109.978 178.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 335' ' ' VAL . . . . . 0.442 HG23 ' HB2' ' B' ' 344' ' ' ALA . 85.3 t -108.14 129.95 61.51 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.633 0 N-CA-C 105.469 -2.049 . . . . 0.06 105.469 173.127 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 336' ' ' THR . . . . . 0.419 ' HB ' ' HB ' ' B' ' 362' ' ' THR . 71.5 m -127.39 119.51 26.35 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 120.862 -1.149 . . . . 0.09 109.046 -178.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 29.1 t -122.52 122.61 39.32 Favored 'General case' 0 N--CA 1.501 2.106 0 C-N-CA 119.992 -0.683 . . . . 0.08 109.843 177.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 62.5 t30 51.73 38.84 24.0 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.886 -1.134 . . . . 0.1 112.87 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 81.81 10.86 83.59 Favored Glycine 0 N--CA 1.501 3.009 0 O-C-N 119.944 -1.722 . . . . 0.11 112.522 177.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 340' ' ' LYS . . . . . 0.408 ' O ' ' HA ' ' B' ' 336' ' ' THR . 26.5 mttp -119.85 136.3 54.54 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 105.221 -2.14 . . . . 0.1 105.221 177.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 68.3 m -124.8 158.55 33.09 Favored 'General case' 0 C--N 1.276 -2.594 0 CA-C-O 123.738 1.732 . . . . 0.09 112.408 -176.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -151.62 151.45 31.53 Favored 'General case' 0 C--N 1.278 -2.51 0 CA-C-N 112.449 -2.159 . . . . 0.08 108.634 177.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 8.0 t -70.63 135.95 48.78 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 105.556 -2.016 . . . . 0.08 105.556 173.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 344' ' ' ALA . . . . . 0.442 ' HB2' HG23 ' B' ' 335' ' ' VAL . . . -72.95 -6.83 47.95 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.691 -1.256 . . . . 0.05 110.703 179.219 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -97.5 13.07 31.18 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.631 -1.293 . . . . 0.08 109.395 -177.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 9.7 t -133.18 104.25 6.4 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 122.153 0.977 . . . . 0.12 110.062 -178.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 347' ' ' LEU . . . . . . . . . . . . . 46.4 tp -57.34 -37.77 73.05 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 115.658 -0.701 . . . . 0.1 109.998 178.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 348' ' ' PHE . . . . . 0.534 ' HB3' ' OE2' ' A' ' 59' ' ' GLU . 77.3 t80 -59.0 -51.35 70.43 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.566 -1.334 . . . . 0.13 113.021 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 37.6 tptt -70.05 -32.46 70.58 Favored 'General case' 0 C--O 1.214 -0.769 0 O-C-N 119.664 -1.898 . . . . 1.55 109.109 -178.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 350' ' ' LEU . . . . . . . . . . . . . 32.3 mt -62.84 -33.7 75.79 Favored 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 118.958 -1.097 . . . . 0.16 109.92 -177.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 351' ' ' GLN . . . . . . . . . . . . . 12.5 tp-100 -67.69 -10.49 52.89 Favored 'General case' 0 C--N 1.293 -1.852 0 O-C-N 121.599 -0.688 . . . . 0.26 109.915 -177.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 352' ' ' THR . . . . . . . . . . . . . 41.7 p -89.72 -7.74 53.87 Favored 'General case' 0 N--CA 1.502 2.132 0 C-N-CA 118.097 -1.441 . . . . 0.12 111.026 -178.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 72.9 mt -93.34 159.34 15.3 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.244 -0.91 . . . . 0.1 110.224 -178.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -86.76 104.8 2.97 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 106.94 -2.464 . . . . 0.08 106.94 177.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 15.5 mt -119.46 47.29 1.73 Allowed 'General case' 0 C--N 1.309 -1.186 0 O-C-N 120.625 -1.515 . . . . 0.1 107.471 -178.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 47.6 p -81.36 172.53 13.46 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 118.849 -1.141 . . . . 0.2 109.16 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -60.74 140.97 57.36 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 119.349 -0.94 . . . . 1.61 109.76 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 91.4 -3.17 79.04 Favored Glycine 0 N--CA 1.5 2.941 0 C-N-CA 120.052 -1.071 . . . . 0.13 111.381 177.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 54.5 m -84.4 135.81 34.13 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 120.918 -1.342 . . . . 0.11 110.66 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 89.2 t -96.47 123.8 48.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 N-CA-C 106.304 -1.739 . . . . 0.11 106.304 176.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 361' ' ' VAL . . . . . 0.487 HG21 ' SD ' ' B' ' 381' ' ' MET . 22.3 m -112.27 160.13 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.335 0 C-N-CA 117.354 -1.739 . . . . 0.09 110.636 178.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 362' ' ' THR . . . . . 0.419 ' HB ' ' HB ' ' B' ' 336' ' ' THR . 90.4 m -108.89 128.34 54.83 Favored 'General case' 0 C--O 1.214 -0.789 0 O-C-N 120.596 -1.315 . . . . 0.1 107.565 175.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 363' ' ' ILE . . . . . 0.459 ' O ' ' HA ' ' B' ' 303' ' ' GLN . 33.2 mt -107.92 121.45 60.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 105.344 -2.095 . . . . 0.1 105.344 176.33 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 364' ' ' SER . . . . . 0.411 ' HB3' ' HB3' ' B' ' 303' ' ' GLN . 0.7 OUTLIER -128.57 147.3 50.7 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 107.809 -1.182 . . . . 0.1 107.809 -179.646 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -139.76 153.32 47.13 Favored 'General case' 0 C--N 1.292 -1.925 0 C-N-CA 118.454 -1.298 . . . . 0.13 109.781 -179.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 366' ' ' GLU . . . . . 0.517 ' HG2' ' HB2' ' B' ' 301' ' ' MET . 0.2 OUTLIER -141.14 110.88 6.48 Favored 'General case' 0 C--N 1.288 -2.081 0 C-N-CA 118.592 -1.243 . . . . 0.16 108.078 178.127 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . 165.22 -170.36 40.16 Favored Glycine 0 C--N 1.297 -1.59 0 C-N-CA 117.981 -2.056 . . . . 0.14 110.327 178.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -58.27 -40.55 82.18 Favored 'General case' 0 C--N 1.277 -2.57 0 CA-C-N 114.33 -0.935 . . . . 0.16 112.306 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 369' ' ' ASP . . . . . . . . . . . . . 12.0 p30 -114.21 36.85 3.54 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 115.834 -2.346 . . . . 0.13 108.519 -178.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 370' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -56.41 -33.56 65.91 Favored 'General case' 0 N--CA 1.521 3.107 0 N-CA-C 116.8 2.148 . . . . 0.16 116.8 -174.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.95 -45.59 27.1 Favored 'General case' 0 N--CA 1.509 2.514 0 O-C-N 119.526 -1.984 . . . . 0.18 110.914 -176.519 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 372' ' ' LYS . . . . . 0.783 ' HG2' ' CE1' ' B' ' 376' ' ' HIS . 11.9 ttpp -63.56 -40.71 97.69 Favored 'General case' 0 C--N 1.283 -2.315 0 N-CA-C 106.965 -1.495 . . . . 0.13 106.965 178.265 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -59.09 -49.51 77.61 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 117.541 -1.664 . . . . 0.11 110.025 -178.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 374' ' ' VAL . . . . . . . . . . . . . 66.9 t -66.86 -42.25 88.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 CA-C-O 122.187 0.994 . . . . 0.11 109.267 -178.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -55.89 -47.78 76.8 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-O 122.059 0.933 . . . . 0.16 108.737 -178.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 376' ' ' HIS . . . . . 0.783 ' CE1' ' HG2' ' B' ' 372' ' ' LYS . 6.3 m80 -69.96 -38.23 76.04 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 116.005 -0.543 . . . . 0.13 111.72 -178.644 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 377' ' ' LEU . . . . . 0.44 HD22 ' CE1' ' B' ' 322' ' ' PHE . 80.5 mt -75.64 -28.56 58.84 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.348 -1.47 . . . . 0.09 110.875 -174.318 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 378' ' ' VAL . . . . . . . . . . . . . 2.1 t -71.44 -39.52 71.3 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.459 0 N-CA-C 106.35 -1.722 . . . . 0.13 106.35 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -67.89 -49.31 62.69 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 108.03 -1.1 . . . . 0.16 108.03 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 380' ' ' LEU . . . . . 0.641 ' O ' HD22 ' B' ' 384' ' ' LEU . 34.1 tp -57.18 -45.24 83.87 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 118.974 -1.09 . . . . 0.12 110.62 177.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 381' ' ' MET . . . . . 0.487 ' SD ' HG21 ' B' ' 361' ' ' VAL . 3.6 ttm -62.29 -37.44 85.53 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.871 -1.143 . . . . 0.12 111.508 -177.495 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -74.89 -31.78 61.67 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.111 -0.993 . . . . 0.15 110.29 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -78.87 -32.41 45.92 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.622 -0.673 . . . . 0.17 111.247 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 384' ' ' LEU . . . . . 0.641 HD22 ' O ' ' B' ' 380' ' ' LEU . 0.0 OUTLIER -50.12 125.54 12.48 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-O 124.432 2.063 . . . . 0.15 112.762 178.802 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 385' ' ' GLU . . . . . 0.966 ' CD ' ' H ' ' B' ' 385' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.279 -2.48 0 CA-C-N 111.085 -2.779 . . . . 0.18 110.093 -177.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 14.4 tp . . . . . 0 N--CA 1.483 1.208 0 N-CA-C 110.502 -0.184 . . . . 0.06 110.502 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 1.259 ' CZ ' ' HD2' ' A' ' 147' ' ' ARG . 40.6 p90 -136.09 141.73 44.24 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 117.476 -1.69 . . . . 0.04 111.884 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.5 mttp -82.27 142.73 31.86 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 107.944 -1.132 . . . . 0.05 107.944 177.36 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 1.02 ' HA ' HD21 ' A' ' 11' ' ' ASN . 13.6 tp -136.81 125.64 24.08 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 107.285 -1.376 . . . . 0.05 107.285 179.131 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -154.02 -166.92 15.44 Favored Glycine 0 C--N 1.289 -2.081 0 N-CA-C 108.557 -1.817 . . . . 0.06 108.557 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.79 -34.24 77.46 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.599 -0.942 . . . . 0.08 111.313 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -65.44 -14.93 62.02 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.759 -1.213 . . . . 0.07 112.332 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 1.02 HD21 ' HA ' ' A' ' 7' ' ' LEU . 2.7 p-10 -123.7 22.85 8.94 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 119.5 -2.0 . . . . 0.05 111.869 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 48.8 mt -118.49 123.35 71.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 107.539 -1.282 . . . . 0.06 107.539 176.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -126.44 106.98 9.85 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.433 -0.792 . . . . 0.06 109.252 -177.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.559 ' HA ' ' HB3' ' A' ' 83' ' ' GLN . 42.4 mt -100.33 160.52 14.27 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-O 122.702 1.239 . . . . 0.08 112.883 -177.423 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 62.34 34.66 89.97 Favored Glycine 0 N--CA 1.497 2.749 0 CA-C-N 114.457 -1.247 . . . . 0.08 113.833 175.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.46 ' HA ' ' HE ' ' A' ' 16' ' ' ARG . 1.0 OUTLIER -83.21 169.14 16.09 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 120.238 -1.742 . . . . 0.08 109.733 178.348 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -140.89 140.75 34.59 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 107.409 -1.33 . . . . 0.08 107.409 178.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -154.17 131.7 11.35 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 108.442 -0.948 . . . . 0.06 108.442 179.134 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -77.48 -25.62 50.58 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.141 -0.975 . . . . 0.06 109.69 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 64.2 p -134.75 159.65 40.66 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 119.075 -1.05 . . . . 0.07 111.466 -178.387 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.669 ' HE3' ' OE1' ' A' ' 50' ' ' GLU . 28.2 pttt -65.98 -32.68 74.31 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.892 -0.781 . . . . 0.09 108.892 175.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 51.4 mp0 -60.28 -42.8 96.21 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.514 -1.366 . . . . 0.08 110.103 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -64.1 -41.73 97.17 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.628 -1.295 . . . . 0.07 110.012 177.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.91 -42.51 94.66 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.636 -1.29 . . . . 0.05 109.609 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.37 -42.29 94.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.262 -0.899 . . . . 0.07 109.802 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.46 ' HE ' ' HB2' ' A' ' 26' ' ' ARG . 4.4 ttm180 -62.61 -37.52 86.61 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.316 -0.865 . . . . 0.1 109.98 178.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -67.25 -49.19 65.34 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.724 -1.235 . . . . 0.07 108.403 179.062 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.19 -47.05 79.1 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.387 -0.821 . . . . 0.06 109.605 178.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.31 -41.34 99.74 Favored Glycine 0 N--CA 1.497 2.722 0 N-CA-C 110.525 -1.03 . . . . 0.08 110.525 179.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -61.18 -37.76 84.08 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.661 -1.494 . . . . 0.09 110.331 177.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 92.4 mm-40 -73.17 -36.05 66.53 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.069 -1.019 . . . . 0.08 110.181 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 73.5 mt -63.95 -38.2 90.19 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.857 -1.152 . . . . 0.07 108.282 174.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 23.7 t -69.34 -45.48 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 O-C-N 120.879 -1.138 . . . . 0.1 108.178 177.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -57.49 -39.3 76.14 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.665 -0.647 . . . . 0.1 112.625 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -86.19 8.42 73.99 Favored Glycine 0 N--CA 1.508 3.486 0 O-C-N 120.236 -1.54 . . . . 0.08 112.796 -178.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.63 17.83 78.37 Favored Glycine 0 N--CA 1.488 2.139 0 O-C-N 120.678 -1.483 . . . . 0.09 111.443 178.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.422 ' CD1' ' HA3' ' A' ' 78' ' ' GLY . 80.3 m-85 -80.93 -36.24 31.3 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.274 -1.721 . . . . 0.08 110.111 -179.256 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 17.4 m -141.96 163.02 19.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-O 122.287 1.042 . . . . 0.1 111.437 -177.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.443 ' OE1' ' NH1' ' A' ' 73' ' ' ARG . 83.3 mt-10 -86.63 165.1 34.54 Favored Pre-proline 0 C--N 1.3 -1.546 0 N-CA-C 107.29 -1.374 . . . . 0.14 107.29 176.334 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.429 ' HD2' ' HB3' ' A' ' 39' ' ' GLU . 50.3 Cg_exo -50.53 -36.86 50.88 Favored 'Trans proline' 0 N--CA 1.51 2.443 0 C-N-CA 123.646 2.897 . . . . 0.13 115.791 -177.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.44 ' CD ' HH21 ' A' ' 73' ' ' ARG . 41.2 mp0 -62.76 -20.59 65.11 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.508 -1.37 . . . . 0.15 112.196 -178.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.466 ' O ' ' HG3' ' A' ' 46' ' ' MET . 39.9 t80 -67.08 -27.79 67.65 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.616 -1.303 . . . . 0.11 112.313 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 22.8 t -61.19 -49.01 86.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 120.265 -1.522 . . . . 0.1 110.396 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 51.8 tp60 -67.11 -35.04 78.91 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.093 -1.004 . . . . 0.12 109.108 179.017 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.2 -33.35 73.32 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.232 -0.917 . . . . 0.11 109.765 177.144 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.466 ' HG3' ' O ' ' A' ' 42' ' ' TYR . 94.5 mtp -70.28 -37.93 74.94 Favored 'General case' 0 N--CA 1.482 1.128 0 O-C-N 120.545 -1.347 . . . . 0.1 107.719 177.24 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 93.9 mt -70.14 -40.2 74.93 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.237 -1.023 . . . . 0.1 108.237 178.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -60.14 -44.31 95.04 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.36 -0.837 . . . . 0.13 109.203 177.153 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.915 HH21 ' P ' ' B' ' 200' ' ' PO3 . 24.5 tpt180 -62.45 -39.19 92.57 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.843 -1.161 . . . . 1.51 110.653 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.669 ' OE1' ' HE3' ' A' ' 21' ' ' LYS . 0.5 OUTLIER -62.54 -39.61 94.14 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.166 -0.959 . . . . 0.1 110.895 -178.545 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.579 ' N ' ' HG2' ' A' ' 50' ' ' GLU . 28.1 tttt -62.87 -38.22 89.98 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 116.333 -0.394 . . . . 2.88 110.853 -178.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 28.7 tp -64.71 -43.56 93.06 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 120.181 -1.574 . . . . 0.16 108.634 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.6 m -166.11 139.11 3.34 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.044 -1.035 . . . . 0.19 109.71 179.181 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -50.34 144.91 22.52 Favored 'Trans proline' 0 C--N 1.314 -1.286 0 C-N-CA 121.175 1.25 . . . . 0.37 113.655 178.181 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.454 HG21 ' HA ' ' A' ' 64' ' ' PRO . 55.3 p -96.54 7.94 45.32 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 114.505 -1.225 . . . . 0.16 107.92 177.298 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -62.36 137.5 58.27 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 105.955 -1.869 . . . . 0.09 105.955 174.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 18.1 mt -117.77 11.97 13.76 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 120.856 -1.152 . . . . 0.1 110.224 -178.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 85.56 170.94 47.67 Favored Glycine 0 C--N 1.302 -1.31 0 N-CA-C 108.667 -1.773 . . . . 0.1 108.667 -178.234 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.81 ' CA ' ' N ' ' A' ' 60' ' ' SER . 76.0 mm-40 57.59 35.4 25.7 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.458 -1.025 . . . . 1.86 113.527 177.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.81 ' N ' ' CA ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER 65.28 21.48 12.02 Favored 'General case' 0 N--CA 1.514 2.771 0 O-C-N 121.039 -1.038 . . . . 0.08 113.555 176.731 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 94.2 mt -121.38 137.48 54.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 120.645 -1.285 . . . . 0.07 111.014 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -129.31 138.85 51.82 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 106.247 -1.76 . . . . 0.06 106.247 174.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.494 ' O ' HG23 ' A' ' 63' ' ' VAL . 16.3 m -130.32 73.41 81.3 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.163 -0.96 . . . . 0.07 110.103 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.454 ' HA ' HG21 ' A' ' 55' ' ' THR . 8.1 Cg_endo -54.57 146.91 50.96 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 120.854 1.036 . . . . 0.38 112.221 -178.708 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 2.4 p-80 -150.37 159.01 44.77 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.315 -0.866 . . . . 0.59 109.447 177.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -76.65 174.81 53.8 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 110.036 -1.226 . . . . 0.12 110.036 -177.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 82.0 p -80.46 167.93 19.57 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.104 -1.233 . . . . 0.59 109.376 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.592 HG12 ' ND2' ' A' ' 109' ' ' ASN . 5.3 m -70.52 -23.65 24.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 121.382 -0.824 . . . . 0.14 109.751 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.501 ' OE1' ' N ' ' A' ' 69' ' ' GLU . 58.7 mp0 -75.27 9.06 2.26 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.985 -1.072 . . . . 0.15 109.725 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -121.73 15.27 11.0 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.709 -0.619 . . . . 0.13 109.813 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 49.5 pttt -60.87 -37.95 83.9 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.016 -1.053 . . . . 0.14 109.136 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -69.27 -4.13 16.68 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.658 -0.651 . . . . 0.14 111.543 -177.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.443 ' NH1' ' OE1' ' A' ' 39' ' ' GLU . 15.6 mmm180 -104.96 7.95 34.32 Favored 'General case' 0 N--CA 1.506 2.33 0 O-C-N 120.444 -1.41 . . . . 0.13 109.374 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 91.1 t -95.48 128.49 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 107.082 -1.451 . . . . 0.11 107.082 177.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 28.1 mt -96.75 -17.15 20.47 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 115.721 -0.672 . . . . 0.11 109.455 -178.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 39.6 pttt -176.6 159.67 1.9 Allowed 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.523 -0.918 . . . . 0.09 108.523 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 18.2 m -76.29 138.14 40.34 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.355 -0.841 . . . . 0.13 111.079 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.422 ' HA3' ' CD1' ' A' ' 37' ' ' TYR . . . -160.69 161.05 32.45 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 118.735 -1.698 . . . . 0.06 110.863 -179.537 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 33.3 m -137.65 150.96 25.62 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 O-C-N 121.603 -0.939 . . . . 0.03 108.842 179.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 80' ' ' VAL . 15.9 m -127.02 113.14 31.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 106.271 -1.752 . . . . 0.04 106.271 175.439 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.649 ' CZ ' HD22 ' A' ' 100' ' ' LEU . 61.6 t80 -86.02 115.38 23.58 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.789 0.804 . . . . 0.05 109.238 -178.528 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 39.5 m -119.0 122.11 41.44 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 121.86 0.838 . . . . 0.04 110.506 -177.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.559 ' HB3' ' HA ' ' A' ' 14' ' ' LEU . 30.7 tt0 -100.71 126.47 47.25 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-O 122.108 0.956 . . . . 0.07 111.805 -178.463 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -123.35 87.24 51.79 Favored Pre-proline 0 C--N 1.302 -1.471 0 N-CA-C 107.025 -1.472 . . . . 0.06 107.025 177.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -54.06 -36.05 83.43 Favored 'Trans proline' 0 N--CA 1.501 1.925 0 C-N-CA 122.847 2.365 . . . . 0.08 113.081 -177.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -81.73 -13.27 58.02 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.481 -0.762 . . . . 0.08 110.323 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 90.08 152.59 27.23 Favored Glycine 0 N--CA 1.485 1.912 0 O-C-N 120.791 -1.193 . . . . 0.06 113.024 175.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 61.5 t -136.47 120.43 24.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 106.549 -1.649 . . . . 0.05 106.549 177.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.873 ' HA ' HD13 ' A' ' 97' ' ' ILE . 4.3 ttt180 -60.31 121.27 11.58 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.829 -1.169 . . . . 0.09 109.131 -179.398 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -119.77 -11.51 9.36 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 118.656 -1.218 . . . . 1.03 111.573 -178.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -118.54 -158.21 10.74 Favored Glycine 1 N--CA 1.516 4.009 0 O-C-N 119.588 -1.945 . . . . 0.14 112.255 -178.61 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -92.54 -22.8 19.33 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 113.842 1.052 . . . . 0.26 113.842 -176.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -96.4 154.45 17.26 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.683 -1.261 . . . . 1.62 109.461 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -60.29 -23.89 64.51 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.747 -1.22 . . . . 2.55 109.964 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -86.52 1.87 50.02 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.692 -1.255 . . . . 1.74 109.461 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -83.2 60.17 5.39 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 118.764 -1.175 . . . . 0.16 107.98 178.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.873 HD13 ' HA ' ' A' ' 89' ' ' ARG . 41.8 mm -101.6 135.32 38.75 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 CA-C-O 121.723 0.773 . . . . 0.08 110.169 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -108.56 130.95 55.28 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 121.545 0.688 . . . . 0.06 109.682 178.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 87.3 mtm180 -102.5 -17.07 15.93 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 106.557 -1.646 . . . . 0.09 106.557 175.365 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.649 HD22 ' CZ ' ' A' ' 81' ' ' PHE . 71.1 mt -116.87 112.16 20.68 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.12 -1.067 . . . . 0.06 108.12 176.675 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 93.8 t -113.4 104.07 16.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 106.257 -1.757 . . . . 0.04 106.257 179.102 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 72.3 mt -107.11 102.91 14.65 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.087 0 CA-C-O 122.292 1.044 . . . . 0.04 111.035 -176.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -77.6 131.97 11.57 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.023 -1.631 . . . . 0.04 109.023 -178.391 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.409 HD13 HG21 ' A' ' 104' ' ' ILE . 19.4 pt -133.45 153.5 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 O-C-N 120.264 -1.727 . . . . 0.1 112.916 -176.143 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -137.38 133.71 35.13 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 106.189 -1.782 . . . . 0.12 106.189 177.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -147.59 140.97 25.3 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 120.113 -1.617 . . . . 0.13 110.955 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 60.6 mtp180 -70.74 156.29 39.7 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.588 0.709 . . . . 3.71 110.331 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 57.81 25.4 11.92 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.069 -0.715 . . . . 1.98 109.069 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.592 ' ND2' HG12 ' A' ' 68' ' ' VAL . 62.9 t30 53.27 37.58 25.6 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.172 -0.955 . . . . 1.22 109.766 178.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -84.05 28.89 0.58 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.131 -0.981 . . . . 0.18 111.093 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.75 ' CA ' ' N ' ' A' ' 112' ' ' ILE . 43.1 p-80 -50.54 -38.3 44.08 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.881 -1.137 . . . . 0.18 112.095 179.067 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.75 ' N ' ' CA ' ' A' ' 111' ' ' HIS . 20.9 tt -63.18 -28.96 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 119.986 -1.696 . . . . 0.12 111.005 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -69.81 -40.94 75.63 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 120.516 -1.365 . . . . 0.87 108.334 178.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 85.1 t -69.38 -43.61 80.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.428 -0.795 . . . . 0.07 109.414 178.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.11 -42.46 95.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.132 -0.98 . . . . 0.08 109.471 178.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 95.7 m -62.35 -42.45 99.41 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.295 -0.878 . . . . 0.14 109.899 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 11.2 t -63.66 -45.91 88.0 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.161 -0.962 . . . . 0.07 109.572 178.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 57.3 mt -64.09 -48.26 76.87 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.07 -1.019 . . . . 0.07 111.173 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 40.0 p -66.38 -28.01 68.31 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 120.986 -1.071 . . . . 0.09 111.589 -178.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -67.81 -35.88 79.41 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 121.007 -1.058 . . . . 1.13 108.145 177.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -80.12 -15.55 56.87 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.967 -1.083 . . . . 0.09 109.844 177.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 80.5 mt -106.01 27.86 8.18 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.984 -1.072 . . . . 0.17 110.675 178.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -72.46 -12.73 61.22 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 120.937 -1.102 . . . . 0.49 111.879 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -110.66 131.38 55.1 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.588 -1.32 . . . . 0.13 110.619 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -57.72 -34.55 69.6 Favored 'General case' 0 N--CA 1.503 2.181 0 C-N-CA 123.306 0.642 . . . . 0.15 112.262 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.484 ' O ' ' HG2' ' A' ' 130' ' ' ARG . 59.7 p -65.75 -34.01 77.18 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 120.694 -1.254 . . . . 0.13 109.88 179.052 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 85.6 t -65.65 -43.9 93.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.638 -1.289 . . . . 0.11 109.974 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 95.8 mt -64.33 -46.06 94.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.941 -1.1 . . . . 0.1 110.228 -179.153 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.614 ' HA ' ' OE1' ' A' ' 129' ' ' GLU . 8.7 mm-40 -57.08 -46.85 82.19 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.223 -0.923 . . . . 0.11 109.864 178.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.484 ' HG2' ' O ' ' A' ' 126' ' ' SER . 42.7 mmm-85 -63.52 -43.7 96.4 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.215 -0.928 . . . . 0.13 110.214 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 83.3 mt -66.89 -35.04 79.12 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.066 -1.022 . . . . 0.08 111.148 -179.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -67.33 -27.18 66.93 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.308 -0.87 . . . . 0.08 113.285 -176.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -126.49 1.7 6.92 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 120.082 -1.637 . . . . 0.1 113.322 -176.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 9.4 t -68.31 145.89 53.8 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.502 -1.374 . . . . 0.1 111.271 -178.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 72.8 p -106.06 9.92 32.29 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.27 -1.381 . . . . 0.12 107.27 176.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 47.0 t -107.02 116.4 31.86 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 121.588 0.709 . . . . 0.11 112.696 -178.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 15.9 t -65.59 -41.67 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 108.501 -0.925 . . . . 0.09 108.501 176.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -56.87 -39.99 75.35 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.233 -0.917 . . . . 0.11 110.408 178.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -63.66 -42.75 98.03 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.936 -1.103 . . . . 0.11 108.45 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 92.0 t -57.29 -51.27 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 108.508 -0.923 . . . . 0.08 108.508 177.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 141' ' ' LEU . 78.4 mt -57.7 -45.98 84.96 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.238 -0.914 . . . . 0.07 110.294 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -58.81 -47.91 83.13 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.814 -1.179 . . . . 0.11 111.02 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 83.7 mt -67.99 -23.49 65.03 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.983 -1.073 . . . . 0.1 112.606 -177.148 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.661 ' O ' ' NH1' ' A' ' 147' ' ' ARG . 91.7 mt -110.05 9.27 24.21 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.367 -1.458 . . . . 0.07 111.391 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.711 ' HA ' HH12 ' A' ' 147' ' ' ARG . . . -76.97 -25.25 52.57 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 120.689 -1.257 . . . . 0.07 112.305 -178.151 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -81.77 -8.81 86.32 Favored Glycine 0 N--CA 1.504 3.211 0 O-C-N 120.57 -1.331 . . . . 0.08 111.156 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 1.259 ' HD2' ' CZ ' ' A' ' 5' ' ' PHE . 2.0 ptt-85 . . . . . 0 N--CA 1.486 1.371 0 O-C-N 121.053 -1.263 . . . . 0.07 109.64 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 301' ' ' MET . . . . . 0.517 ' HB2' ' HG2' ' B' ' 366' ' ' GLU . 3.4 ttm . . . . . 0 C--O 1.214 -0.786 0 CA-C-O 121.931 0.872 . . . . 0.17 108.948 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 302' ' ' PHE . . . . . 0.454 ' N ' ' CG ' ' B' ' 301' ' ' MET . 46.9 t80 -139.74 142.97 36.77 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 107.27 -1.381 . . . . 0.16 107.27 178.511 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 303' ' ' GLN . . . . . 0.49 ' O ' ' HG2' ' B' ' 304' ' ' GLN . 5.4 pt20 -153.0 156.31 38.58 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 120.904 -1.123 . . . . 0.14 109.495 179.236 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 304' ' ' GLN . . . . . 0.49 ' HG2' ' O ' ' B' ' 303' ' ' GLN . 42.2 mm-40 -152.18 149.21 28.51 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 108.033 -1.099 . . . . 0.15 108.033 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -97.19 152.35 18.91 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.046 -1.034 . . . . 0.13 108.428 178.335 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 7.2 p -147.83 144.34 19.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 N-CA-C 107.478 -1.304 . . . . 0.12 107.478 177.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 85.4 m -96.67 136.54 37.06 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 122.169 0.985 . . . . 0.13 110.079 177.197 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 51.7 mt -84.88 114.25 24.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 105.478 -2.045 . . . . 0.13 105.478 177.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 47.4 p -106.7 -4.39 19.51 Favored 'General case' 0 C--N 1.264 -3.117 0 N-CA-C 114.704 1.372 . . . . 0.16 114.704 -178.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -71.44 141.87 86.02 Favored Pre-proline 0 N--CA 1.499 2.012 0 O-C-N 119.683 -1.886 . . . . 0.16 110.658 178.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -45.54 -47.63 13.03 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 124.749 3.633 . . . . 0.19 114.202 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 44.5 t-20 -102.21 27.61 6.54 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 116.035 -2.266 . . . . 0.99 108.725 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 58.83 -147.48 40.68 Favored Glycine 0 N--CA 1.496 2.699 0 C-N-CA 117.708 -2.187 . . . . 0.13 109.52 -179.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 314' ' ' LEU . . . . . . . . . . . . . 12.3 tp -92.23 83.31 5.04 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.859 -1.163 . . . . 0.11 107.859 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -81.46 -163.55 0.64 Allowed 'General case' 0 C--O 1.197 -1.673 0 O-C-N 121.246 -0.909 . . . . 1.2 108.868 -179.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 316' ' ' THR . . . . . 0.888 HG23 ' O2 ' ' B' ' 200' ' ' PO3 . 30.9 p -65.43 -54.85 22.6 Favored 'General case' 0 N--CA 1.524 3.226 0 N-CA-C 119.122 3.008 . . . . 0.16 119.122 -173.105 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 317' ' ' ARG . . . . . 0.678 HH11 ' HG2' ' B' ' 317' ' ' ARG . 4.2 ttt-85 -53.49 -53.33 57.9 Favored Pre-proline 0 N--CA 1.493 1.705 0 C-N-CA 116.88 -1.928 . . . . 1.91 112.446 -175.597 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 318' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' B' ' 317' ' ' ARG . 21.0 Cg_endo -66.41 -32.17 41.12 Favored 'Trans proline' 0 N--CA 1.484 0.963 0 C-N-CA 124.707 3.604 . . . . 0.13 111.563 -177.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 319' ' ' ALA . . . . . 0.419 ' O ' HG23 ' B' ' 323' ' ' VAL . . . -67.07 -38.8 86.43 Favored 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 119.503 -0.879 . . . . 0.1 109.491 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -70.95 -39.68 72.46 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.865 -0.791 . . . . 0.11 108.865 178.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 67.8 tp60 -64.01 -39.31 93.83 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 117.863 -1.535 . . . . 0.12 109.535 177.106 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 322' ' ' PHE . . . . . 0.44 ' CE1' HD22 ' B' ' 377' ' ' LEU . 87.3 t80 -62.76 -45.3 93.32 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 122.583 1.182 . . . . 0.08 108.703 -177.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 323' ' ' VAL . . . . . 0.419 HG23 ' O ' ' B' ' 319' ' ' ALA . 53.4 t -62.58 -42.26 95.24 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.278 0 CA-C-N 114.809 -1.087 . . . . 0.07 110.713 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -63.87 -40.18 95.93 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.325 -0.859 . . . . 1.68 109.851 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 325' ' ' GLU . . . . . 0.494 ' OE1' HD22 ' B' ' 380' ' ' LEU . 31.7 tt0 -68.9 -39.65 79.59 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.37 -0.831 . . . . 0.1 109.56 177.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -59.07 -43.99 91.82 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.708 -1.245 . . . . 0.06 109.417 178.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -61.37 -16.13 43.21 Favored 'General case' 0 N--CA 1.509 2.512 0 O-C-N 121.226 -0.922 . . . . 1.5 113.338 178.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -76.92 -10.65 86.07 Favored Glycine 0 N--CA 1.479 1.529 0 O-C-N 119.999 -1.688 . . . . 0.08 109.338 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 329' ' ' PHE . . . . . 0.402 ' HE1' ' HE3' ' B' ' 372' ' ' LYS . 92.8 m-85 -103.36 143.32 32.83 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.429 -1.63 . . . . 0.09 110.101 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 47.8 p -75.66 -30.08 59.31 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.297 -0.877 . . . . 0.11 112.272 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 331' ' ' SER . . . . . . . . . . . . . 15.9 m -59.68 158.57 9.93 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 119.844 -1.785 . . . . 0.11 112.821 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 332' ' ' GLU . . . . . 0.769 ' OE1' ' N ' ' B' ' 333' ' ' ILE . 0.0 OUTLIER -79.0 130.4 35.49 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 102.81 -3.033 . . . . 0.11 102.81 171.266 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 333' ' ' ILE . . . . . 0.769 ' N ' ' OE1' ' B' ' 332' ' ' GLU . 39.2 mt -126.81 136.5 60.61 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.486 0 CA-C-O 122.192 0.996 . . . . 0.08 109.305 -178.246 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 93.3 m -124.94 143.21 50.99 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-O 123.216 1.484 . . . . 0.09 109.978 178.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 335' ' ' VAL . . . . . 0.442 HG23 ' HB2' ' B' ' 344' ' ' ALA . 85.3 t -108.14 129.95 61.51 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.633 0 N-CA-C 105.469 -2.049 . . . . 0.06 105.469 173.127 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 336' ' ' THR . . . . . 0.419 ' HB ' ' HB ' ' B' ' 362' ' ' THR . 71.5 m -127.39 119.51 26.35 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 120.862 -1.149 . . . . 0.09 109.046 -178.47 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 29.1 t -122.52 122.61 39.32 Favored 'General case' 0 N--CA 1.501 2.106 0 C-N-CA 119.992 -0.683 . . . . 0.08 109.843 177.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 62.5 t30 51.73 38.84 24.0 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.886 -1.134 . . . . 0.1 112.87 -179.267 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 81.81 10.86 83.59 Favored Glycine 0 N--CA 1.501 3.009 0 O-C-N 119.944 -1.722 . . . . 0.11 112.522 177.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 340' ' ' LYS . . . . . 0.408 ' O ' ' HA ' ' B' ' 336' ' ' THR . 26.5 mttp -119.85 136.3 54.54 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 105.221 -2.14 . . . . 0.1 105.221 177.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 68.3 m -124.8 158.55 33.09 Favored 'General case' 0 C--N 1.276 -2.594 0 CA-C-O 123.738 1.732 . . . . 0.09 112.408 -176.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -151.62 151.45 31.53 Favored 'General case' 0 C--N 1.278 -2.51 0 CA-C-N 112.449 -2.159 . . . . 0.08 108.634 177.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 8.0 t -70.63 135.95 48.78 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 105.556 -2.016 . . . . 0.08 105.556 173.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 344' ' ' ALA . . . . . 0.442 ' HB2' HG23 ' B' ' 335' ' ' VAL . . . -72.95 -6.83 47.95 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.691 -1.256 . . . . 0.05 110.703 179.219 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -97.5 13.07 31.18 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.631 -1.293 . . . . 0.08 109.395 -177.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 10.8 t -133.18 104.25 6.4 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 122.153 0.977 . . . . 0.12 110.062 -178.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 347' ' ' LEU . . . . . . . . . . . . . 43.3 tp -57.34 -37.77 73.05 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 115.658 -0.701 . . . . 0.1 109.998 178.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 348' ' ' PHE . . . . . 0.522 ' HB3' ' OE2' ' A' ' 59' ' ' GLU . 75.3 t80 -59.0 -51.35 70.43 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.566 -1.334 . . . . 0.13 113.021 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 37.5 tptt -70.05 -32.46 70.58 Favored 'General case' 0 C--O 1.214 -0.769 0 O-C-N 119.664 -1.898 . . . . 1.55 109.109 -178.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 350' ' ' LEU . . . . . . . . . . . . . 33.7 mt -62.84 -33.7 75.79 Favored 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 118.958 -1.097 . . . . 0.16 109.92 -177.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 351' ' ' GLN . . . . . . . . . . . . . 12.5 tp-100 -67.69 -10.49 52.89 Favored 'General case' 0 C--N 1.293 -1.852 0 O-C-N 121.599 -0.688 . . . . 0.26 109.915 -177.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 352' ' ' THR . . . . . . . . . . . . . 44.6 p -89.72 -7.74 53.87 Favored 'General case' 0 N--CA 1.502 2.132 0 C-N-CA 118.097 -1.441 . . . . 0.12 111.026 -178.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 81.6 mt -93.34 159.34 15.3 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.244 -0.91 . . . . 0.1 110.224 -178.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -86.76 104.8 2.97 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 106.94 -2.464 . . . . 0.08 106.94 177.047 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 15.7 mt -119.46 47.29 1.73 Allowed 'General case' 0 C--N 1.309 -1.186 0 O-C-N 120.625 -1.515 . . . . 0.1 107.471 -178.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 52.0 p -81.36 172.53 13.46 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 118.849 -1.141 . . . . 0.2 109.16 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -60.74 140.97 57.36 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 119.349 -0.94 . . . . 1.61 109.76 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 91.4 -3.17 79.04 Favored Glycine 0 N--CA 1.5 2.941 0 C-N-CA 120.052 -1.071 . . . . 0.13 111.381 177.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 54.5 m -84.4 135.81 34.13 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 120.918 -1.342 . . . . 0.11 110.66 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 89.2 t -96.47 123.8 48.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 N-CA-C 106.304 -1.739 . . . . 0.11 106.304 176.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 361' ' ' VAL . . . . . 0.487 HG21 ' SD ' ' B' ' 381' ' ' MET . 22.3 m -112.27 160.13 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.335 0 C-N-CA 117.354 -1.739 . . . . 0.09 110.636 178.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 362' ' ' THR . . . . . 0.419 ' HB ' ' HB ' ' B' ' 336' ' ' THR . 90.4 m -108.89 128.34 54.83 Favored 'General case' 0 C--O 1.214 -0.789 0 O-C-N 120.596 -1.315 . . . . 0.1 107.565 175.559 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 363' ' ' ILE . . . . . 0.459 ' O ' ' HA ' ' B' ' 303' ' ' GLN . 33.2 mt -107.92 121.45 60.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 105.344 -2.095 . . . . 0.1 105.344 176.33 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 364' ' ' SER . . . . . 0.411 ' HB3' ' HB3' ' B' ' 303' ' ' GLN . 0.7 OUTLIER -128.57 147.3 50.7 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 107.809 -1.182 . . . . 0.1 107.809 -179.646 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -139.76 153.32 47.13 Favored 'General case' 0 C--N 1.292 -1.925 0 C-N-CA 118.454 -1.298 . . . . 0.13 109.781 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 366' ' ' GLU . . . . . 0.517 ' HG2' ' HB2' ' B' ' 301' ' ' MET . 0.2 OUTLIER -141.14 110.88 6.48 Favored 'General case' 0 C--N 1.288 -2.081 0 C-N-CA 118.592 -1.243 . . . . 0.16 108.078 178.127 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . 165.22 -170.36 40.16 Favored Glycine 0 C--N 1.297 -1.59 0 C-N-CA 117.981 -2.056 . . . . 0.14 110.327 178.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -58.27 -40.55 82.18 Favored 'General case' 0 C--N 1.277 -2.57 0 CA-C-N 114.33 -0.935 . . . . 0.16 112.306 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 369' ' ' ASP . . . . . . . . . . . . . 12.0 p30 -114.21 36.85 3.54 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 115.834 -2.346 . . . . 0.13 108.519 -178.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 370' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -56.41 -33.56 65.91 Favored 'General case' 0 N--CA 1.521 3.107 0 N-CA-C 116.8 2.148 . . . . 0.16 116.8 -174.039 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.95 -45.59 27.1 Favored 'General case' 0 N--CA 1.509 2.514 0 O-C-N 119.526 -1.984 . . . . 0.18 110.914 -176.519 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 372' ' ' LYS . . . . . 0.783 ' HG2' ' CE1' ' B' ' 376' ' ' HIS . 11.9 ttpp -63.56 -40.71 97.69 Favored 'General case' 0 C--N 1.283 -2.315 0 N-CA-C 106.965 -1.495 . . . . 0.13 106.965 178.265 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -59.09 -49.51 77.61 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 117.541 -1.664 . . . . 0.11 110.025 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 374' ' ' VAL . . . . . . . . . . . . . 66.9 t -66.86 -42.25 88.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 CA-C-O 122.187 0.994 . . . . 0.11 109.267 -178.094 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -55.89 -47.78 76.8 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-O 122.059 0.933 . . . . 0.16 108.737 -178.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 376' ' ' HIS . . . . . 0.783 ' CE1' ' HG2' ' B' ' 372' ' ' LYS . 6.3 m80 -69.96 -38.23 76.04 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 116.005 -0.543 . . . . 0.13 111.72 -178.644 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 377' ' ' LEU . . . . . 0.44 HD22 ' CE1' ' B' ' 322' ' ' PHE . 80.5 mt -75.64 -28.56 58.84 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.348 -1.47 . . . . 0.09 110.875 -174.318 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 378' ' ' VAL . . . . . . . . . . . . . 2.1 t -71.44 -39.52 71.3 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.459 0 N-CA-C 106.35 -1.722 . . . . 0.13 106.35 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -67.89 -49.31 62.69 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 108.03 -1.1 . . . . 0.16 108.03 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 380' ' ' LEU . . . . . 0.641 ' O ' HD22 ' B' ' 384' ' ' LEU . 34.1 tp -57.18 -45.24 83.87 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 118.974 -1.09 . . . . 0.12 110.62 177.611 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 381' ' ' MET . . . . . 0.487 ' SD ' HG21 ' B' ' 361' ' ' VAL . 3.6 ttm -62.29 -37.44 85.53 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.871 -1.143 . . . . 0.12 111.508 -177.495 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -74.89 -31.78 61.67 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.111 -0.993 . . . . 0.15 110.29 -178.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -78.87 -32.41 45.92 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.622 -0.673 . . . . 0.17 111.247 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 384' ' ' LEU . . . . . 0.641 HD22 ' O ' ' B' ' 380' ' ' LEU . 0.0 OUTLIER -50.12 125.54 12.48 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-O 124.432 2.063 . . . . 0.15 112.762 178.802 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 385' ' ' GLU . . . . . 0.966 ' CD ' ' H ' ' B' ' 385' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.279 -2.48 0 CA-C-N 111.085 -2.779 . . . . 0.18 110.093 -177.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 200' ' ' PO3 . . . . . 0.915 ' P ' HH21 ' A' ' 49' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 14.4 tp . . . . . 0 N--CA 1.483 1.208 0 N-CA-C 110.502 -0.184 . . . . 0.06 110.502 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 1.259 ' CZ ' ' HD2' ' A' ' 147' ' ' ARG . 40.6 p90 -136.09 141.73 44.24 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 117.476 -1.69 . . . . 0.04 111.884 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.5 mttp -82.27 142.73 31.86 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 107.944 -1.132 . . . . 0.05 107.944 177.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 1.02 ' HA ' HD21 ' A' ' 11' ' ' ASN . 13.6 tp -136.81 125.64 24.08 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 107.285 -1.376 . . . . 0.05 107.285 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -154.02 -166.92 15.44 Favored Glycine 0 C--N 1.289 -2.081 0 N-CA-C 108.557 -1.817 . . . . 0.06 108.557 178.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.79 -34.24 77.46 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.599 -0.942 . . . . 0.08 111.313 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -65.44 -14.93 62.02 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.759 -1.213 . . . . 0.07 112.332 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 1.02 HD21 ' HA ' ' A' ' 7' ' ' LEU . 2.7 p-10 -123.7 22.85 8.94 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 119.5 -2.0 . . . . 0.05 111.869 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 48.8 mt -118.49 123.35 71.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 107.539 -1.282 . . . . 0.06 107.539 176.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -126.44 106.98 9.85 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.433 -0.792 . . . . 0.06 109.252 -177.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.559 ' HA ' ' HB3' ' A' ' 83' ' ' GLN . 42.4 mt -100.33 160.52 14.27 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-O 122.702 1.239 . . . . 0.08 112.883 -177.423 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 62.34 34.66 89.97 Favored Glycine 0 N--CA 1.497 2.749 0 CA-C-N 114.457 -1.247 . . . . 0.08 113.833 175.273 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.46 ' HA ' ' HE ' ' A' ' 16' ' ' ARG . 1.0 OUTLIER -83.21 169.14 16.09 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 120.238 -1.742 . . . . 0.08 109.733 178.348 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -140.89 140.75 34.59 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 107.409 -1.33 . . . . 0.08 107.409 178.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -154.17 131.7 11.35 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 108.442 -0.948 . . . . 0.06 108.442 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -77.48 -25.62 50.58 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.141 -0.975 . . . . 0.06 109.69 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 64.2 p -134.75 159.65 40.66 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 119.075 -1.05 . . . . 0.07 111.466 -178.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.669 ' HE3' ' OE1' ' A' ' 50' ' ' GLU . 28.2 pttt -65.98 -32.68 74.31 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.892 -0.781 . . . . 0.09 108.892 175.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 51.4 mp0 -60.28 -42.8 96.21 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.514 -1.366 . . . . 0.08 110.103 179.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -64.1 -41.73 97.17 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.628 -1.295 . . . . 0.07 110.012 177.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.91 -42.51 94.66 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.636 -1.29 . . . . 0.05 109.609 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.37 -42.29 94.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.262 -0.899 . . . . 0.07 109.802 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.46 ' HE ' ' HB2' ' A' ' 26' ' ' ARG . 4.4 ttm180 -62.61 -37.52 86.61 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.316 -0.865 . . . . 0.1 109.98 178.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -67.25 -49.19 65.34 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.724 -1.235 . . . . 0.07 108.403 179.062 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.19 -47.05 79.1 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.387 -0.821 . . . . 0.06 109.605 178.333 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.31 -41.34 99.74 Favored Glycine 0 N--CA 1.497 2.722 0 N-CA-C 110.525 -1.03 . . . . 0.08 110.525 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -61.18 -37.76 84.08 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.661 -1.494 . . . . 0.09 110.331 177.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 92.4 mm-40 -73.17 -36.05 66.53 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.069 -1.019 . . . . 0.08 110.181 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 73.5 mt -63.95 -38.2 90.19 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.857 -1.152 . . . . 0.07 108.282 174.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 23.7 t -69.34 -45.48 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 O-C-N 120.879 -1.138 . . . . 0.1 108.178 177.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -57.49 -39.3 76.14 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.665 -0.647 . . . . 0.1 112.625 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -86.19 8.42 73.99 Favored Glycine 0 N--CA 1.508 3.486 0 O-C-N 120.236 -1.54 . . . . 0.08 112.796 -178.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.63 17.83 78.37 Favored Glycine 0 N--CA 1.488 2.139 0 O-C-N 120.678 -1.483 . . . . 0.09 111.443 178.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.422 ' CD1' ' HA3' ' A' ' 78' ' ' GLY . 80.3 m-85 -80.93 -36.24 31.3 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.274 -1.721 . . . . 0.08 110.111 -179.256 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 17.4 m -141.96 163.02 19.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-O 122.287 1.042 . . . . 0.1 111.437 -177.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.443 ' OE1' ' NH1' ' A' ' 73' ' ' ARG . 83.3 mt-10 -86.63 165.1 34.54 Favored Pre-proline 0 C--N 1.3 -1.546 0 N-CA-C 107.29 -1.374 . . . . 0.14 107.29 176.334 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.429 ' HD2' ' HB3' ' A' ' 39' ' ' GLU . 50.3 Cg_exo -50.53 -36.86 50.88 Favored 'Trans proline' 0 N--CA 1.51 2.443 0 C-N-CA 123.646 2.897 . . . . 0.13 115.791 -177.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.44 ' CD ' HH21 ' A' ' 73' ' ' ARG . 41.2 mp0 -62.76 -20.59 65.11 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.508 -1.37 . . . . 0.15 112.196 -178.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.466 ' O ' ' HG3' ' A' ' 46' ' ' MET . 39.9 t80 -67.08 -27.79 67.65 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.616 -1.303 . . . . 0.11 112.313 -179.462 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 22.8 t -61.19 -49.01 86.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 120.265 -1.522 . . . . 0.1 110.396 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 51.8 tp60 -67.11 -35.04 78.91 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.093 -1.004 . . . . 0.12 109.108 179.017 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.2 -33.35 73.32 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.232 -0.917 . . . . 0.11 109.765 177.144 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.466 ' HG3' ' O ' ' A' ' 42' ' ' TYR . 94.5 mtp -70.28 -37.93 74.94 Favored 'General case' 0 N--CA 1.482 1.128 0 O-C-N 120.545 -1.347 . . . . 0.1 107.719 177.24 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 93.9 mt -70.14 -40.2 74.93 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.237 -1.023 . . . . 0.1 108.237 178.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -60.14 -44.31 95.04 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.36 -0.837 . . . . 0.13 109.203 177.153 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.553 HH21 ' P ' ' B' ' 200' ' ' PO3 . 15.4 tpt180 -62.45 -39.19 92.57 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.843 -1.161 . . . . 1.51 110.653 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.669 ' OE1' ' HE3' ' A' ' 21' ' ' LYS . 0.5 OUTLIER -62.54 -39.71 94.48 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.166 -0.959 . . . . 0.1 110.895 -178.545 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.581 ' N ' ' HG2' ' A' ' 50' ' ' GLU . 28.5 tttt -62.75 -38.16 89.47 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 116.312 -0.403 . . . . 2.88 110.896 -178.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 29.2 tp -64.76 -43.56 92.91 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 120.186 -1.571 . . . . 0.16 108.634 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.6 m -166.11 139.11 3.34 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.044 -1.035 . . . . 0.19 109.71 179.181 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -50.34 144.91 22.52 Favored 'Trans proline' 0 C--N 1.314 -1.286 0 C-N-CA 121.175 1.25 . . . . 0.37 113.655 178.181 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.51 HG21 ' HA ' ' A' ' 64' ' ' PRO . 59.6 p -96.54 7.94 45.32 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 114.505 -1.225 . . . . 0.16 107.92 177.298 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 33.2 t80 -62.36 137.5 58.27 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 105.955 -1.869 . . . . 0.09 105.955 174.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 18.1 mt -117.77 11.97 13.76 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 120.856 -1.152 . . . . 0.1 110.224 -178.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 85.56 170.94 47.67 Favored Glycine 0 C--N 1.302 -1.31 0 N-CA-C 108.667 -1.773 . . . . 0.1 108.667 -178.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.81 ' CA ' ' N ' ' A' ' 60' ' ' SER . 76.6 mm-40 57.59 35.4 25.7 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.458 -1.025 . . . . 1.86 113.527 177.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.81 ' N ' ' CA ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER 65.28 21.48 12.02 Favored 'General case' 0 N--CA 1.514 2.771 0 O-C-N 121.039 -1.038 . . . . 0.08 113.555 176.731 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 94.2 mt -121.38 137.48 54.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 120.645 -1.285 . . . . 0.07 111.014 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -129.31 138.85 51.82 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 106.247 -1.76 . . . . 0.06 106.247 174.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.494 ' O ' HG23 ' A' ' 63' ' ' VAL . 16.3 m -130.32 72.28 81.96 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.163 -0.96 . . . . 0.07 110.103 -179.373 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.51 ' HA ' HG21 ' A' ' 55' ' ' THR . 2.4 Cg_endo -50.24 144.29 23.65 Favored 'Trans proline' 0 C--N 1.298 -2.12 0 CA-C-N 119.874 0.991 . . . . 0.38 111.794 -177.609 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 1.177 ' NE2' ' P ' ' B' ' 200' ' ' PO3 . 2.4 p-80 -141.58 153.9 45.1 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 120.821 -1.174 . . . . 0.59 108.735 175.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -75.51 173.96 52.77 Favored Glycine 0 N--CA 1.501 2.999 0 N-CA-C 109.522 -1.431 . . . . 0.12 109.522 -177.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 82.0 p -80.18 167.93 19.73 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 116.818 -1.953 . . . . 0.59 109.376 179.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.592 HG12 ' ND2' ' A' ' 109' ' ' ASN . 5.3 m -70.52 -23.65 24.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 121.382 -0.824 . . . . 0.14 109.751 -179.441 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.501 ' OE1' ' N ' ' A' ' 69' ' ' GLU . 58.7 mp0 -75.27 9.06 2.26 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.985 -1.072 . . . . 0.15 109.725 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -121.73 15.27 11.0 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.709 -0.619 . . . . 0.13 109.813 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 49.5 pttt -60.87 -37.95 83.9 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.016 -1.053 . . . . 0.14 109.136 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -69.27 -4.13 16.68 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.658 -0.651 . . . . 0.14 111.543 -177.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.443 ' NH1' ' OE1' ' A' ' 39' ' ' GLU . 15.6 mmm180 -104.96 7.95 34.32 Favored 'General case' 0 N--CA 1.506 2.33 0 O-C-N 120.444 -1.41 . . . . 0.13 109.374 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 91.1 t -95.48 128.49 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 107.082 -1.451 . . . . 0.11 107.082 177.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 28.1 mt -96.75 -17.15 20.47 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 115.721 -0.672 . . . . 0.11 109.455 -178.016 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 39.6 pttt -176.6 159.67 1.9 Allowed 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.523 -0.918 . . . . 0.09 108.523 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 18.2 m -76.29 138.14 40.34 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.355 -0.841 . . . . 0.13 111.079 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.422 ' HA3' ' CD1' ' A' ' 37' ' ' TYR . . . -160.69 161.05 32.45 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 118.735 -1.698 . . . . 0.06 110.863 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 33.3 m -137.65 150.96 25.62 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 O-C-N 121.603 -0.939 . . . . 0.03 108.842 179.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 80' ' ' VAL . 15.9 m -127.02 113.14 31.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 106.271 -1.752 . . . . 0.04 106.271 175.439 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.649 ' CZ ' HD22 ' A' ' 100' ' ' LEU . 61.6 t80 -86.02 115.38 23.58 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.789 0.804 . . . . 0.05 109.238 -178.528 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 39.5 m -119.0 122.11 41.44 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 121.86 0.838 . . . . 0.04 110.506 -177.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.559 ' HB3' ' HA ' ' A' ' 14' ' ' LEU . 30.7 tt0 -100.71 126.47 47.25 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-O 122.108 0.956 . . . . 0.07 111.805 -178.463 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -123.35 87.24 51.79 Favored Pre-proline 0 C--N 1.302 -1.471 0 N-CA-C 107.025 -1.472 . . . . 0.06 107.025 177.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -54.06 -36.05 83.43 Favored 'Trans proline' 0 N--CA 1.501 1.925 0 C-N-CA 122.847 2.365 . . . . 0.08 113.081 -177.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -81.73 -13.27 58.02 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.481 -0.762 . . . . 0.08 110.323 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 90.08 152.59 27.23 Favored Glycine 0 N--CA 1.485 1.912 0 O-C-N 120.791 -1.193 . . . . 0.06 113.024 175.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 61.5 t -136.47 120.43 24.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 106.549 -1.649 . . . . 0.05 106.549 177.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.873 ' HA ' HD13 ' A' ' 97' ' ' ILE . 4.3 ttt180 -60.31 121.27 11.58 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.829 -1.169 . . . . 0.09 109.131 -179.398 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -119.77 -11.51 9.36 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 118.656 -1.218 . . . . 1.03 111.573 -178.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -118.54 -158.21 10.74 Favored Glycine 1 N--CA 1.516 4.009 0 O-C-N 119.588 -1.945 . . . . 0.14 112.255 -178.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -92.54 -22.8 19.33 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 113.842 1.052 . . . . 0.26 113.842 -176.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -96.4 154.45 17.26 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.683 -1.261 . . . . 1.62 109.461 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -60.29 -23.89 64.51 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.747 -1.22 . . . . 2.55 109.964 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -86.52 1.87 50.02 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.692 -1.255 . . . . 1.74 109.461 -178.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -83.2 60.17 5.39 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 118.764 -1.175 . . . . 0.16 107.98 178.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.873 HD13 ' HA ' ' A' ' 89' ' ' ARG . 41.8 mm -101.6 135.32 38.75 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 CA-C-O 121.723 0.773 . . . . 0.08 110.169 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -108.56 130.95 55.28 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 121.545 0.688 . . . . 0.06 109.682 178.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -102.5 -17.07 15.93 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 106.557 -1.646 . . . . 0.09 106.557 175.365 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.649 HD22 ' CZ ' ' A' ' 81' ' ' PHE . 71.1 mt -116.87 112.16 20.68 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.12 -1.067 . . . . 0.06 108.12 176.675 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 93.8 t -113.4 104.07 16.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 106.257 -1.757 . . . . 0.04 106.257 179.102 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 72.3 mt -107.11 102.91 14.65 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.087 0 CA-C-O 122.292 1.044 . . . . 0.04 111.035 -176.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -77.6 131.97 11.57 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.023 -1.631 . . . . 0.04 109.023 -178.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.409 HD13 HG21 ' A' ' 104' ' ' ILE . 19.4 pt -133.45 153.5 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 O-C-N 120.264 -1.727 . . . . 0.1 112.916 -176.143 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -137.38 133.71 35.13 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 106.189 -1.782 . . . . 0.12 106.189 177.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -147.59 140.97 25.3 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 120.113 -1.617 . . . . 0.13 110.955 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 60.6 mtp180 -70.74 156.29 39.7 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.588 0.709 . . . . 3.71 110.331 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 57.81 25.4 11.92 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.069 -0.715 . . . . 1.98 109.069 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.592 ' ND2' HG12 ' A' ' 68' ' ' VAL . 63.1 t30 53.27 37.58 25.6 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.172 -0.955 . . . . 1.22 109.766 178.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -84.05 28.89 0.58 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.131 -0.981 . . . . 0.18 111.093 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.75 ' CA ' ' N ' ' A' ' 112' ' ' ILE . 40.0 p-80 -50.54 -38.3 44.08 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.881 -1.137 . . . . 0.18 112.095 179.067 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.75 ' N ' ' CA ' ' A' ' 111' ' ' HIS . 21.0 tt -63.18 -28.96 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 119.986 -1.696 . . . . 0.12 111.005 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -69.81 -40.94 75.63 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 120.516 -1.365 . . . . 0.87 108.334 178.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 85.1 t -69.38 -43.61 80.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.428 -0.795 . . . . 0.07 109.414 178.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.11 -42.46 95.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.132 -0.98 . . . . 0.08 109.471 178.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 94.7 m -62.35 -42.45 99.41 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.295 -0.878 . . . . 0.14 109.899 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 11.2 t -63.66 -45.91 88.0 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.161 -0.962 . . . . 0.07 109.572 178.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 57.3 mt -64.09 -48.26 76.87 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.07 -1.019 . . . . 0.07 111.173 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 40.0 p -66.38 -28.01 68.31 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 120.986 -1.071 . . . . 0.09 111.589 -178.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -67.81 -35.88 79.41 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 121.007 -1.058 . . . . 1.13 108.145 177.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -80.12 -15.55 56.87 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.967 -1.083 . . . . 0.09 109.844 177.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 80.5 mt -106.01 27.86 8.18 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.984 -1.072 . . . . 0.17 110.675 178.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -72.46 -12.73 61.22 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 120.937 -1.102 . . . . 0.49 111.879 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -110.66 131.38 55.1 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.588 -1.32 . . . . 0.13 110.619 179.22 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -57.72 -34.55 69.6 Favored 'General case' 0 N--CA 1.503 2.181 0 C-N-CA 123.306 0.642 . . . . 0.15 112.262 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.495 ' O ' ' HG2' ' A' ' 130' ' ' ARG . 59.7 p -65.75 -34.01 77.18 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 120.694 -1.254 . . . . 0.13 109.88 179.052 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 85.6 t -65.65 -43.9 93.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.638 -1.289 . . . . 0.11 109.974 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 95.8 mt -64.33 -46.06 94.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.941 -1.1 . . . . 0.1 110.228 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.614 ' HA ' ' OE1' ' A' ' 129' ' ' GLU . 8.7 mm-40 -57.08 -46.85 82.19 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.223 -0.923 . . . . 0.11 109.864 178.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.495 ' HG2' ' O ' ' A' ' 126' ' ' SER . 43.4 mmm-85 -63.52 -43.7 96.4 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.215 -0.928 . . . . 0.13 110.214 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 83.3 mt -66.89 -35.04 79.12 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.066 -1.022 . . . . 0.08 111.148 -179.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -67.33 -27.18 66.93 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.308 -0.87 . . . . 0.08 113.285 -176.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -126.49 1.7 6.92 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 120.082 -1.637 . . . . 0.1 113.322 -176.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 9.4 t -68.31 145.89 53.8 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.502 -1.374 . . . . 0.1 111.271 -178.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 72.8 p -106.06 9.92 32.29 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.27 -1.381 . . . . 0.12 107.27 176.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 47.0 t -107.02 116.4 31.86 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 121.588 0.709 . . . . 0.11 112.696 -178.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 15.9 t -65.59 -41.67 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 108.501 -0.925 . . . . 0.09 108.501 176.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -56.87 -39.99 75.35 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.233 -0.917 . . . . 0.11 110.408 178.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -63.66 -42.75 98.03 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.936 -1.103 . . . . 0.11 108.45 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 92.0 t -57.29 -51.27 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 108.508 -0.923 . . . . 0.08 108.508 177.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 141' ' ' LEU . 78.4 mt -57.7 -45.98 84.96 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.238 -0.914 . . . . 0.07 110.294 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -58.81 -47.91 83.13 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.814 -1.179 . . . . 0.11 111.02 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 83.7 mt -67.99 -23.49 65.03 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.983 -1.073 . . . . 0.1 112.606 -177.148 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.661 ' O ' ' NH1' ' A' ' 147' ' ' ARG . 91.7 mt -110.05 9.27 24.21 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.367 -1.458 . . . . 0.07 111.391 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.711 ' HA ' HH12 ' A' ' 147' ' ' ARG . . . -76.97 -25.25 52.57 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 120.689 -1.257 . . . . 0.07 112.305 -178.151 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -81.77 -8.81 86.32 Favored Glycine 0 N--CA 1.504 3.211 0 O-C-N 120.57 -1.331 . . . . 0.08 111.156 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 1.259 ' HD2' ' CZ ' ' A' ' 5' ' ' PHE . 2.0 ptt-85 . . . . . 0 N--CA 1.486 1.371 0 O-C-N 121.053 -1.263 . . . . 0.07 109.64 179.23 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 301' ' ' MET . . . . . 0.517 ' HB2' ' HG2' ' B' ' 366' ' ' GLU . 3.4 ttm . . . . . 0 C--O 1.214 -0.786 0 CA-C-O 121.931 0.872 . . . . 0.17 108.948 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 302' ' ' PHE . . . . . 0.454 ' N ' ' CG ' ' B' ' 301' ' ' MET . 46.9 t80 -139.74 142.97 36.77 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 107.27 -1.381 . . . . 0.16 107.27 178.511 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 303' ' ' GLN . . . . . 0.49 ' O ' ' HG2' ' B' ' 304' ' ' GLN . 5.4 pt20 -153.0 156.31 38.58 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 120.904 -1.123 . . . . 0.14 109.495 179.236 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 304' ' ' GLN . . . . . 0.49 ' HG2' ' O ' ' B' ' 303' ' ' GLN . 42.2 mm-40 -152.18 149.21 28.51 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 108.033 -1.099 . . . . 0.15 108.033 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -97.19 152.35 18.91 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.046 -1.034 . . . . 0.13 108.428 178.335 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 7.2 p -147.83 144.34 19.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 N-CA-C 107.478 -1.304 . . . . 0.12 107.478 177.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 85.4 m -96.67 136.54 37.06 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 122.169 0.985 . . . . 0.13 110.079 177.197 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 51.7 mt -84.88 114.25 24.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 105.478 -2.045 . . . . 0.13 105.478 177.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 47.4 p -106.7 -4.39 19.51 Favored 'General case' 0 C--N 1.264 -3.117 0 N-CA-C 114.704 1.372 . . . . 0.16 114.704 -178.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -71.44 141.87 86.02 Favored Pre-proline 0 N--CA 1.499 2.012 0 O-C-N 119.683 -1.886 . . . . 0.16 110.658 178.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -45.54 -47.63 13.03 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 124.749 3.633 . . . . 0.19 114.202 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 44.5 t-20 -102.21 27.61 6.54 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 116.035 -2.266 . . . . 0.99 108.725 179.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 58.83 -144.0 44.73 Favored Glycine 0 N--CA 1.496 2.699 0 C-N-CA 117.708 -2.187 . . . . 0.13 109.52 -179.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 314' ' ' LEU . . . . . . . . . . . . . 9.8 tp -96.93 82.92 3.3 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.203 -1.175 . . . . 0.11 109.363 178.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 315' ' ' HIS . . . . . 1.162 ' ND1' ' P ' ' B' ' 200' ' ' PO3 . 0.4 OUTLIER -80.85 -159.83 0.27 Allowed 'General case' 0 N--CA 1.503 2.209 0 N-CA-C 107.277 -1.379 . . . . 1.2 107.277 179.058 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 316' ' ' THR . . . . . 0.888 HG23 ' O2 ' ' B' ' 200' ' ' PO3 . 63.7 p -66.39 -53.14 39.31 Favored 'General case' 0 N--CA 1.513 2.687 0 N-CA-C 120.177 3.399 . . . . 0.16 120.177 -174.314 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 317' ' ' ARG . . . . . 0.659 HH11 ' HG2' ' B' ' 317' ' ' ARG . 4.8 ttt-85 -54.9 -53.33 62.23 Favored Pre-proline 0 N--CA 1.493 1.705 0 CA-C-N 122.593 2.451 . . . . 1.91 112.446 -174.661 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 318' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' B' ' 317' ' ' ARG . 21.0 Cg_endo -66.41 -32.17 41.12 Favored 'Trans proline' 0 N--CA 1.484 0.963 0 C-N-CA 124.707 3.604 . . . . 0.13 111.563 -177.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 319' ' ' ALA . . . . . 0.419 ' O ' HG23 ' B' ' 323' ' ' VAL . . . -67.07 -38.8 86.43 Favored 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 119.503 -0.879 . . . . 0.1 109.491 -179.399 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -70.95 -39.68 72.46 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.865 -0.791 . . . . 0.11 108.865 178.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 67.8 tp60 -64.01 -39.31 93.83 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 117.863 -1.535 . . . . 0.12 109.535 177.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 322' ' ' PHE . . . . . 0.44 ' CE1' HD22 ' B' ' 377' ' ' LEU . 87.3 t80 -62.76 -45.3 93.32 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 122.583 1.182 . . . . 0.08 108.703 -177.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 323' ' ' VAL . . . . . 0.419 HG23 ' O ' ' B' ' 319' ' ' ALA . 53.4 t -62.58 -42.26 95.24 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.278 0 CA-C-N 114.809 -1.087 . . . . 0.07 110.713 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -63.87 -40.18 95.93 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.325 -0.859 . . . . 1.68 109.851 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 325' ' ' GLU . . . . . 0.494 ' OE1' HD22 ' B' ' 380' ' ' LEU . 31.7 tt0 -68.9 -39.65 79.59 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.37 -0.831 . . . . 0.1 109.56 177.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -59.07 -43.99 91.82 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.708 -1.245 . . . . 0.06 109.417 178.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -61.37 -16.13 43.21 Favored 'General case' 0 N--CA 1.509 2.512 0 O-C-N 121.226 -0.922 . . . . 1.5 113.338 178.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -76.92 -10.65 86.07 Favored Glycine 0 N--CA 1.479 1.529 0 O-C-N 119.999 -1.688 . . . . 0.08 109.338 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 329' ' ' PHE . . . . . 0.402 ' HE1' ' HE3' ' B' ' 372' ' ' LYS . 92.8 m-85 -103.36 143.32 32.83 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.429 -1.63 . . . . 0.09 110.101 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 47.8 p -75.66 -30.08 59.31 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.297 -0.877 . . . . 0.11 112.272 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 331' ' ' SER . . . . . . . . . . . . . 15.9 m -59.68 158.57 9.93 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 119.844 -1.785 . . . . 0.11 112.821 -179.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 332' ' ' GLU . . . . . 0.769 ' OE1' ' N ' ' B' ' 333' ' ' ILE . 0.0 OUTLIER -79.0 130.4 35.49 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 102.81 -3.033 . . . . 0.11 102.81 171.266 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 333' ' ' ILE . . . . . 0.769 ' N ' ' OE1' ' B' ' 332' ' ' GLU . 39.2 mt -126.81 136.5 60.61 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.486 0 CA-C-O 122.192 0.996 . . . . 0.08 109.305 -178.246 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 93.3 m -124.94 143.21 50.99 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-O 123.216 1.484 . . . . 0.09 109.978 178.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 335' ' ' VAL . . . . . 0.442 HG23 ' HB2' ' B' ' 344' ' ' ALA . 85.3 t -108.14 129.95 61.51 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.633 0 N-CA-C 105.469 -2.049 . . . . 0.06 105.469 173.127 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 336' ' ' THR . . . . . 0.419 ' HB ' ' HB ' ' B' ' 362' ' ' THR . 71.5 m -127.39 119.51 26.35 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 120.862 -1.149 . . . . 0.09 109.046 -178.47 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 29.1 t -122.52 122.61 39.32 Favored 'General case' 0 N--CA 1.501 2.106 0 C-N-CA 119.992 -0.683 . . . . 0.08 109.843 177.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 62.5 t30 51.73 38.84 24.0 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.886 -1.134 . . . . 0.1 112.87 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 81.81 10.86 83.59 Favored Glycine 0 N--CA 1.501 3.009 0 O-C-N 119.944 -1.722 . . . . 0.11 112.522 177.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 340' ' ' LYS . . . . . 0.408 ' O ' ' HA ' ' B' ' 336' ' ' THR . 26.5 mttp -119.85 136.3 54.54 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 105.221 -2.14 . . . . 0.1 105.221 177.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 68.3 m -124.8 158.55 33.09 Favored 'General case' 0 C--N 1.276 -2.594 0 CA-C-O 123.738 1.732 . . . . 0.09 112.408 -176.052 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -151.62 151.45 31.53 Favored 'General case' 0 C--N 1.278 -2.51 0 CA-C-N 112.449 -2.159 . . . . 0.08 108.634 177.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 8.0 t -70.63 135.95 48.78 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 105.556 -2.016 . . . . 0.08 105.556 173.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 344' ' ' ALA . . . . . 0.442 ' HB2' HG23 ' B' ' 335' ' ' VAL . . . -72.95 -6.83 47.95 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.691 -1.256 . . . . 0.05 110.703 179.219 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -97.5 13.07 31.18 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.631 -1.293 . . . . 0.08 109.395 -177.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 11.0 t -133.18 104.25 6.4 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 122.153 0.977 . . . . 0.12 110.062 -178.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 347' ' ' LEU . . . . . . . . . . . . . 43.1 tp -57.34 -37.77 73.05 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 115.658 -0.701 . . . . 0.1 109.998 178.232 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 348' ' ' PHE . . . . . 0.505 ' HB3' ' OE2' ' A' ' 59' ' ' GLU . 75.2 t80 -59.0 -51.35 70.43 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.566 -1.334 . . . . 0.13 113.021 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 37.5 tptt -70.05 -32.46 70.58 Favored 'General case' 0 C--O 1.214 -0.769 0 O-C-N 119.664 -1.898 . . . . 1.55 109.109 -178.333 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 350' ' ' LEU . . . . . . . . . . . . . 33.3 mt -62.84 -33.7 75.79 Favored 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 118.958 -1.097 . . . . 0.16 109.92 -177.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 351' ' ' GLN . . . . . . . . . . . . . 12.5 tp-100 -67.69 -10.49 52.89 Favored 'General case' 0 C--N 1.293 -1.852 0 O-C-N 121.599 -0.688 . . . . 0.26 109.915 -177.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 352' ' ' THR . . . . . . . . . . . . . 45.7 p -89.72 -7.74 53.87 Favored 'General case' 0 N--CA 1.502 2.132 0 C-N-CA 118.097 -1.441 . . . . 0.12 111.026 -178.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 83.2 mt -93.34 159.34 15.3 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.244 -0.91 . . . . 0.1 110.224 -178.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -86.76 104.8 2.97 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 106.94 -2.464 . . . . 0.08 106.94 177.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 16.3 mt -119.46 47.29 1.73 Allowed 'General case' 0 C--N 1.309 -1.186 0 O-C-N 120.625 -1.515 . . . . 0.1 107.471 -178.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 52.8 p -81.36 172.53 13.46 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 118.849 -1.141 . . . . 0.2 109.16 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -60.74 140.97 57.36 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 119.349 -0.94 . . . . 1.61 109.76 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 91.4 -3.17 79.04 Favored Glycine 0 N--CA 1.5 2.941 0 C-N-CA 120.052 -1.071 . . . . 0.13 111.381 177.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 54.5 m -84.4 135.81 34.13 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 120.918 -1.342 . . . . 0.11 110.66 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 89.2 t -96.47 123.8 48.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 N-CA-C 106.304 -1.739 . . . . 0.11 106.304 176.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 361' ' ' VAL . . . . . 0.487 HG21 ' SD ' ' B' ' 381' ' ' MET . 22.3 m -112.27 160.13 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.335 0 C-N-CA 117.354 -1.739 . . . . 0.09 110.636 178.585 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 362' ' ' THR . . . . . 0.419 ' HB ' ' HB ' ' B' ' 336' ' ' THR . 90.4 m -108.89 128.34 54.83 Favored 'General case' 0 C--O 1.214 -0.789 0 O-C-N 120.596 -1.315 . . . . 0.1 107.565 175.559 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 363' ' ' ILE . . . . . 0.459 ' O ' ' HA ' ' B' ' 303' ' ' GLN . 33.2 mt -107.92 121.45 60.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 105.344 -2.095 . . . . 0.1 105.344 176.33 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 364' ' ' SER . . . . . 0.411 ' HB3' ' HB3' ' B' ' 303' ' ' GLN . 0.7 OUTLIER -128.57 147.3 50.7 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 107.809 -1.182 . . . . 0.1 107.809 -179.646 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -139.76 153.32 47.13 Favored 'General case' 0 C--N 1.292 -1.925 0 C-N-CA 118.454 -1.298 . . . . 0.13 109.781 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 366' ' ' GLU . . . . . 0.517 ' HG2' ' HB2' ' B' ' 301' ' ' MET . 0.2 OUTLIER -141.14 110.88 6.48 Favored 'General case' 0 C--N 1.288 -2.081 0 C-N-CA 118.592 -1.243 . . . . 0.16 108.078 178.127 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . 165.22 -170.36 40.16 Favored Glycine 0 C--N 1.297 -1.59 0 C-N-CA 117.981 -2.056 . . . . 0.14 110.327 178.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -58.27 -40.55 82.18 Favored 'General case' 0 C--N 1.277 -2.57 0 CA-C-N 114.33 -0.935 . . . . 0.16 112.306 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 369' ' ' ASP . . . . . . . . . . . . . 12.0 p30 -114.21 36.85 3.54 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 115.834 -2.346 . . . . 0.13 108.519 -178.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 370' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -56.41 -33.56 65.91 Favored 'General case' 0 N--CA 1.521 3.107 0 N-CA-C 116.8 2.148 . . . . 0.16 116.8 -174.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.95 -45.59 27.1 Favored 'General case' 0 N--CA 1.509 2.514 0 O-C-N 119.526 -1.984 . . . . 0.18 110.914 -176.519 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 372' ' ' LYS . . . . . 0.783 ' HG2' ' CE1' ' B' ' 376' ' ' HIS . 11.9 ttpp -63.56 -40.71 97.69 Favored 'General case' 0 C--N 1.283 -2.315 0 N-CA-C 106.965 -1.495 . . . . 0.13 106.965 178.265 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -59.09 -49.51 77.61 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 117.541 -1.664 . . . . 0.11 110.025 -178.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 374' ' ' VAL . . . . . . . . . . . . . 66.9 t -66.86 -42.25 88.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 CA-C-O 122.187 0.994 . . . . 0.11 109.267 -178.094 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -55.89 -47.78 76.8 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-O 122.059 0.933 . . . . 0.16 108.737 -178.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 376' ' ' HIS . . . . . 0.783 ' CE1' ' HG2' ' B' ' 372' ' ' LYS . 6.3 m80 -69.96 -38.23 76.04 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 116.005 -0.543 . . . . 0.13 111.72 -178.644 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 377' ' ' LEU . . . . . 0.44 HD22 ' CE1' ' B' ' 322' ' ' PHE . 80.5 mt -75.64 -28.56 58.84 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.348 -1.47 . . . . 0.09 110.875 -174.318 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 378' ' ' VAL . . . . . . . . . . . . . 2.1 t -71.44 -39.52 71.3 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.459 0 N-CA-C 106.35 -1.722 . . . . 0.13 106.35 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -67.89 -49.31 62.69 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 108.03 -1.1 . . . . 0.16 108.03 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 380' ' ' LEU . . . . . 0.641 ' O ' HD22 ' B' ' 384' ' ' LEU . 34.1 tp -57.18 -45.24 83.87 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 118.974 -1.09 . . . . 0.12 110.62 177.611 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 381' ' ' MET . . . . . 0.487 ' SD ' HG21 ' B' ' 361' ' ' VAL . 3.6 ttm -62.29 -37.44 85.53 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.871 -1.143 . . . . 0.12 111.508 -177.495 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -74.89 -31.78 61.67 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.111 -0.993 . . . . 0.15 110.29 -178.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -78.87 -32.41 45.92 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.622 -0.673 . . . . 0.17 111.247 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 384' ' ' LEU . . . . . 0.641 HD22 ' O ' ' B' ' 380' ' ' LEU . 0.0 OUTLIER -50.12 125.54 12.48 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-O 124.432 2.063 . . . . 0.15 112.762 178.802 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 385' ' ' GLU . . . . . 0.966 ' CD ' ' H ' ' B' ' 385' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.279 -2.48 0 CA-C-N 111.085 -2.779 . . . . 0.18 110.093 -177.598 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 200' ' ' PO3 . . . . . 1.177 ' P ' ' NE2' ' A' ' 65' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 14.4 tp . . . . . 0 N--CA 1.483 1.208 0 N-CA-C 110.502 -0.184 . . . . 0.06 110.502 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 1.259 ' CZ ' ' HD2' ' A' ' 147' ' ' ARG . 40.6 p90 -136.09 141.73 44.24 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 117.476 -1.69 . . . . 0.04 111.884 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.5 mttp -82.27 142.73 31.86 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 107.944 -1.132 . . . . 0.05 107.944 177.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 1.02 ' HA ' HD21 ' A' ' 11' ' ' ASN . 13.6 tp -136.81 125.64 24.08 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 107.285 -1.376 . . . . 0.05 107.285 179.131 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -154.02 -166.92 15.44 Favored Glycine 0 C--N 1.289 -2.081 0 N-CA-C 108.557 -1.817 . . . . 0.06 108.557 178.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.79 -34.24 77.46 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.599 -0.942 . . . . 0.08 111.313 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -65.44 -14.93 62.02 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.759 -1.213 . . . . 0.07 112.332 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 1.02 HD21 ' HA ' ' A' ' 7' ' ' LEU . 2.7 p-10 -123.7 22.85 8.94 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 119.5 -2.0 . . . . 0.05 111.869 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 48.8 mt -118.49 123.35 71.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 107.539 -1.282 . . . . 0.06 107.539 176.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -126.44 106.98 9.85 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.433 -0.792 . . . . 0.06 109.252 -177.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.559 ' HA ' ' HB3' ' A' ' 83' ' ' GLN . 42.4 mt -100.33 160.52 14.27 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-O 122.702 1.239 . . . . 0.08 112.883 -177.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 62.34 34.66 89.97 Favored Glycine 0 N--CA 1.497 2.749 0 CA-C-N 114.457 -1.247 . . . . 0.08 113.833 175.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.46 ' HA ' ' HE ' ' A' ' 16' ' ' ARG . 1.0 OUTLIER -83.21 169.14 16.09 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 120.238 -1.742 . . . . 0.08 109.733 178.348 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -140.89 140.75 34.59 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 107.409 -1.33 . . . . 0.08 107.409 178.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -154.17 131.7 11.35 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 108.442 -0.948 . . . . 0.06 108.442 179.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -77.48 -25.62 50.58 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.141 -0.975 . . . . 0.06 109.69 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 64.2 p -134.75 159.65 40.66 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 119.075 -1.05 . . . . 0.07 111.466 -178.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.669 ' HE3' ' OE1' ' A' ' 50' ' ' GLU . 28.2 pttt -65.98 -32.68 74.31 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.892 -0.781 . . . . 0.09 108.892 175.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 51.4 mp0 -60.28 -42.8 96.21 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.514 -1.366 . . . . 0.08 110.103 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -64.1 -41.73 97.17 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.628 -1.295 . . . . 0.07 110.012 177.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.91 -42.51 94.66 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.636 -1.29 . . . . 0.05 109.609 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.37 -42.29 94.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.262 -0.899 . . . . 0.07 109.802 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.46 ' HE ' ' HB2' ' A' ' 26' ' ' ARG . 4.4 ttm180 -62.61 -37.52 86.61 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.316 -0.865 . . . . 0.1 109.98 178.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -67.25 -49.19 65.34 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.724 -1.235 . . . . 0.07 108.403 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.19 -47.05 79.1 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.387 -0.821 . . . . 0.06 109.605 178.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.31 -41.34 99.74 Favored Glycine 0 N--CA 1.497 2.722 0 N-CA-C 110.525 -1.03 . . . . 0.08 110.525 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -61.18 -37.76 84.08 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.661 -1.494 . . . . 0.09 110.331 177.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 92.4 mm-40 -73.17 -36.05 66.53 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.069 -1.019 . . . . 0.08 110.181 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 73.5 mt -63.95 -38.2 90.19 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.857 -1.152 . . . . 0.07 108.282 174.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 23.7 t -69.34 -45.48 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 O-C-N 120.879 -1.138 . . . . 0.1 108.178 177.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -57.49 -39.3 76.14 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.665 -0.647 . . . . 0.1 112.625 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -86.19 8.42 73.99 Favored Glycine 0 N--CA 1.508 3.486 0 O-C-N 120.236 -1.54 . . . . 0.08 112.796 -178.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.63 17.83 78.37 Favored Glycine 0 N--CA 1.488 2.139 0 O-C-N 120.678 -1.483 . . . . 0.09 111.443 178.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.422 ' CD1' ' HA3' ' A' ' 78' ' ' GLY . 80.3 m-85 -80.93 -36.24 31.3 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.274 -1.721 . . . . 0.08 110.111 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 17.4 m -141.96 163.02 19.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-O 122.287 1.042 . . . . 0.1 111.437 -177.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.443 ' OE1' ' NH1' ' A' ' 73' ' ' ARG . 83.3 mt-10 -86.63 165.1 34.54 Favored Pre-proline 0 C--N 1.3 -1.546 0 N-CA-C 107.29 -1.374 . . . . 0.14 107.29 176.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.429 ' HD2' ' HB3' ' A' ' 39' ' ' GLU . 50.3 Cg_exo -50.53 -36.86 50.88 Favored 'Trans proline' 0 N--CA 1.51 2.443 0 C-N-CA 123.646 2.897 . . . . 0.13 115.791 -177.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.44 ' CD ' HH21 ' A' ' 73' ' ' ARG . 41.2 mp0 -62.76 -20.59 65.11 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.508 -1.37 . . . . 0.15 112.196 -178.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.466 ' O ' ' HG3' ' A' ' 46' ' ' MET . 39.9 t80 -67.08 -27.79 67.65 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.616 -1.303 . . . . 0.11 112.313 -179.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 22.8 t -61.19 -49.01 86.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 120.265 -1.522 . . . . 0.1 110.396 -179.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 51.8 tp60 -67.11 -35.04 78.91 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.093 -1.004 . . . . 0.12 109.108 179.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.2 -33.35 73.32 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.232 -0.917 . . . . 0.11 109.765 177.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.466 ' HG3' ' O ' ' A' ' 42' ' ' TYR . 94.5 mtp -70.28 -37.93 74.94 Favored 'General case' 0 N--CA 1.482 1.128 0 O-C-N 120.545 -1.347 . . . . 0.1 107.719 177.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 93.9 mt -70.14 -40.2 74.93 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.237 -1.023 . . . . 0.1 108.237 178.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -60.14 -44.31 95.04 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.36 -0.837 . . . . 0.13 109.203 177.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.557 ' NE ' ' NE2' ' A' ' 65' ' ' HIS . 27.0 tpt180 -62.45 -39.19 92.57 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.843 -1.161 . . . . 1.51 110.653 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.669 ' OE1' ' HE3' ' A' ' 21' ' ' LYS . 0.5 OUTLIER -62.54 -39.64 94.24 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.166 -0.959 . . . . 0.1 110.895 -178.545 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.579 ' N ' ' HG2' ' A' ' 50' ' ' GLU . 25.8 tttt -62.8 -38.38 90.47 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 116.364 -0.38 . . . . 2.88 110.86 -178.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 25.3 tp -64.54 -43.56 93.62 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 120.193 -1.567 . . . . 0.16 108.634 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.7 m -166.11 139.11 3.34 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.044 -1.035 . . . . 0.19 109.71 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -50.34 144.91 22.52 Favored 'Trans proline' 0 C--N 1.314 -1.286 0 C-N-CA 121.175 1.25 . . . . 0.37 113.655 178.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 47.2 p -96.54 7.94 45.32 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 114.505 -1.225 . . . . 0.16 107.92 177.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 34.2 t80 -62.36 137.5 58.27 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 105.955 -1.869 . . . . 0.09 105.955 174.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 17.8 mt -117.77 11.97 13.76 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 120.856 -1.152 . . . . 0.1 110.224 -178.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 85.56 170.94 47.67 Favored Glycine 0 C--N 1.302 -1.31 0 N-CA-C 108.667 -1.773 . . . . 0.1 108.667 -178.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.81 ' CA ' ' N ' ' A' ' 60' ' ' SER . 74.3 mm-40 57.59 35.4 25.7 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.458 -1.025 . . . . 1.86 113.527 177.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.81 ' N ' ' CA ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER 65.28 21.48 12.02 Favored 'General case' 0 N--CA 1.514 2.771 0 O-C-N 121.039 -1.038 . . . . 0.08 113.555 176.731 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 94.2 mt -121.38 137.48 54.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 120.645 -1.285 . . . . 0.07 111.014 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -129.31 138.85 51.82 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 106.247 -1.76 . . . . 0.06 106.247 174.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.494 ' O ' HG23 ' A' ' 63' ' ' VAL . 16.3 m -130.32 74.93 79.87 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.163 -0.96 . . . . 0.07 110.103 -179.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -58.08 148.94 74.72 Favored 'Trans proline' 0 N--CA 1.49 1.273 0 C-N-CA 121.809 1.672 . . . . 0.38 112.552 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.557 ' NE2' ' NE ' ' A' ' 49' ' ' ARG . 37.2 p-80 -157.19 162.91 39.32 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.637 -0.664 . . . . 0.59 109.611 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -79.1 176.17 54.81 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 110.769 -0.932 . . . . 0.12 110.769 -179.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 82.0 p -81.07 167.93 19.19 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.612 -0.934 . . . . 0.59 109.376 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.585 HG12 ' ND2' ' A' ' 109' ' ' ASN . 4.7 m -70.52 -23.65 24.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 121.382 -0.824 . . . . 0.14 109.751 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.501 ' OE1' ' N ' ' A' ' 69' ' ' GLU . 58.7 mp0 -75.27 9.06 2.26 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.985 -1.072 . . . . 0.15 109.725 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -121.73 15.27 11.0 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.709 -0.619 . . . . 0.13 109.813 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 49.5 pttt -60.87 -37.95 83.9 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.016 -1.053 . . . . 0.14 109.136 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -69.27 -4.13 16.68 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.658 -0.651 . . . . 0.14 111.543 -177.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.443 ' NH1' ' OE1' ' A' ' 39' ' ' GLU . 15.6 mmm180 -104.96 7.95 34.32 Favored 'General case' 0 N--CA 1.506 2.33 0 O-C-N 120.444 -1.41 . . . . 0.13 109.374 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 91.1 t -95.48 128.49 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 107.082 -1.451 . . . . 0.11 107.082 177.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 28.1 mt -96.75 -17.15 20.47 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 115.721 -0.672 . . . . 0.11 109.455 -178.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 39.6 pttt -176.6 159.67 1.9 Allowed 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.523 -0.918 . . . . 0.09 108.523 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 18.2 m -76.29 138.14 40.34 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.355 -0.841 . . . . 0.13 111.079 -179.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.422 ' HA3' ' CD1' ' A' ' 37' ' ' TYR . . . -160.69 161.05 32.45 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 118.735 -1.698 . . . . 0.06 110.863 -179.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 33.3 m -137.65 150.96 25.62 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 O-C-N 121.603 -0.939 . . . . 0.03 108.842 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 80' ' ' VAL . 15.9 m -127.02 113.14 31.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 106.271 -1.752 . . . . 0.04 106.271 175.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.649 ' CZ ' HD22 ' A' ' 100' ' ' LEU . 61.6 t80 -86.02 115.38 23.58 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.789 0.804 . . . . 0.05 109.238 -178.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 39.5 m -119.0 122.11 41.44 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 121.86 0.838 . . . . 0.04 110.506 -177.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.559 ' HB3' ' HA ' ' A' ' 14' ' ' LEU . 30.7 tt0 -100.71 126.47 47.25 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-O 122.108 0.956 . . . . 0.07 111.805 -178.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -123.35 87.24 51.79 Favored Pre-proline 0 C--N 1.302 -1.471 0 N-CA-C 107.025 -1.472 . . . . 0.06 107.025 177.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -54.06 -36.05 83.43 Favored 'Trans proline' 0 N--CA 1.501 1.925 0 C-N-CA 122.847 2.365 . . . . 0.08 113.081 -177.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -81.73 -13.27 58.02 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.481 -0.762 . . . . 0.08 110.323 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 90.08 152.59 27.23 Favored Glycine 0 N--CA 1.485 1.912 0 O-C-N 120.791 -1.193 . . . . 0.06 113.024 175.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 61.5 t -136.47 120.43 24.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 106.549 -1.649 . . . . 0.05 106.549 177.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.873 ' HA ' HD13 ' A' ' 97' ' ' ILE . 4.3 ttt180 -60.31 121.27 11.58 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.829 -1.169 . . . . 0.09 109.131 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -119.77 -11.51 9.36 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 118.656 -1.218 . . . . 1.03 111.573 -178.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -118.54 -158.21 10.74 Favored Glycine 1 N--CA 1.516 4.009 0 O-C-N 119.588 -1.945 . . . . 0.14 112.255 -178.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -92.54 -22.8 19.33 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 113.842 1.052 . . . . 0.26 113.842 -176.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -96.4 154.45 17.26 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.683 -1.261 . . . . 1.62 109.461 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -60.29 -23.89 64.51 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.747 -1.22 . . . . 2.55 109.964 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -86.52 1.87 50.02 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.692 -1.255 . . . . 1.74 109.461 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -83.2 60.17 5.39 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 118.764 -1.175 . . . . 0.16 107.98 178.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.873 HD13 ' HA ' ' A' ' 89' ' ' ARG . 41.8 mm -101.6 135.32 38.75 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 CA-C-O 121.723 0.773 . . . . 0.08 110.169 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -108.56 130.95 55.28 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 121.545 0.688 . . . . 0.06 109.682 178.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 87.2 mtm180 -102.5 -17.07 15.93 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 106.557 -1.646 . . . . 0.09 106.557 175.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.649 HD22 ' CZ ' ' A' ' 81' ' ' PHE . 71.1 mt -116.87 112.16 20.68 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.12 -1.067 . . . . 0.06 108.12 176.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 93.8 t -113.4 104.07 16.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 106.257 -1.757 . . . . 0.04 106.257 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 72.3 mt -107.11 102.91 14.65 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.087 0 CA-C-O 122.292 1.044 . . . . 0.04 111.035 -176.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -77.6 131.97 11.57 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.023 -1.631 . . . . 0.04 109.023 -178.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.409 HD13 HG21 ' A' ' 104' ' ' ILE . 19.4 pt -133.45 153.5 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 O-C-N 120.264 -1.727 . . . . 0.1 112.916 -176.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -137.38 133.71 35.13 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 106.189 -1.782 . . . . 0.12 106.189 177.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -147.59 140.97 25.3 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 120.113 -1.617 . . . . 0.13 110.955 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 60.6 mtp180 -70.74 156.29 39.7 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.588 0.709 . . . . 3.71 110.331 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 57.81 25.4 11.92 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.069 -0.715 . . . . 1.98 109.069 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.585 ' ND2' HG12 ' A' ' 68' ' ' VAL . 61.4 t30 53.27 37.58 25.6 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.172 -0.955 . . . . 1.22 109.766 178.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -84.05 28.89 0.58 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.131 -0.981 . . . . 0.18 111.093 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . 0.75 ' CA ' ' N ' ' A' ' 112' ' ' ILE . 41.6 p-80 -50.54 -38.3 44.08 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.881 -1.137 . . . . 0.18 112.095 179.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.75 ' N ' ' CA ' ' A' ' 111' ' ' HIS . 20.9 tt -63.18 -28.96 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 119.986 -1.696 . . . . 0.12 111.005 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -69.81 -40.94 75.63 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 120.516 -1.365 . . . . 0.87 108.334 178.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 85.1 t -69.38 -43.61 80.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.428 -0.795 . . . . 0.07 109.414 178.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 97.0 mt -62.11 -42.46 95.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.132 -0.98 . . . . 0.08 109.471 178.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 97.6 m -62.35 -42.45 99.41 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.295 -0.878 . . . . 0.14 109.899 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 11.2 t -63.66 -45.91 88.0 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.161 -0.962 . . . . 0.07 109.572 178.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 57.3 mt -64.09 -48.26 76.87 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.07 -1.019 . . . . 0.07 111.173 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 40.4 p -66.38 -28.01 68.31 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 120.986 -1.071 . . . . 0.09 111.589 -178.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -67.81 -35.88 79.41 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 121.007 -1.058 . . . . 1.13 108.145 177.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -80.12 -15.55 56.87 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.967 -1.083 . . . . 0.09 109.844 177.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 80.5 mt -106.01 27.86 8.18 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.984 -1.072 . . . . 0.17 110.675 178.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -72.46 -12.73 61.22 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 120.937 -1.102 . . . . 0.49 111.879 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -110.66 131.38 55.1 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.588 -1.32 . . . . 0.13 110.619 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -57.72 -34.55 69.6 Favored 'General case' 0 N--CA 1.503 2.181 0 C-N-CA 123.306 0.642 . . . . 0.15 112.262 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.449 ' O ' ' HG2' ' A' ' 130' ' ' ARG . 59.7 p -65.75 -34.01 77.18 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 120.694 -1.254 . . . . 0.13 109.88 179.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 85.6 t -65.65 -43.9 93.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.638 -1.289 . . . . 0.11 109.974 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 96.1 mt -64.33 -46.06 94.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.941 -1.1 . . . . 0.1 110.228 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.614 ' HA ' ' OE1' ' A' ' 129' ' ' GLU . 8.7 mm-40 -57.08 -46.85 82.19 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.223 -0.923 . . . . 0.11 109.864 178.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.524 ' NH1' ' HG3' ' A' ' 130' ' ' ARG . 16.5 mmm-85 -63.52 -43.7 96.4 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.215 -0.928 . . . . 0.13 110.214 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 83.3 mt -66.89 -35.04 79.12 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.066 -1.022 . . . . 0.08 111.148 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -67.33 -27.18 66.93 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.308 -0.87 . . . . 0.08 113.285 -176.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -126.49 1.7 6.92 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 120.082 -1.637 . . . . 0.1 113.322 -176.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 9.4 t -68.31 145.89 53.8 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.502 -1.374 . . . . 0.1 111.271 -178.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 72.8 p -106.06 9.92 32.29 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.27 -1.381 . . . . 0.12 107.27 176.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 47.0 t -107.02 116.4 31.86 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 121.588 0.709 . . . . 0.11 112.696 -178.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 15.9 t -65.59 -41.67 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 108.501 -0.925 . . . . 0.09 108.501 176.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -56.87 -39.99 75.35 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.233 -0.917 . . . . 0.11 110.408 178.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -63.66 -42.75 98.03 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.936 -1.103 . . . . 0.11 108.45 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 92.0 t -57.29 -51.27 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 108.508 -0.923 . . . . 0.08 108.508 177.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 141' ' ' LEU . 78.4 mt -57.7 -45.98 84.96 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.238 -0.914 . . . . 0.07 110.294 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -58.81 -47.91 83.13 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.814 -1.179 . . . . 0.11 111.02 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 83.7 mt -67.99 -23.49 65.03 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.983 -1.073 . . . . 0.1 112.606 -177.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.661 ' O ' ' NH1' ' A' ' 147' ' ' ARG . 91.7 mt -110.05 9.27 24.21 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.367 -1.458 . . . . 0.07 111.391 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.711 ' HA ' HH12 ' A' ' 147' ' ' ARG . . . -76.97 -25.25 52.57 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 120.689 -1.257 . . . . 0.07 112.305 -178.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -81.77 -8.81 86.32 Favored Glycine 0 N--CA 1.504 3.211 0 O-C-N 120.57 -1.331 . . . . 0.08 111.156 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . 1.259 ' HD2' ' CZ ' ' A' ' 5' ' ' PHE . 2.0 ptt-85 . . . . . 0 N--CA 1.486 1.371 0 O-C-N 121.053 -1.263 . . . . 0.07 109.64 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 301' ' ' MET . . . . . 0.517 ' HB2' ' HG2' ' B' ' 366' ' ' GLU . 3.4 ttm . . . . . 0 C--O 1.214 -0.786 0 CA-C-O 121.931 0.872 . . . . 0.17 108.948 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 302' ' ' PHE . . . . . 0.454 ' N ' ' CG ' ' B' ' 301' ' ' MET . 46.9 t80 -139.74 142.97 36.77 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 107.27 -1.381 . . . . 0.16 107.27 178.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 303' ' ' GLN . . . . . 0.49 ' O ' ' HG2' ' B' ' 304' ' ' GLN . 5.4 pt20 -153.0 156.31 38.58 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 120.904 -1.123 . . . . 0.14 109.495 179.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 304' ' ' GLN . . . . . 0.49 ' HG2' ' O ' ' B' ' 303' ' ' GLN . 42.2 mm-40 -152.18 149.21 28.51 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 108.033 -1.099 . . . . 0.15 108.033 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -97.19 152.35 18.91 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.046 -1.034 . . . . 0.13 108.428 178.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 7.2 p -147.83 144.34 19.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 N-CA-C 107.478 -1.304 . . . . 0.12 107.478 177.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 85.4 m -96.67 136.54 37.06 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 122.169 0.985 . . . . 0.13 110.079 177.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 51.7 mt -84.88 114.25 24.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 105.478 -2.045 . . . . 0.13 105.478 177.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 47.4 p -106.7 -4.39 19.51 Favored 'General case' 0 C--N 1.264 -3.117 0 N-CA-C 114.704 1.372 . . . . 0.16 114.704 -178.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -71.44 141.87 86.02 Favored Pre-proline 0 N--CA 1.499 2.012 0 O-C-N 119.683 -1.886 . . . . 0.16 110.658 178.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -45.54 -47.63 13.03 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 124.749 3.633 . . . . 0.19 114.202 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -102.21 27.61 6.54 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 116.035 -2.266 . . . . 0.99 108.725 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 58.83 -149.92 36.59 Favored Glycine 0 N--CA 1.496 2.699 0 C-N-CA 117.708 -2.187 . . . . 0.13 109.52 -179.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 314' ' ' LEU . . . . . 0.403 ' HA ' HD12 ' B' ' 314' ' ' LEU . 19.9 tp -83.93 72.58 10.42 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.838 -1.39 . . . . 0.11 109.581 -176.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 12.1 p80 -69.41 -179.71 1.75 Allowed 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 117.846 -1.542 . . . . 1.2 112.131 -177.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 316' ' ' THR . . . . . 0.537 ' OG1' ' NH2' ' A' ' 49' ' ' ARG . 66.4 p -42.1 -66.7 0.32 Allowed 'General case' 0 N--CA 1.505 2.291 0 N-CA-C 117.209 2.299 . . . . 0.16 117.209 -175.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 317' ' ' ARG . . . . . 0.542 ' N ' ' HD2' ' B' ' 318' ' ' PRO . 5.4 ttt-85 -53.2 -53.33 57.0 Favored Pre-proline 0 N--CA 1.493 1.705 0 C-N-CA 120.21 -0.596 . . . . 1.91 112.446 -176.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 318' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' B' ' 317' ' ' ARG . 21.0 Cg_endo -66.41 -32.17 41.12 Favored 'Trans proline' 0 N--CA 1.484 0.963 0 C-N-CA 124.707 3.604 . . . . 0.13 111.563 -177.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 319' ' ' ALA . . . . . 0.419 ' O ' HG23 ' B' ' 323' ' ' VAL . . . -67.07 -38.8 86.43 Favored 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 119.503 -0.879 . . . . 0.1 109.491 -179.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -70.95 -39.68 72.46 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.865 -0.791 . . . . 0.11 108.865 178.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 67.8 tp60 -64.01 -39.31 93.83 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 117.863 -1.535 . . . . 0.12 109.535 177.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 322' ' ' PHE . . . . . 0.44 ' CE1' HD22 ' B' ' 377' ' ' LEU . 87.3 t80 -62.76 -45.3 93.32 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 122.583 1.182 . . . . 0.08 108.703 -177.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 323' ' ' VAL . . . . . 0.419 HG23 ' O ' ' B' ' 319' ' ' ALA . 53.4 t -62.58 -42.26 95.24 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.278 0 CA-C-N 114.809 -1.087 . . . . 0.07 110.713 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 73.7 tttt -63.87 -40.18 95.93 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.325 -0.859 . . . . 1.68 109.851 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 325' ' ' GLU . . . . . 0.494 ' OE1' HD22 ' B' ' 380' ' ' LEU . 31.7 tt0 -68.9 -39.65 79.59 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.37 -0.831 . . . . 0.1 109.56 177.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -59.07 -43.99 91.82 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.708 -1.245 . . . . 0.06 109.417 178.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -61.37 -16.13 43.21 Favored 'General case' 0 N--CA 1.509 2.512 0 O-C-N 121.226 -0.922 . . . . 1.5 113.338 178.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -76.92 -10.65 86.07 Favored Glycine 0 N--CA 1.479 1.529 0 O-C-N 119.999 -1.688 . . . . 0.08 109.338 179.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 329' ' ' PHE . . . . . 0.402 ' HE1' ' HE3' ' B' ' 372' ' ' LYS . 92.8 m-85 -103.36 143.32 32.83 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.429 -1.63 . . . . 0.09 110.101 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 47.8 p -75.66 -30.08 59.31 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.297 -0.877 . . . . 0.11 112.272 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 331' ' ' SER . . . . . . . . . . . . . 15.9 m -59.68 158.57 9.93 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 119.844 -1.785 . . . . 0.11 112.821 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 332' ' ' GLU . . . . . 0.769 ' OE1' ' N ' ' B' ' 333' ' ' ILE . 0.0 OUTLIER -79.0 130.4 35.49 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 102.81 -3.033 . . . . 0.11 102.81 171.266 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 333' ' ' ILE . . . . . 0.769 ' N ' ' OE1' ' B' ' 332' ' ' GLU . 39.2 mt -126.81 136.5 60.61 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.486 0 CA-C-O 122.192 0.996 . . . . 0.08 109.305 -178.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 93.3 m -124.94 143.21 50.99 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-O 123.216 1.484 . . . . 0.09 109.978 178.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 335' ' ' VAL . . . . . 0.442 HG23 ' HB2' ' B' ' 344' ' ' ALA . 85.3 t -108.14 129.95 61.51 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.633 0 N-CA-C 105.469 -2.049 . . . . 0.06 105.469 173.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 336' ' ' THR . . . . . 0.419 ' HB ' ' HB ' ' B' ' 362' ' ' THR . 71.5 m -127.39 119.51 26.35 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 120.862 -1.149 . . . . 0.09 109.046 -178.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 29.1 t -122.52 122.61 39.32 Favored 'General case' 0 N--CA 1.501 2.106 0 C-N-CA 119.992 -0.683 . . . . 0.08 109.843 177.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 51.73 38.84 24.0 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.886 -1.134 . . . . 0.1 112.87 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 81.81 10.86 83.59 Favored Glycine 0 N--CA 1.501 3.009 0 O-C-N 119.944 -1.722 . . . . 0.11 112.522 177.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 340' ' ' LYS . . . . . 0.408 ' O ' ' HA ' ' B' ' 336' ' ' THR . 26.5 mttp -119.85 136.3 54.54 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 105.221 -2.14 . . . . 0.1 105.221 177.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 68.3 m -124.8 158.55 33.09 Favored 'General case' 0 C--N 1.276 -2.594 0 CA-C-O 123.738 1.732 . . . . 0.09 112.408 -176.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -151.62 151.45 31.53 Favored 'General case' 0 C--N 1.278 -2.51 0 CA-C-N 112.449 -2.159 . . . . 0.08 108.634 177.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 8.0 t -70.63 135.95 48.78 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 105.556 -2.016 . . . . 0.08 105.556 173.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 344' ' ' ALA . . . . . 0.442 ' HB2' HG23 ' B' ' 335' ' ' VAL . . . -72.95 -6.83 47.95 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.691 -1.256 . . . . 0.05 110.703 179.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -97.5 13.07 31.18 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.631 -1.293 . . . . 0.08 109.395 -177.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 9.7 t -133.18 104.25 6.4 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 122.153 0.977 . . . . 0.12 110.062 -178.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 347' ' ' LEU . . . . . . . . . . . . . 46.4 tp -57.34 -37.77 73.05 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 115.658 -0.701 . . . . 0.1 109.998 178.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 348' ' ' PHE . . . . . 0.534 ' HB3' ' OE2' ' A' ' 59' ' ' GLU . 77.3 t80 -59.0 -51.35 70.43 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.566 -1.334 . . . . 0.13 113.021 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 37.6 tptt -70.05 -32.46 70.58 Favored 'General case' 0 C--O 1.214 -0.769 0 O-C-N 119.664 -1.898 . . . . 1.55 109.109 -178.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 350' ' ' LEU . . . . . . . . . . . . . 32.3 mt -62.84 -33.7 75.79 Favored 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 118.958 -1.097 . . . . 0.16 109.92 -177.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 351' ' ' GLN . . . . . 0.404 HE22 HG13 ' A' ' 112' ' ' ILE . 69.5 tp60 -67.69 -10.49 52.89 Favored 'General case' 0 C--N 1.293 -1.852 0 O-C-N 121.599 -0.688 . . . . 0.26 109.915 -177.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 352' ' ' THR . . . . . . . . . . . . . 41.7 p -89.72 -7.74 53.87 Favored 'General case' 0 N--CA 1.502 2.132 0 C-N-CA 118.097 -1.441 . . . . 0.12 111.026 -178.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 72.9 mt -93.34 159.34 15.3 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.244 -0.91 . . . . 0.1 110.224 -178.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -86.76 104.8 2.97 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 106.94 -2.464 . . . . 0.08 106.94 177.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 15.5 mt -119.46 47.29 1.73 Allowed 'General case' 0 C--N 1.309 -1.186 0 O-C-N 120.625 -1.515 . . . . 0.1 107.471 -178.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 47.6 p -81.36 172.53 13.46 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 118.849 -1.141 . . . . 0.2 109.16 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -60.74 140.97 57.36 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 119.349 -0.94 . . . . 1.61 109.76 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 91.4 -3.17 79.04 Favored Glycine 0 N--CA 1.5 2.941 0 C-N-CA 120.052 -1.071 . . . . 0.13 111.381 177.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 54.5 m -84.4 135.81 34.13 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 120.918 -1.342 . . . . 0.11 110.66 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 89.2 t -96.47 123.8 48.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 N-CA-C 106.304 -1.739 . . . . 0.11 106.304 176.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 361' ' ' VAL . . . . . 0.487 HG21 ' SD ' ' B' ' 381' ' ' MET . 22.3 m -112.27 160.13 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.335 0 C-N-CA 117.354 -1.739 . . . . 0.09 110.636 178.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 362' ' ' THR . . . . . 0.419 ' HB ' ' HB ' ' B' ' 336' ' ' THR . 90.4 m -108.89 128.34 54.83 Favored 'General case' 0 C--O 1.214 -0.789 0 O-C-N 120.596 -1.315 . . . . 0.1 107.565 175.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 363' ' ' ILE . . . . . 0.459 ' O ' ' HA ' ' B' ' 303' ' ' GLN . 33.2 mt -107.92 121.45 60.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 105.344 -2.095 . . . . 0.1 105.344 176.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 364' ' ' SER . . . . . 0.411 ' HB3' ' HB3' ' B' ' 303' ' ' GLN . 0.7 OUTLIER -128.57 147.3 50.7 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 107.809 -1.182 . . . . 0.1 107.809 -179.646 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -139.76 153.32 47.13 Favored 'General case' 0 C--N 1.292 -1.925 0 C-N-CA 118.454 -1.298 . . . . 0.13 109.781 -179.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 366' ' ' GLU . . . . . 0.517 ' HG2' ' HB2' ' B' ' 301' ' ' MET . 0.2 OUTLIER -141.14 110.88 6.48 Favored 'General case' 0 C--N 1.288 -2.081 0 C-N-CA 118.592 -1.243 . . . . 0.16 108.078 178.127 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . 165.22 -170.36 40.16 Favored Glycine 0 C--N 1.297 -1.59 0 C-N-CA 117.981 -2.056 . . . . 0.14 110.327 178.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -58.27 -40.55 82.18 Favored 'General case' 0 C--N 1.277 -2.57 0 CA-C-N 114.33 -0.935 . . . . 0.16 112.306 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 369' ' ' ASP . . . . . . . . . . . . . 12.0 p30 -114.21 36.85 3.54 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 115.834 -2.346 . . . . 0.13 108.519 -178.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 370' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -56.41 -33.56 65.91 Favored 'General case' 0 N--CA 1.521 3.107 0 N-CA-C 116.8 2.148 . . . . 0.16 116.8 -174.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.95 -45.59 27.1 Favored 'General case' 0 N--CA 1.509 2.514 0 O-C-N 119.526 -1.984 . . . . 0.18 110.914 -176.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 372' ' ' LYS . . . . . 0.786 ' HZ2' ' CE1' ' B' ' 376' ' ' HIS . 11.9 ttpp -63.56 -40.71 97.69 Favored 'General case' 0 C--N 1.283 -2.315 0 N-CA-C 106.965 -1.495 . . . . 0.13 106.965 178.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -59.09 -49.51 77.61 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 117.541 -1.664 . . . . 0.11 110.025 -178.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 374' ' ' VAL . . . . . . . . . . . . . 66.9 t -66.86 -42.25 88.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 CA-C-O 122.187 0.994 . . . . 0.11 109.267 -178.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -55.89 -47.78 76.8 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-O 122.059 0.933 . . . . 0.16 108.737 -178.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 376' ' ' HIS . . . . . 0.786 ' CE1' ' HZ2' ' B' ' 372' ' ' LYS . 13.9 m-70 -69.96 -38.23 76.04 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 116.005 -0.543 . . . . 0.13 111.72 -178.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 377' ' ' LEU . . . . . 0.44 HD22 ' CE1' ' B' ' 322' ' ' PHE . 80.5 mt -75.64 -28.56 58.84 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.348 -1.47 . . . . 0.09 110.875 -174.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 378' ' ' VAL . . . . . . . . . . . . . 2.1 t -71.44 -39.52 71.3 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.459 0 N-CA-C 106.35 -1.722 . . . . 0.13 106.35 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -67.89 -49.31 62.69 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 108.03 -1.1 . . . . 0.16 108.03 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 380' ' ' LEU . . . . . 0.641 ' O ' HD22 ' B' ' 384' ' ' LEU . 34.1 tp -57.18 -45.24 83.87 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 118.974 -1.09 . . . . 0.12 110.62 177.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 381' ' ' MET . . . . . 0.487 ' SD ' HG21 ' B' ' 361' ' ' VAL . 3.6 ttm -62.29 -37.44 85.53 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.871 -1.143 . . . . 0.12 111.508 -177.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -74.89 -31.78 61.67 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.111 -0.993 . . . . 0.15 110.29 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -78.87 -32.41 45.92 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.622 -0.673 . . . . 0.17 111.247 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 384' ' ' LEU . . . . . 0.641 HD22 ' O ' ' B' ' 380' ' ' LEU . 0.0 OUTLIER -50.12 125.54 12.48 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-O 124.432 2.063 . . . . 0.15 112.762 178.802 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 385' ' ' GLU . . . . . 0.966 ' CD ' ' H ' ' B' ' 385' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.279 -2.48 0 CA-C-N 111.085 -2.779 . . . . 0.18 110.093 -177.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 14.4 tp . . . . . 0 N--CA 1.483 1.208 0 N-CA-C 110.502 -0.184 . . . . 0.06 110.502 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 1.259 ' CZ ' ' HD2' ' A' ' 147' ' ' ARG . 40.6 p90 -136.09 141.73 44.24 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 117.476 -1.69 . . . . 0.04 111.884 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.5 mttp -82.27 142.73 31.86 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 107.944 -1.132 . . . . 0.05 107.944 177.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 1.02 ' HA ' HD21 ' A' ' 11' ' ' ASN . 13.6 tp -136.81 125.64 24.08 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 107.285 -1.376 . . . . 0.05 107.285 179.131 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -154.02 -166.92 15.44 Favored Glycine 0 C--N 1.289 -2.081 0 N-CA-C 108.557 -1.817 . . . . 0.06 108.557 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.79 -34.24 77.46 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.599 -0.942 . . . . 0.08 111.313 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -65.44 -14.93 62.02 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.759 -1.213 . . . . 0.07 112.332 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 1.02 HD21 ' HA ' ' A' ' 7' ' ' LEU . 2.7 p-10 -123.7 22.85 8.94 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 119.5 -2.0 . . . . 0.05 111.869 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 48.8 mt -118.49 123.35 71.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 107.539 -1.282 . . . . 0.06 107.539 176.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -126.44 106.98 9.85 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.433 -0.792 . . . . 0.06 109.252 -177.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.559 ' HA ' ' HB3' ' A' ' 83' ' ' GLN . 42.4 mt -100.33 160.52 14.27 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-O 122.702 1.239 . . . . 0.08 112.883 -177.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 62.34 34.66 89.97 Favored Glycine 0 N--CA 1.497 2.749 0 CA-C-N 114.457 -1.247 . . . . 0.08 113.833 175.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.46 ' HA ' ' HE ' ' A' ' 16' ' ' ARG . 1.0 OUTLIER -83.21 169.14 16.09 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 120.238 -1.742 . . . . 0.08 109.733 178.348 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -140.89 140.75 34.59 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 107.409 -1.33 . . . . 0.08 107.409 178.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -154.17 131.7 11.35 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 108.442 -0.948 . . . . 0.06 108.442 179.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -77.48 -25.62 50.58 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.141 -0.975 . . . . 0.06 109.69 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 64.2 p -134.75 159.65 40.66 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 119.075 -1.05 . . . . 0.07 111.466 -178.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.669 ' HE3' ' OE1' ' A' ' 50' ' ' GLU . 28.2 pttt -65.98 -32.68 74.31 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.892 -0.781 . . . . 0.09 108.892 175.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 51.4 mp0 -60.28 -42.8 96.21 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.514 -1.366 . . . . 0.08 110.103 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -64.1 -41.73 97.17 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.628 -1.295 . . . . 0.07 110.012 177.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.91 -42.51 94.66 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.636 -1.29 . . . . 0.05 109.609 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.37 -42.29 94.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.262 -0.899 . . . . 0.07 109.802 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.46 ' HE ' ' HB2' ' A' ' 26' ' ' ARG . 4.4 ttm180 -62.61 -37.52 86.61 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.316 -0.865 . . . . 0.1 109.98 178.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -67.25 -49.19 65.34 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.724 -1.235 . . . . 0.07 108.403 179.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.19 -47.05 79.1 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.387 -0.821 . . . . 0.06 109.605 178.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.31 -41.34 99.74 Favored Glycine 0 N--CA 1.497 2.722 0 N-CA-C 110.525 -1.03 . . . . 0.08 110.525 179.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -61.18 -37.76 84.08 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.661 -1.494 . . . . 0.09 110.331 177.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 92.4 mm-40 -73.17 -36.05 66.53 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.069 -1.019 . . . . 0.08 110.181 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 73.5 mt -63.95 -38.2 90.19 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.857 -1.152 . . . . 0.07 108.282 174.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 23.7 t -69.34 -45.48 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 O-C-N 120.879 -1.138 . . . . 0.1 108.178 177.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -57.49 -39.3 76.14 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.665 -0.647 . . . . 0.1 112.625 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -86.19 8.42 73.99 Favored Glycine 0 N--CA 1.508 3.486 0 O-C-N 120.236 -1.54 . . . . 0.08 112.796 -178.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.63 17.83 78.37 Favored Glycine 0 N--CA 1.488 2.139 0 O-C-N 120.678 -1.483 . . . . 0.09 111.443 178.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.422 ' CD1' ' HA3' ' A' ' 78' ' ' GLY . 80.3 m-85 -80.93 -36.24 31.3 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.274 -1.721 . . . . 0.08 110.111 -179.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 17.4 m -141.96 163.02 19.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-O 122.287 1.042 . . . . 0.1 111.437 -177.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.443 ' OE1' ' NH1' ' A' ' 73' ' ' ARG . 83.3 mt-10 -86.63 165.1 34.54 Favored Pre-proline 0 C--N 1.3 -1.546 0 N-CA-C 107.29 -1.374 . . . . 0.14 107.29 176.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.429 ' HD2' ' HB3' ' A' ' 39' ' ' GLU . 50.3 Cg_exo -50.53 -36.86 50.88 Favored 'Trans proline' 0 N--CA 1.51 2.443 0 C-N-CA 123.646 2.897 . . . . 0.13 115.791 -177.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.44 ' CD ' HH21 ' A' ' 73' ' ' ARG . 41.2 mp0 -62.76 -20.59 65.11 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.508 -1.37 . . . . 0.15 112.196 -178.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.466 ' O ' ' HG3' ' A' ' 46' ' ' MET . 39.9 t80 -67.08 -27.79 67.65 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.616 -1.303 . . . . 0.11 112.313 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 22.8 t -61.19 -49.01 86.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 120.265 -1.522 . . . . 0.1 110.396 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 51.8 tp60 -67.11 -35.04 78.91 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.093 -1.004 . . . . 0.12 109.108 179.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.2 -33.35 73.32 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.232 -0.917 . . . . 0.11 109.765 177.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.466 ' HG3' ' O ' ' A' ' 42' ' ' TYR . 94.5 mtp -70.28 -37.93 74.94 Favored 'General case' 0 N--CA 1.482 1.128 0 O-C-N 120.545 -1.347 . . . . 0.1 107.719 177.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 93.9 mt -70.14 -40.2 74.93 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.237 -1.023 . . . . 0.1 108.237 178.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -60.14 -44.31 95.04 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.36 -0.837 . . . . 0.13 109.203 177.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 24.5 tpt180 -62.45 -39.19 92.57 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.843 -1.161 . . . . 1.51 110.653 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.669 ' OE1' ' HE3' ' A' ' 21' ' ' LYS . 0.5 OUTLIER -62.54 -39.61 94.14 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.166 -0.959 . . . . 0.1 110.895 -178.545 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.579 ' N ' ' HG2' ' A' ' 50' ' ' GLU . 28.1 tttt -62.87 -38.22 89.98 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 116.333 -0.394 . . . . 2.88 110.853 -178.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 28.7 tp -64.71 -43.56 93.06 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 120.181 -1.574 . . . . 0.16 108.634 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.6 m -166.11 139.11 3.34 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.044 -1.035 . . . . 0.19 109.71 179.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -50.34 144.91 22.52 Favored 'Trans proline' 0 C--N 1.314 -1.286 0 C-N-CA 121.175 1.25 . . . . 0.37 113.655 178.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.454 HG21 ' HA ' ' A' ' 64' ' ' PRO . 55.3 p -96.54 7.94 45.32 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 114.505 -1.225 . . . . 0.16 107.92 177.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -62.36 137.5 58.27 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 105.955 -1.869 . . . . 0.09 105.955 174.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 18.1 mt -117.77 11.97 13.76 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 120.856 -1.152 . . . . 0.1 110.224 -178.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 85.56 170.94 47.67 Favored Glycine 0 C--N 1.302 -1.31 0 N-CA-C 108.667 -1.773 . . . . 0.1 108.667 -178.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.81 ' CA ' ' N ' ' A' ' 60' ' ' SER . 76.0 mm-40 57.59 35.4 25.7 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.458 -1.025 . . . . 1.86 113.527 177.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.81 ' N ' ' CA ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER 65.28 21.48 12.02 Favored 'General case' 0 N--CA 1.514 2.771 0 O-C-N 121.039 -1.038 . . . . 0.08 113.555 176.731 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 94.2 mt -121.38 137.48 54.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 120.645 -1.285 . . . . 0.07 111.014 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -129.31 138.85 51.82 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 106.247 -1.76 . . . . 0.06 106.247 174.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.494 ' O ' HG23 ' A' ' 63' ' ' VAL . 16.3 m -130.32 73.41 81.3 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.163 -0.96 . . . . 0.07 110.103 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.454 ' HA ' HG21 ' A' ' 55' ' ' THR . 8.1 Cg_endo -54.57 146.91 50.96 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 120.854 1.036 . . . . 0.38 112.221 -178.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 2.4 p-80 -150.37 159.01 44.77 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.315 -0.866 . . . . 0.59 109.447 177.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -76.65 174.81 53.8 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 110.036 -1.226 . . . . 0.12 110.036 -177.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 82.0 p -80.46 167.93 19.57 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.104 -1.233 . . . . 0.59 109.376 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.592 HG12 ' ND2' ' A' ' 109' ' ' ASN . 5.3 m -70.52 -23.65 24.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 121.382 -0.824 . . . . 0.14 109.751 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.501 ' OE1' ' N ' ' A' ' 69' ' ' GLU . 58.7 mp0 -75.27 9.06 2.26 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.985 -1.072 . . . . 0.15 109.725 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -121.73 15.27 11.0 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.709 -0.619 . . . . 0.13 109.813 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 49.5 pttt -60.87 -37.95 83.9 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.016 -1.053 . . . . 0.14 109.136 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -69.27 -4.13 16.68 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.658 -0.651 . . . . 0.14 111.543 -177.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.443 ' NH1' ' OE1' ' A' ' 39' ' ' GLU . 15.6 mmm180 -104.96 7.95 34.32 Favored 'General case' 0 N--CA 1.506 2.33 0 O-C-N 120.444 -1.41 . . . . 0.13 109.374 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 91.1 t -95.48 128.49 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 107.082 -1.451 . . . . 0.11 107.082 177.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 28.1 mt -96.75 -17.15 20.47 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 115.721 -0.672 . . . . 0.11 109.455 -178.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 39.6 pttt -176.6 159.67 1.9 Allowed 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.523 -0.918 . . . . 0.09 108.523 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 18.2 m -76.29 138.14 40.34 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.355 -0.841 . . . . 0.13 111.079 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.422 ' HA3' ' CD1' ' A' ' 37' ' ' TYR . . . -160.69 161.05 32.45 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 118.735 -1.698 . . . . 0.06 110.863 -179.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 33.3 m -137.65 150.96 25.62 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 O-C-N 121.603 -0.939 . . . . 0.03 108.842 179.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 80' ' ' VAL . 15.9 m -127.02 113.14 31.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 106.271 -1.752 . . . . 0.04 106.271 175.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.649 ' CZ ' HD22 ' A' ' 100' ' ' LEU . 61.6 t80 -86.02 115.38 23.58 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.789 0.804 . . . . 0.05 109.238 -178.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 39.5 m -119.0 122.11 41.44 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 121.86 0.838 . . . . 0.04 110.506 -177.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.559 ' HB3' ' HA ' ' A' ' 14' ' ' LEU . 30.7 tt0 -100.71 126.47 47.25 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-O 122.108 0.956 . . . . 0.07 111.805 -178.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -123.35 87.24 51.79 Favored Pre-proline 0 C--N 1.302 -1.471 0 N-CA-C 107.025 -1.472 . . . . 0.06 107.025 177.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -54.06 -36.05 83.43 Favored 'Trans proline' 0 N--CA 1.501 1.925 0 C-N-CA 122.847 2.365 . . . . 0.08 113.081 -177.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -81.73 -13.27 58.02 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.481 -0.762 . . . . 0.08 110.323 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 90.08 152.59 27.23 Favored Glycine 0 N--CA 1.485 1.912 0 O-C-N 120.791 -1.193 . . . . 0.06 113.024 175.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 61.5 t -136.47 120.43 24.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 106.549 -1.649 . . . . 0.05 106.549 177.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.873 ' HA ' HD13 ' A' ' 97' ' ' ILE . 4.3 ttt180 -60.31 121.27 11.58 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.829 -1.169 . . . . 0.09 109.131 -179.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -119.77 -11.51 9.36 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 118.656 -1.218 . . . . 1.03 111.573 -178.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -118.54 -158.21 10.74 Favored Glycine 1 N--CA 1.516 4.009 0 O-C-N 119.588 -1.945 . . . . 0.14 112.255 -178.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -92.54 -22.8 19.33 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 113.842 1.052 . . . . 0.26 113.842 -176.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -96.4 154.45 17.26 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.683 -1.261 . . . . 1.62 109.461 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -60.29 -23.89 64.51 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.747 -1.22 . . . . 2.55 109.964 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -86.52 1.87 50.02 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.692 -1.255 . . . . 1.74 109.461 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -83.2 60.17 5.39 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 118.764 -1.175 . . . . 0.16 107.98 178.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.873 HD13 ' HA ' ' A' ' 89' ' ' ARG . 41.8 mm -101.6 135.32 38.75 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 CA-C-O 121.723 0.773 . . . . 0.08 110.169 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -108.56 130.95 55.28 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 121.545 0.688 . . . . 0.06 109.682 178.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 87.3 mtm180 -102.5 -17.07 15.93 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 106.557 -1.646 . . . . 0.09 106.557 175.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.649 HD22 ' CZ ' ' A' ' 81' ' ' PHE . 71.1 mt -116.87 112.16 20.68 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.12 -1.067 . . . . 0.06 108.12 176.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 93.8 t -113.4 104.07 16.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 106.257 -1.757 . . . . 0.04 106.257 179.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 72.3 mt -107.11 102.91 14.65 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.087 0 CA-C-O 122.292 1.044 . . . . 0.04 111.035 -176.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -77.6 131.97 11.57 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.023 -1.631 . . . . 0.04 109.023 -178.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.409 HD13 HG21 ' A' ' 104' ' ' ILE . 19.4 pt -133.45 153.5 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 O-C-N 120.264 -1.727 . . . . 0.1 112.916 -176.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -137.38 133.71 35.13 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 106.189 -1.782 . . . . 0.12 106.189 177.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -147.59 140.97 25.3 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 120.113 -1.617 . . . . 0.13 110.955 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 60.6 mtp180 -70.74 156.29 39.7 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.588 0.709 . . . . 3.71 110.331 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 57.81 25.4 11.92 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.069 -0.715 . . . . 1.98 109.069 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.592 ' ND2' HG12 ' A' ' 68' ' ' VAL . 62.9 t30 53.27 37.58 25.6 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.172 -0.955 . . . . 1.22 109.766 178.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -84.05 28.89 0.58 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.131 -0.981 . . . . 0.18 111.093 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . 0.75 ' CA ' ' N ' ' A' ' 112' ' ' ILE . 43.1 p-80 -50.54 -38.3 44.08 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.881 -1.137 . . . . 0.18 112.095 179.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.75 ' N ' ' CA ' ' A' ' 111' ' ' HIS . 20.9 tt -63.18 -28.96 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 119.986 -1.696 . . . . 0.12 111.005 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -69.81 -40.94 75.63 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 120.516 -1.365 . . . . 0.87 108.334 178.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 85.1 t -69.38 -43.61 80.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.428 -0.795 . . . . 0.07 109.414 178.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.11 -42.46 95.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.132 -0.98 . . . . 0.08 109.471 178.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 95.7 m -62.35 -42.45 99.41 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.295 -0.878 . . . . 0.14 109.899 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 11.2 t -63.66 -45.91 88.0 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.161 -0.962 . . . . 0.07 109.572 178.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 57.3 mt -64.09 -48.26 76.87 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.07 -1.019 . . . . 0.07 111.173 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 40.0 p -66.38 -28.01 68.31 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 120.986 -1.071 . . . . 0.09 111.589 -178.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -67.81 -35.88 79.41 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 121.007 -1.058 . . . . 1.13 108.145 177.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -80.12 -15.55 56.87 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.967 -1.083 . . . . 0.09 109.844 177.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 80.5 mt -106.01 27.86 8.18 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.984 -1.072 . . . . 0.17 110.675 178.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -72.46 -12.73 61.22 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 120.937 -1.102 . . . . 0.49 111.879 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -110.66 131.38 55.1 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.588 -1.32 . . . . 0.13 110.619 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -57.72 -34.55 69.6 Favored 'General case' 0 N--CA 1.503 2.181 0 C-N-CA 123.306 0.642 . . . . 0.15 112.262 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.484 ' O ' ' HG2' ' A' ' 130' ' ' ARG . 59.7 p -65.75 -34.01 77.18 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 120.694 -1.254 . . . . 0.13 109.88 179.052 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 85.6 t -65.65 -43.9 93.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.638 -1.289 . . . . 0.11 109.974 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 95.8 mt -64.33 -46.06 94.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.941 -1.1 . . . . 0.1 110.228 -179.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.614 ' HA ' ' OE1' ' A' ' 129' ' ' GLU . 8.7 mm-40 -57.08 -46.85 82.19 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.223 -0.923 . . . . 0.11 109.864 178.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.484 ' HG2' ' O ' ' A' ' 126' ' ' SER . 42.7 mmm-85 -63.52 -43.7 96.4 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.215 -0.928 . . . . 0.13 110.214 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 83.3 mt -66.89 -35.04 79.12 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.066 -1.022 . . . . 0.08 111.148 -179.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -67.33 -27.18 66.93 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.308 -0.87 . . . . 0.08 113.285 -176.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -126.49 1.7 6.92 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 120.082 -1.637 . . . . 0.1 113.322 -176.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 9.4 t -68.31 145.89 53.8 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.502 -1.374 . . . . 0.1 111.271 -178.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 72.8 p -106.06 9.92 32.29 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.27 -1.381 . . . . 0.12 107.27 176.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 47.0 t -107.02 116.4 31.86 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 121.588 0.709 . . . . 0.11 112.696 -178.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 15.9 t -65.59 -41.67 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 108.501 -0.925 . . . . 0.09 108.501 176.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -56.87 -39.99 75.35 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.233 -0.917 . . . . 0.11 110.408 178.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -63.66 -42.75 98.03 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.936 -1.103 . . . . 0.11 108.45 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 92.0 t -57.29 -51.27 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 108.508 -0.923 . . . . 0.08 108.508 177.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 141' ' ' LEU . 78.4 mt -57.7 -45.98 84.96 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.238 -0.914 . . . . 0.07 110.294 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -58.81 -47.91 83.13 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.814 -1.179 . . . . 0.11 111.02 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 83.7 mt -67.99 -23.49 65.03 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.983 -1.073 . . . . 0.1 112.606 -177.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.661 ' O ' ' NH1' ' A' ' 147' ' ' ARG . 91.7 mt -110.05 9.27 24.21 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.367 -1.458 . . . . 0.07 111.391 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.711 ' HA ' HH12 ' A' ' 147' ' ' ARG . . . -76.97 -25.25 52.57 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 120.689 -1.257 . . . . 0.07 112.305 -178.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -81.77 -8.81 86.32 Favored Glycine 0 N--CA 1.504 3.211 0 O-C-N 120.57 -1.331 . . . . 0.08 111.156 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . 1.259 ' HD2' ' CZ ' ' A' ' 5' ' ' PHE . 2.0 ptt-85 . . . . . 0 N--CA 1.486 1.371 0 O-C-N 121.053 -1.263 . . . . 0.07 109.64 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 301' ' ' MET . . . . . 0.517 ' HB2' ' HG2' ' B' ' 366' ' ' GLU . 3.4 ttm . . . . . 0 C--O 1.214 -0.786 0 CA-C-O 121.931 0.872 . . . . 0.17 108.948 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 302' ' ' PHE . . . . . 0.454 ' N ' ' CG ' ' B' ' 301' ' ' MET . 46.9 t80 -139.74 142.97 36.77 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 107.27 -1.381 . . . . 0.16 107.27 178.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 303' ' ' GLN . . . . . 0.49 ' O ' ' HG2' ' B' ' 304' ' ' GLN . 5.4 pt20 -153.0 156.31 38.58 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 120.904 -1.123 . . . . 0.14 109.495 179.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 304' ' ' GLN . . . . . 0.49 ' HG2' ' O ' ' B' ' 303' ' ' GLN . 42.2 mm-40 -152.18 149.21 28.51 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 108.033 -1.099 . . . . 0.15 108.033 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -97.19 152.35 18.91 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.046 -1.034 . . . . 0.13 108.428 178.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 7.2 p -147.83 144.34 19.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 N-CA-C 107.478 -1.304 . . . . 0.12 107.478 177.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 85.4 m -96.67 136.54 37.06 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 122.169 0.985 . . . . 0.13 110.079 177.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 51.7 mt -84.88 114.25 24.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 105.478 -2.045 . . . . 0.13 105.478 177.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 47.4 p -106.7 -4.39 19.51 Favored 'General case' 0 C--N 1.264 -3.117 0 N-CA-C 114.704 1.372 . . . . 0.16 114.704 -178.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -71.44 141.87 86.02 Favored Pre-proline 0 N--CA 1.499 2.012 0 O-C-N 119.683 -1.886 . . . . 0.16 110.658 178.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -45.54 -47.63 13.03 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 124.749 3.633 . . . . 0.19 114.202 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 44.5 t-20 -102.21 27.61 6.54 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 116.035 -2.266 . . . . 0.99 108.725 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 58.83 -147.48 40.68 Favored Glycine 0 N--CA 1.496 2.699 0 C-N-CA 117.708 -2.187 . . . . 0.13 109.52 -179.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 314' ' ' LEU . . . . . . . . . . . . . 12.3 tp -92.23 83.31 5.04 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.859 -1.163 . . . . 0.11 107.859 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -81.46 -163.55 0.64 Allowed 'General case' 0 C--O 1.197 -1.673 0 O-C-N 121.246 -0.909 . . . . 1.2 108.868 -179.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 30.9 p -65.43 -54.85 22.6 Favored 'General case' 0 N--CA 1.524 3.226 0 N-CA-C 119.122 3.008 . . . . 0.16 119.122 -173.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 317' ' ' ARG . . . . . 0.678 HH11 ' HG2' ' B' ' 317' ' ' ARG . 4.2 ttt-85 -53.49 -53.33 57.9 Favored Pre-proline 0 N--CA 1.493 1.705 0 C-N-CA 116.88 -1.928 . . . . 1.91 112.446 -175.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 318' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' B' ' 317' ' ' ARG . 21.0 Cg_endo -66.41 -32.17 41.12 Favored 'Trans proline' 0 N--CA 1.484 0.963 0 C-N-CA 124.707 3.604 . . . . 0.13 111.563 -177.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 319' ' ' ALA . . . . . 0.419 ' O ' HG23 ' B' ' 323' ' ' VAL . . . -67.07 -38.8 86.43 Favored 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 119.503 -0.879 . . . . 0.1 109.491 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -70.95 -39.68 72.46 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.865 -0.791 . . . . 0.11 108.865 178.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 67.8 tp60 -64.01 -39.31 93.83 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 117.863 -1.535 . . . . 0.12 109.535 177.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 322' ' ' PHE . . . . . 0.44 ' CE1' HD22 ' B' ' 377' ' ' LEU . 87.3 t80 -62.76 -45.3 93.32 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 122.583 1.182 . . . . 0.08 108.703 -177.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 323' ' ' VAL . . . . . 0.419 HG23 ' O ' ' B' ' 319' ' ' ALA . 53.4 t -62.58 -42.26 95.24 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.278 0 CA-C-N 114.809 -1.087 . . . . 0.07 110.713 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -63.87 -40.18 95.93 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.325 -0.859 . . . . 1.68 109.851 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 325' ' ' GLU . . . . . 0.494 ' OE1' HD22 ' B' ' 380' ' ' LEU . 31.7 tt0 -68.9 -39.65 79.59 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.37 -0.831 . . . . 0.1 109.56 177.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -59.07 -43.99 91.82 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.708 -1.245 . . . . 0.06 109.417 178.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -61.37 -16.13 43.21 Favored 'General case' 0 N--CA 1.509 2.512 0 O-C-N 121.226 -0.922 . . . . 1.5 113.338 178.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -76.92 -10.65 86.07 Favored Glycine 0 N--CA 1.479 1.529 0 O-C-N 119.999 -1.688 . . . . 0.08 109.338 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 329' ' ' PHE . . . . . 0.402 ' HE1' ' HE3' ' B' ' 372' ' ' LYS . 92.8 m-85 -103.36 143.32 32.83 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.429 -1.63 . . . . 0.09 110.101 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 47.8 p -75.66 -30.08 59.31 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.297 -0.877 . . . . 0.11 112.272 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 331' ' ' SER . . . . . . . . . . . . . 15.9 m -59.68 158.57 9.93 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 119.844 -1.785 . . . . 0.11 112.821 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 332' ' ' GLU . . . . . 0.769 ' OE1' ' N ' ' B' ' 333' ' ' ILE . 0.0 OUTLIER -79.0 130.4 35.49 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 102.81 -3.033 . . . . 0.11 102.81 171.266 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 333' ' ' ILE . . . . . 0.769 ' N ' ' OE1' ' B' ' 332' ' ' GLU . 39.2 mt -126.81 136.5 60.61 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.486 0 CA-C-O 122.192 0.996 . . . . 0.08 109.305 -178.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 93.3 m -124.94 143.21 50.99 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-O 123.216 1.484 . . . . 0.09 109.978 178.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 335' ' ' VAL . . . . . 0.442 HG23 ' HB2' ' B' ' 344' ' ' ALA . 85.3 t -108.14 129.95 61.51 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.633 0 N-CA-C 105.469 -2.049 . . . . 0.06 105.469 173.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 336' ' ' THR . . . . . 0.419 ' HB ' ' HB ' ' B' ' 362' ' ' THR . 71.5 m -127.39 119.51 26.35 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 120.862 -1.149 . . . . 0.09 109.046 -178.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 29.1 t -122.52 122.61 39.32 Favored 'General case' 0 N--CA 1.501 2.106 0 C-N-CA 119.992 -0.683 . . . . 0.08 109.843 177.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 51.73 38.84 24.0 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.886 -1.134 . . . . 0.1 112.87 -179.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 81.81 10.86 83.59 Favored Glycine 0 N--CA 1.501 3.009 0 O-C-N 119.944 -1.722 . . . . 0.11 112.522 177.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 340' ' ' LYS . . . . . 0.408 ' O ' ' HA ' ' B' ' 336' ' ' THR . 26.5 mttp -119.85 136.3 54.54 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 105.221 -2.14 . . . . 0.1 105.221 177.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 68.3 m -124.8 158.55 33.09 Favored 'General case' 0 C--N 1.276 -2.594 0 CA-C-O 123.738 1.732 . . . . 0.09 112.408 -176.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -151.62 151.45 31.53 Favored 'General case' 0 C--N 1.278 -2.51 0 CA-C-N 112.449 -2.159 . . . . 0.08 108.634 177.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 8.0 t -70.63 135.95 48.78 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 105.556 -2.016 . . . . 0.08 105.556 173.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 344' ' ' ALA . . . . . 0.442 ' HB2' HG23 ' B' ' 335' ' ' VAL . . . -72.95 -6.83 47.95 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.691 -1.256 . . . . 0.05 110.703 179.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -97.5 13.07 31.18 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.631 -1.293 . . . . 0.08 109.395 -177.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 10.8 t -133.18 104.25 6.4 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 122.153 0.977 . . . . 0.12 110.062 -178.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 347' ' ' LEU . . . . . . . . . . . . . 43.3 tp -57.34 -37.77 73.05 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 115.658 -0.701 . . . . 0.1 109.998 178.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 348' ' ' PHE . . . . . 0.522 ' HB3' ' OE2' ' A' ' 59' ' ' GLU . 75.3 t80 -59.0 -51.35 70.43 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.566 -1.334 . . . . 0.13 113.021 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 37.5 tptt -70.05 -32.46 70.58 Favored 'General case' 0 C--O 1.214 -0.769 0 O-C-N 119.664 -1.898 . . . . 1.55 109.109 -178.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 350' ' ' LEU . . . . . . . . . . . . . 33.7 mt -62.84 -33.7 75.79 Favored 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 118.958 -1.097 . . . . 0.16 109.92 -177.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 351' ' ' GLN . . . . . 0.402 HE22 HG13 ' A' ' 112' ' ' ILE . 69.1 tp60 -67.69 -10.49 52.89 Favored 'General case' 0 C--N 1.293 -1.852 0 O-C-N 121.599 -0.688 . . . . 0.26 109.915 -177.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 352' ' ' THR . . . . . . . . . . . . . 44.6 p -89.72 -7.74 53.87 Favored 'General case' 0 N--CA 1.502 2.132 0 C-N-CA 118.097 -1.441 . . . . 0.12 111.026 -178.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 81.6 mt -93.34 159.34 15.3 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.244 -0.91 . . . . 0.1 110.224 -178.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -86.76 104.8 2.97 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 106.94 -2.464 . . . . 0.08 106.94 177.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 15.7 mt -119.46 47.29 1.73 Allowed 'General case' 0 C--N 1.309 -1.186 0 O-C-N 120.625 -1.515 . . . . 0.1 107.471 -178.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 52.0 p -81.36 172.53 13.46 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 118.849 -1.141 . . . . 0.2 109.16 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -60.74 140.97 57.36 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 119.349 -0.94 . . . . 1.61 109.76 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 91.4 -3.17 79.04 Favored Glycine 0 N--CA 1.5 2.941 0 C-N-CA 120.052 -1.071 . . . . 0.13 111.381 177.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 54.5 m -84.4 135.81 34.13 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 120.918 -1.342 . . . . 0.11 110.66 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 89.2 t -96.47 123.8 48.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 N-CA-C 106.304 -1.739 . . . . 0.11 106.304 176.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 361' ' ' VAL . . . . . 0.487 HG21 ' SD ' ' B' ' 381' ' ' MET . 22.3 m -112.27 160.13 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.335 0 C-N-CA 117.354 -1.739 . . . . 0.09 110.636 178.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 362' ' ' THR . . . . . 0.419 ' HB ' ' HB ' ' B' ' 336' ' ' THR . 90.4 m -108.89 128.34 54.83 Favored 'General case' 0 C--O 1.214 -0.789 0 O-C-N 120.596 -1.315 . . . . 0.1 107.565 175.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 363' ' ' ILE . . . . . 0.459 ' O ' ' HA ' ' B' ' 303' ' ' GLN . 33.2 mt -107.92 121.45 60.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 105.344 -2.095 . . . . 0.1 105.344 176.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 364' ' ' SER . . . . . 0.411 ' HB3' ' HB3' ' B' ' 303' ' ' GLN . 0.7 OUTLIER -128.57 147.3 50.7 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 107.809 -1.182 . . . . 0.1 107.809 -179.646 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -139.76 153.32 47.13 Favored 'General case' 0 C--N 1.292 -1.925 0 C-N-CA 118.454 -1.298 . . . . 0.13 109.781 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 366' ' ' GLU . . . . . 0.517 ' HG2' ' HB2' ' B' ' 301' ' ' MET . 0.2 OUTLIER -141.14 110.88 6.48 Favored 'General case' 0 C--N 1.288 -2.081 0 C-N-CA 118.592 -1.243 . . . . 0.16 108.078 178.127 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . 165.22 -170.36 40.16 Favored Glycine 0 C--N 1.297 -1.59 0 C-N-CA 117.981 -2.056 . . . . 0.14 110.327 178.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -58.27 -40.55 82.18 Favored 'General case' 0 C--N 1.277 -2.57 0 CA-C-N 114.33 -0.935 . . . . 0.16 112.306 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 369' ' ' ASP . . . . . . . . . . . . . 12.0 p30 -114.21 36.85 3.54 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 115.834 -2.346 . . . . 0.13 108.519 -178.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 370' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -56.41 -33.56 65.91 Favored 'General case' 0 N--CA 1.521 3.107 0 N-CA-C 116.8 2.148 . . . . 0.16 116.8 -174.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.95 -45.59 27.1 Favored 'General case' 0 N--CA 1.509 2.514 0 O-C-N 119.526 -1.984 . . . . 0.18 110.914 -176.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 372' ' ' LYS . . . . . 0.786 ' HZ2' ' CE1' ' B' ' 376' ' ' HIS . 11.9 ttpp -63.56 -40.71 97.69 Favored 'General case' 0 C--N 1.283 -2.315 0 N-CA-C 106.965 -1.495 . . . . 0.13 106.965 178.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -59.09 -49.51 77.61 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 117.541 -1.664 . . . . 0.11 110.025 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 374' ' ' VAL . . . . . . . . . . . . . 66.9 t -66.86 -42.25 88.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 CA-C-O 122.187 0.994 . . . . 0.11 109.267 -178.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -55.89 -47.78 76.8 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-O 122.059 0.933 . . . . 0.16 108.737 -178.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 376' ' ' HIS . . . . . 0.786 ' CE1' ' HZ2' ' B' ' 372' ' ' LYS . 13.9 m-70 -69.96 -38.23 76.04 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 116.005 -0.543 . . . . 0.13 111.72 -178.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 377' ' ' LEU . . . . . 0.44 HD22 ' CE1' ' B' ' 322' ' ' PHE . 80.5 mt -75.64 -28.56 58.84 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.348 -1.47 . . . . 0.09 110.875 -174.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 378' ' ' VAL . . . . . . . . . . . . . 2.1 t -71.44 -39.52 71.3 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.459 0 N-CA-C 106.35 -1.722 . . . . 0.13 106.35 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -67.89 -49.31 62.69 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 108.03 -1.1 . . . . 0.16 108.03 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 380' ' ' LEU . . . . . 0.641 ' O ' HD22 ' B' ' 384' ' ' LEU . 34.1 tp -57.18 -45.24 83.87 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 118.974 -1.09 . . . . 0.12 110.62 177.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 381' ' ' MET . . . . . 0.487 ' SD ' HG21 ' B' ' 361' ' ' VAL . 3.6 ttm -62.29 -37.44 85.53 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.871 -1.143 . . . . 0.12 111.508 -177.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -74.89 -31.78 61.67 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.111 -0.993 . . . . 0.15 110.29 -178.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -78.87 -32.41 45.92 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.622 -0.673 . . . . 0.17 111.247 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 384' ' ' LEU . . . . . 0.641 HD22 ' O ' ' B' ' 380' ' ' LEU . 0.0 OUTLIER -50.12 125.54 12.48 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-O 124.432 2.063 . . . . 0.15 112.762 178.802 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 385' ' ' GLU . . . . . 0.966 ' CD ' ' H ' ' B' ' 385' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.279 -2.48 0 CA-C-N 111.085 -2.779 . . . . 0.18 110.093 -177.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 14.4 tp . . . . . 0 N--CA 1.483 1.208 0 N-CA-C 110.502 -0.184 . . . . 0.06 110.502 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 1.259 ' CZ ' ' HD2' ' A' ' 147' ' ' ARG . 40.6 p90 -136.09 141.73 44.24 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 117.476 -1.69 . . . . 0.04 111.884 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.5 mttp -82.27 142.73 31.86 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 107.944 -1.132 . . . . 0.05 107.944 177.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 1.02 ' HA ' HD21 ' A' ' 11' ' ' ASN . 13.6 tp -136.81 125.64 24.08 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 107.285 -1.376 . . . . 0.05 107.285 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -154.02 -166.92 15.44 Favored Glycine 0 C--N 1.289 -2.081 0 N-CA-C 108.557 -1.817 . . . . 0.06 108.557 178.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.79 -34.24 77.46 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.599 -0.942 . . . . 0.08 111.313 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -65.44 -14.93 62.02 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.759 -1.213 . . . . 0.07 112.332 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 1.02 HD21 ' HA ' ' A' ' 7' ' ' LEU . 2.7 p-10 -123.7 22.85 8.94 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 119.5 -2.0 . . . . 0.05 111.869 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 48.8 mt -118.49 123.35 71.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 107.539 -1.282 . . . . 0.06 107.539 176.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -126.44 106.98 9.85 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.433 -0.792 . . . . 0.06 109.252 -177.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.559 ' HA ' ' HB3' ' A' ' 83' ' ' GLN . 42.4 mt -100.33 160.52 14.27 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-O 122.702 1.239 . . . . 0.08 112.883 -177.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 62.34 34.66 89.97 Favored Glycine 0 N--CA 1.497 2.749 0 CA-C-N 114.457 -1.247 . . . . 0.08 113.833 175.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.46 ' HA ' ' HE ' ' A' ' 16' ' ' ARG . 1.0 OUTLIER -83.21 169.14 16.09 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 120.238 -1.742 . . . . 0.08 109.733 178.348 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -140.89 140.75 34.59 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 107.409 -1.33 . . . . 0.08 107.409 178.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -154.17 131.7 11.35 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 108.442 -0.948 . . . . 0.06 108.442 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -77.48 -25.62 50.58 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.141 -0.975 . . . . 0.06 109.69 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 64.2 p -134.75 159.65 40.66 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 119.075 -1.05 . . . . 0.07 111.466 -178.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.669 ' HE3' ' OE1' ' A' ' 50' ' ' GLU . 28.2 pttt -65.98 -32.68 74.31 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.892 -0.781 . . . . 0.09 108.892 175.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 51.4 mp0 -60.28 -42.8 96.21 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.514 -1.366 . . . . 0.08 110.103 179.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -64.1 -41.73 97.17 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.628 -1.295 . . . . 0.07 110.012 177.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.91 -42.51 94.66 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.636 -1.29 . . . . 0.05 109.609 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.37 -42.29 94.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.262 -0.899 . . . . 0.07 109.802 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.46 ' HE ' ' HB2' ' A' ' 26' ' ' ARG . 4.4 ttm180 -62.61 -37.52 86.61 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.316 -0.865 . . . . 0.1 109.98 178.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -67.25 -49.19 65.34 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.724 -1.235 . . . . 0.07 108.403 179.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.19 -47.05 79.1 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.387 -0.821 . . . . 0.06 109.605 178.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.31 -41.34 99.74 Favored Glycine 0 N--CA 1.497 2.722 0 N-CA-C 110.525 -1.03 . . . . 0.08 110.525 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -61.18 -37.76 84.08 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.661 -1.494 . . . . 0.09 110.331 177.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 92.4 mm-40 -73.17 -36.05 66.53 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.069 -1.019 . . . . 0.08 110.181 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 73.5 mt -63.95 -38.2 90.19 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.857 -1.152 . . . . 0.07 108.282 174.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 23.7 t -69.34 -45.48 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 O-C-N 120.879 -1.138 . . . . 0.1 108.178 177.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -57.49 -39.3 76.14 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.665 -0.647 . . . . 0.1 112.625 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -86.19 8.42 73.99 Favored Glycine 0 N--CA 1.508 3.486 0 O-C-N 120.236 -1.54 . . . . 0.08 112.796 -178.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.63 17.83 78.37 Favored Glycine 0 N--CA 1.488 2.139 0 O-C-N 120.678 -1.483 . . . . 0.09 111.443 178.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.422 ' CD1' ' HA3' ' A' ' 78' ' ' GLY . 80.3 m-85 -80.93 -36.24 31.3 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.274 -1.721 . . . . 0.08 110.111 -179.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 17.4 m -141.96 163.02 19.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-O 122.287 1.042 . . . . 0.1 111.437 -177.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.443 ' OE1' ' NH1' ' A' ' 73' ' ' ARG . 83.3 mt-10 -86.63 165.1 34.54 Favored Pre-proline 0 C--N 1.3 -1.546 0 N-CA-C 107.29 -1.374 . . . . 0.14 107.29 176.334 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.429 ' HD2' ' HB3' ' A' ' 39' ' ' GLU . 50.3 Cg_exo -50.53 -36.86 50.88 Favored 'Trans proline' 0 N--CA 1.51 2.443 0 C-N-CA 123.646 2.897 . . . . 0.13 115.791 -177.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.44 ' CD ' HH21 ' A' ' 73' ' ' ARG . 41.2 mp0 -62.76 -20.59 65.11 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.508 -1.37 . . . . 0.15 112.196 -178.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.466 ' O ' ' HG3' ' A' ' 46' ' ' MET . 39.9 t80 -67.08 -27.79 67.65 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.616 -1.303 . . . . 0.11 112.313 -179.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 22.8 t -61.19 -49.01 86.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 120.265 -1.522 . . . . 0.1 110.396 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 51.8 tp60 -67.11 -35.04 78.91 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.093 -1.004 . . . . 0.12 109.108 179.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.2 -33.35 73.32 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.232 -0.917 . . . . 0.11 109.765 177.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.466 ' HG3' ' O ' ' A' ' 42' ' ' TYR . 94.5 mtp -70.28 -37.93 74.94 Favored 'General case' 0 N--CA 1.482 1.128 0 O-C-N 120.545 -1.347 . . . . 0.1 107.719 177.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 93.9 mt -70.14 -40.2 74.93 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.237 -1.023 . . . . 0.1 108.237 178.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -60.14 -44.31 95.04 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.36 -0.837 . . . . 0.13 109.203 177.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 15.4 tpt180 -62.45 -39.19 92.57 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.843 -1.161 . . . . 1.51 110.653 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.669 ' OE1' ' HE3' ' A' ' 21' ' ' LYS . 0.5 OUTLIER -62.54 -39.71 94.48 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.166 -0.959 . . . . 0.1 110.895 -178.545 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.581 ' N ' ' HG2' ' A' ' 50' ' ' GLU . 28.5 tttt -62.75 -38.16 89.47 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 116.312 -0.403 . . . . 2.88 110.896 -178.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 29.2 tp -64.76 -43.56 92.91 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 120.186 -1.571 . . . . 0.16 108.634 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.6 m -166.11 139.11 3.34 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.044 -1.035 . . . . 0.19 109.71 179.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -50.34 144.91 22.52 Favored 'Trans proline' 0 C--N 1.314 -1.286 0 C-N-CA 121.175 1.25 . . . . 0.37 113.655 178.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.51 HG21 ' HA ' ' A' ' 64' ' ' PRO . 59.6 p -96.54 7.94 45.32 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 114.505 -1.225 . . . . 0.16 107.92 177.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 33.2 t80 -62.36 137.5 58.27 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 105.955 -1.869 . . . . 0.09 105.955 174.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 18.1 mt -117.77 11.97 13.76 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 120.856 -1.152 . . . . 0.1 110.224 -178.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 85.56 170.94 47.67 Favored Glycine 0 C--N 1.302 -1.31 0 N-CA-C 108.667 -1.773 . . . . 0.1 108.667 -178.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.81 ' CA ' ' N ' ' A' ' 60' ' ' SER . 76.6 mm-40 57.59 35.4 25.7 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.458 -1.025 . . . . 1.86 113.527 177.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.81 ' N ' ' CA ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER 65.28 21.48 12.02 Favored 'General case' 0 N--CA 1.514 2.771 0 O-C-N 121.039 -1.038 . . . . 0.08 113.555 176.731 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 94.2 mt -121.38 137.48 54.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 120.645 -1.285 . . . . 0.07 111.014 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -129.31 138.85 51.82 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 106.247 -1.76 . . . . 0.06 106.247 174.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.494 ' O ' HG23 ' A' ' 63' ' ' VAL . 16.3 m -130.32 72.28 81.96 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.163 -0.96 . . . . 0.07 110.103 -179.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.51 ' HA ' HG21 ' A' ' 55' ' ' THR . 2.4 Cg_endo -50.24 144.29 23.65 Favored 'Trans proline' 0 C--N 1.298 -2.12 0 CA-C-N 119.874 0.991 . . . . 0.38 111.794 -177.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 2.4 p-80 -141.58 153.9 45.1 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 120.821 -1.174 . . . . 0.59 108.735 175.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -75.51 173.96 52.77 Favored Glycine 0 N--CA 1.501 2.999 0 N-CA-C 109.522 -1.431 . . . . 0.12 109.522 -177.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 82.0 p -80.18 167.93 19.73 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 116.818 -1.953 . . . . 0.59 109.376 179.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.592 HG12 ' ND2' ' A' ' 109' ' ' ASN . 5.3 m -70.52 -23.65 24.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 121.382 -0.824 . . . . 0.14 109.751 -179.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.501 ' OE1' ' N ' ' A' ' 69' ' ' GLU . 58.7 mp0 -75.27 9.06 2.26 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.985 -1.072 . . . . 0.15 109.725 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -121.73 15.27 11.0 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.709 -0.619 . . . . 0.13 109.813 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 49.5 pttt -60.87 -37.95 83.9 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.016 -1.053 . . . . 0.14 109.136 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -69.27 -4.13 16.68 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.658 -0.651 . . . . 0.14 111.543 -177.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.443 ' NH1' ' OE1' ' A' ' 39' ' ' GLU . 15.6 mmm180 -104.96 7.95 34.32 Favored 'General case' 0 N--CA 1.506 2.33 0 O-C-N 120.444 -1.41 . . . . 0.13 109.374 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 91.1 t -95.48 128.49 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 107.082 -1.451 . . . . 0.11 107.082 177.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 28.1 mt -96.75 -17.15 20.47 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 115.721 -0.672 . . . . 0.11 109.455 -178.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 39.6 pttt -176.6 159.67 1.9 Allowed 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.523 -0.918 . . . . 0.09 108.523 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 18.2 m -76.29 138.14 40.34 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.355 -0.841 . . . . 0.13 111.079 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.422 ' HA3' ' CD1' ' A' ' 37' ' ' TYR . . . -160.69 161.05 32.45 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 118.735 -1.698 . . . . 0.06 110.863 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 33.3 m -137.65 150.96 25.62 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 O-C-N 121.603 -0.939 . . . . 0.03 108.842 179.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 80' ' ' VAL . 15.9 m -127.02 113.14 31.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 106.271 -1.752 . . . . 0.04 106.271 175.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.649 ' CZ ' HD22 ' A' ' 100' ' ' LEU . 61.6 t80 -86.02 115.38 23.58 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.789 0.804 . . . . 0.05 109.238 -178.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 39.5 m -119.0 122.11 41.44 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 121.86 0.838 . . . . 0.04 110.506 -177.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.559 ' HB3' ' HA ' ' A' ' 14' ' ' LEU . 30.7 tt0 -100.71 126.47 47.25 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-O 122.108 0.956 . . . . 0.07 111.805 -178.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -123.35 87.24 51.79 Favored Pre-proline 0 C--N 1.302 -1.471 0 N-CA-C 107.025 -1.472 . . . . 0.06 107.025 177.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -54.06 -36.05 83.43 Favored 'Trans proline' 0 N--CA 1.501 1.925 0 C-N-CA 122.847 2.365 . . . . 0.08 113.081 -177.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -81.73 -13.27 58.02 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.481 -0.762 . . . . 0.08 110.323 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 90.08 152.59 27.23 Favored Glycine 0 N--CA 1.485 1.912 0 O-C-N 120.791 -1.193 . . . . 0.06 113.024 175.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 61.5 t -136.47 120.43 24.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 106.549 -1.649 . . . . 0.05 106.549 177.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.873 ' HA ' HD13 ' A' ' 97' ' ' ILE . 4.3 ttt180 -60.31 121.27 11.58 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.829 -1.169 . . . . 0.09 109.131 -179.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -119.77 -11.51 9.36 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 118.656 -1.218 . . . . 1.03 111.573 -178.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -118.54 -158.21 10.74 Favored Glycine 1 N--CA 1.516 4.009 0 O-C-N 119.588 -1.945 . . . . 0.14 112.255 -178.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -92.54 -22.8 19.33 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 113.842 1.052 . . . . 0.26 113.842 -176.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -96.4 154.45 17.26 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.683 -1.261 . . . . 1.62 109.461 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -60.29 -23.89 64.51 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.747 -1.22 . . . . 2.55 109.964 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -86.52 1.87 50.02 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.692 -1.255 . . . . 1.74 109.461 -178.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -83.2 60.17 5.39 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 118.764 -1.175 . . . . 0.16 107.98 178.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.873 HD13 ' HA ' ' A' ' 89' ' ' ARG . 41.8 mm -101.6 135.32 38.75 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 CA-C-O 121.723 0.773 . . . . 0.08 110.169 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -108.56 130.95 55.28 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 121.545 0.688 . . . . 0.06 109.682 178.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -102.5 -17.07 15.93 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 106.557 -1.646 . . . . 0.09 106.557 175.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.649 HD22 ' CZ ' ' A' ' 81' ' ' PHE . 71.1 mt -116.87 112.16 20.68 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.12 -1.067 . . . . 0.06 108.12 176.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 93.8 t -113.4 104.07 16.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 106.257 -1.757 . . . . 0.04 106.257 179.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 72.3 mt -107.11 102.91 14.65 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.087 0 CA-C-O 122.292 1.044 . . . . 0.04 111.035 -176.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -77.6 131.97 11.57 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.023 -1.631 . . . . 0.04 109.023 -178.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.409 HD13 HG21 ' A' ' 104' ' ' ILE . 19.4 pt -133.45 153.5 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 O-C-N 120.264 -1.727 . . . . 0.1 112.916 -176.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -137.38 133.71 35.13 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 106.189 -1.782 . . . . 0.12 106.189 177.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -147.59 140.97 25.3 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 120.113 -1.617 . . . . 0.13 110.955 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 60.6 mtp180 -70.74 156.29 39.7 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.588 0.709 . . . . 3.71 110.331 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 57.81 25.4 11.92 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.069 -0.715 . . . . 1.98 109.069 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.592 ' ND2' HG12 ' A' ' 68' ' ' VAL . 63.1 t30 53.27 37.58 25.6 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.172 -0.955 . . . . 1.22 109.766 178.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -84.05 28.89 0.58 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.131 -0.981 . . . . 0.18 111.093 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . 0.75 ' CA ' ' N ' ' A' ' 112' ' ' ILE . 40.0 p-80 -50.54 -38.3 44.08 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.881 -1.137 . . . . 0.18 112.095 179.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.75 ' N ' ' CA ' ' A' ' 111' ' ' HIS . 21.0 tt -63.18 -28.96 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 119.986 -1.696 . . . . 0.12 111.005 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -69.81 -40.94 75.63 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 120.516 -1.365 . . . . 0.87 108.334 178.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 85.1 t -69.38 -43.61 80.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.428 -0.795 . . . . 0.07 109.414 178.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.11 -42.46 95.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.132 -0.98 . . . . 0.08 109.471 178.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 94.7 m -62.35 -42.45 99.41 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.295 -0.878 . . . . 0.14 109.899 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 11.2 t -63.66 -45.91 88.0 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.161 -0.962 . . . . 0.07 109.572 178.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 57.3 mt -64.09 -48.26 76.87 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.07 -1.019 . . . . 0.07 111.173 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 40.0 p -66.38 -28.01 68.31 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 120.986 -1.071 . . . . 0.09 111.589 -178.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -67.81 -35.88 79.41 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 121.007 -1.058 . . . . 1.13 108.145 177.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -80.12 -15.55 56.87 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.967 -1.083 . . . . 0.09 109.844 177.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 80.5 mt -106.01 27.86 8.18 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.984 -1.072 . . . . 0.17 110.675 178.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -72.46 -12.73 61.22 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 120.937 -1.102 . . . . 0.49 111.879 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -110.66 131.38 55.1 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.588 -1.32 . . . . 0.13 110.619 179.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -57.72 -34.55 69.6 Favored 'General case' 0 N--CA 1.503 2.181 0 C-N-CA 123.306 0.642 . . . . 0.15 112.262 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.495 ' O ' ' HG2' ' A' ' 130' ' ' ARG . 59.7 p -65.75 -34.01 77.18 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 120.694 -1.254 . . . . 0.13 109.88 179.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 85.6 t -65.65 -43.9 93.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.638 -1.289 . . . . 0.11 109.974 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 95.8 mt -64.33 -46.06 94.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.941 -1.1 . . . . 0.1 110.228 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.614 ' HA ' ' OE1' ' A' ' 129' ' ' GLU . 8.7 mm-40 -57.08 -46.85 82.19 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.223 -0.923 . . . . 0.11 109.864 178.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.495 ' HG2' ' O ' ' A' ' 126' ' ' SER . 43.4 mmm-85 -63.52 -43.7 96.4 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.215 -0.928 . . . . 0.13 110.214 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 83.3 mt -66.89 -35.04 79.12 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.066 -1.022 . . . . 0.08 111.148 -179.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -67.33 -27.18 66.93 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.308 -0.87 . . . . 0.08 113.285 -176.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -126.49 1.7 6.92 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 120.082 -1.637 . . . . 0.1 113.322 -176.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 9.4 t -68.31 145.89 53.8 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.502 -1.374 . . . . 0.1 111.271 -178.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 72.8 p -106.06 9.92 32.29 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.27 -1.381 . . . . 0.12 107.27 176.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 47.0 t -107.02 116.4 31.86 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 121.588 0.709 . . . . 0.11 112.696 -178.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 15.9 t -65.59 -41.67 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 108.501 -0.925 . . . . 0.09 108.501 176.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -56.87 -39.99 75.35 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.233 -0.917 . . . . 0.11 110.408 178.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -63.66 -42.75 98.03 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.936 -1.103 . . . . 0.11 108.45 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 92.0 t -57.29 -51.27 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 108.508 -0.923 . . . . 0.08 108.508 177.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 141' ' ' LEU . 78.4 mt -57.7 -45.98 84.96 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.238 -0.914 . . . . 0.07 110.294 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -58.81 -47.91 83.13 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.814 -1.179 . . . . 0.11 111.02 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 83.7 mt -67.99 -23.49 65.03 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.983 -1.073 . . . . 0.1 112.606 -177.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.661 ' O ' ' NH1' ' A' ' 147' ' ' ARG . 91.7 mt -110.05 9.27 24.21 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.367 -1.458 . . . . 0.07 111.391 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.711 ' HA ' HH12 ' A' ' 147' ' ' ARG . . . -76.97 -25.25 52.57 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 120.689 -1.257 . . . . 0.07 112.305 -178.151 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -81.77 -8.81 86.32 Favored Glycine 0 N--CA 1.504 3.211 0 O-C-N 120.57 -1.331 . . . . 0.08 111.156 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . 1.259 ' HD2' ' CZ ' ' A' ' 5' ' ' PHE . 2.0 ptt-85 . . . . . 0 N--CA 1.486 1.371 0 O-C-N 121.053 -1.263 . . . . 0.07 109.64 179.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 301' ' ' MET . . . . . 0.517 ' HB2' ' HG2' ' B' ' 366' ' ' GLU . 3.4 ttm . . . . . 0 C--O 1.214 -0.786 0 CA-C-O 121.931 0.872 . . . . 0.17 108.948 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 302' ' ' PHE . . . . . 0.454 ' N ' ' CG ' ' B' ' 301' ' ' MET . 46.9 t80 -139.74 142.97 36.77 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 107.27 -1.381 . . . . 0.16 107.27 178.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 303' ' ' GLN . . . . . 0.49 ' O ' ' HG2' ' B' ' 304' ' ' GLN . 5.4 pt20 -153.0 156.31 38.58 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 120.904 -1.123 . . . . 0.14 109.495 179.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 304' ' ' GLN . . . . . 0.49 ' HG2' ' O ' ' B' ' 303' ' ' GLN . 42.2 mm-40 -152.18 149.21 28.51 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 108.033 -1.099 . . . . 0.15 108.033 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -97.19 152.35 18.91 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.046 -1.034 . . . . 0.13 108.428 178.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 7.2 p -147.83 144.34 19.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 N-CA-C 107.478 -1.304 . . . . 0.12 107.478 177.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 85.4 m -96.67 136.54 37.06 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 122.169 0.985 . . . . 0.13 110.079 177.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 51.7 mt -84.88 114.25 24.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 105.478 -2.045 . . . . 0.13 105.478 177.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 47.4 p -106.7 -4.39 19.51 Favored 'General case' 0 C--N 1.264 -3.117 0 N-CA-C 114.704 1.372 . . . . 0.16 114.704 -178.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -71.44 141.87 86.02 Favored Pre-proline 0 N--CA 1.499 2.012 0 O-C-N 119.683 -1.886 . . . . 0.16 110.658 178.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -45.54 -47.63 13.03 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 124.749 3.633 . . . . 0.19 114.202 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 44.5 t-20 -102.21 27.61 6.54 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 116.035 -2.266 . . . . 0.99 108.725 179.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 58.83 -144.0 44.73 Favored Glycine 0 N--CA 1.496 2.699 0 C-N-CA 117.708 -2.187 . . . . 0.13 109.52 -179.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 314' ' ' LEU . . . . . . . . . . . . . 9.8 tp -96.93 82.92 3.3 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.203 -1.175 . . . . 0.11 109.363 178.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 315' ' ' HIS . . . . . 0.609 ' CG ' ' N ' ' B' ' 316' ' ' THR . 0.4 OUTLIER -80.85 -159.83 0.27 Allowed 'General case' 0 N--CA 1.503 2.209 0 N-CA-C 107.277 -1.379 . . . . 1.2 107.277 179.058 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 316' ' ' THR . . . . . 0.609 ' N ' ' CG ' ' B' ' 315' ' ' HIS . 63.7 p -66.39 -53.14 39.31 Favored 'General case' 0 N--CA 1.513 2.687 0 N-CA-C 120.177 3.399 . . . . 0.16 120.177 -174.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 317' ' ' ARG . . . . . 0.659 HH11 ' HG2' ' B' ' 317' ' ' ARG . 4.8 ttt-85 -54.9 -53.33 62.23 Favored Pre-proline 0 N--CA 1.493 1.705 0 CA-C-N 122.593 2.451 . . . . 1.91 112.446 -174.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 318' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' B' ' 317' ' ' ARG . 21.0 Cg_endo -66.41 -32.17 41.12 Favored 'Trans proline' 0 N--CA 1.484 0.963 0 C-N-CA 124.707 3.604 . . . . 0.13 111.563 -177.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 319' ' ' ALA . . . . . 0.419 ' O ' HG23 ' B' ' 323' ' ' VAL . . . -67.07 -38.8 86.43 Favored 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 119.503 -0.879 . . . . 0.1 109.491 -179.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -70.95 -39.68 72.46 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.865 -0.791 . . . . 0.11 108.865 178.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 67.8 tp60 -64.01 -39.31 93.83 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 117.863 -1.535 . . . . 0.12 109.535 177.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 322' ' ' PHE . . . . . 0.44 ' CE1' HD22 ' B' ' 377' ' ' LEU . 87.3 t80 -62.76 -45.3 93.32 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 122.583 1.182 . . . . 0.08 108.703 -177.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 323' ' ' VAL . . . . . 0.419 HG23 ' O ' ' B' ' 319' ' ' ALA . 53.4 t -62.58 -42.26 95.24 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.278 0 CA-C-N 114.809 -1.087 . . . . 0.07 110.713 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -63.87 -40.18 95.93 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.325 -0.859 . . . . 1.68 109.851 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 325' ' ' GLU . . . . . 0.494 ' OE1' HD22 ' B' ' 380' ' ' LEU . 31.7 tt0 -68.9 -39.65 79.59 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.37 -0.831 . . . . 0.1 109.56 177.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -59.07 -43.99 91.82 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.708 -1.245 . . . . 0.06 109.417 178.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -61.37 -16.13 43.21 Favored 'General case' 0 N--CA 1.509 2.512 0 O-C-N 121.226 -0.922 . . . . 1.5 113.338 178.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -76.92 -10.65 86.07 Favored Glycine 0 N--CA 1.479 1.529 0 O-C-N 119.999 -1.688 . . . . 0.08 109.338 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 329' ' ' PHE . . . . . 0.402 ' HE1' ' HE3' ' B' ' 372' ' ' LYS . 92.8 m-85 -103.36 143.32 32.83 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.429 -1.63 . . . . 0.09 110.101 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 47.8 p -75.66 -30.08 59.31 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.297 -0.877 . . . . 0.11 112.272 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 331' ' ' SER . . . . . . . . . . . . . 15.9 m -59.68 158.57 9.93 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 119.844 -1.785 . . . . 0.11 112.821 -179.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 332' ' ' GLU . . . . . 0.769 ' OE1' ' N ' ' B' ' 333' ' ' ILE . 0.0 OUTLIER -79.0 130.4 35.49 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 102.81 -3.033 . . . . 0.11 102.81 171.266 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 333' ' ' ILE . . . . . 0.769 ' N ' ' OE1' ' B' ' 332' ' ' GLU . 39.2 mt -126.81 136.5 60.61 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.486 0 CA-C-O 122.192 0.996 . . . . 0.08 109.305 -178.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 93.3 m -124.94 143.21 50.99 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-O 123.216 1.484 . . . . 0.09 109.978 178.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 335' ' ' VAL . . . . . 0.442 HG23 ' HB2' ' B' ' 344' ' ' ALA . 85.3 t -108.14 129.95 61.51 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.633 0 N-CA-C 105.469 -2.049 . . . . 0.06 105.469 173.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 336' ' ' THR . . . . . 0.419 ' HB ' ' HB ' ' B' ' 362' ' ' THR . 71.5 m -127.39 119.51 26.35 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 120.862 -1.149 . . . . 0.09 109.046 -178.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 29.1 t -122.52 122.61 39.32 Favored 'General case' 0 N--CA 1.501 2.106 0 C-N-CA 119.992 -0.683 . . . . 0.08 109.843 177.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 51.73 38.84 24.0 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.886 -1.134 . . . . 0.1 112.87 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 81.81 10.86 83.59 Favored Glycine 0 N--CA 1.501 3.009 0 O-C-N 119.944 -1.722 . . . . 0.11 112.522 177.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 340' ' ' LYS . . . . . 0.408 ' O ' ' HA ' ' B' ' 336' ' ' THR . 26.5 mttp -119.85 136.3 54.54 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 105.221 -2.14 . . . . 0.1 105.221 177.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 68.3 m -124.8 158.55 33.09 Favored 'General case' 0 C--N 1.276 -2.594 0 CA-C-O 123.738 1.732 . . . . 0.09 112.408 -176.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -151.62 151.45 31.53 Favored 'General case' 0 C--N 1.278 -2.51 0 CA-C-N 112.449 -2.159 . . . . 0.08 108.634 177.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 8.0 t -70.63 135.95 48.78 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 105.556 -2.016 . . . . 0.08 105.556 173.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 344' ' ' ALA . . . . . 0.442 ' HB2' HG23 ' B' ' 335' ' ' VAL . . . -72.95 -6.83 47.95 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.691 -1.256 . . . . 0.05 110.703 179.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -97.5 13.07 31.18 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.631 -1.293 . . . . 0.08 109.395 -177.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 11.0 t -133.18 104.25 6.4 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 122.153 0.977 . . . . 0.12 110.062 -178.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 347' ' ' LEU . . . . . . . . . . . . . 43.1 tp -57.34 -37.77 73.05 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 115.658 -0.701 . . . . 0.1 109.998 178.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 348' ' ' PHE . . . . . 0.505 ' HB3' ' OE2' ' A' ' 59' ' ' GLU . 75.2 t80 -59.0 -51.35 70.43 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.566 -1.334 . . . . 0.13 113.021 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 37.5 tptt -70.05 -32.46 70.58 Favored 'General case' 0 C--O 1.214 -0.769 0 O-C-N 119.664 -1.898 . . . . 1.55 109.109 -178.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 350' ' ' LEU . . . . . . . . . . . . . 33.3 mt -62.84 -33.7 75.79 Favored 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 118.958 -1.097 . . . . 0.16 109.92 -177.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 351' ' ' GLN . . . . . 0.401 HE22 HG13 ' A' ' 112' ' ' ILE . 69.1 tp60 -67.69 -10.49 52.89 Favored 'General case' 0 C--N 1.293 -1.852 0 O-C-N 121.599 -0.688 . . . . 0.26 109.915 -177.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 352' ' ' THR . . . . . . . . . . . . . 45.7 p -89.72 -7.74 53.87 Favored 'General case' 0 N--CA 1.502 2.132 0 C-N-CA 118.097 -1.441 . . . . 0.12 111.026 -178.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 83.2 mt -93.34 159.34 15.3 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.244 -0.91 . . . . 0.1 110.224 -178.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -86.76 104.8 2.97 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 106.94 -2.464 . . . . 0.08 106.94 177.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 16.3 mt -119.46 47.29 1.73 Allowed 'General case' 0 C--N 1.309 -1.186 0 O-C-N 120.625 -1.515 . . . . 0.1 107.471 -178.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 52.8 p -81.36 172.53 13.46 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 118.849 -1.141 . . . . 0.2 109.16 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -60.74 140.97 57.36 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 119.349 -0.94 . . . . 1.61 109.76 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 91.4 -3.17 79.04 Favored Glycine 0 N--CA 1.5 2.941 0 C-N-CA 120.052 -1.071 . . . . 0.13 111.381 177.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 54.5 m -84.4 135.81 34.13 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 120.918 -1.342 . . . . 0.11 110.66 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 89.2 t -96.47 123.8 48.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 N-CA-C 106.304 -1.739 . . . . 0.11 106.304 176.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 361' ' ' VAL . . . . . 0.487 HG21 ' SD ' ' B' ' 381' ' ' MET . 22.3 m -112.27 160.13 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.335 0 C-N-CA 117.354 -1.739 . . . . 0.09 110.636 178.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 362' ' ' THR . . . . . 0.419 ' HB ' ' HB ' ' B' ' 336' ' ' THR . 90.4 m -108.89 128.34 54.83 Favored 'General case' 0 C--O 1.214 -0.789 0 O-C-N 120.596 -1.315 . . . . 0.1 107.565 175.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 363' ' ' ILE . . . . . 0.459 ' O ' ' HA ' ' B' ' 303' ' ' GLN . 33.2 mt -107.92 121.45 60.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 105.344 -2.095 . . . . 0.1 105.344 176.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 364' ' ' SER . . . . . 0.411 ' HB3' ' HB3' ' B' ' 303' ' ' GLN . 0.7 OUTLIER -128.57 147.3 50.7 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 107.809 -1.182 . . . . 0.1 107.809 -179.646 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -139.76 153.32 47.13 Favored 'General case' 0 C--N 1.292 -1.925 0 C-N-CA 118.454 -1.298 . . . . 0.13 109.781 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 366' ' ' GLU . . . . . 0.517 ' HG2' ' HB2' ' B' ' 301' ' ' MET . 0.2 OUTLIER -141.14 110.88 6.48 Favored 'General case' 0 C--N 1.288 -2.081 0 C-N-CA 118.592 -1.243 . . . . 0.16 108.078 178.127 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . 165.22 -170.36 40.16 Favored Glycine 0 C--N 1.297 -1.59 0 C-N-CA 117.981 -2.056 . . . . 0.14 110.327 178.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -58.27 -40.55 82.18 Favored 'General case' 0 C--N 1.277 -2.57 0 CA-C-N 114.33 -0.935 . . . . 0.16 112.306 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 369' ' ' ASP . . . . . . . . . . . . . 12.0 p30 -114.21 36.85 3.54 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 115.834 -2.346 . . . . 0.13 108.519 -178.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 370' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -56.41 -33.56 65.91 Favored 'General case' 0 N--CA 1.521 3.107 0 N-CA-C 116.8 2.148 . . . . 0.16 116.8 -174.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.95 -45.59 27.1 Favored 'General case' 0 N--CA 1.509 2.514 0 O-C-N 119.526 -1.984 . . . . 0.18 110.914 -176.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 372' ' ' LYS . . . . . 0.786 ' HZ2' ' CE1' ' B' ' 376' ' ' HIS . 11.9 ttpp -63.56 -40.71 97.69 Favored 'General case' 0 C--N 1.283 -2.315 0 N-CA-C 106.965 -1.495 . . . . 0.13 106.965 178.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -59.09 -49.51 77.61 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 117.541 -1.664 . . . . 0.11 110.025 -178.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 374' ' ' VAL . . . . . . . . . . . . . 66.9 t -66.86 -42.25 88.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 CA-C-O 122.187 0.994 . . . . 0.11 109.267 -178.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -55.89 -47.78 76.8 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-O 122.059 0.933 . . . . 0.16 108.737 -178.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 376' ' ' HIS . . . . . 0.786 ' CE1' ' HZ2' ' B' ' 372' ' ' LYS . 13.9 m-70 -69.96 -38.23 76.04 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 116.005 -0.543 . . . . 0.13 111.72 -178.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 377' ' ' LEU . . . . . 0.44 HD22 ' CE1' ' B' ' 322' ' ' PHE . 80.5 mt -75.64 -28.56 58.84 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.348 -1.47 . . . . 0.09 110.875 -174.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 378' ' ' VAL . . . . . . . . . . . . . 2.1 t -71.44 -39.52 71.3 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.459 0 N-CA-C 106.35 -1.722 . . . . 0.13 106.35 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -67.89 -49.31 62.69 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 108.03 -1.1 . . . . 0.16 108.03 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 380' ' ' LEU . . . . . 0.641 ' O ' HD22 ' B' ' 384' ' ' LEU . 34.1 tp -57.18 -45.24 83.87 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 118.974 -1.09 . . . . 0.12 110.62 177.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 381' ' ' MET . . . . . 0.487 ' SD ' HG21 ' B' ' 361' ' ' VAL . 3.6 ttm -62.29 -37.44 85.53 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.871 -1.143 . . . . 0.12 111.508 -177.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -74.89 -31.78 61.67 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.111 -0.993 . . . . 0.15 110.29 -178.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -78.87 -32.41 45.92 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.622 -0.673 . . . . 0.17 111.247 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 384' ' ' LEU . . . . . 0.641 HD22 ' O ' ' B' ' 380' ' ' LEU . 0.0 OUTLIER -50.12 125.54 12.48 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-O 124.432 2.063 . . . . 0.15 112.762 178.802 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 385' ' ' GLU . . . . . 0.966 ' CD ' ' H ' ' B' ' 385' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.279 -2.48 0 CA-C-N 111.085 -2.779 . . . . 0.18 110.093 -177.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 14.4 tp . . . . . 0 N--CA 1.483 1.208 0 N-CA-C 110.502 -0.184 . . . . 0.06 110.502 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 1.259 ' CZ ' ' HD2' ' A' ' 147' ' ' ARG . 40.6 p90 -136.09 141.73 44.24 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 117.476 -1.69 . . . . 0.04 111.884 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.5 mttp -82.27 142.73 31.86 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 107.944 -1.132 . . . . 0.05 107.944 177.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 1.02 ' HA ' HD21 ' A' ' 11' ' ' ASN . 13.6 tp -136.81 125.64 24.08 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 107.285 -1.376 . . . . 0.05 107.285 179.131 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -154.02 -166.92 15.44 Favored Glycine 0 C--N 1.289 -2.081 0 N-CA-C 108.557 -1.817 . . . . 0.06 108.557 178.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.79 -34.24 77.46 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.599 -0.942 . . . . 0.08 111.313 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -65.44 -14.93 62.02 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.759 -1.213 . . . . 0.07 112.332 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 1.02 HD21 ' HA ' ' A' ' 7' ' ' LEU . 2.7 p-10 -123.7 22.85 8.94 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 119.5 -2.0 . . . . 0.05 111.869 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 48.8 mt -118.49 123.35 71.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 107.539 -1.282 . . . . 0.06 107.539 176.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -126.44 106.98 9.85 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.433 -0.792 . . . . 0.06 109.252 -177.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.559 ' HA ' ' HB3' ' A' ' 83' ' ' GLN . 42.4 mt -100.33 160.52 14.27 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-O 122.702 1.239 . . . . 0.08 112.883 -177.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 62.34 34.66 89.97 Favored Glycine 0 N--CA 1.497 2.749 0 CA-C-N 114.457 -1.247 . . . . 0.08 113.833 175.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.46 ' HA ' ' HE ' ' A' ' 16' ' ' ARG . 1.0 OUTLIER -83.21 169.14 16.09 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 120.238 -1.742 . . . . 0.08 109.733 178.348 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -140.89 140.75 34.59 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 107.409 -1.33 . . . . 0.08 107.409 178.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -154.17 131.7 11.35 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 108.442 -0.948 . . . . 0.06 108.442 179.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -77.48 -25.62 50.58 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.141 -0.975 . . . . 0.06 109.69 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 64.2 p -134.75 159.65 40.66 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 119.075 -1.05 . . . . 0.07 111.466 -178.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.669 ' HE3' ' OE1' ' A' ' 50' ' ' GLU . 28.2 pttt -65.98 -32.68 74.31 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.892 -0.781 . . . . 0.09 108.892 175.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 51.4 mp0 -60.28 -42.8 96.21 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.514 -1.366 . . . . 0.08 110.103 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -64.1 -41.73 97.17 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.628 -1.295 . . . . 0.07 110.012 177.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.91 -42.51 94.66 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.636 -1.29 . . . . 0.05 109.609 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.37 -42.29 94.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.262 -0.899 . . . . 0.07 109.802 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.46 ' HE ' ' HB2' ' A' ' 26' ' ' ARG . 4.4 ttm180 -62.61 -37.52 86.61 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.316 -0.865 . . . . 0.1 109.98 178.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -67.25 -49.19 65.34 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.724 -1.235 . . . . 0.07 108.403 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.19 -47.05 79.1 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.387 -0.821 . . . . 0.06 109.605 178.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.31 -41.34 99.74 Favored Glycine 0 N--CA 1.497 2.722 0 N-CA-C 110.525 -1.03 . . . . 0.08 110.525 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -61.18 -37.76 84.08 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.661 -1.494 . . . . 0.09 110.331 177.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 92.4 mm-40 -73.17 -36.05 66.53 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.069 -1.019 . . . . 0.08 110.181 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 73.5 mt -63.95 -38.2 90.19 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.857 -1.152 . . . . 0.07 108.282 174.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 23.7 t -69.34 -45.48 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 O-C-N 120.879 -1.138 . . . . 0.1 108.178 177.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -57.49 -39.3 76.14 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.665 -0.647 . . . . 0.1 112.625 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -86.19 8.42 73.99 Favored Glycine 0 N--CA 1.508 3.486 0 O-C-N 120.236 -1.54 . . . . 0.08 112.796 -178.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.63 17.83 78.37 Favored Glycine 0 N--CA 1.488 2.139 0 O-C-N 120.678 -1.483 . . . . 0.09 111.443 178.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.422 ' CD1' ' HA3' ' A' ' 78' ' ' GLY . 80.3 m-85 -80.93 -36.24 31.3 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.274 -1.721 . . . . 0.08 110.111 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 17.4 m -141.96 163.02 19.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-O 122.287 1.042 . . . . 0.1 111.437 -177.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.443 ' OE1' ' NH1' ' A' ' 73' ' ' ARG . 83.3 mt-10 -86.63 165.1 34.54 Favored Pre-proline 0 C--N 1.3 -1.546 0 N-CA-C 107.29 -1.374 . . . . 0.14 107.29 176.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.429 ' HD2' ' HB3' ' A' ' 39' ' ' GLU . 50.3 Cg_exo -50.53 -36.86 50.88 Favored 'Trans proline' 0 N--CA 1.51 2.443 0 C-N-CA 123.646 2.897 . . . . 0.13 115.791 -177.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.44 ' CD ' HH21 ' A' ' 73' ' ' ARG . 41.2 mp0 -62.76 -20.59 65.11 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.508 -1.37 . . . . 0.15 112.196 -178.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.466 ' O ' ' HG3' ' A' ' 46' ' ' MET . 39.9 t80 -67.08 -27.79 67.65 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.616 -1.303 . . . . 0.11 112.313 -179.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 22.8 t -61.19 -49.01 86.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 120.265 -1.522 . . . . 0.1 110.396 -179.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 51.8 tp60 -67.11 -35.04 78.91 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.093 -1.004 . . . . 0.12 109.108 179.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.2 -33.35 73.32 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.232 -0.917 . . . . 0.11 109.765 177.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.466 ' HG3' ' O ' ' A' ' 42' ' ' TYR . 94.5 mtp -70.28 -37.93 74.94 Favored 'General case' 0 N--CA 1.482 1.128 0 O-C-N 120.545 -1.347 . . . . 0.1 107.719 177.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 93.9 mt -70.14 -40.2 74.93 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.237 -1.023 . . . . 0.1 108.237 178.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -60.14 -44.31 95.04 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.36 -0.837 . . . . 0.13 109.203 177.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.557 ' NE ' ' NE2' ' A' ' 65' ' ' HIS . 27.0 tpt180 -62.45 -39.19 92.57 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.843 -1.161 . . . . 1.51 110.653 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.669 ' OE1' ' HE3' ' A' ' 21' ' ' LYS . 0.5 OUTLIER -62.54 -39.64 94.24 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.166 -0.959 . . . . 0.1 110.895 -178.545 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.579 ' N ' ' HG2' ' A' ' 50' ' ' GLU . 25.8 tttt -62.8 -38.38 90.47 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 116.364 -0.38 . . . . 2.88 110.86 -178.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 25.3 tp -64.54 -43.56 93.62 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 120.193 -1.567 . . . . 0.16 108.634 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.7 m -166.11 139.11 3.34 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.044 -1.035 . . . . 0.19 109.71 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -50.34 144.91 22.52 Favored 'Trans proline' 0 C--N 1.314 -1.286 0 C-N-CA 121.175 1.25 . . . . 0.37 113.655 178.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 47.2 p -96.54 7.94 45.32 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 114.505 -1.225 . . . . 0.16 107.92 177.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 34.2 t80 -62.36 137.5 58.27 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 105.955 -1.869 . . . . 0.09 105.955 174.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 17.8 mt -117.77 11.97 13.76 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 120.856 -1.152 . . . . 0.1 110.224 -178.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 85.56 170.94 47.67 Favored Glycine 0 C--N 1.302 -1.31 0 N-CA-C 108.667 -1.773 . . . . 0.1 108.667 -178.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.81 ' CA ' ' N ' ' A' ' 60' ' ' SER . 74.3 mm-40 57.59 35.4 25.7 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.458 -1.025 . . . . 1.86 113.527 177.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.81 ' N ' ' CA ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER 65.28 21.48 12.02 Favored 'General case' 0 N--CA 1.514 2.771 0 O-C-N 121.039 -1.038 . . . . 0.08 113.555 176.731 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 94.2 mt -121.38 137.48 54.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 120.645 -1.285 . . . . 0.07 111.014 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -129.31 138.85 51.82 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 106.247 -1.76 . . . . 0.06 106.247 174.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.494 ' O ' HG23 ' A' ' 63' ' ' VAL . 16.3 m -130.32 74.93 79.87 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.163 -0.96 . . . . 0.07 110.103 -179.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -58.08 148.94 74.72 Favored 'Trans proline' 0 N--CA 1.49 1.273 0 C-N-CA 121.809 1.672 . . . . 0.38 112.552 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.557 ' NE2' ' NE ' ' A' ' 49' ' ' ARG . 37.2 p-80 -157.19 162.91 39.32 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.637 -0.664 . . . . 0.59 109.611 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -79.1 176.17 54.81 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 110.769 -0.932 . . . . 0.12 110.769 -179.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 82.0 p -81.07 167.93 19.19 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.612 -0.934 . . . . 0.59 109.376 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.585 HG12 ' ND2' ' A' ' 109' ' ' ASN . 4.7 m -70.52 -23.65 24.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 121.382 -0.824 . . . . 0.14 109.751 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.501 ' OE1' ' N ' ' A' ' 69' ' ' GLU . 58.7 mp0 -75.27 9.06 2.26 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.985 -1.072 . . . . 0.15 109.725 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -121.73 15.27 11.0 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.709 -0.619 . . . . 0.13 109.813 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 49.5 pttt -60.87 -37.95 83.9 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.016 -1.053 . . . . 0.14 109.136 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -69.27 -4.13 16.68 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.658 -0.651 . . . . 0.14 111.543 -177.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.443 ' NH1' ' OE1' ' A' ' 39' ' ' GLU . 15.6 mmm180 -104.96 7.95 34.32 Favored 'General case' 0 N--CA 1.506 2.33 0 O-C-N 120.444 -1.41 . . . . 0.13 109.374 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 91.1 t -95.48 128.49 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 107.082 -1.451 . . . . 0.11 107.082 177.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 28.1 mt -96.75 -17.15 20.47 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 115.721 -0.672 . . . . 0.11 109.455 -178.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 39.6 pttt -176.6 159.67 1.9 Allowed 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.523 -0.918 . . . . 0.09 108.523 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 18.2 m -76.29 138.14 40.34 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.355 -0.841 . . . . 0.13 111.079 -179.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.422 ' HA3' ' CD1' ' A' ' 37' ' ' TYR . . . -160.69 161.05 32.45 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 118.735 -1.698 . . . . 0.06 110.863 -179.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 33.3 m -137.65 150.96 25.62 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 O-C-N 121.603 -0.939 . . . . 0.03 108.842 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 80' ' ' VAL . 15.9 m -127.02 113.14 31.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 106.271 -1.752 . . . . 0.04 106.271 175.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.649 ' CZ ' HD22 ' A' ' 100' ' ' LEU . 61.6 t80 -86.02 115.38 23.58 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.789 0.804 . . . . 0.05 109.238 -178.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 39.5 m -119.0 122.11 41.44 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 121.86 0.838 . . . . 0.04 110.506 -177.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.559 ' HB3' ' HA ' ' A' ' 14' ' ' LEU . 30.7 tt0 -100.71 126.47 47.25 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-O 122.108 0.956 . . . . 0.07 111.805 -178.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -123.35 87.24 51.79 Favored Pre-proline 0 C--N 1.302 -1.471 0 N-CA-C 107.025 -1.472 . . . . 0.06 107.025 177.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -54.06 -36.05 83.43 Favored 'Trans proline' 0 N--CA 1.501 1.925 0 C-N-CA 122.847 2.365 . . . . 0.08 113.081 -177.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -81.73 -13.27 58.02 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.481 -0.762 . . . . 0.08 110.323 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 90.08 152.59 27.23 Favored Glycine 0 N--CA 1.485 1.912 0 O-C-N 120.791 -1.193 . . . . 0.06 113.024 175.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 61.5 t -136.47 120.43 24.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 106.549 -1.649 . . . . 0.05 106.549 177.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.873 ' HA ' HD13 ' A' ' 97' ' ' ILE . 4.3 ttt180 -60.31 121.27 11.58 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.829 -1.169 . . . . 0.09 109.131 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -119.77 -11.51 9.36 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 118.656 -1.218 . . . . 1.03 111.573 -178.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -118.54 -158.21 10.74 Favored Glycine 1 N--CA 1.516 4.009 0 O-C-N 119.588 -1.945 . . . . 0.14 112.255 -178.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -92.54 -22.8 19.33 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 113.842 1.052 . . . . 0.26 113.842 -176.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -96.4 154.45 17.26 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.683 -1.261 . . . . 1.62 109.461 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -60.29 -23.89 64.51 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.747 -1.22 . . . . 2.55 109.964 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -86.52 1.87 50.02 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.692 -1.255 . . . . 1.74 109.461 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -83.2 60.17 5.39 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 118.764 -1.175 . . . . 0.16 107.98 178.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.873 HD13 ' HA ' ' A' ' 89' ' ' ARG . 41.8 mm -101.6 135.32 38.75 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 CA-C-O 121.723 0.773 . . . . 0.08 110.169 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -108.56 130.95 55.28 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 121.545 0.688 . . . . 0.06 109.682 178.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 87.2 mtm180 -102.5 -17.07 15.93 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 106.557 -1.646 . . . . 0.09 106.557 175.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.649 HD22 ' CZ ' ' A' ' 81' ' ' PHE . 71.1 mt -116.87 112.16 20.68 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.12 -1.067 . . . . 0.06 108.12 176.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 93.8 t -113.4 104.07 16.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 106.257 -1.757 . . . . 0.04 106.257 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 72.3 mt -107.11 102.91 14.65 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.087 0 CA-C-O 122.292 1.044 . . . . 0.04 111.035 -176.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -77.6 131.97 11.57 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.023 -1.631 . . . . 0.04 109.023 -178.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.409 HD13 HG21 ' A' ' 104' ' ' ILE . 19.4 pt -133.45 153.5 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 O-C-N 120.264 -1.727 . . . . 0.1 112.916 -176.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -137.38 133.71 35.13 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 106.189 -1.782 . . . . 0.12 106.189 177.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -147.59 140.97 25.3 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 120.113 -1.617 . . . . 0.13 110.955 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 60.6 mtp180 -70.74 156.29 39.7 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.588 0.709 . . . . 3.71 110.331 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 57.81 25.4 11.92 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.069 -0.715 . . . . 1.98 109.069 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.585 ' ND2' HG12 ' A' ' 68' ' ' VAL . 61.4 t30 53.27 37.58 25.6 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.172 -0.955 . . . . 1.22 109.766 178.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -84.05 28.89 0.58 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.131 -0.981 . . . . 0.18 111.093 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.75 ' CA ' ' N ' ' A' ' 112' ' ' ILE . 41.6 p-80 -50.54 -38.3 44.08 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.881 -1.137 . . . . 0.18 112.095 179.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.75 ' N ' ' CA ' ' A' ' 111' ' ' HIS . 20.9 tt -63.18 -28.96 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 119.986 -1.696 . . . . 0.12 111.005 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -69.81 -40.94 75.63 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 120.516 -1.365 . . . . 0.87 108.334 178.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 85.1 t -69.38 -43.61 80.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.428 -0.795 . . . . 0.07 109.414 178.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 97.0 mt -62.11 -42.46 95.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.132 -0.98 . . . . 0.08 109.471 178.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 97.6 m -62.35 -42.45 99.41 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.295 -0.878 . . . . 0.14 109.899 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 11.2 t -63.66 -45.91 88.0 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.161 -0.962 . . . . 0.07 109.572 178.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 57.3 mt -64.09 -48.26 76.87 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.07 -1.019 . . . . 0.07 111.173 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 40.4 p -66.38 -28.01 68.31 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 120.986 -1.071 . . . . 0.09 111.589 -178.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -67.81 -35.88 79.41 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 121.007 -1.058 . . . . 1.13 108.145 177.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -80.12 -15.55 56.87 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.967 -1.083 . . . . 0.09 109.844 177.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 80.5 mt -106.01 27.86 8.18 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.984 -1.072 . . . . 0.17 110.675 178.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -72.46 -12.73 61.22 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 120.937 -1.102 . . . . 0.49 111.879 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -110.66 131.38 55.1 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.588 -1.32 . . . . 0.13 110.619 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -57.72 -34.55 69.6 Favored 'General case' 0 N--CA 1.503 2.181 0 C-N-CA 123.306 0.642 . . . . 0.15 112.262 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.449 ' O ' ' HG2' ' A' ' 130' ' ' ARG . 59.7 p -65.75 -34.01 77.18 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 120.694 -1.254 . . . . 0.13 109.88 179.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 85.6 t -65.65 -43.9 93.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.638 -1.289 . . . . 0.11 109.974 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 96.1 mt -64.33 -46.06 94.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.941 -1.1 . . . . 0.1 110.228 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.614 ' HA ' ' OE1' ' A' ' 129' ' ' GLU . 8.7 mm-40 -57.08 -46.85 82.19 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.223 -0.923 . . . . 0.11 109.864 178.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.524 ' NH1' ' HG3' ' A' ' 130' ' ' ARG . 16.5 mmm-85 -63.52 -43.7 96.4 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.215 -0.928 . . . . 0.13 110.214 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 83.3 mt -66.89 -35.04 79.12 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.066 -1.022 . . . . 0.08 111.148 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -67.33 -27.18 66.93 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.308 -0.87 . . . . 0.08 113.285 -176.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -126.49 1.7 6.92 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 120.082 -1.637 . . . . 0.1 113.322 -176.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 9.4 t -68.31 145.89 53.8 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.502 -1.374 . . . . 0.1 111.271 -178.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 72.8 p -106.06 9.92 32.29 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.27 -1.381 . . . . 0.12 107.27 176.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 47.0 t -107.02 116.4 31.86 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 121.588 0.709 . . . . 0.11 112.696 -178.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 15.9 t -65.59 -41.67 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 108.501 -0.925 . . . . 0.09 108.501 176.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -56.87 -39.99 75.35 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.233 -0.917 . . . . 0.11 110.408 178.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -63.66 -42.75 98.03 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.936 -1.103 . . . . 0.11 108.45 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 92.0 t -57.29 -51.27 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 108.508 -0.923 . . . . 0.08 108.508 177.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 141' ' ' LEU . 78.4 mt -57.7 -45.98 84.96 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.238 -0.914 . . . . 0.07 110.294 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -58.81 -47.91 83.13 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.814 -1.179 . . . . 0.11 111.02 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 83.7 mt -67.99 -23.49 65.03 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.983 -1.073 . . . . 0.1 112.606 -177.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.661 ' O ' ' NH1' ' A' ' 147' ' ' ARG . 91.7 mt -110.05 9.27 24.21 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.367 -1.458 . . . . 0.07 111.391 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.711 ' HA ' HH12 ' A' ' 147' ' ' ARG . . . -76.97 -25.25 52.57 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 120.689 -1.257 . . . . 0.07 112.305 -178.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -81.77 -8.81 86.32 Favored Glycine 0 N--CA 1.504 3.211 0 O-C-N 120.57 -1.331 . . . . 0.08 111.156 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 1.259 ' HD2' ' CZ ' ' A' ' 5' ' ' PHE . 2.0 ptt-85 . . . . . 0 N--CA 1.486 1.371 0 O-C-N 121.053 -1.263 . . . . 0.07 109.64 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 301' ' ' MET . . . . . 0.517 ' HB2' ' HG2' ' B' ' 366' ' ' GLU . 3.4 ttm . . . . . 0 C--O 1.214 -0.786 0 CA-C-O 121.931 0.872 . . . . 0.17 108.948 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 302' ' ' PHE . . . . . 0.454 ' N ' ' CG ' ' B' ' 301' ' ' MET . 46.9 t80 -139.74 142.97 36.77 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 107.27 -1.381 . . . . 0.16 107.27 178.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 303' ' ' GLN . . . . . 0.49 ' O ' ' HG2' ' B' ' 304' ' ' GLN . 5.4 pt20 -153.0 156.31 38.58 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 120.904 -1.123 . . . . 0.14 109.495 179.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 304' ' ' GLN . . . . . 0.49 ' HG2' ' O ' ' B' ' 303' ' ' GLN . 42.2 mm-40 -152.18 149.21 28.51 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 108.033 -1.099 . . . . 0.15 108.033 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -97.19 152.35 18.91 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.046 -1.034 . . . . 0.13 108.428 178.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 7.2 p -147.83 144.34 19.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 N-CA-C 107.478 -1.304 . . . . 0.12 107.478 177.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 85.4 m -96.67 136.54 37.06 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 122.169 0.985 . . . . 0.13 110.079 177.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 51.7 mt -84.88 114.25 24.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 105.478 -2.045 . . . . 0.13 105.478 177.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 47.4 p -106.7 -4.39 19.51 Favored 'General case' 0 C--N 1.264 -3.117 0 N-CA-C 114.704 1.372 . . . . 0.16 114.704 -178.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -71.44 141.87 86.02 Favored Pre-proline 0 N--CA 1.499 2.012 0 O-C-N 119.683 -1.886 . . . . 0.16 110.658 178.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -45.54 -47.63 13.03 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 124.749 3.633 . . . . 0.19 114.202 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -102.21 27.61 6.54 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 116.035 -2.266 . . . . 0.99 108.725 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 58.83 -149.92 36.59 Favored Glycine 0 N--CA 1.496 2.699 0 C-N-CA 117.708 -2.187 . . . . 0.13 109.52 -179.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 314' ' ' LEU . . . . . 0.403 ' HA ' HD12 ' B' ' 314' ' ' LEU . 19.9 tp -83.93 72.58 10.42 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.838 -1.39 . . . . 0.11 109.581 -176.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 12.1 p80 -69.41 -179.71 1.75 Allowed 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 117.846 -1.542 . . . . 1.2 112.131 -177.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 316' ' ' THR . . . . . 0.537 ' OG1' ' NH2' ' A' ' 49' ' ' ARG . 66.4 p -42.1 -66.7 0.32 Allowed 'General case' 0 N--CA 1.505 2.291 0 N-CA-C 117.209 2.299 . . . . 0.16 117.209 -175.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 317' ' ' ARG . . . . . 0.542 ' N ' ' HD2' ' B' ' 318' ' ' PRO . 5.4 ttt-85 -53.2 -53.33 57.0 Favored Pre-proline 0 N--CA 1.493 1.705 0 C-N-CA 120.21 -0.596 . . . . 1.91 112.446 -176.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 318' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' B' ' 317' ' ' ARG . 21.0 Cg_endo -66.41 -32.17 41.12 Favored 'Trans proline' 0 N--CA 1.484 0.963 0 C-N-CA 124.707 3.604 . . . . 0.13 111.563 -177.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 319' ' ' ALA . . . . . 0.419 ' O ' HG23 ' B' ' 323' ' ' VAL . . . -67.07 -38.8 86.43 Favored 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 119.503 -0.879 . . . . 0.1 109.491 -179.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -70.95 -39.68 72.46 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.865 -0.791 . . . . 0.11 108.865 178.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 67.8 tp60 -64.01 -39.31 93.83 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 117.863 -1.535 . . . . 0.12 109.535 177.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 322' ' ' PHE . . . . . 0.44 ' CE1' HD22 ' B' ' 377' ' ' LEU . 87.3 t80 -62.76 -45.3 93.32 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 122.583 1.182 . . . . 0.08 108.703 -177.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 323' ' ' VAL . . . . . 0.419 HG23 ' O ' ' B' ' 319' ' ' ALA . 53.4 t -62.58 -42.26 95.24 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.278 0 CA-C-N 114.809 -1.087 . . . . 0.07 110.713 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 73.7 tttt -63.87 -40.18 95.93 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.325 -0.859 . . . . 1.68 109.851 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 325' ' ' GLU . . . . . 0.494 ' OE1' HD22 ' B' ' 380' ' ' LEU . 31.7 tt0 -68.9 -39.65 79.59 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.37 -0.831 . . . . 0.1 109.56 177.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -59.07 -43.99 91.82 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.708 -1.245 . . . . 0.06 109.417 178.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -61.37 -16.13 43.21 Favored 'General case' 0 N--CA 1.509 2.512 0 O-C-N 121.226 -0.922 . . . . 1.5 113.338 178.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -76.92 -10.65 86.07 Favored Glycine 0 N--CA 1.479 1.529 0 O-C-N 119.999 -1.688 . . . . 0.08 109.338 179.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 329' ' ' PHE . . . . . 0.402 ' HE1' ' HE3' ' B' ' 372' ' ' LYS . 92.8 m-85 -103.36 143.32 32.83 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.429 -1.63 . . . . 0.09 110.101 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 47.8 p -75.66 -30.08 59.31 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.297 -0.877 . . . . 0.11 112.272 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 331' ' ' SER . . . . . . . . . . . . . 15.9 m -59.68 158.57 9.93 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 119.844 -1.785 . . . . 0.11 112.821 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 332' ' ' GLU . . . . . 0.769 ' OE1' ' N ' ' B' ' 333' ' ' ILE . 0.0 OUTLIER -79.0 130.4 35.49 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 102.81 -3.033 . . . . 0.11 102.81 171.266 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 333' ' ' ILE . . . . . 0.769 ' N ' ' OE1' ' B' ' 332' ' ' GLU . 39.2 mt -126.81 136.5 60.61 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.486 0 CA-C-O 122.192 0.996 . . . . 0.08 109.305 -178.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 93.3 m -124.94 143.21 50.99 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-O 123.216 1.484 . . . . 0.09 109.978 178.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 335' ' ' VAL . . . . . 0.442 HG23 ' HB2' ' B' ' 344' ' ' ALA . 85.3 t -108.14 129.95 61.51 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.633 0 N-CA-C 105.469 -2.049 . . . . 0.06 105.469 173.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 336' ' ' THR . . . . . 0.419 ' HB ' ' HB ' ' B' ' 362' ' ' THR . 71.5 m -127.39 119.51 26.35 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 120.862 -1.149 . . . . 0.09 109.046 -178.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 29.1 t -122.52 122.61 39.32 Favored 'General case' 0 N--CA 1.501 2.106 0 C-N-CA 119.992 -0.683 . . . . 0.08 109.843 177.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 51.73 38.84 24.0 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.886 -1.134 . . . . 0.1 112.87 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 81.81 10.86 83.59 Favored Glycine 0 N--CA 1.501 3.009 0 O-C-N 119.944 -1.722 . . . . 0.11 112.522 177.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 340' ' ' LYS . . . . . 0.408 ' O ' ' HA ' ' B' ' 336' ' ' THR . 26.5 mttp -119.85 136.3 54.54 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 105.221 -2.14 . . . . 0.1 105.221 177.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 68.3 m -124.8 158.55 33.09 Favored 'General case' 0 C--N 1.276 -2.594 0 CA-C-O 123.738 1.732 . . . . 0.09 112.408 -176.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -151.62 151.45 31.53 Favored 'General case' 0 C--N 1.278 -2.51 0 CA-C-N 112.449 -2.159 . . . . 0.08 108.634 177.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 8.0 t -70.63 135.95 48.78 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 105.556 -2.016 . . . . 0.08 105.556 173.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 344' ' ' ALA . . . . . 0.442 ' HB2' HG23 ' B' ' 335' ' ' VAL . . . -72.95 -6.83 47.95 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.691 -1.256 . . . . 0.05 110.703 179.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -97.5 13.07 31.18 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.631 -1.293 . . . . 0.08 109.395 -177.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 9.7 t -133.18 104.25 6.4 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 122.153 0.977 . . . . 0.12 110.062 -178.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 347' ' ' LEU . . . . . . . . . . . . . 46.4 tp -57.34 -37.77 73.05 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 115.658 -0.701 . . . . 0.1 109.998 178.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 348' ' ' PHE . . . . . 0.534 ' HB3' ' OE2' ' A' ' 59' ' ' GLU . 77.3 t80 -59.0 -51.35 70.43 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.566 -1.334 . . . . 0.13 113.021 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 37.6 tptt -70.05 -32.46 70.58 Favored 'General case' 0 C--O 1.214 -0.769 0 O-C-N 119.664 -1.898 . . . . 1.55 109.109 -178.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 350' ' ' LEU . . . . . . . . . . . . . 32.3 mt -62.84 -33.7 75.79 Favored 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 118.958 -1.097 . . . . 0.16 109.92 -177.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 351' ' ' GLN . . . . . 0.404 HE22 HG13 ' A' ' 112' ' ' ILE . 69.5 tp60 -67.69 -10.49 52.89 Favored 'General case' 0 C--N 1.293 -1.852 0 O-C-N 121.599 -0.688 . . . . 0.26 109.915 -177.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 352' ' ' THR . . . . . . . . . . . . . 41.7 p -89.72 -7.74 53.87 Favored 'General case' 0 N--CA 1.502 2.132 0 C-N-CA 118.097 -1.441 . . . . 0.12 111.026 -178.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 72.9 mt -93.34 159.34 15.3 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.244 -0.91 . . . . 0.1 110.224 -178.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -86.76 104.8 2.97 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 106.94 -2.464 . . . . 0.08 106.94 177.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 15.5 mt -119.46 47.29 1.73 Allowed 'General case' 0 C--N 1.309 -1.186 0 O-C-N 120.625 -1.515 . . . . 0.1 107.471 -178.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 47.6 p -81.36 172.53 13.46 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 118.849 -1.141 . . . . 0.2 109.16 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -60.74 140.97 57.36 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 119.349 -0.94 . . . . 1.61 109.76 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 91.4 -3.17 79.04 Favored Glycine 0 N--CA 1.5 2.941 0 C-N-CA 120.052 -1.071 . . . . 0.13 111.381 177.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 54.5 m -84.4 135.81 34.13 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 120.918 -1.342 . . . . 0.11 110.66 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 89.2 t -96.47 123.8 48.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 N-CA-C 106.304 -1.739 . . . . 0.11 106.304 176.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 361' ' ' VAL . . . . . 0.487 HG21 ' SD ' ' B' ' 381' ' ' MET . 22.3 m -112.27 160.13 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.335 0 C-N-CA 117.354 -1.739 . . . . 0.09 110.636 178.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 362' ' ' THR . . . . . 0.419 ' HB ' ' HB ' ' B' ' 336' ' ' THR . 90.4 m -108.89 128.34 54.83 Favored 'General case' 0 C--O 1.214 -0.789 0 O-C-N 120.596 -1.315 . . . . 0.1 107.565 175.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 363' ' ' ILE . . . . . 0.459 ' O ' ' HA ' ' B' ' 303' ' ' GLN . 33.2 mt -107.92 121.45 60.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 105.344 -2.095 . . . . 0.1 105.344 176.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 364' ' ' SER . . . . . 0.411 ' HB3' ' HB3' ' B' ' 303' ' ' GLN . 0.7 OUTLIER -128.57 147.3 50.7 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 107.809 -1.182 . . . . 0.1 107.809 -179.646 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -139.76 153.32 47.13 Favored 'General case' 0 C--N 1.292 -1.925 0 C-N-CA 118.454 -1.298 . . . . 0.13 109.781 -179.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 366' ' ' GLU . . . . . 0.517 ' HG2' ' HB2' ' B' ' 301' ' ' MET . 0.2 OUTLIER -141.14 110.88 6.48 Favored 'General case' 0 C--N 1.288 -2.081 0 C-N-CA 118.592 -1.243 . . . . 0.16 108.078 178.127 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . 165.22 -170.36 40.16 Favored Glycine 0 C--N 1.297 -1.59 0 C-N-CA 117.981 -2.056 . . . . 0.14 110.327 178.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -58.27 -40.55 82.18 Favored 'General case' 0 C--N 1.277 -2.57 0 CA-C-N 114.33 -0.935 . . . . 0.16 112.306 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 369' ' ' ASP . . . . . . . . . . . . . 12.0 p30 -114.21 36.85 3.54 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 115.834 -2.346 . . . . 0.13 108.519 -178.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 370' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -56.41 -33.56 65.91 Favored 'General case' 0 N--CA 1.521 3.107 0 N-CA-C 116.8 2.148 . . . . 0.16 116.8 -174.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.95 -45.59 27.1 Favored 'General case' 0 N--CA 1.509 2.514 0 O-C-N 119.526 -1.984 . . . . 0.18 110.914 -176.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 372' ' ' LYS . . . . . 0.786 ' HZ2' ' CE1' ' B' ' 376' ' ' HIS . 11.9 ttpp -63.56 -40.71 97.69 Favored 'General case' 0 C--N 1.283 -2.315 0 N-CA-C 106.965 -1.495 . . . . 0.13 106.965 178.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -59.09 -49.51 77.61 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 117.541 -1.664 . . . . 0.11 110.025 -178.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 374' ' ' VAL . . . . . . . . . . . . . 66.9 t -66.86 -42.25 88.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 CA-C-O 122.187 0.994 . . . . 0.11 109.267 -178.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -55.89 -47.78 76.8 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-O 122.059 0.933 . . . . 0.16 108.737 -178.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 376' ' ' HIS . . . . . 0.786 ' CE1' ' HZ2' ' B' ' 372' ' ' LYS . 13.9 m-70 -69.96 -38.23 76.04 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 116.005 -0.543 . . . . 0.13 111.72 -178.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 377' ' ' LEU . . . . . 0.44 HD22 ' CE1' ' B' ' 322' ' ' PHE . 80.5 mt -75.64 -28.56 58.84 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.348 -1.47 . . . . 0.09 110.875 -174.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 378' ' ' VAL . . . . . . . . . . . . . 2.1 t -71.44 -39.52 71.3 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.459 0 N-CA-C 106.35 -1.722 . . . . 0.13 106.35 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -67.89 -49.31 62.69 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 108.03 -1.1 . . . . 0.16 108.03 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 380' ' ' LEU . . . . . 0.641 ' O ' HD22 ' B' ' 384' ' ' LEU . 34.1 tp -57.18 -45.24 83.87 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 118.974 -1.09 . . . . 0.12 110.62 177.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 381' ' ' MET . . . . . 0.487 ' SD ' HG21 ' B' ' 361' ' ' VAL . 3.6 ttm -62.29 -37.44 85.53 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.871 -1.143 . . . . 0.12 111.508 -177.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -74.89 -31.78 61.67 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.111 -0.993 . . . . 0.15 110.29 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -78.87 -32.41 45.92 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.622 -0.673 . . . . 0.17 111.247 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 384' ' ' LEU . . . . . 0.641 HD22 ' O ' ' B' ' 380' ' ' LEU . 0.0 OUTLIER -50.12 125.54 12.48 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-O 124.432 2.063 . . . . 0.15 112.762 178.802 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 385' ' ' GLU . . . . . 0.966 ' CD ' ' H ' ' B' ' 385' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.279 -2.48 0 CA-C-N 111.085 -2.779 . . . . 0.18 110.093 -177.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 14.4 tp . . . . . 0 N--CA 1.483 1.208 0 N-CA-C 110.502 -0.184 . . . . 0.06 110.502 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 1.259 ' CZ ' ' HD2' ' A' ' 147' ' ' ARG . 40.6 p90 -136.09 141.73 44.24 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 117.476 -1.69 . . . . 0.04 111.884 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.5 mttp -82.27 142.73 31.86 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 107.944 -1.132 . . . . 0.05 107.944 177.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 1.02 ' HA ' HD21 ' A' ' 11' ' ' ASN . 13.6 tp -136.81 125.64 24.08 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 107.285 -1.376 . . . . 0.05 107.285 179.131 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -154.02 -166.92 15.44 Favored Glycine 0 C--N 1.289 -2.081 0 N-CA-C 108.557 -1.817 . . . . 0.06 108.557 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.79 -34.24 77.46 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.599 -0.942 . . . . 0.08 111.313 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -65.44 -14.93 62.02 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.759 -1.213 . . . . 0.07 112.332 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 1.02 HD21 ' HA ' ' A' ' 7' ' ' LEU . 2.7 p-10 -123.7 22.85 8.94 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 119.5 -2.0 . . . . 0.05 111.869 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 48.8 mt -118.49 123.35 71.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 107.539 -1.282 . . . . 0.06 107.539 176.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -126.44 106.98 9.85 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.433 -0.792 . . . . 0.06 109.252 -177.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.559 ' HA ' ' HB3' ' A' ' 83' ' ' GLN . 42.4 mt -100.33 160.52 14.27 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-O 122.702 1.239 . . . . 0.08 112.883 -177.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 62.34 34.66 89.97 Favored Glycine 0 N--CA 1.497 2.749 0 CA-C-N 114.457 -1.247 . . . . 0.08 113.833 175.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.46 ' HA ' ' HE ' ' A' ' 16' ' ' ARG . 1.0 OUTLIER -83.21 169.14 16.09 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 120.238 -1.742 . . . . 0.08 109.733 178.348 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -140.89 140.75 34.59 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 107.409 -1.33 . . . . 0.08 107.409 178.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -154.17 131.7 11.35 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 108.442 -0.948 . . . . 0.06 108.442 179.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -77.48 -25.62 50.58 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.141 -0.975 . . . . 0.06 109.69 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 64.2 p -134.75 159.65 40.66 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 119.075 -1.05 . . . . 0.07 111.466 -178.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.669 ' HE3' ' OE1' ' A' ' 50' ' ' GLU . 28.2 pttt -65.98 -32.68 74.31 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.892 -0.781 . . . . 0.09 108.892 175.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 51.4 mp0 -60.28 -42.8 96.21 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.514 -1.366 . . . . 0.08 110.103 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -64.1 -41.73 97.17 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.628 -1.295 . . . . 0.07 110.012 177.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.91 -42.51 94.66 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.636 -1.29 . . . . 0.05 109.609 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.37 -42.29 94.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.262 -0.899 . . . . 0.07 109.802 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.46 ' HE ' ' HB2' ' A' ' 26' ' ' ARG . 4.4 ttm180 -62.61 -37.52 86.61 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.316 -0.865 . . . . 0.1 109.98 178.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -67.25 -49.19 65.34 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.724 -1.235 . . . . 0.07 108.403 179.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.19 -47.05 79.1 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.387 -0.821 . . . . 0.06 109.605 178.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.31 -41.34 99.74 Favored Glycine 0 N--CA 1.497 2.722 0 N-CA-C 110.525 -1.03 . . . . 0.08 110.525 179.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -61.18 -37.76 84.08 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.661 -1.494 . . . . 0.09 110.331 177.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 92.4 mm-40 -73.17 -36.05 66.53 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.069 -1.019 . . . . 0.08 110.181 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 73.5 mt -63.95 -38.2 90.19 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.857 -1.152 . . . . 0.07 108.282 174.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 23.7 t -69.34 -45.48 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 O-C-N 120.879 -1.138 . . . . 0.1 108.178 177.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -57.49 -39.3 76.14 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.665 -0.647 . . . . 0.1 112.625 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -86.19 8.42 73.99 Favored Glycine 0 N--CA 1.508 3.486 0 O-C-N 120.236 -1.54 . . . . 0.08 112.796 -178.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.63 17.83 78.37 Favored Glycine 0 N--CA 1.488 2.139 0 O-C-N 120.678 -1.483 . . . . 0.09 111.443 178.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.422 ' CD1' ' HA3' ' A' ' 78' ' ' GLY . 80.3 m-85 -80.93 -36.24 31.3 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.274 -1.721 . . . . 0.08 110.111 -179.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 17.4 m -141.96 163.02 19.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-O 122.287 1.042 . . . . 0.1 111.437 -177.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.443 ' OE1' ' NH1' ' A' ' 73' ' ' ARG . 83.3 mt-10 -86.63 165.1 34.54 Favored Pre-proline 0 C--N 1.3 -1.546 0 N-CA-C 107.29 -1.374 . . . . 0.14 107.29 176.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.429 ' HD2' ' HB3' ' A' ' 39' ' ' GLU . 50.3 Cg_exo -50.53 -36.86 50.88 Favored 'Trans proline' 0 N--CA 1.51 2.443 0 C-N-CA 123.646 2.897 . . . . 0.13 115.791 -177.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.44 ' CD ' HH21 ' A' ' 73' ' ' ARG . 41.2 mp0 -62.76 -20.59 65.11 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.508 -1.37 . . . . 0.15 112.196 -178.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.466 ' O ' ' HG3' ' A' ' 46' ' ' MET . 39.9 t80 -67.08 -27.79 67.65 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.616 -1.303 . . . . 0.11 112.313 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 22.8 t -61.19 -49.01 86.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 120.265 -1.522 . . . . 0.1 110.396 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 51.8 tp60 -67.11 -35.04 78.91 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.093 -1.004 . . . . 0.12 109.108 179.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.2 -33.35 73.32 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.232 -0.917 . . . . 0.11 109.765 177.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.466 ' HG3' ' O ' ' A' ' 42' ' ' TYR . 94.5 mtp -70.28 -37.93 74.94 Favored 'General case' 0 N--CA 1.482 1.128 0 O-C-N 120.545 -1.347 . . . . 0.1 107.719 177.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 93.9 mt -70.14 -40.2 74.93 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.237 -1.023 . . . . 0.1 108.237 178.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -60.14 -44.31 95.04 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.36 -0.837 . . . . 0.13 109.203 177.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.915 HH21 ' P ' ' B' ' 200' ' ' PO3 . 24.5 tpt180 -62.45 -39.19 92.57 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.843 -1.161 . . . . 1.51 110.653 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.669 ' OE1' ' HE3' ' A' ' 21' ' ' LYS . 0.5 OUTLIER -62.54 -39.61 94.14 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.166 -0.959 . . . . 0.1 110.895 -178.545 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.579 ' N ' ' HG2' ' A' ' 50' ' ' GLU . 28.1 tttt -62.87 -38.22 89.98 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 116.333 -0.394 . . . . 2.88 110.853 -178.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 28.7 tp -64.71 -43.56 93.06 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 120.181 -1.574 . . . . 0.16 108.634 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.6 m -166.11 139.11 3.34 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.044 -1.035 . . . . 0.19 109.71 179.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -50.34 144.91 22.52 Favored 'Trans proline' 0 C--N 1.314 -1.286 0 C-N-CA 121.175 1.25 . . . . 0.37 113.655 178.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.454 HG21 ' HA ' ' A' ' 64' ' ' PRO . 55.3 p -96.54 7.94 45.32 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 114.505 -1.225 . . . . 0.16 107.92 177.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -62.36 137.5 58.27 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 105.955 -1.869 . . . . 0.09 105.955 174.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 18.1 mt -117.77 11.97 13.76 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 120.856 -1.152 . . . . 0.1 110.224 -178.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 85.56 170.94 47.67 Favored Glycine 0 C--N 1.302 -1.31 0 N-CA-C 108.667 -1.773 . . . . 0.1 108.667 -178.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.81 ' CA ' ' N ' ' A' ' 60' ' ' SER . 76.0 mm-40 57.59 35.4 25.7 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.458 -1.025 . . . . 1.86 113.527 177.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.81 ' N ' ' CA ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER 65.28 21.48 12.02 Favored 'General case' 0 N--CA 1.514 2.771 0 O-C-N 121.039 -1.038 . . . . 0.08 113.555 176.731 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 94.2 mt -121.38 137.48 54.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 120.645 -1.285 . . . . 0.07 111.014 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -129.31 138.85 51.82 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 106.247 -1.76 . . . . 0.06 106.247 174.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.494 ' O ' HG23 ' A' ' 63' ' ' VAL . 16.3 m -130.32 73.41 81.3 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.163 -0.96 . . . . 0.07 110.103 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.454 ' HA ' HG21 ' A' ' 55' ' ' THR . 8.1 Cg_endo -54.57 146.91 50.96 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 120.854 1.036 . . . . 0.38 112.221 -178.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 2.4 p-80 -150.37 159.01 44.77 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.315 -0.866 . . . . 0.59 109.447 177.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -76.65 174.81 53.8 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 110.036 -1.226 . . . . 0.12 110.036 -177.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 82.0 p -80.46 167.93 19.57 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.104 -1.233 . . . . 0.59 109.376 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.592 HG12 ' ND2' ' A' ' 109' ' ' ASN . 5.3 m -70.52 -23.65 24.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 121.382 -0.824 . . . . 0.14 109.751 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.501 ' OE1' ' N ' ' A' ' 69' ' ' GLU . 58.7 mp0 -75.27 9.06 2.26 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.985 -1.072 . . . . 0.15 109.725 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -121.73 15.27 11.0 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.709 -0.619 . . . . 0.13 109.813 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 49.5 pttt -60.87 -37.95 83.9 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.016 -1.053 . . . . 0.14 109.136 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -69.27 -4.13 16.68 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.658 -0.651 . . . . 0.14 111.543 -177.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.443 ' NH1' ' OE1' ' A' ' 39' ' ' GLU . 15.6 mmm180 -104.96 7.95 34.32 Favored 'General case' 0 N--CA 1.506 2.33 0 O-C-N 120.444 -1.41 . . . . 0.13 109.374 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 91.1 t -95.48 128.49 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 107.082 -1.451 . . . . 0.11 107.082 177.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 28.1 mt -96.75 -17.15 20.47 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 115.721 -0.672 . . . . 0.11 109.455 -178.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 39.6 pttt -176.6 159.67 1.9 Allowed 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.523 -0.918 . . . . 0.09 108.523 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 18.2 m -76.29 138.14 40.34 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.355 -0.841 . . . . 0.13 111.079 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.422 ' HA3' ' CD1' ' A' ' 37' ' ' TYR . . . -160.69 161.05 32.45 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 118.735 -1.698 . . . . 0.06 110.863 -179.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 33.3 m -137.65 150.96 25.62 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 O-C-N 121.603 -0.939 . . . . 0.03 108.842 179.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 80' ' ' VAL . 15.9 m -127.02 113.14 31.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 106.271 -1.752 . . . . 0.04 106.271 175.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.649 ' CZ ' HD22 ' A' ' 100' ' ' LEU . 61.6 t80 -86.02 115.38 23.58 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.789 0.804 . . . . 0.05 109.238 -178.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 39.5 m -119.0 122.11 41.44 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 121.86 0.838 . . . . 0.04 110.506 -177.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.559 ' HB3' ' HA ' ' A' ' 14' ' ' LEU . 30.7 tt0 -100.71 126.47 47.25 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-O 122.108 0.956 . . . . 0.07 111.805 -178.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -123.35 87.24 51.79 Favored Pre-proline 0 C--N 1.302 -1.471 0 N-CA-C 107.025 -1.472 . . . . 0.06 107.025 177.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -54.06 -36.05 83.43 Favored 'Trans proline' 0 N--CA 1.501 1.925 0 C-N-CA 122.847 2.365 . . . . 0.08 113.081 -177.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -81.73 -13.27 58.02 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.481 -0.762 . . . . 0.08 110.323 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 90.08 152.59 27.23 Favored Glycine 0 N--CA 1.485 1.912 0 O-C-N 120.791 -1.193 . . . . 0.06 113.024 175.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 61.5 t -136.47 120.43 24.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 106.549 -1.649 . . . . 0.05 106.549 177.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.873 ' HA ' HD13 ' A' ' 97' ' ' ILE . 4.3 ttt180 -60.31 121.27 11.58 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.829 -1.169 . . . . 0.09 109.131 -179.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -119.77 -11.51 9.36 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 118.656 -1.218 . . . . 1.03 111.573 -178.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -118.54 -158.21 10.74 Favored Glycine 1 N--CA 1.516 4.009 0 O-C-N 119.588 -1.945 . . . . 0.14 112.255 -178.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -92.54 -22.8 19.33 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 113.842 1.052 . . . . 0.26 113.842 -176.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -96.4 154.45 17.26 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.683 -1.261 . . . . 1.62 109.461 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -60.29 -23.89 64.51 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.747 -1.22 . . . . 2.55 109.964 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -86.52 1.87 50.02 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.692 -1.255 . . . . 1.74 109.461 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -83.2 60.17 5.39 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 118.764 -1.175 . . . . 0.16 107.98 178.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.873 HD13 ' HA ' ' A' ' 89' ' ' ARG . 41.8 mm -101.6 135.32 38.75 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 CA-C-O 121.723 0.773 . . . . 0.08 110.169 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -108.56 130.95 55.28 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 121.545 0.688 . . . . 0.06 109.682 178.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 87.3 mtm180 -102.5 -17.07 15.93 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 106.557 -1.646 . . . . 0.09 106.557 175.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.649 HD22 ' CZ ' ' A' ' 81' ' ' PHE . 71.1 mt -116.87 112.16 20.68 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.12 -1.067 . . . . 0.06 108.12 176.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 93.8 t -113.4 104.07 16.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 106.257 -1.757 . . . . 0.04 106.257 179.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 72.3 mt -107.11 102.91 14.65 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.087 0 CA-C-O 122.292 1.044 . . . . 0.04 111.035 -176.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -77.6 131.97 11.57 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.023 -1.631 . . . . 0.04 109.023 -178.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.409 HD13 HG21 ' A' ' 104' ' ' ILE . 19.4 pt -133.45 153.5 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 O-C-N 120.264 -1.727 . . . . 0.1 112.916 -176.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -137.38 133.71 35.13 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 106.189 -1.782 . . . . 0.12 106.189 177.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -147.59 140.97 25.3 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 120.113 -1.617 . . . . 0.13 110.955 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 60.6 mtp180 -70.74 156.29 39.7 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.588 0.709 . . . . 3.71 110.331 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 57.81 25.4 11.92 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.069 -0.715 . . . . 1.98 109.069 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.592 ' ND2' HG12 ' A' ' 68' ' ' VAL . 62.9 t30 53.27 37.58 25.6 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.172 -0.955 . . . . 1.22 109.766 178.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -84.05 28.89 0.58 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.131 -0.981 . . . . 0.18 111.093 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.75 ' CA ' ' N ' ' A' ' 112' ' ' ILE . 43.1 p-80 -50.54 -38.3 44.08 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.881 -1.137 . . . . 0.18 112.095 179.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.75 ' N ' ' CA ' ' A' ' 111' ' ' HIS . 20.9 tt -63.18 -28.96 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 119.986 -1.696 . . . . 0.12 111.005 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -69.81 -40.94 75.63 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 120.516 -1.365 . . . . 0.87 108.334 178.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 85.1 t -69.38 -43.61 80.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.428 -0.795 . . . . 0.07 109.414 178.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.11 -42.46 95.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.132 -0.98 . . . . 0.08 109.471 178.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 95.7 m -62.35 -42.45 99.41 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.295 -0.878 . . . . 0.14 109.899 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 11.2 t -63.66 -45.91 88.0 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.161 -0.962 . . . . 0.07 109.572 178.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 57.3 mt -64.09 -48.26 76.87 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.07 -1.019 . . . . 0.07 111.173 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 40.0 p -66.38 -28.01 68.31 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 120.986 -1.071 . . . . 0.09 111.589 -178.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -67.81 -35.88 79.41 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 121.007 -1.058 . . . . 1.13 108.145 177.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -80.12 -15.55 56.87 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.967 -1.083 . . . . 0.09 109.844 177.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 80.5 mt -106.01 27.86 8.18 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.984 -1.072 . . . . 0.17 110.675 178.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -72.46 -12.73 61.22 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 120.937 -1.102 . . . . 0.49 111.879 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -110.66 131.38 55.1 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.588 -1.32 . . . . 0.13 110.619 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -57.72 -34.55 69.6 Favored 'General case' 0 N--CA 1.503 2.181 0 C-N-CA 123.306 0.642 . . . . 0.15 112.262 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.484 ' O ' ' HG2' ' A' ' 130' ' ' ARG . 59.7 p -65.75 -34.01 77.18 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 120.694 -1.254 . . . . 0.13 109.88 179.052 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 85.6 t -65.65 -43.9 93.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.638 -1.289 . . . . 0.11 109.974 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 95.8 mt -64.33 -46.06 94.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.941 -1.1 . . . . 0.1 110.228 -179.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.614 ' HA ' ' OE1' ' A' ' 129' ' ' GLU . 8.7 mm-40 -57.08 -46.85 82.19 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.223 -0.923 . . . . 0.11 109.864 178.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.484 ' HG2' ' O ' ' A' ' 126' ' ' SER . 42.7 mmm-85 -63.52 -43.7 96.4 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.215 -0.928 . . . . 0.13 110.214 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 83.3 mt -66.89 -35.04 79.12 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.066 -1.022 . . . . 0.08 111.148 -179.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -67.33 -27.18 66.93 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.308 -0.87 . . . . 0.08 113.285 -176.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -126.49 1.7 6.92 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 120.082 -1.637 . . . . 0.1 113.322 -176.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 9.4 t -68.31 145.89 53.8 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.502 -1.374 . . . . 0.1 111.271 -178.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 72.8 p -106.06 9.92 32.29 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.27 -1.381 . . . . 0.12 107.27 176.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 47.0 t -107.02 116.4 31.86 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 121.588 0.709 . . . . 0.11 112.696 -178.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 15.9 t -65.59 -41.67 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 108.501 -0.925 . . . . 0.09 108.501 176.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -56.87 -39.99 75.35 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.233 -0.917 . . . . 0.11 110.408 178.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -63.66 -42.75 98.03 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.936 -1.103 . . . . 0.11 108.45 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 92.0 t -57.29 -51.27 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 108.508 -0.923 . . . . 0.08 108.508 177.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 141' ' ' LEU . 78.4 mt -57.7 -45.98 84.96 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.238 -0.914 . . . . 0.07 110.294 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -58.81 -47.91 83.13 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.814 -1.179 . . . . 0.11 111.02 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 83.7 mt -67.99 -23.49 65.03 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.983 -1.073 . . . . 0.1 112.606 -177.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.661 ' O ' ' NH1' ' A' ' 147' ' ' ARG . 91.7 mt -110.05 9.27 24.21 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.367 -1.458 . . . . 0.07 111.391 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.711 ' HA ' HH12 ' A' ' 147' ' ' ARG . . . -76.97 -25.25 52.57 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 120.689 -1.257 . . . . 0.07 112.305 -178.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -81.77 -8.81 86.32 Favored Glycine 0 N--CA 1.504 3.211 0 O-C-N 120.57 -1.331 . . . . 0.08 111.156 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 1.259 ' HD2' ' CZ ' ' A' ' 5' ' ' PHE . 2.0 ptt-85 . . . . . 0 N--CA 1.486 1.371 0 O-C-N 121.053 -1.263 . . . . 0.07 109.64 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 301' ' ' MET . . . . . 0.517 ' HB2' ' HG2' ' B' ' 366' ' ' GLU . 3.4 ttm . . . . . 0 C--O 1.214 -0.786 0 CA-C-O 121.931 0.872 . . . . 0.17 108.948 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 302' ' ' PHE . . . . . 0.454 ' N ' ' CG ' ' B' ' 301' ' ' MET . 46.9 t80 -139.74 142.97 36.77 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 107.27 -1.381 . . . . 0.16 107.27 178.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 303' ' ' GLN . . . . . 0.49 ' O ' ' HG2' ' B' ' 304' ' ' GLN . 5.4 pt20 -153.0 156.31 38.58 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 120.904 -1.123 . . . . 0.14 109.495 179.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 304' ' ' GLN . . . . . 0.49 ' HG2' ' O ' ' B' ' 303' ' ' GLN . 42.2 mm-40 -152.18 149.21 28.51 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 108.033 -1.099 . . . . 0.15 108.033 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -97.19 152.35 18.91 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.046 -1.034 . . . . 0.13 108.428 178.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 7.2 p -147.83 144.34 19.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 N-CA-C 107.478 -1.304 . . . . 0.12 107.478 177.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 85.4 m -96.67 136.54 37.06 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 122.169 0.985 . . . . 0.13 110.079 177.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 51.7 mt -84.88 114.25 24.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 105.478 -2.045 . . . . 0.13 105.478 177.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 47.4 p -106.7 -4.39 19.51 Favored 'General case' 0 C--N 1.264 -3.117 0 N-CA-C 114.704 1.372 . . . . 0.16 114.704 -178.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -71.44 141.87 86.02 Favored Pre-proline 0 N--CA 1.499 2.012 0 O-C-N 119.683 -1.886 . . . . 0.16 110.658 178.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -45.54 -47.63 13.03 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 124.749 3.633 . . . . 0.19 114.202 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 44.5 t-20 -102.21 27.61 6.54 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 116.035 -2.266 . . . . 0.99 108.725 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 58.83 -147.48 40.68 Favored Glycine 0 N--CA 1.496 2.699 0 C-N-CA 117.708 -2.187 . . . . 0.13 109.52 -179.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 314' ' ' LEU . . . . . . . . . . . . . 12.3 tp -92.23 83.31 5.04 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.859 -1.163 . . . . 0.11 107.859 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -81.46 -163.55 0.64 Allowed 'General case' 0 C--O 1.197 -1.673 0 O-C-N 121.246 -0.909 . . . . 1.2 108.868 -179.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 316' ' ' THR . . . . . 0.888 HG23 ' O2 ' ' B' ' 200' ' ' PO3 . 30.9 p -65.43 -54.85 22.6 Favored 'General case' 0 N--CA 1.524 3.226 0 N-CA-C 119.122 3.008 . . . . 0.16 119.122 -173.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 317' ' ' ARG . . . . . 0.678 HH11 ' HG2' ' B' ' 317' ' ' ARG . 4.2 ttt-85 -53.49 -53.33 57.9 Favored Pre-proline 0 N--CA 1.493 1.705 0 C-N-CA 116.88 -1.928 . . . . 1.91 112.446 -175.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 318' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' B' ' 317' ' ' ARG . 21.0 Cg_endo -66.41 -32.17 41.12 Favored 'Trans proline' 0 N--CA 1.484 0.963 0 C-N-CA 124.707 3.604 . . . . 0.13 111.563 -177.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 319' ' ' ALA . . . . . 0.419 ' O ' HG23 ' B' ' 323' ' ' VAL . . . -67.07 -38.8 86.43 Favored 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 119.503 -0.879 . . . . 0.1 109.491 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -70.95 -39.68 72.46 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.865 -0.791 . . . . 0.11 108.865 178.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 67.8 tp60 -64.01 -39.31 93.83 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 117.863 -1.535 . . . . 0.12 109.535 177.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 322' ' ' PHE . . . . . 0.44 ' CE1' HD22 ' B' ' 377' ' ' LEU . 87.3 t80 -62.76 -45.3 93.32 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 122.583 1.182 . . . . 0.08 108.703 -177.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 323' ' ' VAL . . . . . 0.419 HG23 ' O ' ' B' ' 319' ' ' ALA . 53.4 t -62.58 -42.26 95.24 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.278 0 CA-C-N 114.809 -1.087 . . . . 0.07 110.713 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -63.87 -40.18 95.93 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.325 -0.859 . . . . 1.68 109.851 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 325' ' ' GLU . . . . . 0.494 ' OE1' HD22 ' B' ' 380' ' ' LEU . 31.7 tt0 -68.9 -39.65 79.59 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.37 -0.831 . . . . 0.1 109.56 177.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -59.07 -43.99 91.82 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.708 -1.245 . . . . 0.06 109.417 178.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -61.37 -16.13 43.21 Favored 'General case' 0 N--CA 1.509 2.512 0 O-C-N 121.226 -0.922 . . . . 1.5 113.338 178.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -76.92 -10.65 86.07 Favored Glycine 0 N--CA 1.479 1.529 0 O-C-N 119.999 -1.688 . . . . 0.08 109.338 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 329' ' ' PHE . . . . . 0.402 ' HE1' ' HE3' ' B' ' 372' ' ' LYS . 92.8 m-85 -103.36 143.32 32.83 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.429 -1.63 . . . . 0.09 110.101 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 47.8 p -75.66 -30.08 59.31 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.297 -0.877 . . . . 0.11 112.272 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 331' ' ' SER . . . . . . . . . . . . . 15.9 m -59.68 158.57 9.93 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 119.844 -1.785 . . . . 0.11 112.821 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 332' ' ' GLU . . . . . 0.769 ' OE1' ' N ' ' B' ' 333' ' ' ILE . 0.0 OUTLIER -79.0 130.4 35.49 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 102.81 -3.033 . . . . 0.11 102.81 171.266 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 333' ' ' ILE . . . . . 0.769 ' N ' ' OE1' ' B' ' 332' ' ' GLU . 39.2 mt -126.81 136.5 60.61 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.486 0 CA-C-O 122.192 0.996 . . . . 0.08 109.305 -178.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 93.3 m -124.94 143.21 50.99 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-O 123.216 1.484 . . . . 0.09 109.978 178.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 335' ' ' VAL . . . . . 0.442 HG23 ' HB2' ' B' ' 344' ' ' ALA . 85.3 t -108.14 129.95 61.51 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.633 0 N-CA-C 105.469 -2.049 . . . . 0.06 105.469 173.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 336' ' ' THR . . . . . 0.419 ' HB ' ' HB ' ' B' ' 362' ' ' THR . 71.5 m -127.39 119.51 26.35 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 120.862 -1.149 . . . . 0.09 109.046 -178.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 29.1 t -122.52 122.61 39.32 Favored 'General case' 0 N--CA 1.501 2.106 0 C-N-CA 119.992 -0.683 . . . . 0.08 109.843 177.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 51.73 38.84 24.0 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.886 -1.134 . . . . 0.1 112.87 -179.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 81.81 10.86 83.59 Favored Glycine 0 N--CA 1.501 3.009 0 O-C-N 119.944 -1.722 . . . . 0.11 112.522 177.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 340' ' ' LYS . . . . . 0.408 ' O ' ' HA ' ' B' ' 336' ' ' THR . 26.5 mttp -119.85 136.3 54.54 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 105.221 -2.14 . . . . 0.1 105.221 177.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 68.3 m -124.8 158.55 33.09 Favored 'General case' 0 C--N 1.276 -2.594 0 CA-C-O 123.738 1.732 . . . . 0.09 112.408 -176.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -151.62 151.45 31.53 Favored 'General case' 0 C--N 1.278 -2.51 0 CA-C-N 112.449 -2.159 . . . . 0.08 108.634 177.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 8.0 t -70.63 135.95 48.78 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 105.556 -2.016 . . . . 0.08 105.556 173.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 344' ' ' ALA . . . . . 0.442 ' HB2' HG23 ' B' ' 335' ' ' VAL . . . -72.95 -6.83 47.95 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.691 -1.256 . . . . 0.05 110.703 179.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -97.5 13.07 31.18 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.631 -1.293 . . . . 0.08 109.395 -177.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 10.8 t -133.18 104.25 6.4 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 122.153 0.977 . . . . 0.12 110.062 -178.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 347' ' ' LEU . . . . . . . . . . . . . 43.3 tp -57.34 -37.77 73.05 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 115.658 -0.701 . . . . 0.1 109.998 178.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 348' ' ' PHE . . . . . 0.522 ' HB3' ' OE2' ' A' ' 59' ' ' GLU . 75.3 t80 -59.0 -51.35 70.43 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.566 -1.334 . . . . 0.13 113.021 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 37.5 tptt -70.05 -32.46 70.58 Favored 'General case' 0 C--O 1.214 -0.769 0 O-C-N 119.664 -1.898 . . . . 1.55 109.109 -178.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 350' ' ' LEU . . . . . . . . . . . . . 33.7 mt -62.84 -33.7 75.79 Favored 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 118.958 -1.097 . . . . 0.16 109.92 -177.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 351' ' ' GLN . . . . . 0.402 HE22 HG13 ' A' ' 112' ' ' ILE . 69.1 tp60 -67.69 -10.49 52.89 Favored 'General case' 0 C--N 1.293 -1.852 0 O-C-N 121.599 -0.688 . . . . 0.26 109.915 -177.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 352' ' ' THR . . . . . . . . . . . . . 44.6 p -89.72 -7.74 53.87 Favored 'General case' 0 N--CA 1.502 2.132 0 C-N-CA 118.097 -1.441 . . . . 0.12 111.026 -178.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 81.6 mt -93.34 159.34 15.3 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.244 -0.91 . . . . 0.1 110.224 -178.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -86.76 104.8 2.97 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 106.94 -2.464 . . . . 0.08 106.94 177.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 15.7 mt -119.46 47.29 1.73 Allowed 'General case' 0 C--N 1.309 -1.186 0 O-C-N 120.625 -1.515 . . . . 0.1 107.471 -178.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 52.0 p -81.36 172.53 13.46 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 118.849 -1.141 . . . . 0.2 109.16 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -60.74 140.97 57.36 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 119.349 -0.94 . . . . 1.61 109.76 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 91.4 -3.17 79.04 Favored Glycine 0 N--CA 1.5 2.941 0 C-N-CA 120.052 -1.071 . . . . 0.13 111.381 177.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 54.5 m -84.4 135.81 34.13 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 120.918 -1.342 . . . . 0.11 110.66 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 89.2 t -96.47 123.8 48.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 N-CA-C 106.304 -1.739 . . . . 0.11 106.304 176.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 361' ' ' VAL . . . . . 0.487 HG21 ' SD ' ' B' ' 381' ' ' MET . 22.3 m -112.27 160.13 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.335 0 C-N-CA 117.354 -1.739 . . . . 0.09 110.636 178.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 362' ' ' THR . . . . . 0.419 ' HB ' ' HB ' ' B' ' 336' ' ' THR . 90.4 m -108.89 128.34 54.83 Favored 'General case' 0 C--O 1.214 -0.789 0 O-C-N 120.596 -1.315 . . . . 0.1 107.565 175.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 363' ' ' ILE . . . . . 0.459 ' O ' ' HA ' ' B' ' 303' ' ' GLN . 33.2 mt -107.92 121.45 60.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 105.344 -2.095 . . . . 0.1 105.344 176.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 364' ' ' SER . . . . . 0.411 ' HB3' ' HB3' ' B' ' 303' ' ' GLN . 0.7 OUTLIER -128.57 147.3 50.7 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 107.809 -1.182 . . . . 0.1 107.809 -179.646 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -139.76 153.32 47.13 Favored 'General case' 0 C--N 1.292 -1.925 0 C-N-CA 118.454 -1.298 . . . . 0.13 109.781 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 366' ' ' GLU . . . . . 0.517 ' HG2' ' HB2' ' B' ' 301' ' ' MET . 0.2 OUTLIER -141.14 110.88 6.48 Favored 'General case' 0 C--N 1.288 -2.081 0 C-N-CA 118.592 -1.243 . . . . 0.16 108.078 178.127 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . 165.22 -170.36 40.16 Favored Glycine 0 C--N 1.297 -1.59 0 C-N-CA 117.981 -2.056 . . . . 0.14 110.327 178.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -58.27 -40.55 82.18 Favored 'General case' 0 C--N 1.277 -2.57 0 CA-C-N 114.33 -0.935 . . . . 0.16 112.306 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 369' ' ' ASP . . . . . . . . . . . . . 12.0 p30 -114.21 36.85 3.54 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 115.834 -2.346 . . . . 0.13 108.519 -178.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 370' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -56.41 -33.56 65.91 Favored 'General case' 0 N--CA 1.521 3.107 0 N-CA-C 116.8 2.148 . . . . 0.16 116.8 -174.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.95 -45.59 27.1 Favored 'General case' 0 N--CA 1.509 2.514 0 O-C-N 119.526 -1.984 . . . . 0.18 110.914 -176.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 372' ' ' LYS . . . . . 0.786 ' HZ2' ' CE1' ' B' ' 376' ' ' HIS . 11.9 ttpp -63.56 -40.71 97.69 Favored 'General case' 0 C--N 1.283 -2.315 0 N-CA-C 106.965 -1.495 . . . . 0.13 106.965 178.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -59.09 -49.51 77.61 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 117.541 -1.664 . . . . 0.11 110.025 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 374' ' ' VAL . . . . . . . . . . . . . 66.9 t -66.86 -42.25 88.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 CA-C-O 122.187 0.994 . . . . 0.11 109.267 -178.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -55.89 -47.78 76.8 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-O 122.059 0.933 . . . . 0.16 108.737 -178.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 376' ' ' HIS . . . . . 0.786 ' CE1' ' HZ2' ' B' ' 372' ' ' LYS . 13.9 m-70 -69.96 -38.23 76.04 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 116.005 -0.543 . . . . 0.13 111.72 -178.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 377' ' ' LEU . . . . . 0.44 HD22 ' CE1' ' B' ' 322' ' ' PHE . 80.5 mt -75.64 -28.56 58.84 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.348 -1.47 . . . . 0.09 110.875 -174.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 378' ' ' VAL . . . . . . . . . . . . . 2.1 t -71.44 -39.52 71.3 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.459 0 N-CA-C 106.35 -1.722 . . . . 0.13 106.35 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -67.89 -49.31 62.69 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 108.03 -1.1 . . . . 0.16 108.03 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 380' ' ' LEU . . . . . 0.641 ' O ' HD22 ' B' ' 384' ' ' LEU . 34.1 tp -57.18 -45.24 83.87 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 118.974 -1.09 . . . . 0.12 110.62 177.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 381' ' ' MET . . . . . 0.487 ' SD ' HG21 ' B' ' 361' ' ' VAL . 3.6 ttm -62.29 -37.44 85.53 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.871 -1.143 . . . . 0.12 111.508 -177.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -74.89 -31.78 61.67 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.111 -0.993 . . . . 0.15 110.29 -178.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -78.87 -32.41 45.92 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.622 -0.673 . . . . 0.17 111.247 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 384' ' ' LEU . . . . . 0.641 HD22 ' O ' ' B' ' 380' ' ' LEU . 0.0 OUTLIER -50.12 125.54 12.48 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-O 124.432 2.063 . . . . 0.15 112.762 178.802 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 385' ' ' GLU . . . . . 0.966 ' CD ' ' H ' ' B' ' 385' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.279 -2.48 0 CA-C-N 111.085 -2.779 . . . . 0.18 110.093 -177.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 200' ' ' PO3 . . . . . 0.915 ' P ' HH21 ' A' ' 49' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 14.4 tp . . . . . 0 N--CA 1.483 1.208 0 N-CA-C 110.502 -0.184 . . . . 0.06 110.502 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 1.259 ' CZ ' ' HD2' ' A' ' 147' ' ' ARG . 40.6 p90 -136.09 141.73 44.24 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 117.476 -1.69 . . . . 0.04 111.884 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.5 mttp -82.27 142.73 31.86 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 107.944 -1.132 . . . . 0.05 107.944 177.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 1.02 ' HA ' HD21 ' A' ' 11' ' ' ASN . 13.6 tp -136.81 125.64 24.08 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 107.285 -1.376 . . . . 0.05 107.285 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -154.02 -166.92 15.44 Favored Glycine 0 C--N 1.289 -2.081 0 N-CA-C 108.557 -1.817 . . . . 0.06 108.557 178.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.79 -34.24 77.46 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.599 -0.942 . . . . 0.08 111.313 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -65.44 -14.93 62.02 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.759 -1.213 . . . . 0.07 112.332 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 1.02 HD21 ' HA ' ' A' ' 7' ' ' LEU . 2.7 p-10 -123.7 22.85 8.94 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 119.5 -2.0 . . . . 0.05 111.869 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 48.8 mt -118.49 123.35 71.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 107.539 -1.282 . . . . 0.06 107.539 176.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -126.44 106.98 9.85 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.433 -0.792 . . . . 0.06 109.252 -177.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.559 ' HA ' ' HB3' ' A' ' 83' ' ' GLN . 42.4 mt -100.33 160.52 14.27 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-O 122.702 1.239 . . . . 0.08 112.883 -177.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 62.34 34.66 89.97 Favored Glycine 0 N--CA 1.497 2.749 0 CA-C-N 114.457 -1.247 . . . . 0.08 113.833 175.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.46 ' HA ' ' HE ' ' A' ' 16' ' ' ARG . 1.0 OUTLIER -83.21 169.14 16.09 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 120.238 -1.742 . . . . 0.08 109.733 178.348 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -140.89 140.75 34.59 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 107.409 -1.33 . . . . 0.08 107.409 178.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -154.17 131.7 11.35 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 108.442 -0.948 . . . . 0.06 108.442 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -77.48 -25.62 50.58 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.141 -0.975 . . . . 0.06 109.69 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 64.2 p -134.75 159.65 40.66 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 119.075 -1.05 . . . . 0.07 111.466 -178.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.669 ' HE3' ' OE1' ' A' ' 50' ' ' GLU . 28.2 pttt -65.98 -32.68 74.31 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.892 -0.781 . . . . 0.09 108.892 175.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 51.4 mp0 -60.28 -42.8 96.21 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.514 -1.366 . . . . 0.08 110.103 179.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -64.1 -41.73 97.17 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.628 -1.295 . . . . 0.07 110.012 177.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.91 -42.51 94.66 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.636 -1.29 . . . . 0.05 109.609 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.37 -42.29 94.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.262 -0.899 . . . . 0.07 109.802 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.46 ' HE ' ' HB2' ' A' ' 26' ' ' ARG . 4.4 ttm180 -62.61 -37.52 86.61 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.316 -0.865 . . . . 0.1 109.98 178.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -67.25 -49.19 65.34 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.724 -1.235 . . . . 0.07 108.403 179.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.19 -47.05 79.1 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.387 -0.821 . . . . 0.06 109.605 178.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.31 -41.34 99.74 Favored Glycine 0 N--CA 1.497 2.722 0 N-CA-C 110.525 -1.03 . . . . 0.08 110.525 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -61.18 -37.76 84.08 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.661 -1.494 . . . . 0.09 110.331 177.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 92.4 mm-40 -73.17 -36.05 66.53 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.069 -1.019 . . . . 0.08 110.181 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 73.5 mt -63.95 -38.2 90.19 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.857 -1.152 . . . . 0.07 108.282 174.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 23.7 t -69.34 -45.48 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 O-C-N 120.879 -1.138 . . . . 0.1 108.178 177.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -57.49 -39.3 76.14 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.665 -0.647 . . . . 0.1 112.625 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -86.19 8.42 73.99 Favored Glycine 0 N--CA 1.508 3.486 0 O-C-N 120.236 -1.54 . . . . 0.08 112.796 -178.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.63 17.83 78.37 Favored Glycine 0 N--CA 1.488 2.139 0 O-C-N 120.678 -1.483 . . . . 0.09 111.443 178.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.422 ' CD1' ' HA3' ' A' ' 78' ' ' GLY . 80.3 m-85 -80.93 -36.24 31.3 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.274 -1.721 . . . . 0.08 110.111 -179.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 17.4 m -141.96 163.02 19.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-O 122.287 1.042 . . . . 0.1 111.437 -177.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.443 ' OE1' ' NH1' ' A' ' 73' ' ' ARG . 83.3 mt-10 -86.63 165.1 34.54 Favored Pre-proline 0 C--N 1.3 -1.546 0 N-CA-C 107.29 -1.374 . . . . 0.14 107.29 176.334 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.429 ' HD2' ' HB3' ' A' ' 39' ' ' GLU . 50.3 Cg_exo -50.53 -36.86 50.88 Favored 'Trans proline' 0 N--CA 1.51 2.443 0 C-N-CA 123.646 2.897 . . . . 0.13 115.791 -177.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.44 ' CD ' HH21 ' A' ' 73' ' ' ARG . 41.2 mp0 -62.76 -20.59 65.11 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.508 -1.37 . . . . 0.15 112.196 -178.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.466 ' O ' ' HG3' ' A' ' 46' ' ' MET . 39.9 t80 -67.08 -27.79 67.65 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.616 -1.303 . . . . 0.11 112.313 -179.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 22.8 t -61.19 -49.01 86.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 120.265 -1.522 . . . . 0.1 110.396 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 51.8 tp60 -67.11 -35.04 78.91 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.093 -1.004 . . . . 0.12 109.108 179.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.2 -33.35 73.32 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.232 -0.917 . . . . 0.11 109.765 177.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.466 ' HG3' ' O ' ' A' ' 42' ' ' TYR . 94.5 mtp -70.28 -37.93 74.94 Favored 'General case' 0 N--CA 1.482 1.128 0 O-C-N 120.545 -1.347 . . . . 0.1 107.719 177.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 93.9 mt -70.14 -40.2 74.93 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.237 -1.023 . . . . 0.1 108.237 178.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -60.14 -44.31 95.04 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.36 -0.837 . . . . 0.13 109.203 177.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.553 HH21 ' P ' ' B' ' 200' ' ' PO3 . 15.4 tpt180 -62.45 -39.19 92.57 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.843 -1.161 . . . . 1.51 110.653 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.669 ' OE1' ' HE3' ' A' ' 21' ' ' LYS . 0.5 OUTLIER -62.54 -39.71 94.48 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.166 -0.959 . . . . 0.1 110.895 -178.545 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.581 ' N ' ' HG2' ' A' ' 50' ' ' GLU . 28.5 tttt -62.75 -38.16 89.47 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 116.312 -0.403 . . . . 2.88 110.896 -178.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 29.2 tp -64.76 -43.56 92.91 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 120.186 -1.571 . . . . 0.16 108.634 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.6 m -166.11 139.11 3.34 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.044 -1.035 . . . . 0.19 109.71 179.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -50.34 144.91 22.52 Favored 'Trans proline' 0 C--N 1.314 -1.286 0 C-N-CA 121.175 1.25 . . . . 0.37 113.655 178.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.51 HG21 ' HA ' ' A' ' 64' ' ' PRO . 59.6 p -96.54 7.94 45.32 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 114.505 -1.225 . . . . 0.16 107.92 177.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 33.2 t80 -62.36 137.5 58.27 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 105.955 -1.869 . . . . 0.09 105.955 174.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 18.1 mt -117.77 11.97 13.76 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 120.856 -1.152 . . . . 0.1 110.224 -178.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 85.56 170.94 47.67 Favored Glycine 0 C--N 1.302 -1.31 0 N-CA-C 108.667 -1.773 . . . . 0.1 108.667 -178.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.81 ' CA ' ' N ' ' A' ' 60' ' ' SER . 76.6 mm-40 57.59 35.4 25.7 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.458 -1.025 . . . . 1.86 113.527 177.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.81 ' N ' ' CA ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER 65.28 21.48 12.02 Favored 'General case' 0 N--CA 1.514 2.771 0 O-C-N 121.039 -1.038 . . . . 0.08 113.555 176.731 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 94.2 mt -121.38 137.48 54.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 120.645 -1.285 . . . . 0.07 111.014 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -129.31 138.85 51.82 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 106.247 -1.76 . . . . 0.06 106.247 174.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.494 ' O ' HG23 ' A' ' 63' ' ' VAL . 16.3 m -130.32 72.28 81.96 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.163 -0.96 . . . . 0.07 110.103 -179.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.51 ' HA ' HG21 ' A' ' 55' ' ' THR . 2.4 Cg_endo -50.24 144.29 23.65 Favored 'Trans proline' 0 C--N 1.298 -2.12 0 CA-C-N 119.874 0.991 . . . . 0.38 111.794 -177.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 1.177 ' NE2' ' P ' ' B' ' 200' ' ' PO3 . 2.4 p-80 -141.58 153.9 45.1 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 120.821 -1.174 . . . . 0.59 108.735 175.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -75.51 173.96 52.77 Favored Glycine 0 N--CA 1.501 2.999 0 N-CA-C 109.522 -1.431 . . . . 0.12 109.522 -177.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 82.0 p -80.18 167.93 19.73 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 116.818 -1.953 . . . . 0.59 109.376 179.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.592 HG12 ' ND2' ' A' ' 109' ' ' ASN . 5.3 m -70.52 -23.65 24.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 121.382 -0.824 . . . . 0.14 109.751 -179.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.501 ' OE1' ' N ' ' A' ' 69' ' ' GLU . 58.7 mp0 -75.27 9.06 2.26 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.985 -1.072 . . . . 0.15 109.725 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -121.73 15.27 11.0 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.709 -0.619 . . . . 0.13 109.813 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 49.5 pttt -60.87 -37.95 83.9 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.016 -1.053 . . . . 0.14 109.136 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -69.27 -4.13 16.68 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.658 -0.651 . . . . 0.14 111.543 -177.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.443 ' NH1' ' OE1' ' A' ' 39' ' ' GLU . 15.6 mmm180 -104.96 7.95 34.32 Favored 'General case' 0 N--CA 1.506 2.33 0 O-C-N 120.444 -1.41 . . . . 0.13 109.374 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 91.1 t -95.48 128.49 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 107.082 -1.451 . . . . 0.11 107.082 177.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 28.1 mt -96.75 -17.15 20.47 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 115.721 -0.672 . . . . 0.11 109.455 -178.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 39.6 pttt -176.6 159.67 1.9 Allowed 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.523 -0.918 . . . . 0.09 108.523 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 18.2 m -76.29 138.14 40.34 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.355 -0.841 . . . . 0.13 111.079 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.422 ' HA3' ' CD1' ' A' ' 37' ' ' TYR . . . -160.69 161.05 32.45 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 118.735 -1.698 . . . . 0.06 110.863 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 33.3 m -137.65 150.96 25.62 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 O-C-N 121.603 -0.939 . . . . 0.03 108.842 179.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 80' ' ' VAL . 15.9 m -127.02 113.14 31.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 106.271 -1.752 . . . . 0.04 106.271 175.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.649 ' CZ ' HD22 ' A' ' 100' ' ' LEU . 61.6 t80 -86.02 115.38 23.58 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.789 0.804 . . . . 0.05 109.238 -178.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 39.5 m -119.0 122.11 41.44 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 121.86 0.838 . . . . 0.04 110.506 -177.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.559 ' HB3' ' HA ' ' A' ' 14' ' ' LEU . 30.7 tt0 -100.71 126.47 47.25 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-O 122.108 0.956 . . . . 0.07 111.805 -178.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -123.35 87.24 51.79 Favored Pre-proline 0 C--N 1.302 -1.471 0 N-CA-C 107.025 -1.472 . . . . 0.06 107.025 177.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -54.06 -36.05 83.43 Favored 'Trans proline' 0 N--CA 1.501 1.925 0 C-N-CA 122.847 2.365 . . . . 0.08 113.081 -177.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -81.73 -13.27 58.02 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.481 -0.762 . . . . 0.08 110.323 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 90.08 152.59 27.23 Favored Glycine 0 N--CA 1.485 1.912 0 O-C-N 120.791 -1.193 . . . . 0.06 113.024 175.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 61.5 t -136.47 120.43 24.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 106.549 -1.649 . . . . 0.05 106.549 177.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.873 ' HA ' HD13 ' A' ' 97' ' ' ILE . 4.3 ttt180 -60.31 121.27 11.58 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.829 -1.169 . . . . 0.09 109.131 -179.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -119.77 -11.51 9.36 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 118.656 -1.218 . . . . 1.03 111.573 -178.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -118.54 -158.21 10.74 Favored Glycine 1 N--CA 1.516 4.009 0 O-C-N 119.588 -1.945 . . . . 0.14 112.255 -178.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -92.54 -22.8 19.33 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 113.842 1.052 . . . . 0.26 113.842 -176.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -96.4 154.45 17.26 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.683 -1.261 . . . . 1.62 109.461 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -60.29 -23.89 64.51 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.747 -1.22 . . . . 2.55 109.964 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -86.52 1.87 50.02 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.692 -1.255 . . . . 1.74 109.461 -178.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -83.2 60.17 5.39 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 118.764 -1.175 . . . . 0.16 107.98 178.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.873 HD13 ' HA ' ' A' ' 89' ' ' ARG . 41.8 mm -101.6 135.32 38.75 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 CA-C-O 121.723 0.773 . . . . 0.08 110.169 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -108.56 130.95 55.28 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 121.545 0.688 . . . . 0.06 109.682 178.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -102.5 -17.07 15.93 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 106.557 -1.646 . . . . 0.09 106.557 175.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.649 HD22 ' CZ ' ' A' ' 81' ' ' PHE . 71.1 mt -116.87 112.16 20.68 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.12 -1.067 . . . . 0.06 108.12 176.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 93.8 t -113.4 104.07 16.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 106.257 -1.757 . . . . 0.04 106.257 179.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 72.3 mt -107.11 102.91 14.65 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.087 0 CA-C-O 122.292 1.044 . . . . 0.04 111.035 -176.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -77.6 131.97 11.57 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.023 -1.631 . . . . 0.04 109.023 -178.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.409 HD13 HG21 ' A' ' 104' ' ' ILE . 19.4 pt -133.45 153.5 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 O-C-N 120.264 -1.727 . . . . 0.1 112.916 -176.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -137.38 133.71 35.13 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 106.189 -1.782 . . . . 0.12 106.189 177.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -147.59 140.97 25.3 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 120.113 -1.617 . . . . 0.13 110.955 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 60.6 mtp180 -70.74 156.29 39.7 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.588 0.709 . . . . 3.71 110.331 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 57.81 25.4 11.92 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.069 -0.715 . . . . 1.98 109.069 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.592 ' ND2' HG12 ' A' ' 68' ' ' VAL . 63.1 t30 53.27 37.58 25.6 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.172 -0.955 . . . . 1.22 109.766 178.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -84.05 28.89 0.58 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.131 -0.981 . . . . 0.18 111.093 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.75 ' CA ' ' N ' ' A' ' 112' ' ' ILE . 40.0 p-80 -50.54 -38.3 44.08 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.881 -1.137 . . . . 0.18 112.095 179.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.75 ' N ' ' CA ' ' A' ' 111' ' ' HIS . 21.0 tt -63.18 -28.96 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 119.986 -1.696 . . . . 0.12 111.005 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -69.81 -40.94 75.63 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 120.516 -1.365 . . . . 0.87 108.334 178.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 85.1 t -69.38 -43.61 80.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.428 -0.795 . . . . 0.07 109.414 178.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.11 -42.46 95.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.132 -0.98 . . . . 0.08 109.471 178.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 94.7 m -62.35 -42.45 99.41 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.295 -0.878 . . . . 0.14 109.899 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 11.2 t -63.66 -45.91 88.0 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.161 -0.962 . . . . 0.07 109.572 178.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 57.3 mt -64.09 -48.26 76.87 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.07 -1.019 . . . . 0.07 111.173 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 40.0 p -66.38 -28.01 68.31 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 120.986 -1.071 . . . . 0.09 111.589 -178.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -67.81 -35.88 79.41 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 121.007 -1.058 . . . . 1.13 108.145 177.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -80.12 -15.55 56.87 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.967 -1.083 . . . . 0.09 109.844 177.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 80.5 mt -106.01 27.86 8.18 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.984 -1.072 . . . . 0.17 110.675 178.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -72.46 -12.73 61.22 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 120.937 -1.102 . . . . 0.49 111.879 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -110.66 131.38 55.1 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.588 -1.32 . . . . 0.13 110.619 179.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -57.72 -34.55 69.6 Favored 'General case' 0 N--CA 1.503 2.181 0 C-N-CA 123.306 0.642 . . . . 0.15 112.262 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.495 ' O ' ' HG2' ' A' ' 130' ' ' ARG . 59.7 p -65.75 -34.01 77.18 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 120.694 -1.254 . . . . 0.13 109.88 179.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 85.6 t -65.65 -43.9 93.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.638 -1.289 . . . . 0.11 109.974 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 95.8 mt -64.33 -46.06 94.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.941 -1.1 . . . . 0.1 110.228 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.614 ' HA ' ' OE1' ' A' ' 129' ' ' GLU . 8.7 mm-40 -57.08 -46.85 82.19 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.223 -0.923 . . . . 0.11 109.864 178.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.495 ' HG2' ' O ' ' A' ' 126' ' ' SER . 43.4 mmm-85 -63.52 -43.7 96.4 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.215 -0.928 . . . . 0.13 110.214 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 83.3 mt -66.89 -35.04 79.12 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.066 -1.022 . . . . 0.08 111.148 -179.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -67.33 -27.18 66.93 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.308 -0.87 . . . . 0.08 113.285 -176.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -126.49 1.7 6.92 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 120.082 -1.637 . . . . 0.1 113.322 -176.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 9.4 t -68.31 145.89 53.8 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.502 -1.374 . . . . 0.1 111.271 -178.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 72.8 p -106.06 9.92 32.29 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.27 -1.381 . . . . 0.12 107.27 176.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 47.0 t -107.02 116.4 31.86 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 121.588 0.709 . . . . 0.11 112.696 -178.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 15.9 t -65.59 -41.67 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 108.501 -0.925 . . . . 0.09 108.501 176.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -56.87 -39.99 75.35 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.233 -0.917 . . . . 0.11 110.408 178.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -63.66 -42.75 98.03 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.936 -1.103 . . . . 0.11 108.45 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 92.0 t -57.29 -51.27 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 108.508 -0.923 . . . . 0.08 108.508 177.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 141' ' ' LEU . 78.4 mt -57.7 -45.98 84.96 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.238 -0.914 . . . . 0.07 110.294 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -58.81 -47.91 83.13 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.814 -1.179 . . . . 0.11 111.02 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 83.7 mt -67.99 -23.49 65.03 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.983 -1.073 . . . . 0.1 112.606 -177.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.661 ' O ' ' NH1' ' A' ' 147' ' ' ARG . 91.7 mt -110.05 9.27 24.21 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.367 -1.458 . . . . 0.07 111.391 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.711 ' HA ' HH12 ' A' ' 147' ' ' ARG . . . -76.97 -25.25 52.57 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 120.689 -1.257 . . . . 0.07 112.305 -178.151 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -81.77 -8.81 86.32 Favored Glycine 0 N--CA 1.504 3.211 0 O-C-N 120.57 -1.331 . . . . 0.08 111.156 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 1.259 ' HD2' ' CZ ' ' A' ' 5' ' ' PHE . 2.0 ptt-85 . . . . . 0 N--CA 1.486 1.371 0 O-C-N 121.053 -1.263 . . . . 0.07 109.64 179.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 301' ' ' MET . . . . . 0.517 ' HB2' ' HG2' ' B' ' 366' ' ' GLU . 3.4 ttm . . . . . 0 C--O 1.214 -0.786 0 CA-C-O 121.931 0.872 . . . . 0.17 108.948 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 302' ' ' PHE . . . . . 0.454 ' N ' ' CG ' ' B' ' 301' ' ' MET . 46.9 t80 -139.74 142.97 36.77 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 107.27 -1.381 . . . . 0.16 107.27 178.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 303' ' ' GLN . . . . . 0.49 ' O ' ' HG2' ' B' ' 304' ' ' GLN . 5.4 pt20 -153.0 156.31 38.58 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 120.904 -1.123 . . . . 0.14 109.495 179.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 304' ' ' GLN . . . . . 0.49 ' HG2' ' O ' ' B' ' 303' ' ' GLN . 42.2 mm-40 -152.18 149.21 28.51 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 108.033 -1.099 . . . . 0.15 108.033 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -97.19 152.35 18.91 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.046 -1.034 . . . . 0.13 108.428 178.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 7.2 p -147.83 144.34 19.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 N-CA-C 107.478 -1.304 . . . . 0.12 107.478 177.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 85.4 m -96.67 136.54 37.06 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 122.169 0.985 . . . . 0.13 110.079 177.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 51.7 mt -84.88 114.25 24.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 105.478 -2.045 . . . . 0.13 105.478 177.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 47.4 p -106.7 -4.39 19.51 Favored 'General case' 0 C--N 1.264 -3.117 0 N-CA-C 114.704 1.372 . . . . 0.16 114.704 -178.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -71.44 141.87 86.02 Favored Pre-proline 0 N--CA 1.499 2.012 0 O-C-N 119.683 -1.886 . . . . 0.16 110.658 178.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -45.54 -47.63 13.03 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 124.749 3.633 . . . . 0.19 114.202 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 44.5 t-20 -102.21 27.61 6.54 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 116.035 -2.266 . . . . 0.99 108.725 179.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 58.83 -144.0 44.73 Favored Glycine 0 N--CA 1.496 2.699 0 C-N-CA 117.708 -2.187 . . . . 0.13 109.52 -179.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 314' ' ' LEU . . . . . . . . . . . . . 9.8 tp -96.93 82.92 3.3 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.203 -1.175 . . . . 0.11 109.363 178.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 315' ' ' HIS . . . . . 1.162 ' ND1' ' P ' ' B' ' 200' ' ' PO3 . 0.4 OUTLIER -80.85 -159.83 0.27 Allowed 'General case' 0 N--CA 1.503 2.209 0 N-CA-C 107.277 -1.379 . . . . 1.2 107.277 179.058 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 316' ' ' THR . . . . . 0.888 HG23 ' O2 ' ' B' ' 200' ' ' PO3 . 63.7 p -66.39 -53.14 39.31 Favored 'General case' 0 N--CA 1.513 2.687 0 N-CA-C 120.177 3.399 . . . . 0.16 120.177 -174.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 317' ' ' ARG . . . . . 0.659 HH11 ' HG2' ' B' ' 317' ' ' ARG . 4.8 ttt-85 -54.9 -53.33 62.23 Favored Pre-proline 0 N--CA 1.493 1.705 0 CA-C-N 122.593 2.451 . . . . 1.91 112.446 -174.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 318' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' B' ' 317' ' ' ARG . 21.0 Cg_endo -66.41 -32.17 41.12 Favored 'Trans proline' 0 N--CA 1.484 0.963 0 C-N-CA 124.707 3.604 . . . . 0.13 111.563 -177.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 319' ' ' ALA . . . . . 0.419 ' O ' HG23 ' B' ' 323' ' ' VAL . . . -67.07 -38.8 86.43 Favored 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 119.503 -0.879 . . . . 0.1 109.491 -179.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -70.95 -39.68 72.46 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.865 -0.791 . . . . 0.11 108.865 178.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 67.8 tp60 -64.01 -39.31 93.83 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 117.863 -1.535 . . . . 0.12 109.535 177.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 322' ' ' PHE . . . . . 0.44 ' CE1' HD22 ' B' ' 377' ' ' LEU . 87.3 t80 -62.76 -45.3 93.32 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 122.583 1.182 . . . . 0.08 108.703 -177.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 323' ' ' VAL . . . . . 0.419 HG23 ' O ' ' B' ' 319' ' ' ALA . 53.4 t -62.58 -42.26 95.24 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.278 0 CA-C-N 114.809 -1.087 . . . . 0.07 110.713 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -63.87 -40.18 95.93 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.325 -0.859 . . . . 1.68 109.851 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 325' ' ' GLU . . . . . 0.494 ' OE1' HD22 ' B' ' 380' ' ' LEU . 31.7 tt0 -68.9 -39.65 79.59 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.37 -0.831 . . . . 0.1 109.56 177.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -59.07 -43.99 91.82 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.708 -1.245 . . . . 0.06 109.417 178.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -61.37 -16.13 43.21 Favored 'General case' 0 N--CA 1.509 2.512 0 O-C-N 121.226 -0.922 . . . . 1.5 113.338 178.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -76.92 -10.65 86.07 Favored Glycine 0 N--CA 1.479 1.529 0 O-C-N 119.999 -1.688 . . . . 0.08 109.338 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 329' ' ' PHE . . . . . 0.402 ' HE1' ' HE3' ' B' ' 372' ' ' LYS . 92.8 m-85 -103.36 143.32 32.83 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.429 -1.63 . . . . 0.09 110.101 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 47.8 p -75.66 -30.08 59.31 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.297 -0.877 . . . . 0.11 112.272 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 331' ' ' SER . . . . . . . . . . . . . 15.9 m -59.68 158.57 9.93 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 119.844 -1.785 . . . . 0.11 112.821 -179.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 332' ' ' GLU . . . . . 0.769 ' OE1' ' N ' ' B' ' 333' ' ' ILE . 0.0 OUTLIER -79.0 130.4 35.49 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 102.81 -3.033 . . . . 0.11 102.81 171.266 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 333' ' ' ILE . . . . . 0.769 ' N ' ' OE1' ' B' ' 332' ' ' GLU . 39.2 mt -126.81 136.5 60.61 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.486 0 CA-C-O 122.192 0.996 . . . . 0.08 109.305 -178.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 93.3 m -124.94 143.21 50.99 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-O 123.216 1.484 . . . . 0.09 109.978 178.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 335' ' ' VAL . . . . . 0.442 HG23 ' HB2' ' B' ' 344' ' ' ALA . 85.3 t -108.14 129.95 61.51 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.633 0 N-CA-C 105.469 -2.049 . . . . 0.06 105.469 173.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 336' ' ' THR . . . . . 0.419 ' HB ' ' HB ' ' B' ' 362' ' ' THR . 71.5 m -127.39 119.51 26.35 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 120.862 -1.149 . . . . 0.09 109.046 -178.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 29.1 t -122.52 122.61 39.32 Favored 'General case' 0 N--CA 1.501 2.106 0 C-N-CA 119.992 -0.683 . . . . 0.08 109.843 177.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 51.73 38.84 24.0 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.886 -1.134 . . . . 0.1 112.87 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 81.81 10.86 83.59 Favored Glycine 0 N--CA 1.501 3.009 0 O-C-N 119.944 -1.722 . . . . 0.11 112.522 177.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 340' ' ' LYS . . . . . 0.408 ' O ' ' HA ' ' B' ' 336' ' ' THR . 26.5 mttp -119.85 136.3 54.54 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 105.221 -2.14 . . . . 0.1 105.221 177.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 68.3 m -124.8 158.55 33.09 Favored 'General case' 0 C--N 1.276 -2.594 0 CA-C-O 123.738 1.732 . . . . 0.09 112.408 -176.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -151.62 151.45 31.53 Favored 'General case' 0 C--N 1.278 -2.51 0 CA-C-N 112.449 -2.159 . . . . 0.08 108.634 177.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 8.0 t -70.63 135.95 48.78 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 105.556 -2.016 . . . . 0.08 105.556 173.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 344' ' ' ALA . . . . . 0.442 ' HB2' HG23 ' B' ' 335' ' ' VAL . . . -72.95 -6.83 47.95 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.691 -1.256 . . . . 0.05 110.703 179.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -97.5 13.07 31.18 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.631 -1.293 . . . . 0.08 109.395 -177.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 11.0 t -133.18 104.25 6.4 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 122.153 0.977 . . . . 0.12 110.062 -178.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 347' ' ' LEU . . . . . . . . . . . . . 43.1 tp -57.34 -37.77 73.05 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 115.658 -0.701 . . . . 0.1 109.998 178.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 348' ' ' PHE . . . . . 0.505 ' HB3' ' OE2' ' A' ' 59' ' ' GLU . 75.2 t80 -59.0 -51.35 70.43 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.566 -1.334 . . . . 0.13 113.021 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 37.5 tptt -70.05 -32.46 70.58 Favored 'General case' 0 C--O 1.214 -0.769 0 O-C-N 119.664 -1.898 . . . . 1.55 109.109 -178.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 350' ' ' LEU . . . . . . . . . . . . . 33.3 mt -62.84 -33.7 75.79 Favored 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 118.958 -1.097 . . . . 0.16 109.92 -177.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 351' ' ' GLN . . . . . 0.401 HE22 HG13 ' A' ' 112' ' ' ILE . 69.1 tp60 -67.69 -10.49 52.89 Favored 'General case' 0 C--N 1.293 -1.852 0 O-C-N 121.599 -0.688 . . . . 0.26 109.915 -177.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 352' ' ' THR . . . . . . . . . . . . . 45.7 p -89.72 -7.74 53.87 Favored 'General case' 0 N--CA 1.502 2.132 0 C-N-CA 118.097 -1.441 . . . . 0.12 111.026 -178.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 83.2 mt -93.34 159.34 15.3 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.244 -0.91 . . . . 0.1 110.224 -178.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -86.76 104.8 2.97 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 106.94 -2.464 . . . . 0.08 106.94 177.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 16.3 mt -119.46 47.29 1.73 Allowed 'General case' 0 C--N 1.309 -1.186 0 O-C-N 120.625 -1.515 . . . . 0.1 107.471 -178.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 52.8 p -81.36 172.53 13.46 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 118.849 -1.141 . . . . 0.2 109.16 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -60.74 140.97 57.36 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 119.349 -0.94 . . . . 1.61 109.76 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 91.4 -3.17 79.04 Favored Glycine 0 N--CA 1.5 2.941 0 C-N-CA 120.052 -1.071 . . . . 0.13 111.381 177.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 54.5 m -84.4 135.81 34.13 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 120.918 -1.342 . . . . 0.11 110.66 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 89.2 t -96.47 123.8 48.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 N-CA-C 106.304 -1.739 . . . . 0.11 106.304 176.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 361' ' ' VAL . . . . . 0.487 HG21 ' SD ' ' B' ' 381' ' ' MET . 22.3 m -112.27 160.13 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.335 0 C-N-CA 117.354 -1.739 . . . . 0.09 110.636 178.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 362' ' ' THR . . . . . 0.419 ' HB ' ' HB ' ' B' ' 336' ' ' THR . 90.4 m -108.89 128.34 54.83 Favored 'General case' 0 C--O 1.214 -0.789 0 O-C-N 120.596 -1.315 . . . . 0.1 107.565 175.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 363' ' ' ILE . . . . . 0.459 ' O ' ' HA ' ' B' ' 303' ' ' GLN . 33.2 mt -107.92 121.45 60.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 105.344 -2.095 . . . . 0.1 105.344 176.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 364' ' ' SER . . . . . 0.411 ' HB3' ' HB3' ' B' ' 303' ' ' GLN . 0.7 OUTLIER -128.57 147.3 50.7 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 107.809 -1.182 . . . . 0.1 107.809 -179.646 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -139.76 153.32 47.13 Favored 'General case' 0 C--N 1.292 -1.925 0 C-N-CA 118.454 -1.298 . . . . 0.13 109.781 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 366' ' ' GLU . . . . . 0.517 ' HG2' ' HB2' ' B' ' 301' ' ' MET . 0.2 OUTLIER -141.14 110.88 6.48 Favored 'General case' 0 C--N 1.288 -2.081 0 C-N-CA 118.592 -1.243 . . . . 0.16 108.078 178.127 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . 165.22 -170.36 40.16 Favored Glycine 0 C--N 1.297 -1.59 0 C-N-CA 117.981 -2.056 . . . . 0.14 110.327 178.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -58.27 -40.55 82.18 Favored 'General case' 0 C--N 1.277 -2.57 0 CA-C-N 114.33 -0.935 . . . . 0.16 112.306 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 369' ' ' ASP . . . . . . . . . . . . . 12.0 p30 -114.21 36.85 3.54 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 115.834 -2.346 . . . . 0.13 108.519 -178.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 370' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -56.41 -33.56 65.91 Favored 'General case' 0 N--CA 1.521 3.107 0 N-CA-C 116.8 2.148 . . . . 0.16 116.8 -174.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.95 -45.59 27.1 Favored 'General case' 0 N--CA 1.509 2.514 0 O-C-N 119.526 -1.984 . . . . 0.18 110.914 -176.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 372' ' ' LYS . . . . . 0.786 ' HZ2' ' CE1' ' B' ' 376' ' ' HIS . 11.9 ttpp -63.56 -40.71 97.69 Favored 'General case' 0 C--N 1.283 -2.315 0 N-CA-C 106.965 -1.495 . . . . 0.13 106.965 178.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -59.09 -49.51 77.61 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 117.541 -1.664 . . . . 0.11 110.025 -178.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 374' ' ' VAL . . . . . . . . . . . . . 66.9 t -66.86 -42.25 88.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 CA-C-O 122.187 0.994 . . . . 0.11 109.267 -178.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -55.89 -47.78 76.8 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-O 122.059 0.933 . . . . 0.16 108.737 -178.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 376' ' ' HIS . . . . . 0.786 ' CE1' ' HZ2' ' B' ' 372' ' ' LYS . 13.9 m-70 -69.96 -38.23 76.04 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 116.005 -0.543 . . . . 0.13 111.72 -178.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 377' ' ' LEU . . . . . 0.44 HD22 ' CE1' ' B' ' 322' ' ' PHE . 80.5 mt -75.64 -28.56 58.84 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.348 -1.47 . . . . 0.09 110.875 -174.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 378' ' ' VAL . . . . . . . . . . . . . 2.1 t -71.44 -39.52 71.3 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.459 0 N-CA-C 106.35 -1.722 . . . . 0.13 106.35 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -67.89 -49.31 62.69 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 108.03 -1.1 . . . . 0.16 108.03 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 380' ' ' LEU . . . . . 0.641 ' O ' HD22 ' B' ' 384' ' ' LEU . 34.1 tp -57.18 -45.24 83.87 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 118.974 -1.09 . . . . 0.12 110.62 177.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 381' ' ' MET . . . . . 0.487 ' SD ' HG21 ' B' ' 361' ' ' VAL . 3.6 ttm -62.29 -37.44 85.53 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.871 -1.143 . . . . 0.12 111.508 -177.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -74.89 -31.78 61.67 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.111 -0.993 . . . . 0.15 110.29 -178.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -78.87 -32.41 45.92 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.622 -0.673 . . . . 0.17 111.247 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 384' ' ' LEU . . . . . 0.641 HD22 ' O ' ' B' ' 380' ' ' LEU . 0.0 OUTLIER -50.12 125.54 12.48 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-O 124.432 2.063 . . . . 0.15 112.762 178.802 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 385' ' ' GLU . . . . . 0.966 ' CD ' ' H ' ' B' ' 385' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.279 -2.48 0 CA-C-N 111.085 -2.779 . . . . 0.18 110.093 -177.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 200' ' ' PO3 . . . . . 1.177 ' P ' ' NE2' ' A' ' 65' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_